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In general, parametric regression models can be motivated by allowing the pa-
rameters of a probability distribution to depend on covariates. Furthermore,
it is standard practice to relate covariates to one parameter of particular in-
terest; we will refer to this approach as single parameter regression (SPR). In
these SPR models, the role of the other (covariate independent) parameters
is often little more than to provide the model with sufficient generality to
adapt to data. A more flexible approach is to also regress these other pa-
rameters on covariates; we call this multi-parameter regression (MPR). The
primary focus of this thesis is the development of MPR models in the setting
of survival analysis (of course, MPR models are not limited to the field of
survival analysis).
In Chapter 1 we review some basic concepts of survival analysis - these
are standard and may be skipped by the reader familiar with the area. Chap-
ter 2 is largely concerned with developing likelihood theory for survival data
which, again, is quite standard and may be skipped. However, in Section
2.3.2 we propose a method - m.l.e. simulation - for calculating the stan-
dard error / confidence intervals for functions of parameters. M.l.e. simu-
lation, which competes with the well-known delta method and method of
bootstrapping, is based on simulating a sample of θ̂ vectors, {θ̂(1), . . . , θ̂(m)},
from θ̂(b) ∼ N(θ̂, Σ̂) and is used throughout the thesis. In Chapter 3 we
discuss a method for simulating survival data and, furthermore, we extend
this method to handle models that support a cured proportion (Section 3.5).
This is followed by some interesting simulation studies (Section 3.6) where,
among other things, we compare the delta method to m.l.e. simulation and
investigate how reliably the cured proportion can be estimated (if it exists).
We consider standard regression models for survival data in Chapter 4;
in particular, Section 4.18 contains a brief review of some commonly used
SPR survival models. Chapter 5 contains our development of MPR survival
models: we display the flexibility of MPR (relative to SPR) and discuss the
consequences of the approach in terms of interpreting covariate effects (via
the hazard ratio), carrying out hypothesis tests (on regression coefficients)
and variable selection procedures. Motivated by the need to enhance inter-
v
vi
pretability of MPR models (and indeed any regression model), in Chapter
6 we propose a least squares approximation to covariate-dependent model
quantities, e.g., the hazard function. The proposed method allows straight-
forward interpretation of covariate effects in terms of the quantity in question
but, of course, depends on the adequacy of the approximation. In Chap-
ter 7 we consider frailty modelling - an area of survival analysis concerned
with the analysis of unexplained variation (or heterogeneity). In particular,
we go through the straightforward algebra of multiplicative gamma frailty
which can be used to generalise any parametric model, e.g., Weibull MPR
model with multiplicative gamma frailty. Furthermore, using gamma frailty
as our starting point, we propose some extensions which combine the ideas
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Chapter 1
Review of Survival Analysis
1.1 Introduction
Survival data typically measure the time elapsed from a well-defined time
origin until the occurrence of an event, for example, time from diagnosis of
a disease until death from that disease, treatment start date until patient
is cured, marriage until divorce, birth of first child until birth of second
child, start-up of a business until its closure, unemployment date until re-
employment date or commencement of operation until failure of a mechanical
component. The survival time is the length of this interval. The use of the
word “survival” refers to surviving in a particular state, for example, the
state of living, the state of being married or the state of being unemployed.
It is clear therefore, that we are not necessarily describing survival in a literal
sense with the endpoint being death. This terminology comes from the field
of medicine, where death often is the endpoint, but survival-type data arise
in many other areas (e.g. engineering, social sciences and econometrics) as
is clear from the examples mentioned above.
Survival analysis has arisen as a rich field of statistics due to the special re-
quirements of, and interesting challenges presented by, these particular types
of data. One issue is that the data are typically skewed to the right. This is
easily dealt with, for example, by using a parametric distribution which can
handle skewness or by transforming the data to remove it. However, the most
distinctive feature of survival data is a particular type of missingness called
3
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censoring and it is this feature that necessitates special theory and meth-
ods of analysis. In particular we consider right-censoring which is the most
common form of censoring. An individual’s survival time is right-censored
when that particular individual has not yet experienced the event of interest
on the last observation date. The event therefore occurs at some point in
time which is greater than, i.e. to the right of, the final observation date.
We therefore observe some survival times and have a lower bound on others.
Censoring occurs due to the way survival times are measured; we must wait
for an event to happen to retrieve a measurement. This differs from other
data where measurements are typically recorded without such a delay, for
example, distance, weight, age, temperature, income etc. A study of survival
will take place over some period of time. By the end of the study, not all
individuals may have experienced an event and it is usually infeasible to run
such studies until all individuals do experience the event on account of, for
example, financial or ethical reasons. More practically, we may have gained
enough relevant information from our current sample without waiting for fur-
ther events to occur. In a clinical setting some individuals can become lost
to follow-up, that is, they may stop reporting to the clinician for potentially
unknown reasons. Again, we only know that the event occurs sometime after
the last observation date for this individual.
An artificial example of survival data is depicted in Fig. 1.1. The left
panel shows the study in calendar time beginning at zero when the study
commenced. There is typically a recruitment period, after which no more
individuals are introduced into the sample, and finally the study ends on
some date. We see that individuals 3, 4 and 6 experience an event during
the study. Individuals 2 and 5 do not experience an event before the study
ends and are therefore right-censored. Individual 1 is also right-censored as
he/she dropped out during the study. The right panel is realigned so that
time zero corresponds to the individual’s specific starting point which may
be date of birth, diagnosis of a disease, treatment commencement etc.
Another form of censoring is interval censoring which occurs when the
event time is unavailable but is known to lie in an interval. A separate
idea is that of left truncation (also called delayed entry). This occurs when
some individuals’ current survival times are not at time zero at recruitment,
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Figure 1.1. Survival of six individuals. The left panel shows the recruitment and study
period in calendar time. The right panel shows the corresponding observed times. Event
times are labeled “E” and censoring times are labelled “C”.
that is to say, they have survived up until time of recruitment and have yet
to experience an event. Thus, analysis must be made conditional on having
survived up to recruitment time. We will not consider these issues but various
censoring mechanisms are discussed in detail in Kalbfleisch & Prentice (2002,
chap. 3) and Lawless (2003, chap. 2).
It should be clear from the above that standard statistical methods will
not suffice for survival data due to the presence of censoring. For example,
calculation of the mean or the median of the observed times or produc-
ing graphical summaries such as a histogram or box-plot are all rendered
meaningless, as are standard hypothesis testing procedures and regression
analyses.
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1.2 Theory and Relationships
Here we define some probability functions which we split into two groups:
standard probability functions and survival functions. We put the probability
density function and the cumulative distribution function into the first group,
being familiar functions which appear in the usual probability and statistical
theory, and the survivor function and hazard function into the second group.
All of these are in fact probability functions, and are all equivalent represen-
tations of the underlying distribution, but the distinction is made because
the latter two are regarded as being more fundamental in survival theory.
1.2.1 Standard Probability Functions
We start by defining T to be the random variable representing the survival
time. Here we only consider the case where T is continuous although it is
possible for T to be discrete or to have both continuous and discrete compo-
nents. Thus T ∈ [0,∞) has probability density function, f(t) ≥ 0, such that
∫∞
0
f(t)dt = 1 and the probability of T falling in some interval [t1, t2] ⊆ [0,∞)
is given by





Pr(t ≤ T < t+∆t) ≈ f(t)∆t, (1.1)
for small ∆t. The cumulative distribution function, F (t), is the probability
that T is less than or equal t,







F (t) = f(t). (1.3)
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1.2.2 Survival Functions
The survivor function, S(t), is given by
S(t) = Pr(T > t) =
∫ ∞
t
f(u)du = 1− F (t), (1.4)
and represents the probability of surviving past time t. It is a monotone
decreasing function with S(0) = 1 and S(∞) = limt→∞ S(t) = 0. In certain
situations it is useful to allow S(∞) > 0 which leads to an improper, or
defective, distribution. In survival literature such models are often called
cure rate models.
It is common in survival analysis to report quantities such as “the 5-
year survival probability” which is the probability of living longer than 5
years, i.e., S(5) if T represents years. Survivor curves for different groups
of individuals are often plotted to compare, for example, a new treatment
with an existing one. The survivor function is also essential in likelihood
construction to handle right-censoring. This is discussed briefly in Section
1.2.3 and more formally in Chapter 2.
The hazard function, λ(t), also known as the hazard rate, failure rate or
intensity, represents the instantaneous risk (hazard) of an event occurring at
time t. It is defined as
λ(t) = lim
∆t→0
Pr(t ≤ T < t+∆t | T ≥ t)
∆t
, (1.5)
and can be any non-negative function. The hazard function specifies entirely
the distribution of T , as do the functions f(t), F (t) and S(t), but it is the
hazard which is regarded as the key quantity in survival analysis and is
therefore seen as the starting point.
It is instructive to write
Pr(t ≤ T < t+∆t | T ≥ t) ≈ λ(t)∆t, (1.6)
and compare this to (1.1) which represents the unconditional probability of
failure in the interval [t, t+∆t). Equation (1.6) however represents failure in
the interval [t, t+∆t) given survival up to that point. Thus, conditioning on
T ≥ t gives rise to a quantity which focusses on that specific moment in time
- hence the importance of the hazard function.
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Understanding the shape of the hazard will therefore give insights into
the process under study which may be, for example, biological, mechanical
or sociological. Some common shapes of the hazard are: constant, mono-
tone increasing/decreasing or hazards which first increase and then decrease
(Lawless, 2003, pp. 14–16). Different shapes will fit different situations, for
example, an increasing hazard describes a wearout process where longer du-
ration leads to an increased number of failures. The importance of the shape
of the hazard is discussed in Aalen & Gjessing (2001). Indeed, the effect of
covariates on the shape of the hazard is one of the main focusses of this thesis
and is discussed in Chapter 5.
Another important function is the cumulative hazard function, also called





and represents the cumulative risk of an event occurring from time zero to
time t. It also has the interpretation of the expected number of events at
time t. Defining N(t) as a process counting the observed number of events
at time t, it turns out that
M(t) = N(t)− Λ(t) (1.8)
defines a type of residual, i.e. observed minus expected. More importantly,
it is a martingale. Using this fact, asymptotics of various survival estimators
can be derived via martingale theory. The counting process approach to
survival is due to Aalen (1975) and provides a unified framework to study
more complex survival models (e.g., competing risks and multistate models)
and censoring patterns. More information can be found in Andersen et al.
(1993) and Fleming & Harrington (2005).
1.2.3 Relationships Between Functions
Some important relationships exist between the above survival functions
which will now be proved. Applying the law of conditional probability to




























f(t) = λ(t)S(t). (1.10)
Splitting up the density function in this way is useful in order to incorporate
right-censoring into the likelihood function. For a right-censored individual,
we only know that the event occurs after time ti, where ti is the observed
time for that particular individual. This individual therefore contributes
S(ti) to the likelihood function. For an individual who experiences an event
at time ti, we know that they survived up to time ti but then had an event
at that time. This individual contributes S(ti)λ(ti) = f(ti) to the likelihood.
Putting this together suggests the form λ(ti)
δiS(ti) where δi ∈ {0, 1} is an
indicator variable taking the value one for event times and zero for right-
censored times. Further discussion on the right-censored likelihood function
is deferred until Chapter 2.
It turns out that a relationship between the two key survival functions,
the hazard and survivor functions, can be established. From (1.9) and the
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We may equivalently write
Λ(t) = − logS(t). (1.13)
It is clear from the above that we require limt→∞ Λ(t) =∞, i.e., the integrated
hazard must diverge, to define a proper distribution. However, as previously
mentioned, defective distributions have a place in survival analysis and so we
may allow the integrated hazard to converge to a (positive) constant.
Combining (1.10) and (1.12) leads to








That the density can be expressed solely in terms of the hazard function
further highlights the importance of this function.
The relationship given in (1.12) can be motivated by different means
and it is instructive to do so; we follow a similar line of argument to Lan-
caster (1990, p. 11). First divide the interval [0, t) into m sub-intervals
[t0, t1), [t1, t2), . . . , [tm−1, tm) where t0 = 0 and tm = t. We will assume that
all intervals are of length ∆t, although the proceeding results hold without
this requirement.
Pr(T ≥ t) = Pr(T ≥ t0 ∩ T ≥ t1 ∩ . . . ∩ T ≥ tm)
= Pr(T ≥ t0)× Pr(T ≥ t1 | T ≥ t0)× · · ·
× Pr(T ≥ tm | T ≥ tm−1 ∩ . . . ∩ T ≥ t0)




Pr(T ≥ ti | T ≥ ti−1). (1.15)
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We can write
Pr(T ≥ ti | T ≥ ti−1) = 1− Pr(T < ti | T ≥ ti−1)
= 1− Pr(ti−1 ≤ T < ti | T ≥ ti−1)
= 1− Pr(ti−1 ≤ T < ti−1+∆t | T ≥ ti−1)
≈ 1− λ(ti−1)∆t, (1.16)
where the last line follows from (1.6) and our assumption that the intervals
are all of length ∆t. Inserting (1.16) into (1.15) gives




which has the following intuitive interpretation: survival to time t is equiv-
alent to not having experienced an event in the sequence of sub-intervals
[ti−1, ti), i = 1, . . . , m. Taking the limit as m→∞ leads to





= P t0 [1− λ(u)du]
= P t0 [1− dΛ(u)] (1.17)
where the limit m → ∞ ensures that ∆t → 0 and the second line follows
from the definition of the product integral1. Here we use P as the symbol
for product integration. From the properties of product integration, and the
fact that T is continuous, (1.17) becomes exp[−Λ(t)] (Gill & Johansen, 1990).
Thus, we arrive at (1.12) via probability arguments which highlight the deep
connection between the hazard and survivor functions. In fact (1.17) is more
general than (1.12) and includes the cases where T is discrete or a mixture
of both discrete and continuous components. In these cases (1.12) does not
hold but (1.17) does. The product integral representation is an important
one which, among other things, underpins counting processes and likelihood
construction (Kalbfleisch & Prentice, 2002, sec. 1.2.3).
1Note that product integrals are to products, as standard (Riemann) integrals are to
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1.3 Non-Parametric Methods
Although the focus of this thesis is mainly parametric approaches, we will
first discuss non-parametric estimators as they can provide us with useful
preliminary summaries of data and sometimes help in suggesting a parametric
model. Standard non-parametric procedures, e.g., the empirical distribution
function or histogram, cannot simply be applied to survival data due to
censoring and, in addition to this, we would like some impression of the
hazard function (given its importance in survival analysis) which is not a
quantity estimated in other areas of statistics.
The two most important non-parametric survival estimators are theKaplan-
Meier estimate of the survivor function, denoted ŜKM(t), and the Nelson-
Aalen estimate of the cumulative hazard function, denoted Λ̂NA(t). Both
estimators can be derived via maximum likelihood arguments, without mak-
ing any distributional assumptions, thereby giving the closest estimates of
the true functions, S(t) and Λ(t), on the space of all possible functions. For
this reason they are often treated as the truth and used for graphical com-
parison with a corresponding parametric estimator in order to establish the
fit of the parametric model. It is also possible to estimate f(t) and λ(t),
based on ŜKM(t) and Λ̂NA(t) respectively, but we will not consider this as it
is more difficult, owing to kernel and bandwidth selection, and can be subject
to high variability.
In what follows, let’s assume we have a sample of n individuals with
observed times denoted ti, i = 1, . . . , n. Some of these will be event times
and some of these will be censoring times. Let t(1) < t(2) < · · · < t(r) represent
the r distinct ordered event times from our sample which, in the presence
of tied event times, will correspond to more than r individuals’ times, i.e.,
r ≤ n. Also define t(0) = 0 and t(r+1) =∞, respectively, and construct r + 1
intervals Ij = [t(j), t(j+1)), j = 0, . . . , r. Each of these intervals will contain dj
events and mj censored observations. Note that d0 = 0. Any censoring times
in Ij recorded as being equal to the event time t(j) are conventionally assumed
to be infinitesimally larger than t(j) so that the interval Ij begins with the
event time. We also define nj = (dj +mj) + (dj+1 +mj+1) + · · ·+ (dr +mr)
to be the number of individuals at risk just prior to t(j). Thus, n0 = n.
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1.3.1 Empirical Survivor Function
First we introduce the empirical survivor function which is given by
Ŝn(t) =
Number of event times > t
n
, (1.18)
and is the most simple estimate of the survivor function but cannot be used
when there are censored times. The empirical survivor function equals one
for t < t(1), zero for t ≥ t(r) and is assumed to be constant between adjacent
event times. Therefore Ŝn(t) is a step-function which decreases by dj/n
just after each observed event time. We mention this estimator due to its
simplicity and relationship with the familiar empirical distribution function,
F̂n(t), i.e., Ŝn(t) = 1− F̂n(t), but it is of little practical use for survival data
due to censoring.
1.3.2 Kaplan-Meier Estimate of Survivor Curve
The Kaplan-Meier estimator, also known as the product limit estimator,
generalises the empirical survivor function to allow for right-censored data.
It was first proposed by Böhmer (1912) but was not pursued further until
Kaplan & Meier (1958) reintroduced it, providing formal treatment including
its derivation as a non-parametric maximum likelihood estimator. Assuming
that censoring occurs independently of event times2, it can be shown that




dj log λj + (nj − dj) log(1− λj) (1.19)
where θ = (λ0, λ1, . . . , λr)
T and λj = Pr(T = t(j) | T ≥ t(j)) which is a
discrete version of (1.5). Maximising (1.19), by solving dℓ/dλj = 0 for j =
0, . . . , r, leads to λ̂j = dj/nj which is the empirical hazard. The Kaplan-
2See Section 2.1.2 for information on likelihood construction for right-censored data.
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and is a step-function, equal to one for t < t(1), dropping by the factor
(nj − dj)/nj just after each event time. When the largest observed time
corresponds to an event, i.e., tmax = t(r), then ŜKM(t) = 0 for t > t(r),
whereas, if it is a censored observation then ŜKM(t) does not drop to zero and
is undefined for t > tmax. Note also that the Kaplan-Meier estimator reduces
to the empirical survivor function when there are no censored observations.
We now discuss briefly the calculation of the standard error of ŜKM(t) at
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which is known as Greenwood’s formula and is due to Greenwood (1926) who
derived it as the standard error of the actuarial life-table estimator. One may
therefore construct a 95% confidence interval for ŜKM(t) via
ŜKM(t)± 1.96 σ̂KM(t). (1.22)
However, due to the fact that ŜKM(t) ∈ [0, 1], it is well known that (1.22)
can produce unsatisfactory results, i.e., values that are larger than one or
negative. The log[− log(·)] transformation maps ŜKM(t) onto (−∞,∞). It is




















and therefore, through back-transformation,
[
ŜKM(t)
]exp{±1.96 σ̂KM(t)/[ŜKM(t) log ŜKM(t)]}
(1.23)
gives a 95% confidence interval with better properties than (1.22).
Note that in all of the above, the likelihood function (1.19) has been
treated as though θ is a vector of parameters. This is not true as θ is
data-dependent and dim(θ) increases as n increases leading to an infinite-
dimensional parameter space as n → ∞. More formal results can be found
in Johansen (1978) or, using martingale methods, Gill (1983).
Example 1.1. Lung Cancer in Northern Ireland
We now calculate the Kaplan-Meier survivor curve for a subset of 19 indi-
viduals from the lung cancer dataset described in Appendix A; the subset
in question is the group of males under the age of 50. The estimated sur-
vival probabilities along with standard errors (calculated using (1.21)) and
confidence intervals (obtained using (1.22) and (1.23), respectively) are sum-
marised in Table 1.1. The corresponding graph can be seen in Fig. 1.2.
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Table 1.1. Kaplan-Meier Estimates for Lung Cancer Data
t(j) dj nj ŜKM(t) No transform. log[− log(·)]
0.132 1 19 0.947 (0.051) [0.847, 1.048] [0.681, 0.992]
0.230 1 18 0.895 (0.070) [0.757, 1.033] [0.641, 0.973]
0.460 1 17 0.842 (0.084) [0.678, 1.006] [0.587, 0.946]
0.493 1 16 0.789 (0.094) [0.606, 0.973] [0.532, 0.915]
0.986 1 15 0.737 (0.101) [0.539, 0.935] [0.479, 0.881]
1.710 1 14 0.684 (0.107) [0.475, 0.893] [0.428, 0.844]
1.841 1 13 0.632 (0.111) [0.415, 0.848] [0.379, 0.804]
3.945 1 12 0.579 (0.113) [0.357, 0.801] [0.332, 0.763]
4.603 1 11 0.526 (0.115) [0.302, 0.751] [0.287, 0.719]
6.016 1 10 0.474 (0.115) [0.249, 0.698] [0.244, 0.673]
8.942 1 9 0.421 (0.113) [0.199, 0.643] [0.204, 0.625]
9.008 1 8 0.368 (0.111) [0.152, 0.585] [0.165, 0.575]
12.756 1 4 0.276 (0.115) [0.051, 0.502] [0.088, 0.506]
Note: ŜKM(t) is defined up to t = 19.627 as this is the largest observed time and it
is a censored observation.



















Figure 1.2. Kaplan-Meier curve with C.I.s based on the untransformed
estimator (dash) and the log[− log(·)] transformation (dot) respectively.
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One may wish to estimate the pth percentile using the formula
t̂p/100 =
[
t(j) | ŜKM(t(j)) = 1− p/100
]
.
However, due to the fact that the Kaplan-Meier estimator is a step-function,
it is usually the case that there is no t(j) for which Kaplan-Meier is exactly
equal to 1 − p/100. For example, in Table 1.1, since ŜKM(4.603) = 0.526
and ŜKM(6.016) = 0.474, we may choose to estimate the median as t̂0.5 =
(4.603+6.016)/2 = 5.31 months. One may prefer an interval estimate rather
than a point estimate, and this has been considered by many authors (Efron,
1981; Reid, 1981; Brookmeyer & Crowley, 1982; Emerson, 1982), but we will
not pursue such approaches here.
1.3.3 Nelson-Aalen Estimate of Cumulative Hazard
Function
The Nelson-Aalen estimator of the cumulative hazard function was first in-
troduced by Nelson (1969, 1972) and was independently derived by Altshuler
(1970). The estimator was later studied by Aalen (1975, 1978) in detail using
the counting process formulation (briefly mentioned in Section 1.2.2) who,
among other things, extended its use to Markov chains and more general
event history models.










It is noteworthy that this estimator is formed using the empirical hazard es-
timates which maximise the non-parametric log-likelihood (1.19). Thus, the
estimators (1.20) and (1.24) come from the same estimation procedure which
highlights the fact that they are the non-parametric maximum likelihood es-
timators of the survivor and cumulative hazard functions respectively. In
fact, the two estimators are functionally related and we will show this in
Section 1.3.4.
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Using a similar approach to that shown in the previous section, one may












and the corresponding 95% confidence interval is
Λ̂NA(t)± 1.96 σ̂NA(t). (1.26)



















gives a 95% confidence interval which has better properties than (1.26).
1.3.4 Relationship Between Estimators
The fundamental relationship given in (1.17) shows how the survivor func-
tion is closely related to the corresponding cumulative hazard function for a
general distribution, i.e., continuous, discrete or mixed. It is easy to verify










which follows from the discrete nature of Λ̂NA(u), i.e., it is a step function (see
Gill & Johansen (1990)). This tells us that by maximising the log-likelihood
in (1.19), we obtain a (discrete) non-parametric estimator for the distribution
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of T with survivor function and cumulative hazard function given by ŜKM(t)
and Λ̂NA(t) respectively.
Textbooks based on the counting process approach typically regard esti-
mation of the cumulative hazard function as being most important and derive
the Nelson-Aalen estimator first, albeit, using martingale theory (Aalen et al.,
2008; Andersen et al., 1993). The Kaplan-Meier estimator is then motivated
via (1.28) and, consequently, its asymptotic properties are derived (Andersen
et al., 1993, sec. IV.3). It is worth noting that the asymptotic variances ob-
tained using martingales differ slightly from those given in (1.21) and (1.25).
Discussion of these different variance estimates can be found in Klein (1991).
In addition to the Kaplan-Meier and Nelson-Aalen estimators, one may
motivate the following alternative estimators






using the relationships given in (1.13) and (1.12) respectively. For exam-
ple, (1.30) is sometimes called the Breslow estimator (Breslow, 1972); note
that Fleming & Harrington (1984) compare this to the Kaplan-Meier estima-
tor. Clearly (1.29) and (1.30) are not non-parametric maximum likelihood
estimators as Λ̃(t) 6= Λ̂NA(t) and S̃(t) 6= ŜKM(t). However, these will be
approximately equal when the λ̂j’s are small:














where we have used the fact that log(1−x) ≈ −x when x is small. Thus, when
dj is small relative to nj (j = 0, . . . , r), Λ̃KM(t) is close to the Nelson-Aalen
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estimator. One may similarly show that S̃NA(t) ≈ ŜKM(t) when the λ̂j’s are
small.
1.4 Parametric Survival Distributions
The advantage of the non-parametric methods mentioned above is that no
assumptions about the data are made and thus we “let the data speak for
themselves”. However, parametric models have many advantages. Often a
parametric model can adequately fit the data and in this case it is much
preferable to describe, for example, the survivor function with a compact
formula, such as S(t) = exp(−t0.8), than a table such as Table 1.1 (which
grows with the sample size). Having simple mathematical formulae makes
estimation of quantities, such as the mean or median survival time, and their
corresponding standard errors quite straightforward. In addition to this, es-
timates can have higher efficiency (i.e., lower variance) than the correspond-
ing non-parametric estimates (see Miller (1983) and Cox & Oakes (1984,
sec. 8.5)). We may also simulate from the model to estimate more complex
quantities or extrapolate beyond the data3. Parametric survival functions
typically vary smoothly with t, unlike the non-parametric estimators, and
this may be preferable as it is usually assumed that the true functions are
also smooth (when t is continuous).
Parametric modelling allows the use standard likelihood theory (see Chap-
ter 2) for inference purposes whereas non-parametric methods require more
specialised treatment (as mentioned in Section 1.3). Furthermore, the use of
parametric regression models has been advocated by Efron (1988), Royston
& Parmar (2002) and Nardi & Schemper (2003) among others and, indeed,
the incorporation of covariates is straightforward in a parametric framework
owing again to the use standard likelihood theory (see Chapters 4 and 5).
For all of these reasons, parametric analyses can be very fruitful in helping
us gain understanding of the phenomenon at hand. Furthermore, as noted
in Aalen et al. (2008, p. 207):
3Extrapolation far beyond the range of the data is of course ill-advised (see Sections
3.6.2, 3.6.5 and 3.6.6).
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It has become a tradition to use non- and semi-parametric methods
. . . to analyse censored survival data . . . (Practitioners) would
gain from the use of a wider range of statistical methods, includ-
ing parametric methods, than is the current practice.
This is a point of view with which we agree. Therefore, our approach to
survival will mainly be parametric due to the typical over-emphasis of non-
parametric methods in the survival literature.
In the proceeding sections we will describe some useful parametric survival
distributions (Johnson et al., 1994, 1995; Lawless, 2003; Marshall & Olkin,
2007). For each distribution we will start with the hazard function and
derive the cumulative hazard and survivor function, respectively, using (1.7)
and (1.12). We will also derive the inverse survivor function, S−1(u), which
is useful for simulation (see Chapter 3) and calculation of percentiles. We
mainly consider two-parameter models (λ = scale parameter and γ = shape
parameter) where, in our setup, the scale parameter controls the magnitude
of the hazard while the shape parameter controls its time evolution. The
categorisation of various types of parameters is treated much more formally
in Marshall & Olkin (2007, chap. 7); our setup does not necessarily adhere to
these definitions. Note also that we only consider parametric models where
S(t) has a closed form, leading a closed form likelihood function. Thus we
do not consider, for example, the gamma, log-normal or inverse-Gaussian
distributions (though the latter two are similar in shape to the log-logistic
considered below). Information on these models can be found in the above
references.
1.4.1 Exponential
The exponential distribution is the most simple parametric survival model.
The hazard function is given by
λ(t) = λ, (1.31)
where λ > 0 is a scale parameter. Regardless of the point in time, t, the
hazard is constant, thereby assuming that events can occur randomly at any
time.
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The cumulative hazard is given by
Λ(t) = λt (1.32)
and the survivor function is
S(t) = exp(−λt). (1.33)
The inverse survivor function is given by




where u ∈ (0, 1), and is useful for simulation and calculating percentiles. The





for example, t0.5 = (log 2)/λ.
The assumption of constant hazard is usually too strict for the model to
be of much practical use and more flexible distributions are discussed in the
proceeding sections. However, we introduce this model for two reasons. The
first is historical. The exponential distribution was one of the first widely
used survival models due to its simplicity. For early examples of its use see
Davis (1952) and Epstein & Sobel (1953). Bartholomew (1957) showed that
the maximum likelihood estimator of λ is given by the closed form expression
λ̂ =
The total number of events
The sum of all observed event times and censoring times
,
and, therefore, in a time when computing was less powerful, one could easily
calculate λ̂ on a pocket calculator for example.
The second reason we introduce the exponential distribution is that all
survival distributions are related to it via
T ∼ “any distribution”
⇒ Λ(t) ∼ Exp(λ = 1).
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Here Λ(t) is the cumulative hazard function corresponding to T and Exp(λ = 1)
is the unit exponential distribution, i.e., an exponential distribution with
λ = 1. This is easy to show. First, define the transformation X = Λ(t),
where the random variable T can have any distribution. Thus, we have that
Pr(T > t) = Pr [Λ(T ) > Λ(t)] = Pr(X > x).
Furthermore, from (1.12), we also know that
Pr(T > t) = exp [−Λ(t)] = exp(−x).
Hence, combining the above expressions gives
Pr(X > x) = exp(−x),
which is the survivor function for a unit exponential distribution. Therefore,
the cumulative hazard function can be viewed as a function which transforms
T into a unit exponential variable. This property is discussed in Singpurwalla
(2006) who, among other things, uses it to generate multivariate survival
distributions.
1.4.2 Weibull
The Weibull distribution is a very popular distribution - not only in survival
analysis - and this is clear from the wide variety of applications mentioned in
Johnson et al. (1994, pp. 684–685). Its popularity is both due to its flexibility,
as originally demonstrated by Weibull (1951), and its theoretical derivation
as one of the three possible extremal distributions (Fisher & Tippett, 1928).
The hazard function is given by
λ(t) = λγtγ−1, (1.36)
where λ > 0 and γ > 0 are the scale and shape parameters respectively.
The hazard function can increase (γ > 1), decrease (γ < 1) or remain con-
stant (γ = 1) over time (see Fig. 1.3). The Weibull distribution therefore
generalises the exponential distribution.
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Figure 1.3. Weibull hazard function with median time fixed at t0.5 = 5
and γ = 0.5, 1.0, 1.5 and 2.5 ⇒ λ ≈ 0.31, 0.14, 0.06 and 0.01.
The cumulative hazard is given by
Λ(t) = λtγ , (1.37)
and the survivor function is
S(t) = exp(−λtγ). (1.38)
The inverse survivor function is given by

















Example 1.2. Lung Cancer Data in Northern Ireland
Upon fitting the Weibull model to the data described in Example 1.1 we
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obtain the maximum likelihood estimates λ̂ = 0.221 and γ̂ = 0.625 re-
spectively. Figure 1.4 shows that the estimated Weibull survivor function,
Ŝ(t) = exp(−0.221t0.625), closely agrees with the Kaplan-Meier estimate. The
estimate of the median based on the Weibull model is t̂0.5 = 6.22 months.

















Figure 1.4. Kaplan-Meier and Weibull survivor curves overlayed.
1.4.3 Gompertz
The Gompertz distribution was derived by Gompertz (1825), a practicing
actuary, as a model for human mortality and has received much attention in
actuarial literature (Olshansky & Carnes, 1997). The model is based on the
assumption that the change in the hazard, at time t, is proportional to its





λ(t) = exp(At +B).
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In our notation, the hazard is given by
λ(t) = λ exp(γt), (1.41)
where λ > 0 and γ ∈ (−∞,∞) are the scale and shape parameters respec-
tively. The hazard function can increase (γ > 0), decrease (γ < 0) or remain
constant (γ = 0) over time (see Fig. 1.5). The Gompertz hazard is similar
to the Weibull but, due to the exponentiation of time, has a faster rate of
growth/decay than the Weibull which grows/decays according to a power of
time.


















Figure 1.5. Gompertz hazard function with median time fixed at t0.5 =
5 and γ = −0.5, 0.0, 0.5 and 1.5 ⇒ λ ≈ 0.38, 0.14, 0.03 and 0.0006.
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Clearly, when γ < 0, S(∞) = exp(λ/γ) ⇒ proportion of non-susceptible
individuals or cured fraction. It is worth noting how this differs from the
Weibull model. Decreasing Gompertz hazards imply that not all individuals
experience the event whereas decreasing Weibull hazards still imply that the
event is inevitable.
The Gompertz inverse survivor function is given by





















log(1− p/100) + 1
]
, (1.45)
and, if γ < 0, then tp/100 =∞ for p > 100[1− exp(λ/γ)].
1.4.4 Log-Logistic
The log-logistic distribution is defined via T = exp(Y ) where Y ∼ logistic
distribution (see Johnson et al. (1995, chap. 23) for details on the logistic
distribution), analogous to the relationship between the log-normal and the
normal distribution. In fact, the log-logistic distribution is very similar to the
log-normal in shape but has the advantage of closed form survivor and hazard
functions. This makes it more useful in survival analysis. Bennett (1983)
provides an early application of the log-logistic distribution to lung cancer
data. In econometrics literature it is often called the “Fisk” distribution after
Fisk (1961).
The Weibull and Gompertz hazards are monotonic increasing/decreasing
which may not be appropriate in certain situations. Hazards are commonly
found to rise initially to a peak followed thereafter by a decline, for example,
survival after heart transplantation - the patient faces an increased risk of
death in the initial days after the transplant while the body is adapting. The
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where λ > 0 and γ > 0 are the scale and shape parameters respectively. For
γ ≤ 1, the hazard decreases over time while for γ > 1 the hazard increases to






the highest-risk point. A variety of log-logistic hazard shapes can be seen in
Fig. 1.6.


















Figure 1.6. Log-logistic hazard function with median time fixed at
t0.5 = 5 and γ = 0.5, 1.0, 2.0 and 3.5 ⇒ λ ≈ 0.45, 0.20, 0.04 and 0.0035.
The cumulative hazard is given by
Λ(t) = log(1 + λtγ), (1.47)
and the survivor function is
S(t) = (1 + λtγ)−1. (1.48)
The inverse survivor function is given by






where u ∈ (0, 1), and the pth percentile is
tp/100 =
[
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1.4.5 Burr Type XII
The Burr Type XII distribution contains both the Weibull and log-logistic
distributions as special cases and can be derived via frailty arguments (see
Section 7.5). Burr (1942) introduced twelve probability distributions and
paid particular attention to the twelfth (hence “type XII”) which has become
the most prominent in the literature (Rodriguez, 1977; Tadikamalla, 1980).





where λ > 0 is a scale parameter and γ > 0 and ρ > 0 are the shape
parameters. One easily sees that the hazard reduces to the log-logistic hazard
when ρ = 1 and approaches the Weibull hazard as ρ→ 0. The Burr hazard
decreases for γ ≤ 1 and increases to a mode followed by a decline for γ > 1.





. This behaviour is very similar to
the log-logistic hazard, i.e., the hazard cannot theoretically increase without
peaking and declining. However, since tmode → ∞ as ρ → 0, the hazard
can be treated as increasing-only over a relevant time-range (when ρ ≈ 0).
Accordingly, the Burr hazard is very flexible (see Fig. 1.7).




log(1 + λρtγ), (1.52)
and the survivor function is
S(t) = (1 + λρtγ)−1/ρ. (1.53)
The inverse survivor function is given by







where u ∈ (0, 1), and the pth percentile is
tp/100 =
[
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ρ = 0.1, γ = 0.5
ρ = 0.1, γ = 1
ρ = 0.1, γ = 3
ρ = 1, γ = 3
ρ = 4, γ = 3
Figure 1.7. Burr hazard function with median time fixed at t0.5 = 5
and (ρ, γ) = (0.1, 0.5), (0.1, 1.0), (0.1, 3.0), (1.0, 3.0) and (4.0, 3.0)⇒ λ ≈
0.32, 0.14, 0.006, 0.008 and 0.03.
1.4.6 Time-Dependent Logistic
The time-dependent logistic distribution, TDL, was introduced by MacKenzie
(1996). It was motivated by using a logistic function, exp(z)/[1 + exp(z)], as
a model for the hazard function. Thus,
λ(t) =
exp(γt + λ)
1 + exp(γt+ λ)
, (1.56)
where λ, γ ∈ (−∞,∞) are the scale and shape parameters respectively4.
When the parameter λ is modelled as a linear function of covariates (1.56)
generalises logistic regression to time-dependence (see Chapter 4 for more
information on regression models). The hazard function can increase (γ > 0),
decrease (γ < 0) or remain constant (γ = 0) over time (see Fig. 1.8). The
TDL distribution therefore generalises the exponential distribution.
4That presented in MacKenzie (1996) is a more general three-parameter hazard but we
only consider a two-parameter sub-model due to identifiability issues concerned with the
third parameter.
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Figure 1.8. TDL hazard function with median time fixed at t0.5 = 5
and γ = −0.5, 0, 0.5 and 2.0 ⇒ λ ≈ −0.76,−1.83,−3.26 and − 8.90.










and the survivor function is
S(t) =
[




Note that, like the Gompertz model, when γ < 0 the TDL is a cure rate
model with S(∞) = [1 + exp(λ)]1/γ . The TDL inverse survivor function is
given by











where u ∈ (0, 1) if γ ≥ 0 and u ∈ (0, [1 + exp(λ)]1/γ ] if γ < 0. The pth












and, if γ < 0, then tp/100 =∞ for p > 100{1− [1 + exp(λ)]
1/γ}.
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1.4.7 Piecewise Exponential
The piecewise exponential model, also known as the piecewise constant model,
is a flexible parametric model which lies between the parametric and non-
parametric approaches mentioned above. It has been considered by Holford
(1976), Breslow (1974) and Friedman (1982). The hazard function is assumed
to be constant between specified intervals Ij = [t(j−1), t(j)), j = 1 . . . , m,
where t(0) = 0 and t(m) =∞. Note that, unlike the non-parametric methods,
there will not be an interval for every distinct event time in the dataset.
Thus,
λ(t) = λj t ∈ Ij
= a(t)Tλ, (1.61)
where λ = (λ1, . . . , λm)
T ∈ Rm+ is the vector of positive parameters and a(t)
is an m-dimensional vector function of t whose jth component is given by
aj(t) =
{
1 if t ∈ Ij ,
0 otherwise.
(1.62)
Thus a(t) is a vector indicating which interval t lies in, e.g., if m = 4 and
t ∈ I3 then a(t) = (0, 0, 1, 0)T . The piecewise exponential hazard is clearly
very flexible as it can approximate any arbitrary hazard shape (Fig. 1.9),
essentially letting the data speak for themselves whilst keeping the dimension
low relative to non-parametric methods.








λ1du+ · · ·+
∫ t
t(j−1)








+ (t− t(j−1))λj t ∈ Ij
= d(t)Tλ, (1.64)
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Figure 1.9. Piecewise exponential hazard function: Increasing (solid),
decreasing followed by increasing (dash) and change point (dot).






t(j) − t(j−1) if t > t(j),
t− t(j−1) if t(j−1) ≤ t ≤ t(j),
0 if t < t(j−1).
(1.65)
Thus d(t) represents the time spent in each interval for a particular value of
t, e.g., if m = 4 and t ∈ I3 then d(t) = (t(1) − t(0), t(2) − t(1), t− t(2), 0)
T . The






Using the fact that d(t)Tλ = d(t(j−1))
Tλ+(t− t(j−1))λj for t ∈ Ij, the inverse
survivor function is given by





for u ∈ (S(t(j)), S(t(j−1))], and the pth percentile is given by
tp/100 = t(j−1) −
log(1− p/100) + d(t(j−1))Tλ
λj
, (1.68)
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for 1− p/100 ∈ (S(t(j)), S(t(j−1))].
The above functions are discontinuous at the cut points which is a disad-
vantage of the piecewise exponential model. Alternatively one could model
the hazard function using splines (polynomials which join at the cut points).
Continuity is then gained at the expense of some added computational effort
relative to the piecewise constant model. Hazard modelling using splines has
been considered by Kooperberg et al. (1995), Rosenberg (1995) and Royston




As in many other areas of statistics, the primary vehicle for parameter esti-
mation and inference in survival analysis is the so-called likelihood function.
Fisher (1922, 1925, 1934) originally developed the theory of maximum likeli-
hood, setting forth many of the fundamental concepts of modern statistics1.
As noted by Efron (1998):
Statistics went from an ad hoc collection of ingenious techniques
to a coherent discipline (due to the work of Fisher).
Because maximum likelihood methods are now well-known and covered in
many texts (such as Silvey (1975), Pawitan (2001) and Cox (2006)), we will
only summarise the main results here. These standard likelihood methods
must be adapted for survival-type data (to handle right-censoring) which we
discuss in Section 2.1.2.
2.1.1 Maximising the Likelihood Function
First we consider the case of full information, i.e., no censoring. In this case
the data consist of n observed times, t1, . . . , tn, all of which correspond to
1We will not consider Bayesian methods here. For details see Gelman et al. (2003)
and Robert & Casella (2010). A Bayesian treatment of survival analysis can be found in
Ibrahim et al. (2005).
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event times. Given that these times arise according to a probability dis-
tribution with p.d.f. f(t | θ), where θ is a k-dimensional vector of unknown




f(ti | θ), (2.1)
where we can multiply densities by assuming that observations are indepen-
dent. This function tells us how likely a particular θ vector is given the
observed data. Thus, we wish to find the parameter vector which is most
likely. This vector, denoted θ̂, maximises the likelihood function and is known
as the maximum likelihood estimator (m.l.e.) of θ. We seldom work with the
likelihood function itself. Rather we use the log-likelihood function which is
given by
ℓ(θ) = logL(θ) =
n∑
i=1
log f(ti | θ). (2.2)
This is due to the fact that it is easier to maximise a sum than a product






We maximise ℓ(θ), using standard calculus methodology, by setting the
first derivatives equal to zero, i.e.,
∂l(θ)
∂θj
= 0, j = 1, . . . , k. (2.4)
These equations are referred to as the score equations and are solved simul-
taneously to give the m.l.e. θ̂ = (θ̂1, . . . , θ̂k)
T . This solution is typically not
analytic necessitating the use of numerical methods, such as the Newton-
Raphson method. Note that a parametrisation of the model where θ ∈ Rk
is usually preferable. This prevents optimisation algorithms from moving
into regions outside of a constrained parameter space, which may cause the
algorithm to fail. For example, if θ ∈ Rk+ in a particular parametrisation,
then one should work with θ∗ = log θ ∈ Rk.
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It can be shown that the m.l.e. is a consistent estimator of the true
parameter vector, i.e.,
θ̂→ θ as n→∞,
where θ denotes the true parameter vector (Pawitan, 2001, sec. 9.3). Fur-
thermore, θ̂ has an asymptotic multivariate normal distribution centered at θ
(see Section 2.3.1). Similarly, any function of θ is also estimated consistently,
i.e.,
g(θ̂)→ g(θ) as n→∞,
for example, the median survival time t̂0.5 = S
−1(0.5 | θ̂) → S−1(0.5 | θ).
Indeed, like θ̂, g(θ̂) also has an asymptotic multivariate normal distribution
(see Section 2.3.2).
Although the notation above suggests a basic (no covariate) model as in
Section 1.4, the methodology applies equally for regression models (Chapters
4 and 5). In this case we use the notation f(t | x, θ) where we now make the
assumption that observations are conditionally independent, given covariates,
to motivate the likelihood function (2.1). For regression models, the vector θ
will contain regression coefficients in addition to distributional parameters.
2.1.2 Right-Censored Likelihood
Random Censoring
In the previous section we considered the case of full information. However,
in survival data, we will typically have right-censored times2. In this case the
response variable is not an event time but rather a pair (ti, δi), i = 1, . . . , n,




1 if ti is an event time,
0 if ti is a censoring time.
(2.5)
We will also have explanatory variables but, as in the previous section, we
will suppress x-dependence for notational convenience.
2We may also have interval-censored or left-truncated times but these will not be con-
sidered here (see Kalbfleisch & Prentice (2002, chap. 3) and Lawless (2003, chap. 2)).
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We need to form a joint distribution for the pair of random variables
(T, δ) from which we can derive the likelihood function using (2.1). First
we will discuss the important case of random censoring, where both event
and censoring times are random variables, which includes type I censoring,
where censoring times are fixed by design, as a special case. Let T̃ and C
represent the true event time and the censoring time respectively. Moreover,
these variables are assumed to be independent (given covariates) with den-
sity functions given by f(t | θ) and g(t | φ), and survivor functions given by
S(t | θ) and G(t | φ) respectively. Note the assumption that the distributions
for T̃ and C depend on different parameters; this is called non-informative
censoring. The observed survival time is therefore T = min(T̃ , C) and the
censoring indicator is δ = 1(T̃ ≤ C) = 1(T = T̃ ). Thus
Pr(T = t, δ = 1) = Pr(T̃ = t, C > t)
= f(t | θ)G(t | φ), (by independence of T̃ and C)
Pr(T = t, δ = 0) = Pr(T̃ > t, C = t)
= S(t | θ)g(t | φ). (by independence of T̃ and C)
The above can be combined to give the joint density
Pr(T = t, δ) = [f(t)G(t)]δ[S(t)g(t)]1−δ,
and, for a given dataset comprising (ti, δi), i = 1, . . . , n, the likelihood func-







As with (2.1), we require that individual observations are independent (or
conditionally independent given x) to multiply densities in the above. Typi-
cally we are only interested in modelling the survival distribution and, hence,
























δi log λ(ti) + log S(ti), (2.7)
which holds for any possible independent censoring distribution. We only
assume a (parametric) model for survival; the censoring distribution is arbi-
trary. To fit such model we insert the relevant hazard and survivor functions
into (2.7) and solve the score equations (2.4).












which shows the importance of the hazard function, i.e., the likelihood contri-
bution for each individual is fully encompassed by the hazard. Another im-
portant re-expression of the log-likelihood function (similar to that in Aalen
et al. (2008, sec. 5.1)) is given by









which is written in counting process notation3. Here Ni(t) = 1(ti ≤ t, δi = 1)
is the observed counting process and Yi(t) = 1(ti ≥ t) is the at-risk process for
the ith individual, respectively. Setting t∗ = ∞ ensures equality with (2.8);
3See Andersen et al. (1993, chap. 2), Kalbfleisch & Prentice (2002, chap. 5) and Aalen
et al. (2008, chap. 1) for details on counting processes.
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in fact we require that t∗ ≥ tmax = max(t1, . . . , tn), i.e., ℓ(θ | t∗ ≥ tmax) = ℓ(θ).
More generally, when viewed as a function of t∗ ∈ [0,∞), (2.9) describes the
likelihood contribution from the whole dataset as it unfolds over time; the
total contribution is attained at t∗ = tmax. Viewing the survival experience of
the whole dataset in this way underpins the study of more general censoring
schemes which we now discuss briefly (see also Kalbfleisch & Prentice (2002,
secs. 3.1-3.4) and Aalen et al. (2008, sec. 5.1)).
Independent Censoring
We have seen that the log-likelihood function given by (2.7) holds for any
independent censoring distribution. It turns out that (2.7) is even more
general than this. We have only considered the case of random censoring,
where both the survival and censoring times follow probability distributions.
This does not cover censoring processes such as type II censoring, where the
study is terminated after ne events have occurred (Lawless, 2003, pp. 55–
56). In this case, censoring times depend on the course of the study rather
than coming from a distribution. However, it can be shown using martingale
techniques, that (2.9) (which is equivalent to (2.7)) is the likelihood function
for right-censored data arising from any independent censoring process (see
Kalbfleisch & Prentice (2002, sec. 6.2) and Aalen et al. (2008, sec. 5.1)).
Such a process must be independent of the survival process at time t, given
the history of the study up to that time (and covariates), but is otherwise
arbitrary. Hence the likelihood function above is quite general.
It is worth noting that censoring was assumed to be non-informative
(i.e., does not depend on θ). Even if censoring is informative, the use of
(2.7) can still be justified as a partial likelihood (as defined by Cox (1975))
with some loss of efficiency in estimating θ. However, Kalbfleisch & Prentice
(2002, p. 196) note that it is difficult to construct a realistic example where
censoring is informative yet independent of survival. Therefore, independence
is the key assumption. The censoring mechanism would not be independent
if individuals were censored (i.e., withdrawn from a study) whenever they
had a particularly high/low risk of an event. We would be unable to make
valid conclusions based on such data unless the nature of the dependence
could be modelled appropriately.
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2.2 Comparing Models
In Section 2.1 it has been implicitly assumed that the model we are fitting
to the data, f(t), is the true model and that the m.l.e. converges to the
true parameter vector. In practice however, this is rarely the case. Indeed
any model we assume is a simplification of reality and is therefore not the
true model. The true model may be sufficiently complex that it cannot be
expressed as a simple mathematical formula. Nonetheless, statistical models
(which approximate reality) can provide estimates of key features, such as
the median survival time or the hazard function, and give insights into the
data generating process. Hence the famous phrase: “all models are wrong
but some are useful” (Box & Draper, 1987).
For the purposes of this section we introduce the notation
Assumed Model: f(t | θ), (2.10)
True Model: f ∗(t | θ∗).
We can then define the Kullback-Leibler distance (Kullback & Leibler, 1951)
as






which measures the average information lost when f ∗ is approximated by f
(Burnham & Anderson, 2002, sec. 2.1). It can be shown that KL(f ∗, f) ≥ 0
with equality when f(t) = f ∗(t), i.e., the best fitting model is the true model
(Pawitan, 2001, sec. 13.2). Thus, KL(f ∗, f) is typically greater than zero,
but there is some θ = θ̃ which minimises its value. In other words f(t | θ̃) is
the closest we can get to f ∗(t | θ∗) among all models in the family f(t | θ).
In light of the above, it may seem reasonable to use KL(f ∗, f) as an ob-
jective function (to be minimised) for model estimation. This is not possible
however as KL(f ∗, f) depends on the unknown distribution f ∗. It is easy
to show that maximising the likelihood function is equivalent to minimising
KL(f ∗, f) (Pawitan, 2001, sec. 13.3) and, thus, the m.l.e. θ̂ is a consistent
estimator of θ̃ - the parameter vector for which f(t) is closest to f ∗(t). In
practice we may fit a variety of different models to the data. The model with
the highest likelihood is closest to the truth but we must also take into ac-
count its complexity. If a more complex models only offers a modest increase
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in the value of the likelihood, the simpler model is typically preferable. This
is a philosophy often referred to as Occam’s razor which states that “entities
must not be multiplied beyond necessity”.
2.2.1 Nested Models
In the case where the models are nested, we can compare them by means of
a likelihood ratio test. Let’s assume we have two models: f = f(t | θ ∈ Θ)
and f0 = f(t | θ0 ∈ Θ0 ⊂ Θ), where dim(Θ) = k and dim(Θ0) = k − r. In
other words f reduces to f0 by setting r of its parameters equal to specified
constants, e.g., Exp(λ) = Weibull(λ, γ = 1) (see Section 1.4). Wilks (1938)
showed that





as n→∞ (see also Silvey (1975, chap. 7)). Thus, ifW > χ2r,1−α, we conclude
that the fit provided by f is significantly better than f0 (at the α level of
significance).
2.2.2 Non-Nested Models
More generally, models can be non-nested, i.e., there is no configuration of
parameters which makes the two models equal. Therefore, we cannot use
(2.12). The most widely applied method for comparing models is the so-
called Akaike information criterion (Akaike, 1973, 1974) which is given by
AIC = −2ℓ(θ̂) + 2k, (2.13)
for a model f(t | θ) where dim(θ) = k. The AIC is a measure of fit where
smaller values indicate superior fit. AIC can be motivated in a number
of different ways (see Pawitan (2001, secs. 3.5 and 13.6) and Burnham &
Anderson (2002, sec. 7.2)) and can be used as a general model selection
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tool for both nested and non-nested models. Burnham & Anderson (2002)
advocate its general use (see also Lindsey (1999)).
It is important to note that AIC is on an interval scale due the omission
of an unknown constant in its derivation (equal to E log f ∗(T ) from (2.11)).
Thus, in a set of competing models, {f1, . . . , fm}, Burnham & Anderson
(2002, chap. 2) define the AIC difference as
∆j = AICj − AICmin, j = 1, . . . , m, (2.14)
where AICmin is the minimum AIC value in the set. Burnham & Anderson
also provide some rules of thumb shown in Table. 2.1 below. The use of
Table 2.1. Rules of Thumb for AIC Differences
∆j Level of Support of Model j
0− 2 Substantial
4− 7 Considerably less
> 10 Essentially none
∆j makes presentation/comparison clearer and also avoids the issue of mis-
takenly interpreting AIC values on a ratio scale, for example, thinking no
significant difference exists between AIC1 = 100, 000 and AIC2 = 100, 020
due to their magnitude when, in truth, ∆2 = 20 means that there is little
support for model 2. The AIC differences can be used further (in a pseudo-
Bayesian manner) to define individual model probabilities/odds and for the
purpose of model averaging (Burnham & Anderson, 2002, chaps. 2-4).
Another method for model comparison, based on Bayesian arguments,
is the Bayesian information criterion, also known as the Schwarz criterion
(Schwarz, 1978), which is given by
BIC = −2ℓ(θ̂) + log(n)k. (2.15)
BIC is used in the same way as AIC (we aim to minimise its value) but has
a larger penalty for complexity when n ≥ 8 (which it typically is). For a de-
tailed account of model selection based on information criteria see Burnham
& Anderson (2002). In particular see Burnham & Anderson (2002, chap. 6)
for a comparison of selection methods, e.g., AIC versus BIC.
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Example 2.1. Lung Cancer Data in Northern Ireland
We fitted the Weibull and log-logistic models to the lung cancer dataset using
maximum likelihood and have summarised the results in Table 2.2. The log-
logistic model has a lower AIC value and is therefore closer to the truth.
We can also check the fit graphically by comparing the estimated Weibull
and log-logistic survivor curves to the Kaplan-Meier curve (recall that the
Kaplan-Meier curve is the closest estimate of the true survivor function).
In Fig. 2.1 we can see that the log-logistic curve matches the Kaplan-Meier
curve more closely than the Weibull.
Table 2.2. Model Comparison
Weibull Log-Logistic
Shape γ̂ 0.858 1.151
Scale λ̂ 0.170 0.173
AIC 4126.8 4114.5
∆AIC 12.3 0.0




















Figure 2.1. Kaplan-Meier curve (black) with predicted Weibull (red)
and log-logistic (green) curves overlayed.
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2.3 Uncertainty
2.3.1 Uncertainty in the M.L.E.
It is generally unsatisfactory to produce a point estimate without conveying
some sense of uncertainty associated with this estimate. The m.l.e., θ̂, is
found by solving the score equations, (2.4), i.e., the first derivatives of the
log-likelihood function, ℓ(θ). The precision of the estimate however, comes
from the second derivatives - these measure curvature. High curvature at θ̂
implies a tight peak and, hence, less uncertainty about the true parameter
vector θ. The Hessian matrix (named after German mathematician Lud-











































where ∇θ = (∂/∂θ1, . . . , ∂/∂θk)T denotes the operation of partial differenti-
ation with respect to θ.
In likelihood theory the Hessian is not the key quantity, but rather its
negation, the so-called observed information matrix,
Io(θ) = −H(θ). (2.18)
The observed information quantifies the information carried in the dataset
at hand. Moreover, the expected information matrix, or Fisher information
matrix, is defined as
I(θ) = E[Io(θ)], (2.19)
where expectation is taken with respect to the data generating process which
depends on both the survival and censoring processes. Note that, without
censoring, expectation is with respect to the probability distribution of T .
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While the observed information varies from sample to sample, the expected
information is an average quantity (over all possible datasets) that does not
depend on any particular dataset. Therefore, I(θ) tells us how difficult it
is to estimate θ on average; parameters with higher expected information
attain a greater level of precision for a given sample size. In particular, if
we have some idea a priori as to the value of θ, then I(θ) can be used for
sample size determination.
Related to the above discussion is the fact that, as n→∞,
θ̂ ∼ N [θ,Σ = I(θ)−1], (2.20)
where θ is the true parameter vector. This is a well-known result of likeli-
hood theory (see Silvey (1975, pp. 74-78) and Pawitan (2001, secs. 9.4 and
9.9)) which can be shown to extend to right-censored survival data using the
martingale central limit theorem (see Borgan (1984), Andersen et al. (1993,
sec. 6.1) and Kalbfleisch & Prentice (2002, sec. 5.8)).
We noted in Section 2.1.1 that, for the purpose of optimisation, one should
work with a model parametrisation where θ ∈ R. In addition to this, an
unconstrained parametrisation means that (2.20) cannot place density on
unallowable regions. Therefore, hypothesis tests and confidence intervals
will have better properties if θ ∈ R and, for this reason, we typically choose
to parametrise our models in this way. With this in mind, (2.20) can be used
to test the hypothesis H0 : θ = θ0 or to form joint confidence regions for
the parameters. It is more common however to test hypotheses pertaining
to individual parameters. As a consequence of (2.20), we have that
θ̂j ∼ N [θj , σ
2
θj
], j = 1, . . . , k, (2.21)
where σ2θj , the variance of θ̂j , is the jth diagonal element of the covariance
matrix Σ in (2.20). Thus, the hypothesis H0 : θj = θj0 can be tested using




∼ N(0, 1). (2.22)
Similarly, a (1− α)100% confidence interval for θj is given by
θ̂j ± z1−α/2 σθj , (2.23)
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where z1−α/2 is the (1 − α/2)100th percentile of the standard normal distri-
bution.
In the above construction of Z-scores and confidence intervals, an estimate
of Σ is required. The two possibilities are Σ̂ = I(θ̂)−1 or Σ̂ = Io(θ̂)−1, i.e.,
the expected or observed information matrix evaluated at the m.l.e. It turns
out that the use of the observed information is preferable for a number of
reasons:
Computation: Calculation of I requires integration which is usually
intractable whereas Io is always readily available. Even if I is tractable,
one must then programme its functional form into statistical software
which can be laborious. Standard maximisation software (e.g. nlm or
optim in R) provide the Hessian matrix, H(θ̂), as part of the output
from which we can calculate Io(θ̂) = −H(θ̂). Thus, we only need to
programme the log-likelihood function to get an estimate of Σ.
Censoring : In order to calculate I, one must integrate over the data
generating process which includes both the survival and the censoring
processes. The dependence on censoring means it is impossible to cal-
culate I unless we assume a model for the censoring process - something
which we prefer to keep arbitrary (see Section 2.1.2).
Relevant Information: The superiority of Io over I was investigated
by Efron & Hinkley (1978) who argued that inference based on Io(θ̂)
is approximately conditional on relevant information from the dataset
(called ancillary information). This leads to a better estimate of Σ and,
hence, better behaved Z-scores and confidence intervals. The expected
information matrix is averaged over all possible datasets and, there-
fore, does not have access to dataset-specific information. For further
discussion see Pawitan (2001, secs. 8.3, 9.6 and 9.7) and Cox (2006,
sec. 6.6).
2.3.2 Uncertainty in Functions of the M.L.E.
In the previous section we showed how to account for uncertainty in the es-
timation of parameters via the asymptotic distribution of θ̂ given in (2.20).
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However, often we are not interested in θ̂ itself but rather a function of θ̂,
for example, the survivor function or median. Thus, methods for produc-
ing confidence intervals or hypothesis tests for such estimated functions are
required.
Delta Method
The delta method is a well known classical method for deriving the asymptotic
distribution of statistical estimates. Assuming that g(θ̂) is some function of
the m.l.e. then, as n→∞,
g(θ̂) ∼ N [g(θ),∇Tθ g(θ) Σ ∇θg(θ)], (2.24)
where ∇θ = (∂/∂θ1, . . . , ∂/∂θk)T denotes the operation of partial differenti-
ation with respect to θ and Σ = I(θ)−1 (see Pawitan (2001, sec. 4.7) and






which can be used in the usual way to test hypotheses or compute confidence
intervals.
An important special case of (2.24) arises when g(·) is a function of just
one of the estimated parameters, the jth say. In this case
g(θ̂j) ∼ N [g(θj), g
′(θj)
2σ2θj ], (2.26)
where σ2θj is the variance of θ̂j , i.e., the jth diagonal element of the covariance
matrix Σ. This is due to the fact that ∇θg(θj) = (0, . . . , 0, g′(θj), 0, . . . , 0)T .
We previously mentioned the advantages of using a model parametrisation
where θ is unconstrained; this is also relevant to g(θ). Often the range of
the function g(θ) is constrained, i.e., g(θ) ∈ C ⊂ R. Confidence intervals
based on (2.24) may have bad properties if the true value of g(θ) lies near
the upper/lower limit of C. It is typically better to transform the function
such that g∗[g(θ)] ∈ R. Using (2.26) we get
g∗[g(θ̂)] ∼ N{g∗[g(θ)], g∗′[g(θ)]2σ2g(θ)}, (2.27)
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from which we can compute a confidence interval for g∗[g(θ)]. Applying
g∗−1(·), i.e., back-transforming, gives a confidence interval for g(θ) which
remains within the constrained space C. This was discussed in Section 1.3 in
relation to the Kaplan-Meier and Nelson-Aalen estimators. In particular see
Example 1.1.
M.L.E. Simulation
The method of m.l.e. simulation is something suggested by the author that
does not seem to appear elsewhere in the literature. This is an easy to im-
plement method which avoids calculating/programming analytic derivatives:
a tedious process where we are left open to making errors.
We know that θ̂ has a multivariate normal distribution (asymptotically)
given by (2.20). We can then simulate θ̂(b) vectors, b = 1, . . . , m, directly
from
θ̂(b) ∼ N [θ̂, Io(θ̂)
−1], (2.28)
where θ̂ is the m.l.e. and Io(θ̂) is the observed information matrix in a par-
ticular application. The empirical distribution of our simulated sample of
“m.l.e.” vectors {θ̂(1), . . . , θ̂(m)} will then approximate the asymptotic dis-
tribution in (2.20) for m sufficiently large. In other words, the simulated
sample {θ̂(1), . . . , θ̂(m)} is equivalent to a sample of m.l.e. vectors arising from
m independent datasets. All we need is a routine for simulating multivariate
normal vectors; the function mvrnorm in the R package MASS does just this.
As mvrnorm can simulate a sample of 10,000 100-dimensional multivariate
normal vectors in a fraction of a second, the computational burden of setting
m large is very minimal. It is important however that θ is unconstrained for
m.l.e. simulation, i.e., θ ∈ R. Otherwise we may simulate values which are
not allowed, leading to nonsensical results.
For some function g(·), we can calculate ĝ(b) = g(θ̂(b)), b = 1, . . . , m,
to produce a univariate sample {ĝ(1), . . . , ĝ(m)} whose empirical distribution
will approximate the sampling distribution of g(θ̂). The standard deviation
of this sample gives se[g(θ̂)] if required. However, in order to construct a
(1− α)100% confidence interval for g(θ) we suggest using
[ĝα/2, ĝ1−α/2],
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where ĝα denotes the α-percentile of the simulated sample {ĝ(1), . . . , ĝ(m)}.
Note that if g(·) ∈ C ⊂ R then ĝ(b) ∈ C ∀ b, i.e., confidence intervals based on
m.l.e. simulation will always respect C without the need to transform g(θ) as
in (2.27).
It is clear that this method can be implemented easily without tedious
calculations and with much less room for error (compared with the delta
method). It may appear similar to computational Bayesian approaches which
simulate from a posterior distribution. However, we are not treating the true
parameter vector, θ, as random here; nor is (2.28) viewed as a posterior dis-
tribution. Rather, simulating from (2.28) is used as a computational tool
to approximate the asymptotic distribution of the m.l.e., θ̂. Although philo-
sophically different from the Bayesian view, a simulated sample of θ̂(b) vectors
from (2.28) may be very similar to that of a corresponding Bayesian analysis
in cases where n is large and reasonably flat priors are assumed.
Bootstrapping
The method of bootstrapping is a technique based on resampling the observed
data in order to determine the sampling distribution of statistical estimates.
This simple, widely applicable, method was first introduced by Efron (1979)
and has since become a standard computational tool in statistics (Efron &
Tibshirani, 1994; Davison & Hinkley, 1997).
The observed data {y1, . . . , yn} have an empirical distribution function
which associates a probability mass of 1/n to each observation; this empir-
ical distribution approximates the true distribution of the data. Thus we
can draw samples (of size n) {y(b)1 , . . . , y
(b)
n }, b = 1, . . . , m, from the empiri-
cal distribution which are equivalent to independent samples of data. This
is done by sampling with replacement from the original set {y1, . . . , yn}.
Note that for survival data yi = (ti, δi, x
T
i ) (Efron, 1981). Upon fitting our
assumed model to each of the m datasets, using maximum likelihood, we
attain a sample of m.l.e. vectors, {θ̂(1), . . . , θ̂(m)}. We can then calculate
ĝ(b) = g(θ̂(b)), b = 1, . . . , m, to produce a sample {ĝ(1), . . . , ĝ(m)}. As for the
method of m.l.e. simulation, we can form confidence intervals for g(θ) based
on {ĝ(1), . . . , ĝ(m)}.
Bootstrapping is a very general procedure that can be used in any situa-
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tion where replicate datasets are desired, e.g., cross validation, estimation of
prediction error or calculation of standard error for non-parametric estima-
tors. However, if we only require an estimate of the sampling distribution of
g(θ̂), as is the goal of this section, m.l.e. simulation will perform well (if n
is large enough). Moreover, m.l.e. simulation is much less computationally
expensive as it does not require refitting of the model to multiple datasets.
Example 2.2. Confidence Intervals for Weibull Survivor Function
Here we parametrise the Weibull model in terms of θ = (α, β)T ∈ R2 where
α = log γ and β = log λ respectively. Thus, the survivor function is
g(θ) = S(t | θ) = exp[− exp(β)texp(α)]. (2.29)
The delta method gives
σ̂2g = ∇
T
θ g(θ̂) Σ̂ ∇θg(θ̂),
where∇θg(θ) = [− exp(β) exp(α)texp(α)S(t | θ) log t, − exp(β)texp(α)S(t | θ) ]T ,
and Σ̂ = I−1o (θ̂). Therefore
g(θ̂)± 1.96σ̂g (2.30)
is the corresponding 95% confidence interval (which depends on t). Given
that g(θ) ∈ [0, 1] we can apply the transformation g∗(·) = log[− log(·)]






A 95% confidence interval for g∗[g(θ)] is then given by g∗[g(θ̂)] ± 1.96σ̂g∗◦g.
Back-transforming, i.e., applying g∗−1(·) = exp[− exp(·)], gives
g(θ̂)exp(±σ̂g∗◦g) = g(θ̂)exp{±σ̂g/[g(θ̂) log g(θ̂)]}, (2.31)
which is a 95% confidence interval for g(θ) constrained to lie in [0, 1].
We fitted the Weibull model to three subsets of the lung cancer dataset,
namely: (i) individuals aged 90 and older, (ii) individuals aged 86 - 90 and
(iii) individuals aged 82 - 86. We also fitted the model to (iv) the full lung
cancer dataset. The sample sizes are 6, 19, 58 and 855 respectively. For
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each fitted model we evaluated the survivor function (2.29) at 100 values of
t ranging from t = 0 to t = 20. The corresponding 95% confidence intervals
(at each t value) were calculated analytically using the delta method, (2.30),
and the transformed delta method, (2.31). Additionally, 95% confidence
intervals were calculated using m.l.e. simulation and bootstrapping, both
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Figure 2.2. Confidence intervals for estimated survivor curves calcu-
lated using the delta method, transformed delta method, m.l.e. simulation
and bootstrapping.
We can see that, for the 90+ group (n = 6) the delta method produces
confidence intervals which breach the [0, 1] bounds; this is rectified using the
transformed delta method. This breach of allowable bounds is much less
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prominent for the 86 - 90 group (n = 19) and, moreover, there is little dif-
ference between the confidence intervals produced by any of the methods.
For the 82 - 86 group (n = 58), and also for the full dataset, the confidence
intervals are virtually indistinguishable. Thus we can see that, even for rel-
atively small datasets, the methods produce similar results. Furthermore, in
Section 3.6.4, we carry out a simulation study to evaluate confidence inter-
vals constructed using m.l.e. simulation and the delta method; again we find
close agreement.
As the methods produce similar results, we must be aware of the ease of
implementation and the computational expense required. We have already
established that both m.l.e. simulation and bootstrapping require very little
effort to implement as calculation/programming of derivatives is not required.
In order to determine computational expense we recorded the time taken to
produce the confidence intervals shown in Fig. 2.2. These times are displayed
in Table 2.3 and exclude the time taken to initially fit the model, as this is
something that must be carried out in any case.
Table 2.3. Time Taken (in seconds) to Produce Confidence Intervals in Fig. 2.2
Group n Delta Delta g∗ M.l.e. Sim. Boot. Boot. 0.01
Time
age ≥ 90 6 0.007 0.007 0.109 12.877 17.357
86 ≤ age < 90 19 0.006 0.007 0.110 13.302 18.915
82 ≤ age < 86 58 0.005 0.009 0.110 13.155 20.504
All ages 855 0.006 0.008 0.110 27.815 44.340
Relative to
age ≥ 90 6 1.00 1.00 15.57 1839.57 2479.57
Delta
86 ≤ age < 90 19 1.00 1.17 18.33 2217.00 3152.50
82 ≤ age < 86 58 1.00 1.80 22.00 2631.00 4100.80
All ages 855 1.00 1.33 18.33 4635.83 7390.00
Relative to
age ≥ 90 6 0.06 0.06 1.00 118.14 159.24
M.l.e. Sim
86 ≤ age < 90 19 0.05 0.06 1.00 120.93 171.95
82 ≤ age < 86 58 0.05 0.08 1.00 119.59 186.40
All ages 855 0.05 0.07 1.00 252.86 403.09
Note: Times shown above are in fact averages over 50 repetitions (carried out on an
Intel® Core i7 620M 2.67 Ghz). This was done to absorb any random fluctuations
in computation time.
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The table shows two versions of the bootstrap, namely: “Boot.” and
“Boot. 0.01”. The former uses the m.l.e., θ̂ = (α̂, β̂)T , from the initial model
fit, as a starting value for the Newton-Raphson algorithm in each of the
1000 bootstrapped fits. The latter uses generic starting values: (0.01, 0.01)T .
Since each bootstrapped dataset will not be vastly different from the original
dataset, we expect that θ̂(b) ≈ θ̂, b = 1, . . . , 1000. Thus, using θ̂ as a starting
value should help the Newton-Raphson algorithm to converge to θ̂(b) more
quickly; this indeed turned out to be the case as we can see from Table
2.3. Even with this speed-up however, the bootstrap takes much longer
than the delta method or m.l.e. simulation. Obviously, for larger sample
sizes (e.g., when n = 855) the bootstrap time increases as we must refit the
model 1000 times to large replicate datasets. Neither the delta method nor
m.l.e. simulation depend on sample size; the former is instantaneous whilst
the latter takes a fraction of a second. Thus, we favour m.l.e. simulation in




In a simulation study we generate data from a known statistical model. This
gives us access to something we rarely have in reality - the truth. Accordingly,
we can investigate a variety of model properties, in a controlled environment,
affording us useful knowledge which is transferable to our applied work. First
we must choose a model from which we will simulate, f(t | θ), and values
for the elements of the simulation scenario vector - sample size, censored
proportion and parameter values - denoted by (n, p, θ) ∈ N × P × Θ = S.
The scenario space, S, is the set of all scenarios to be considered in our
simulation study and is of finite dimension, i.e., dim(S) = r ≪ ∞. For a
particular scenario sk = (nk, pk, θk), k = 1, . . . , r, we proceed as follows:
1. Generate data from f(t) for scenario sk.
2. Fit a model to these data.
3. Compute/store quantities of interest - simulation responses.
4. Repeat the steps 1 - 3 m times to produce simulation replicates.
We carry out the above procedure for all sk ∈ S in order to explore the
behaviour of the responses across the scenario space. Thus, we could employ
the use of standard experimental design techniques to design our simulation
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study efficiently; this fact is touched on in Ripley (1987, sec. 5.5) and is
the subject of Kleijnen (2008). However, we will opt for a full factorial
design in our simulation work, i.e., dim(S) = dim(N ) · dim(P) · dim(Θ).
Uncertainty can be reduced to any desired level by increasing the number of
replicates (which only depends on our patience in waiting for the results of
our simulation). As noted by Ripley (1987): “randomness was introduced
by the experimenter and hence is under his or her complete control”. Thus,
sufficient reduction in uncertainty enables “proof” by simulation.
3.2 Reasons for Simulating
The objective of analysing simulation experiments is to answer questions on
properties of statistical models. As we ultimately apply these models to real
data, understanding their properties reinforces such applications. Some items
of potential interest, which can be investigated by simulation, are outlined
below (for further information on the uses of simulation see Ripley (1987)). We may wish to discover how well features of f(t | θ) (e.g., the survivor
function, hazard function, median survival time etc.) can be recovered
using f(t | θ̂). By monitoring these estimates over the scenario space,
we can determine how badly inference may be compromised in less than
ideal situations, e.g., small sample size with high censoring. Standard likelihood theory (Chapter 2) says that θ̂ is an unbiased es-
timator of θ and follows a multivariate normal distribution asymp-
totically. By examining the sets of m.l.e. vectors {θ̂(k)1 , . . . , θ̂
(k)
m }, for
k = 1, . . . , r, we can determine when such asymptotic theory is rea-
sonable. Furthermore, we can investigate the properties of confidence
intervals for parameters, or functions of parameters, and check that
they have the correct coverage, i.e., that 95% confidence intervals in-
clude the true parameter 95% of the time. We can generate data from f1(t) and fit an alternative model, f2(t),
to these data. In this way we can understand how well a misspecified
model can perform (cf. Ha & MacKenzie (2010)).
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asymptotic independence of parameter estimates (Cox & Reid, 1987).
It is possible to determine orthogonality (or lack thereof) analytically in
terms of the expected information matrix but, as mentioned in Section
2.3.1, the expected information matrix can be difficult to work out
(particularly when censoring is present). However, it is easy to calculate
the simulation-based correlation matrix for estimated parameters (in a
given scenario) using the fact that we have m replicates of θ̂. Moreover,
we can examine the pattern of correlation across the scenario space. In a regression setting it is useful to know how often important covari-
ates can be found using a particular variable selection procedure. We
can check this by simulation and compare different procedures.
With everything under our “complete control” we may investigate any
model property of interest. In certain cases deriving analytic results is dif-
ficult/impossible, whereas a simulation study can easily be carried out to
uncover the necessary results. Furthermore, advances in modern comput-
ing power make large-scale simulation studies feasible which, therefore, make
complicated modelling questions accessible.
As is clear from the above, simulation is very powerful. However, it does
have its limitations. Firstly, a statistical model is just that: a model, or ideal-
isation, of reality (see Section 2.2). Real life data-generating mechanisms are
complex and may potentially be so complex that they cannot be expressed
as a mathematical formula. However, we simulate data from models which
typically have a relatively simple mathematical form. A second issue is that
there is nothing to prevent us from simulating scenarios which lead to unre-
alistic data. We may choose a very implausible point on the parameter space
leading to simulated data unlike anything found in practice.
Of course, the above criticisms do not invalidate any simulation study
from a mathematical perspective; all results are still relevant within the
framework of the simulation, i.e., for the given model and scenario space.
However, these findings may not be exactly reproducible in real life applica-
tions where, for example, there are many more sources of variation than our
theoretical model can allow for. If desired, we can generate data which more
58 CHAPTER 3. SIMULATING SURVIVAL DATA
closely resemble real data through data directed simulation. This involves us-
ing experience fitting models to real data to inform us as to what parameter
values typically arise in reality. However, it is worth noting that the ability
to simulate “unrealistic” data can also be seen as a strength; we can explore,
for example, limiting cases on the boundary of the scenario space. Indeed,
just because we have not seen such data, does not mean we will not.
3.3 Inverse Survivor Function
We simulate using the method of inversion which is based on the well-known
fact that, for any distribution, the corresponding cumulative distribution
function, F (t), is uniformly distributed on [0, 1] (see Devroye (1986, sec. 2.2)).
This implies that the survivor function, S(t), is also uniformly distributed
on [0, 1]. Thus, given U ∼ Uniform(0, 1),
S(T ) ∼ U ⇒ T ∼ S−1(U), (3.1)
where we use S(t) rather than F (t) due its central role in survival analysis.
Therefore, upon generating a sample of uniform variables, {u1, . . . , un}, we
can produce a sample of survival times using (3.1): {t1 = S−1(u1), . . . , tn =
S−1(un)}. Note that we have given the functional form of S−1(·) for a variety
of commonly used survival distributions in Section 1.4.
We may also wish to simulate data which depend on covariates. In this
case we must first generate a vector of covariates for each individual xi =
(x1i, . . . , xpi)
T , i = 1, . . . , n. We can then allow the model parameters to
depend on these covariates in some way, i.e., θi = g(xi) for some function
g(·). Our sample of survival times, which depend on covariates, is then
{t1 = S−1(u1 | x1, θ1), . . . , tn = S−1(un | xn, θn)}. For more information on
regression models see Chapters 4 and 5.
The above clearly depends on our ability to generate {u1, . . . , un}. Com-
puter algorithms used to produce such a sample aim to mimic randomness but
are, in fact, deterministic; the jth number is constructed using the sequence
of numbers preceding it. Thus, such a sample is referred to as pseudo-random.
Generating a sample of pseudo-random variables, and assessing their proper-
ties, is non-trivial. This specialist topic is covered in detail in Gentle (2003,
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chaps. 1-3) (see also Devroye (1986, chap. 1) and Ripley (1987, chap. 2)).
Modern software typically provides uniform generators with good properties,
for example, runif in R. There is no need for the uninformed user to try to
create their own routines as these are highly unlikely to surpass the quality
of those provided by existing software.
3.4 Random Censoring
In the previous section we have shown how to simulate uncensored survival
data. As we typically have censored data in practice, we would like to in-
corporate this feature in our simulated data. Here we use random censoring
as a mechanism for censoring simulated observations. Using the notation
of Section 2.1.2, we let T̃ and C represent the event time and the censor-
ing time respectively. These random variables are independent with density
functions given by f(t | θ) and g(t | φ), and survivor functions given by S(t | θ)
and G(t | φ) respectively. Using (3.1), we generate
T̃ = S−1(U1) and C = G
−1(U2), (3.2)
where U1 ⊥ U2 ⇒ T̃ ⊥ C. The observed survival time is then given by
T = min(T̃ , C) and the censoring indicator is δ = 1(T̃ ≤ C) = 1(T = T̃ ).
Thus, from a simulated sample {(u11, u21), . . . , (u1n, u2n)}, a censored sample
of survival data, {(t1, δ1), . . . , (tn, δn)}, is produced.
We now show how to control the censored proportion in a simulated
sample by following the work of MacKenzie (1994). The probability that T
is a censoring time is given by
p = Pr(T̃ > C) =
∫ ∞
0








S(t | θ)g(t | φ) dt. (3.3)
We would like to be able to generate data with a prespecified censored pro-
portion, pfix, so that we can determine the effect of varying its value. In
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(3.3) above, p is implied by the chosen values of θ and φ. However, we are
generally only interested in the value of θ and prefer φ to be implied by the
chosen values of θ and pfix. Therefore, setting θ in advance, we consider p




S(t | θ)g(t | φ) dt.




S(t | θ)φ exp(−φt) dt, (3.4)
and φ is chosen as the solution of p(φ) = pfix, i.e., φ = p
−1(pfix) where p
−1(·)
is the inverse of (3.4). This φ value ensures that the proportion censored in a
simulated sample is approximately equal to pfix, i.e., 1−
∑n
i=1 δi/n ≈ pfix. If
we wish, we can iteratively generate data (using a while loop) until we arrive
at a dataset where the censored proportion is exactly equal to pfix.
If our simulated data depends on covariates then, as mentioned in Section




S(t | θi)φ exp(−φt) dt. (3.5)
If there are n distinct covariate profiles then there are n distinct θi values,
each with a corresponding φ value: φi = p
−1
i (pfix) for i = 1, . . . , n. However,
if there are m < n covariate profiles then we only need to invert (3.5) m
times, e.g., if our simulated data depend on a single binary covariate then
there are only two θ values and, hence, two φ values.
The functional form of (3.4) (or (3.5)) is typically not analytic and must
be approximated using numerical integration. Therefore, p−1(·) is itself non-
analytic and our desired φ value does not have a closed-form solution. How-
ever, MacKenzie’s J-function, given by
J(φ) = [pfix − p(φ)]
2, (3.6)
can be minimised using numerical optimisation to yield the φ value for which
p(φ) is closest to pfix (MacKenzie, 1994). It is worth mentioning a simple case
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3.5 Extension to Include Cure Rate Models
Cure rate models (also known as defective or tail deficit models) are those
supporting survivor curves which do not fall to zero but to some positive
limit, i.e., limt→∞ S(t) 6= 0. The Gompertz and time-dependent logistic
models (Sections 1.4.3 and 1.4.6) are both examples of cure rate models.
In particular, these two models imply a cured proportion when their shape
parameter, γ, is negative. Thus, we generalise the method of MacKenzie
(1994) described in the previous section in order to facilitate the simulation
of cure rate data.
First we define pcure = limt→∞ S(t), the cured proportion. Following
Section 3.4, we simulate data based on the method of inversion and assume
random censoring. However, in the case of a cure rate model
T̃ =
{
S−1(U1) if U1 < 1− pcure
∞ if U1 ≥ 1− pcure,
(3.7)
i.e., the model generates cured individuals with probability pcure and these
individuals have a survival time of infinity. This intuitively means that such
individuals never experience the event. As before, censoring times are gen-
erated via C = G−1(U2).
In this setting the censored proportion is
p = Pr(T̃ > C)
= Pr(T̃ > C ∩ T̃ <∞) + Pr(T̃ > C ∩ T̃ =∞)
= Pr(T̃ <∞) Pr(T̃ > C | T̃ <∞) + Pr(T̃ =∞) Pr(T̃ > C | T̃ =∞)
= (1− pcure) p
∗ + pcure, (3.8)
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where the last line comes from fact that all cured individuals are censored
by definition, i.e., Pr(T̃ > C | T̃ = ∞) = 1. Note also that we have defined
p∗ = Pr(T̃ > C | T̃ < ∞) which is the censored proportion in the non-cured
individuals. The value of pcure is implied by the parameter vector θ and
therefore, in order to control p, we must control p∗. It is clear from (3.8) that
we now have a lower bound on p, i.e., p ≥ pcure.
As in Section 3.4, we assume that C ∼ Exp(φ). However, in the case of
cure rate data we choose a value of φ such that p∗(φ) = p∗fix where p
∗
fix is a
prespecified censored proportion for the non-cured individuals. Considering





where p(φ) is still defined as in (3.4). Thus, φ is chosen as the solution of
p∗(φ) = p∗fix. To this end, we define the J
∗-function (generalising MacKenzie’s
J-function):
J∗(φ) = [p∗fix − p
∗(φ)]2, (3.10)
which is minimised using numerical methods. The solution of the J∗-function
produces a φ value such that 1 −
∑n
i=1 δi1(t̃i < ∞)/
∑n
i=1 1(t̃i < ∞) ≈ p
∗
fix
in any simulated sample. Furthermore, we may wish to iteratively generate
data (using a while loop) until we arrive at a dataset where this proportion
is exactly equal to p∗fix.
In the case where parameters depend on covariates we have θi = θ(xi),





where pi(φ) is defined in (3.5) and J
∗





2 must be solved for
i = 1, . . . , n. In this case the overall censored proportion is
p = (1− p̄cure) pfix + p̄cure, (3.12)
where p̄cure =
∑n
i=1 pcure,i/n and is the lower bound of p.
Clearly the above can be used as a general procedure for simulating sur-
vival data: both cure rate and standard survival models. In the latter case,
pcure = 0 and hence p
∗ = p, p∗fix = pfix and J
∗ = J .
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3.6 Some Simulation Studies
We simulated data from a Weibull model with parameter vector θ = (α =
log γ, β = log λ)T . In total there were 24 = 16 simulation scenarios arising
from all combinations of values shown in Table. 3.1. Each of the 16 scenarios
Table 3.1. Simulation Settings
n p α β
Values
100 20% -0.8 -0.8
1000 80% 0.8 0.8
was repeated 1000 times. At each repetition we fitted a Weibull model (i.e.,
the true model) to the simulated data. All of the studies below (except that
of Section 3.6.5) are based on this simulation setup and are intended to show
some of the uses of simulation (as mentioned in Section 3.2).
3.6.1 True Model Versus an Incorrect Model
In addition to fitting the true (Weibull) model to the simulated data, we
also fitted a log-logistic model. At each repetition of a particular scenario we
calculated the difference between AIC values,
∆AIC,j = AIClog-logistic,j −AICWeibull,j,








The average AIC differences from all scenarios are shown in Table 3.2.
All ∆̄AIC are positive which means that the true model provides a better
fit on average. It is clear that ∆̄AIC increases as information increases (i.e.,
n ↑ or p ↓) which we would expect; it is well-known that it is easier to choose
among competing models/hypotheses when the level of information is high.
In addition to this, the ∆̄AIC value is lower for α = −0.8 compared with
α = 0.8. This is also to be expected given the shapes of hazard supported
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Table 3.2. Average AIC Differences
n 100 1000















by the two models (see Section 1.4). When α > 0 the Weibull hazard is
increasing monotonically whereas the closest shape supported by the log-
logistic model is a hazard that increases to a peak followed by monotonic
decrease. On the other hand, when α < 0 the Weibull hazard is decreasing
monotonically which is a hazard shape also supported by the log-logistic
model.
We denote by (a) and (b) the scenarios with (n, p, α, β) = (100, 80%,−0.8,
−0.8) and (n, p, α, β) = (1000, 20%, 0.8,−0.8) respectively. These represent
cases where the fitted models are both difficult and easy to distinguish from
each other (as ∆̄aAIC = 0.0 and ∆̄
b
AIC = 91.9 respectively). In these scenarios
we now judge the fit provided by both models in terms of their estimated
survivor and hazard functions. The average estimated survivor curve (arising







where Ŝj(t) = S(t | α̂j, β̂j) is the jth (j = 1, . . . , 1000) estimated survivor
curve evaluated at time t. The corresponding 95% confidence intervals are
given by percentile 2.5 and 97.5 in the sample {Ŝ1(t), . . . , Ŝ1000(t)}. We can
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also calculate the average estimated hazard function, and corresponding 95%
confidence interval, in the same way.
Figure 3.1 compares the average estimated survivor and hazard curves
(using both fitted models) with the true curves in scenario (a) and (b). The
results are in agreement with the AIC values: the two models provide a
similar fit to the data arising from scenario (a) whereas the failings of the
log-logistic model are clear for scenario (b) where, as previously noted, this




































































Figure 3.1. Average estimated survivor and hazard curves (solid) with
95% confidence intervals (dash) for two scenarios: (a) (n, p, α, β) =
(100, 80%,−0.8,−0.8) and (b) (n, p, α, β) = (1000, 20%, 0.8,−0.8).
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3.6.2 Extrapolating Beyond the Data
In Fig. 3.1 we have not evaluated the survivor curves in scenario (a) to the
point where they are near zero. This is because the estimated curves are
evaluated at time-points within the range of the data. In this particular sce-
nario no observed time was greater than t = 2.5, due to the high probability
of being censored. Thus, we can say that the two models fit the data ade-
quately given the information at hand. Figure 3.2 shows what happens if we






































Figure 3.2. Extrapolating estimated survivor and hazard curves
beyond the range of the data for scenario (a) where (n, p, α, β) =
(100, 80%,−0.8,−0.8). Average curves (solid) with C.I. (dash) shown.
We can see that the log-logistic hazard decreases faster than the true
hazard which results in overestimated survival probabilities. The Weibull
estimate remains close to the truth as it is the correct model. Thus, either
model is suitable for describing the data within the observed time range
(t = 0 to t = 2.5) but only the correct model maintains suitability beyond
this. In reality we typically do not know which model is the correct model
(or if any fitted model is “correct”). It is therefore very risky to extrapolate
any estimated quantity too far beyond the data. This advice is, of course,
well-known but has been confirmed by our simulation (See Sections 3.6.5
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and 3.6.6 also where we investigate the estimation of a cured proportion, i.e.,
extrapolating the survivor curve to t =∞).
3.6.3 Bias, S.E. and Correlation in Estimates
Here we investigate the bias in estimating parameters for the fitted Weibull
model (as this is the data generating model). We also look at the standard
error in these estimates and the correlation between them. In each scenario












where α̂j and β̂j are the estimated parameters from the jth repetition (j =
1, . . . , 1000) of that scenario. Similarly, we calculated the average relative






















The results are summarised in Table 3.3.
Clearly bias decreases as information increases (i.e., n ↑ or p ↓). Bias
is larger when less information is available, as we may expect, but is not
alarmingly high even in the worst case scenario with n = 100 and p = 80%.
This explains why we could extrapolate beyond the data reliably using the
Weibull model in Fig. 3.2 where (n, p, α, β) = (100, 80%,−0.8,−0.8); even
though information is low, the bias in θ̂ = (α̂, β̂)T remains relatively low
(on average) and we can recover the true survivor and hazard functions (on
average). Turning our attention to the standard errors, we can see that they
decrease as information increases (i.e., n ↑ or p ↓).
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Table 3.3. Average Parameter Estimates with Standard Error and Relative Bias
n p α β α̂ S.E. R.Bias β̂ S.E. R.Bias
20%
-0.8
-0.8 -0.791 (0.089) 0.011 -0.808 (0.122) -0.010
0.8 -0.789 (0.095) 0.014 0.810 (0.092) 0.013
0.8
-0.8 0.807 (0.085) 0.008 -0.797 (0.148) 0.004




-0.8 -0.779 (0.209) 0.026 -0.775 (0.139) 0.032
0.8 -0.778 (0.204) 0.028 0.897 (0.488) 0.122
0.8
-0.8 0.839 (0.162) 0.048 -0.792 (0.179) 0.010
0.8 0.819 (0.154) 0.024 0.863 (0.301) 0.079
20%
-0.8
-0.8 -0.799 (0.028) 0.001 -0.800 (0.038) 0.000
0.8 -0.801 (0.028) -0.001 0.801 (0.028) 0.002
0.8
-0.8 0.802 (0.028) 0.002 -0.802 (0.047) -0.003




-0.8 -0.798 (0.064) 0.002 -0.797 (0.042) 0.004
0.8 -0.798 (0.061) 0.002 0.808 (0.137) 0.011
0.8
-0.8 0.803 (0.048) 0.004 -0.800 (0.055) 0.000
0.8 0.804 (0.047) 0.005 0.808 (0.092) 0.010
Plotting the estimated parameters against each other (Fig. 3.3) reveals
that the estimates tend to be quite correlated with each other in general (see
Table 3.4 for corresponding correlation values). Moreover, the correlation
increases when p increases except in the case with (α, β) = (0.8,−0.8) where
correlation becomes lower. We can see that all scatter plots are centred at
the true values in all cases which, in light of Table 3.3, is to be expected.
Similarly, the precision of the estimates, and how it depends on n and p, can
be clearly visualised from these scatter plots.























Figure 3.3. Scatter plots of estimated regression coefficients for each
scenario with least squares line (red) overlayed. Reference lines (grey)
at the true parameter values are also shown.
Table 3.4. Correlation Between Estimates
n 100 1000
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When parameter estimates are highly correlated, the stability of the esti-
mation procedure, and reliability of such estimates, may be of concern (Lee
& Whitmore, 2006). However, in our simulation work, the models fitted the
simulated data without issue (using the Newton-Raphson method) despite
the fact that the parameter estimates are correlated. Furthermore, the esti-
mates are unbiased (as seen in Table 3.3) and we can recover quantities of
interest such as the survivor or hazard function (Fig. 3.1). Thus, we conclude
that, even in cases where estimated parameters are correlated or information
is low, the estimation procedure remains stable.
3.6.4 Delta Method Versus M.L.E. Simulation
Here we compare our proposed method of m.l.e. simulation with the classical
delta method (both described in Section 2.3.2). In Example 2.2 we showed
a case where the resulting confidence intervals are numerically very close.
From that we may conjecture that the coverage provided by either method
should also be quite similar1. We investigate this now, more formally, by
simulation. We will produce confidence intervals for two quantities, namely:
(i) the median, t0.5, and (ii) S(t0.99), i.e., the survivor function evaluated at
the 99th percentile. Note that the value of the median depends on the (α, β)
combination whereas S(t0.99) ≡ 0.01.
The confidence intervals are based on fitting the Weibull model (the true
model) to the simulated data. In the case of the median (i.e., g(θ) =
t0.5 = [exp(−β) log 2]exp(−α)), the estimated variance is given by σ̂2t0.5 =
∇θ t̂T0.5 Σ̂ ∇θ t̂0.5 where ∇θt0.5 = [−t0.5 log t0.5, − exp(−α)t0.5 ]
T , t̂0.5 = g(θ̂)
and Σ̂ = I−1o (θ̂). Thus, the delta method gives the 95% confidence interval
t̂0.5 ± 1.96σ̂t0.5 . (3.16)
Given that the median is constrained to be positive, we also applied the
transformation g∗(·) = log(·) ⇒ log t0.5 ∈ (−∞,∞). Using the fact that
(log x)′ = 1/x, we get σ̂2log t0.5 = σ̂
2
t0.5/(t̂0.5)
2 and the 95% confidence interval
for log t0.5 is then given by log t̂0.5± 1.96σ̂log t0.5 . Back-transforming gives the
1Of course this does not guarantee that either method attains the specified level of
confidence.
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transformed delta method 95% confidence interval
t̂0.5 exp(±σ̂t0.5/t̂0.5), (3.17)
which is constrained to lie in [0,∞). In the case of S(t0.99), confidence inter-
vals, produced using the delta method and transformed delta method, can
be calculated using the algebra in Example 2.2.
The method of m.l.e. simulation (with 1000 replicates) provides us with
samples {t̂(1)0.5, . . . , t̂
(1000)
0.5 } and {Ŝ(t0.99)
(1), . . . , Ŝ(t0.99)
(1000)}. Confidence in-
tervals for t0.5 and S(t0.99) are then formed by selecting percentiles 2.5 and
97.5 from each sample; these confidence intervals will always lie within the
allowable range of each quantity.
For each of the 16 simulation scenarios, confidence intervals for t0.5 and
S(t0.99) were constructed using the delta method, transformed delta method
and m.l.e. simulation as described above. The coverage percentage associated






1(lj ≤ g(θ) ≤ uj)
]
× 100,
where g(θ) is one of the quantities of interest (either t0.5 or S(t0.99)) and
[lj, uj] is the 95% confidence interval for g(θ) in the jth repetition of the
particular simulation scenario. The results are given in Table 3.5.
With respect to the confidence intervals for t0.5, all methods have very
similar coverage levels. The only exceptions to this are the cases where
(n, p, α, β) = (100, 80%,−0.8,−0.8) and (n, p, α, β) = (100, 80%,−0.8, 0.8).
It is noteworthy that, for all methods, coverage is almost uniformly higher
than the stated 95%. While one may wish to address this issue, it is not our
intention to do so. We only aim to show that the method of m.l.e. simulation
produces results similar to more conventional methods without the burden
of calculating/programming analytic derivatives. Turning to the confidence
intervals for S(t0.99) we can see that those constructed using the untrans-
formed delta method have very bad properties when the level of information
is lower, i.e., coverage much lower than 95%, whereas the transformed delta
method and m.l.e. simulation have better coverage.
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Table 3.5. Coverage Percentage for Confidence Intervals Calculated Using the Delta
Method, Transformed Delta Method and M.L.E. Simulation
n 100 1000
p α β Delta Delta g∗ M. Sim. Delta Delta g∗ M. Sim.
Coverage of 95% C.I.s for t0.5
20%
-0.8
-0.8 97.3 98.4 98.9 98.4 98.3 98.5
0.8 98.1 98.4 98.5 98.4 98.5 98.2
0.8
-0.8 93.6 94.0 93.5 95.1 94.8 94.7
0.8 95.3 95.0 95.7 96.1 96.1 96.0
80%
-0.8
-0.8 93.0 97.4 99.0 98.6 99.5 99.2
0.8 93.4 98.0 99.5 98.6 99.8 99.7
0.8
-0.8 96.4 97.1 98.0 98.6 98.6 98.5
0.8 97.3 97.4 98.2 98.3 98.4 98.4
Coverage of 95% C.I.s for S(t0.99)
20%
-0.8
-0.8 92.6 98.4 98.0 97.0 98.9 98.3
0.8 90.8 97.9 97.8 98.3 99.5 99.3
0.8
-0.8 86.2 94.6 94.1 94.2 95.5 95.1
0.8 87.8 95.6 95.6 93.6 95.6 95.4
80%
-0.8
-0.8 69.4 95.0 95.6 88.6 96.5 96.2
0.8 72.5 97.1 96.6 89.4 96.5 96.6
0.8
-0.8 70.8 97.2 95.0 91.7 95.3 95.1
0.8 75.6 95.9 95.9 90.3 95.6 95.1
We now look at some of the individual confidence intervals produced
using the three methods for the two quantities of interest. In particular
Fig. 3.4 shows confidence intervals for the first 50 repetitions of the first sce-
nario, (n, p, α, β) = (100, 20%,−0.8,−0.8), where t0.5 ≈ 2.6 and, of course,
S(t0.99) = 0.01. We can see that all confidence intervals for t0.5 are numeri-
cally quite close. The defect in the confidence intervals for S(t0.99) produced
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using the untransformed delta method is clear: they extend below zero and



























Figure 3.4. Confidence intervals for the first 50 repetitions of the first
simulation scenario, (n, p, α, β) = (100, 20%,−0.8,−0.8). Horizontal
reference lines are shown at the true values.
This study shows that m.l.e. simulation produces results which are com-
parable to standard methods. In particular, the confidence intervals are
numerically closer to the transformed delta method; both methods respect
the allowable range of g(θ) which is advantageous. Thus, we conclude that
m.l.e. simulation is a useful and easily applied method for constructing con-
fidence intervals for functions of the parameters.
74 CHAPTER 3. SIMULATING SURVIVAL DATA
3.6.5 Estimating the Cured Proportion
In this simulation study we investigate the properties of estimating the pro-
portion of cured individuals in a dataset. Thus, we simulated data from a
Gompertz model with parameter vector θ = (α = γ, β = log λ)T . However,
rather than setting α and β values, we set pcure and β. The implied α value





as pcure = S(∞) = exp [exp(β)/α] for the Gompertz model.
In total there were 24 = 16 simulation scenarios arising from all combina-
tions of values shown in Table. 3.6. Each of the 16 scenarios was repeated
Table 3.6. Simulation Settings
n p∗ pcure β
Values
100 20% 30% -0.8
1000 80% 60% 0.8
Note: Recall that, for cure rate data, the cen-
sored proportion applies to the non-cured indi-
viduals which we denote by p∗ (see Section 3.5).
1000 times. At each repetition we fitted a Gompertz model (i.e., the true
model) to the simulated data from which we estimated the cured proportion
via p̂cure = exp[exp(β̂)/α̂]. Furthermore, the average estimate, relative bias
and standard error were calculated for each scenario (analogous to (3.13),
(3.14) and (3.15) respectively).
The results are shown in Table 3.7 and are very clear. When the censored
proportion of non-cured individuals is low (p∗ = 20%), p̂cure is unbiased with
a small standard error. However, when p∗ is higher (= 80%), the estimation
of pcure becomes more unstable, i.e., we observe bias (which is worse when
pcure is higher) and large standard errors. Furthermore, the bias and large
standard errors persist even at larger sample sizes. In other words, it is
hard to recover the true value of pcure when the censored proportion (of the
non-cured individuals) is high. Note that pcure is a tail probability and it
is well known that the presence of (high) censoring obscures our ability to
estimate the tail reliably as it is not observed in the data. Clearly, we are
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extrapolating beyond the data (i.e., to time infinity) when estimating the
cured proportion and, of course, extrapolation is always advised against (as
discussed in Section 3.6.2).
Table 3.7. Estimates of Cured Proportion for Gompertz Data
n 100 1000
p∗ pcure β p̂cure S.E. R.Bias p̂cure S.E. R.Bias
20%
30%
-0.8 0.299 (0.061) -0.005 0.300 (0.019) 0.000
0.8 0.298 (0.061) -0.005 0.300 (0.019) 0.000
60%
-0.8 0.596 (0.062) -0.006 0.599 (0.018) -0.001
0.8 0.600 (0.058) 0.000 0.600 (0.019) 0.000
80%
30%
-0.8 0.322 (0.303) 0.074 0.280 (0.180) -0.067
0.8 0.309 (0.297) 0.030 0.289 (0.183) -0.037
60%
-0.8 0.467 (0.371) -0.221 0.519 (0.237) -0.134
0.8 0.504 (0.364) -0.159 0.522 (0.229) -0.130
The numerical findings of this simulation study are in line with previous
anecdotal evidence in the literature. Farewell (1982) found that “for some
data sets the likelihood function . . . may be quite flat (over a range of pcure
values)”. Based on our simulation work, it seems very likely that these data
sets contained a large proportion of censored individuals. Indeed, Lawless
(2003, p. 183) noted that “in settings where censoring is heavy . . . an impre-
cise estimate of (pcure is observed)”. Lambert et al. (2007) also discuss the
instability of cure proportion estimates.
3.6.6 Decreasing Hazards or Cured Proportion?
We continue with our investigation of cure rate modelling. In particular, for
the Gompertz model (and also the time-dependent logistic model), a negative
value of the shape parameter implies both a decreasing hazard and a cured
proportion. Of course, this is plausible in itself: a proportion of individuals
never experience an event and, hence, the hazard decreases over time. How-
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ever, in other models (e.g., the Weibull) a decreasing hazard does not imply a
cured proportion. In these models events occur less frequently over time but
eventually every individual experiences an event. This suggests that, if the
latter case is true, a Gompertz model will imply a cured proportion when, in
fact, it does not exist.
In order to investigate the above conjecture, we fitted the Gompertz
model to the simulated Weibull data (described in Table 3.1) and estimated
the cured proportion. For each scenario, we calculated the average estimate
and the standard error (over 1000 replications). The results are shown in
Table 3.8.
Table 3.8. Estimates of Cured Proportion for Non-Cure (Weibull) Data
n 100 1000
p α β p̂cure S.E. p̂cure S.E.
20%
-0.8
-0.8 0.077 (0.022) 0.075 (0.007)
0.8 0.075 (0.023) 0.075 (0.007)
0.8
-0.8 0.000 (0.000) 0.000 (0.000)
0.8 0.000 (0.000) 0.000 (0.000)
80%
-0.8
-0.8 0.653 (0.101) 0.667 (0.023)
0.8 0.654 (0.098) 0.667 (0.023)
0.8
-0.8 0.000 (0.000) 0.000 (0.000)
0.8 0.000 (0.000) 0.000 (0.000)
The findings are as expected. In order for the Gompertz model to fit the
situation of decreasing hazards, it must also imply a cure rate. Thus, when-
ever α = −0.8 for the Weibull model, the fitted Gompertz model estimates
a non-zero cure probability (the value of which is very high when censoring
is high). Note that the standard errors are small (especially when n = 1000)
meaning that model consistently (but incorrectly) assigns a cured proportion
to the data.
The Gompertz model is constrained in the sense that the cured proportion
and the shape of the hazard are controlled by the same parameter (this
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also applies to the time-dependent logistic model). Thus, the classical cure
mixture model (Boag, 1949; Berkson & Gage, 1952; Farewell, 1977, 1982,
1986; Maller & Zhou, 1995) which is defined by
S(t) = (1− pcure)S0(t) + pcure, (3.19)
may seem preferable as pcure is a free parameter. Here S0(t) is the survivor
curve for the non-cured individuals, for example, if S0(t) is a Weibull survivor
curve then the model has three parameters and can, in theory, distinguish
between the two types of decreasing hazard mentioned above (i.e., decreas-
ing due to cure or simply decreasing). However, Farewell (1986) noted that
“there is a degree of non-identifiability” between pcure and the shape param-
eters of S0(t) in this mixture model for some data sets (i.e., when censoring
rate is high). Thus, even though the Weibull mixture model has three pa-
rameters, it can behave as if it has two when the information is low. This is
not surprising in light of the difficulties we found in estimating pcure reliably
(when it does exist) in low information cases (Section 3.6.5).
It is clear from the above, and Section 3.6.5, that one should exercise
some caution when reporting estimates of the cured proportion. Moreover,
Farewell (1986) advised caution on the grounds of scientific plausibility also,
stating that estimates of cured proportions may be indefensible in certain
cases. However, this does not imply that cure rate models cannot be used
in these cases. The issues that we have discussed arise solely due to extrap-
olation beyond the data. Just because the survivor curve has an asymptote
as t → ∞, does not mean we have to report this value. For example, Lam-
bert et al. (2007) suggested that “even when it is not reasonable to assume
a cure fraction . . . the models may still fit the data well for the observed
follow-up period”. Indeed, as is clear from Table 3.8, the Gompertz model
recognises when the true (Weibull) hazard is decreasing and when it is in-
creasing. Thus, the fitted Gompertz model may explain the data quite well,
and produce reasonable estimates, within the observed time range. Further-
more, Perperoglou et al. (2007) found that a cure rate analysis resulted in
conclusions similar to that of other (non-cure) analyses (in terms of estimated





In the methods considered thus far, we have not been concerned with deter-
mining covariate effects (although we have alluded to covariate analyses in
Chapter 2 and simulation from regression models in Chapter 3). While the
methods considered up to now are useful for determining quantities such as
the population survivor curve, hazard function or percentiles, data generally
do not arise from a homogeneous population. Individual survival times typ-
ically depend on a variety of features which cause heterogeneity in the data.
Indeed, interest usually lies in explaining this heterogeneity through the in-
corporation of covariates, or explanatory variables, in our analysis. Hence the
need to generalise the methods of the previous sections to include covariates.
As is standard in statistical modelling, regression approaches are used to fa-
cilitate this requirement. The advantage of regression models is that they
allow us to determine if a particular covariate influences the (survival) process
and to measure, via the corresponding regression coefficient, the magnitude
of this influence while adjusting for the other covariates present in the model.
Given the central role played by the hazard function in survival analysis
(as described in Sections 1.2.2 and 1.2.3), it is natural to consider the effect of
covariates via λ(t | x), where λ(·) is the hazard function and x = (x1, . . . , xp)T
is a vector of measured covariates. Thus, we must specify how λ(t | x) depends
on x.
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4.2 The Proportional Hazards Model
The most popular regression model in survival analysis is the so-called pro-
portional hazards, PH, model. This model assumes that covariate effects act
multiplicatively on a baseline hazard function, i.e.,
λ(t | x) = φ(x)λ0(t), (4.1)
where φ(x) is a proportionality factor which depends on the vector of co-
variates, x = (1, x1, . . . , xp)
T , and the corresponding regression coefficients
β = (β0, β1, . . . , βp)
T . The function λ0(t) is the baseline hazard function
common to all individuals. Thus, the effect of covariates is to increase or
decrease the overall magnitude of the hazard according to φ(x) being greater
than or less than one respectively. At a given time, t, the ratio of the hazards











which is a constant - in the sense that it does not depend on t - and hence
the hazards are proportional.
Typically, covariates enter φ through a log-link to ensure positivity of
hazards:
logφ = β0 + x1β1 + . . .+ xpβp
= xTβ,
⇒ φ = exp(xTβ).
Other functional forms for φ are possible (see Fiegl & Zelen (1965) and Hudec
& Platz (1983)) but will not be considered here. Thus, the hazard function is
λ(t | x) = exp(xTβ)λ0(t), (4.3)
4.2. THE PROPORTIONAL HAZARDS MODEL 81




= exp[(xi − xj)
Tβ]. (4.4)
Assuming, without the loss of generality, that all covariates are equal apart
from the first, x1, gives
ψ(s) = exp[(x1i − x1j)β1]
= exp(sβ1),
⇒ ψ(1) = exp(β1). (4.5)
Thus, exponentiating a β coefficient gives the factor by which the hazard
changes for a one unit increase in the corresponding x, assuming all other
covariates are equal, e.g., “the hazard (or risk) in group A is exp(β) times
that of group B”. This simple relative risk interpretation is quite appealing
which explains the popularity of the proportional hazards model.
Given that the hazard function for the PH model is (4.3), we can derive
the other survival functions using the theory outlined in Section 1.2.3. The
cumulative hazard function is









and the survivor function is




The baseline hazard function, λ0(t), may be given a parametric specifica-
tion, leading to a fully parametric PH model, or may be a non-parametric
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function. In the latter case the model is semi-parametric as it comprises a
non-parametric component, λ0(t), and a parametric component, exp(x
Tβ).
Cox (1972) introduced the semi-parametric PH model, typically referred to
as “the Cox model”, which we will describe briefly in Section 4.4. First we
will highlight some other regression specifications.
4.3 Other Regression Models
The proportional hazards model, although the most popular, is but one way
of incorporating covariates in survival analysis. Some other possibilities are
Accelerated Failure Time: λ(t | x) = exp(xTβ)λ0[exp(x
Tβ)t],
(4.8)
S(t | x) = S0[exp(x
Tβ)t],









where the baseline function (indicated by a subscript 0) may be parametric
or non-parametric.
The accelerated failure time model is commonly used in an engineer-
ing setting where λ0(t) is typically a parametric function (Lawless, 2003,
chap. 6). Semi-parametric accelerated failure time models have also been de-
veloped but are less popular (Buckley & James, 1979; Ying, 1993; Jin et al.,
2003). Details on the additive hazard model can be found in Aalen (1989),
McKeague & Sasieni (1994) and Aalen et al. (2008, chap. 4). The propor-
tional odds model links covariates to the baseline survivor function, rather
than the hazard function, and has been considered by Bennett (1983) and
Pettitt (1984). It is worth noting that all of the above regression models,
(4.3) and (4.8) – (4.10), are linear on some scale (summarised in Table 4.1).
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Table 4.1. Linearity of Regression Models
Model Linear Scale
Proportional Hazards log-hazard
Accelerated Failure Time log-time
Additive Hazards hazard
Proportional Odds log-odds
4.4 Cox’s Semi-Parametric Proportional
Hazards Model
Although our approach to the analysis of survival data will mainly be para-
metric, Cox’s model warrants specific mention due to its popularity. Indeed
this model has become the standard method for analysing survival data, is
widely available in statistical software and routinely used. Cox (1972) intro-
duced an estimation procedure which allows the β coefficients to be estimated









where the subscript (j) denotes the jth of r ordered event times in a sample
(see Section 1.3 for notation) and R(t(j)) is the set of individuals at risk
just prior to t(j), i.e., those currently uncensored and yet to experience an
event just before t(j). This likelihood function does not arise in the usual
way (as a product of probability densities), rather it is a partial likelihood :
an object formally defined in Cox (1975) which ignores some information
from the full likelihood. Nonetheless, for the purposes of model fitting and
inference, standard likelihood theory (described in Chapter 2) can be applied
to this partial likelihood (Andersen & Gill, 1982).
It is clear from (4.11) that only individuals who experience events con-
tribute to the numerator. Moreover, only one individual can contribute to
this numerator at each event time via the term exp(xT(j)β). Therefore, (4.11)
cannot be used if any events occur at the same time, known as tied events1.
1Censoring times being tied with each other or with event times present no difficulties.
Their contributions appear in the denominator of (4.11) irrespective of this.
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One way to deal with ties is to artificially break them. Let’s assume that
two event times occur at time t(j) which we denote by t(j1) and t(j2). We
can define two new variables, t′(j1) = t(j1) + ǫ1 and t
′
(j2)
+ ǫ2, where ǫ1 and
ǫ2 are small random disturbances, e.g., ǫ1, ǫ2 ∼ N(0, σ2) with σ2 small. We
can then proceed with (4.11) as the times are now distinct. However, the
most popular approach is to treat the times as distinct without perturbation




























where dj is the number of events at time t(j) and s(j) is the sum of covari-
ate vectors from these dj individuals, i.e., s(j) =
∑dj
l=1 x(jl) where x(jl) is the
covariate vector for the lth individual at the jth event time2. Other meth-
ods for handling ties are available and these are discussed in Therneau &
Grambsch (2000, sec. 3.3) and Kalbfleisch & Prentice (2002, sec. 4.2.3).
After obtaining β̂ values by maximising (4.12), one can then estimate
the baseline cumulative hazard function, Λ0(t), using the Breslow estimator









and can be motivated either as an approximation to a maximum likelihood
estimator proposed by Kalbfleisch & Prentice (1973) or using martingale
theory (Andersen & Gill, 1982). Given the discrete nature of (4.13), one may
formulate an estimator for S0(t) based on product integration (see Sections
2Note that (4.12) reduces to (4.11) in the absence of tied event times.
3It is also known as the Nelson-Aalen estimator, as it reduces to (1.24) when β̂ = 0.
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as an estimator for S0(t). Using (4.6) and (4.7) we have
Λ̂(t | x) = exp(xT β̂)Λ̂0(t), (4.15)
and
Ŝ(t | x) = Ŝ0(t)
exp(xT β̂). (4.16)
Note that one could also estimate λ0(t), and hence λ0(t | x), by differencing
Λ̂0(t) but this estimator is inconsistent (Burr, 1994); consistency can be
achieved via the use of splines (Whittemore & Keller, 1986; Rosenberg, 1995)
or kernel smoothers (Ramlau-Hansen, 1983; Tanner & Wong, 1984).
The advantage of the Cox model is that we can retrieve estimates of the
covariate effects without specifying the underlying baseline distribution. On
the surface this seems a very flexible approach as we avoid parametric as-
sumptions about the distribution. However, we are making the assumption
that covariates enter the hazard through a parametric multiplicative compo-
nent (4.3). This assumption that hazards are proportional is a strong one in
itself. Also, because Cox’s framework allows us, and in fact encourages us,
to estimate the covariate effects (using (4.11)) without worrying about the
underlying distributional functions, many analyses are carried out without
thinking about these functions and the insights they may provide.
Example 4.1. Cox Analysis of Lung Cancer Data
We fitted the Cox model to the lung cancer dataset using only the treat-
ment covariate which has five levels, namely: palliative care (the reference
category), surgery, chemotherapy, radiotherapy and chemotherapy + radio-
therapy combined. The results are summarised in Table 4.2 where the esti-
mated coefficients come from maximising (4.12) and the standard errors are
obtained using standard likelihood theory (see Chapter 2). The signs of the
coefficients are all negative implying that all treatments reduce the hazard
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Table 4.2. Cox Model Fit
β̂ S.E. |Z|
Palliative 0.00 —— ——
Surgery -2.18 (0.23) 9.68
Chemo -0.38 (0.17) 2.23
Radio -0.55 (0.09) 6.34
C+R -0.85 (0.20) 4.18
relative to palliative care; this reduction is statistically significant in all cases
(|Z| > 1.96). As outlined in Section 4.2, we can interpret the coefficients in
terms of hazard ratios through exponentiation. Thus, an individual receiv-
ing surgery has exp(−2.18) = 0.11 times the risk of death compared with
an individual receiving palliative care. Similarly, the hazard ratios for the
other three treatments (relative to palliative care) are 0.68, 0.57 and 0.43
respectively.
We note that while the proportional hazards model provides us with ease






















Figure 4.1. Kaplan-Meier (solid) curves for each treatment group with
Cox model (dash) fitted curves overlayed.
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of interpretation, appropriate use of the model depends on the validity of the
proportional hazards assumption in (4.3). The estimated Cox survivor curves
for each treatment group are shown in Figure 4.1. The corresponding Kaplan-
Meier curves, which are the closest to the data by definition, are also shown
for comparison. The Cox model’s simplifying assumption of proportionality
approximates reality but may be questionable in this case.
4.5 Parametric Models
As mentioned in Section 1.4, parametric distributions have the advantage
of offering mathematical formulae to describe the survivor/hazard functions
or quantities such as mean/median survival time. When we generalise to
parametric regression models, we can investigate the effects of covariates on
any of these functions/quantities. Of course we must understand the capa-
bilities of each parametric distribution and the interpretation of parameters
but, when equipped with this knowledge, we can gain many insights into
the underlying survival process. In addition to this, parametric regression
models are fitted to data using the classical (full) likelihood function which
is well understood and where the presence of tied event times presents no
difficulty. The theory in Chapter 2 holds for parametric regression models
but the likelihood function, where individuals are now assumed conditionally




δi log λ(ti | xi) + log S(ti | xi), (4.17)
where xi = (x1i, . . . , xpi)
T is the vector of covariates for the ith individual
and θ now contains regression coefficients in addition to distributional pa-
rameters.
In order to generate such a parametric regression model, one could first
start with the regression specification (from Sections 4.2 and 4.3) and then
select a parametric baseline function, e.g., one may choose a proportional
hazards specification with λ0(t) = λγt
γ−1 giving a Weibull PH model. The
approach we will take however is to generalise the parametric distributions
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of Section 1.4 by allowing their distributional parameters to depend on co-
variates. The hazard regression is then implied by the chosen model. Our
parameter naming scheme in Section 1.4 is such that, for each distribution,
the parameter λ corresponds to the standard “interest” parameter in survival
literature. This is the scale parameter which controls the overall magnitude
of the hazard. Thus, one arrives at a parametric regression model by letting
g(λ) = xTβ, (4.18)
where g(·) is an appropriate link function, x = (1, x1, . . . , xp)T is the vector of
covariates and β = (β0, β1, . . . , βp)
T is the corresponding vector of regression
coefficients. For most of the distributions in Section 1.4 the scale parameter
is constrained to be positive and so, in these cases, g(·) = log(·). Note that
one could also allow other distributional parameters to depend on covariates
(simultaneously with λ). We will refer to such models, where multiple pa-
rameters depend on covariates, asmulti-parameter regression (MPR) models.
MPR models are not traditionally considered in survival analysis but are the
main focus of this thesis. At this stage however, we will only discuss the
standard single-parameter regression (SPR) models defined by (4.18).
Given the popularity of the proportional hazards model in survival, prac-
titioners have become accustomed to hazard ratios as a means of summarising
covariate effects. For this reason we give the functional form of the hazard
ratio, which we denote by ψ, for each of the regression models below. Our
discussion is brief as these SPR models are special cases of the MPR models
which are developed in detail in Chapter 5. First we will introduce some
notation. Without the loss of generality, let’s assume that we are interested
in determining the effect of the (binary) covariate x1 via its hazard ratio. In
what follows, it is helpful to decompose the linear predictor xTβ into two
parts: the term involving x1 and the remaining terms, i.e.,
xTβ = β0 + x1β1 + . . .+ xpβp
= x1β1 + β0 + . . .+ xpβp
= x1β1 + x̃
Tβ,
where x̃ = (1, 0, x2, . . . , xp)
T . As we will see, the term x̃Tβ appears in the
hazard ratio for some of the SPR models below. We defer our discussion of
such terms until Section 5.3.
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4.5.1 Weibull
For the Weibull SPR model, log(λ) = xTβ. Thus, the hazard and survivor
functions are given by
λ(t | x) = exp(xTβ)γtγ−1, (4.19)
and
S(t | x) = exp[− exp(xTβ)tγ ], (4.20)
where β ∈ Rp+1 and γ > 0.
At time t, the hazard ratio for x1 is given by
ψ(t) =
λ(t | x1 = 1)
λ(t | x1 = 0)
= exp(β1), (4.21)
which is time constant and, therefore, we see that the Weibull SPR model is
a PH model, i.e., it has the proportional hazards property.
4.5.2 Gompertz
For the Gompertz SPR model, log(λ) = xTβ. Thus, the hazard and survivor
functions are given by
λ(t | x) = exp(xTβ) exp(γt)
= exp(xTβ + γt), (4.22)
and








where β ∈ Rp+1 and γ ∈ R.
At time t, the hazard ratio for x1 is given by
ψ(t) = exp(β1). (4.24)
and we see that the Gompertz SPR model also has the proportional hazards
property.
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4.5.3 Log-logistic
The log-logistic SPR model also requires a log-link for the scale parameter.
Thus, the hazard and survivor functions are given by





S(t | x) = [1 + exp(xTβ)tγ]−1, (4.26)
where β ∈ Rp+1 and γ > 0.
At time t, the hazard ratio for x1 is given by
ψ(t) = exp(β1)
1 + exp(x̃Tβ)tγ
1 + exp(β1 + x̃Tβ)tγ
, (4.27)
which is time-dependent. Therefore, the log-logistic model may be a useful
alternative to a PH model.
It is worth noting that limt→∞ ψ(t) = 1. Therefore, the log-logistic model
naturally handles convergent hazards. The rate of convergence is controlled
by the shape parameter γ. In practice this could arise, for example, where
an initial treatment effect wears off over time.
4.5.4 Burr
The Burr SPR model again requires a log-link for the scale parameter. Thus,
the hazard and survivor functions are given by





S(t | x) = [1 + exp(xTβ)ρtγ]−1/ρ, (4.29)
where β ∈ Rp+1 and γ, ρ > 0.
The hazard ratio, at time t, for x1 is given by
ψ(t) = exp(β1)
1 + exp(x̃Tβ)ρtγ
1 + exp(β1 + x̃Tβ)ρtγ
. (4.30)
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This has a similar form to the log-logistic hazard ratio and, as in the log-
logistic case, converges to one with time. However, the Burr hazard ratio has
the additional property that limρ→0 ψ(t) = exp(β1). This is a consequence
of the fact that when ρ → 0, the Burr model reduces to the Weibull model
(see Section 1.4.5). Thus, the Burr SPR model unifies proportional haz-
ards regression and non-proportional hazards regression making it a flexible
parametric model which supersedes both the Weibull and log-logistic models.
Note however that, because ρ is a constant, all covariate effects are either
proportional on the hazard scale or non-proportional. This is something that
we can relax by letting ρ depend on covariates, i.e., a multi-parameter regres-
sion Burr model. Such a model will allow some effects to be proportional and
some non-proportional. This Burr MPR model will be very flexible indeed
(see Section 5.2.4).
4.5.5 Time-Dependent Logistic
The scale parameter in the TDL distribution is unconstrained and therefore
λ = xTβ. The hazard and survivor functions are given by
λ(t | x) =
exp(γt + xTβ)
1 + exp(γt+ xTβ)
, (4.31)
and
S(t | x) =
[




where β ∈ Rp+1 and γ ∈ R. It is worth noting that
logitλ(t | x) = log
(
λ(t | x)
1− λ(t | x)
)
= γt + xTβ,
which is a generalisation of the standard logistic regression model to time-
dependence. Hence the name “time-dependent logistic”.
The hazard ratio, at time t, for x1 is given by
ψ(t) = exp(β1)
1 + exp(γt + x̃Tβ)
1 + exp(γt+ β1 + x̃Tβ)
. (4.33)
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4.5.6 Piecewise Exponential
Covariates are introduced into the piecewise exponential model by assuming
a proportional hazards specification, λ(t | x) = exp(xTβ)λ0(t). Recall that
for the piecewise exponential distribution (Section 1.4.7) the time axis is split
(not necessarily at event times) into intervals Ij = [t(j−1), t(j)), j = 1 . . . , m,
where t(0) = 0 and t(m) =∞. Thus,
λ(t | x) = exp(xTβ)a(t)Tλ, (4.34)
where x = (x1, . . . , xp)
T , β = (β1, . . . , βp)
T , λ = (λ1, . . . , λm)
T and a(t) is an
m-dimensional vector indicating which interval t lies in, e.g., if m = 4 and
t ∈ I3 then a(t) = (0, 0, 1, 0)






where d(t) represents the time spent in each interval for a particular value of
t, e.g., if m = 4 and t ∈ I3 then d(t) = (t(1) − t(0), t(2) − t(1), t− t(2), 0)
T .
At time t, the hazard ratio for x1 is given by
ψ(t) = exp(β1), (4.36)
as this is a PH model.
This regression model may also be viewed as letting the jth distributional
parameter of the piecewise exponential model depend on covariates via
log λj = β0j + x
Tβ, (4.37)
for j = 1, . . . , m. In other words, the intercept term varies in each time
interval. It is also worth noting that if we split the time axis at each distinct
event time (creating r+1 intervals where r is the total number of events) we
get the Cox model (Section 4.4). Thus, assumingm≪ r+1, the PH piecewise
exponential model is a flexible parametric PH model of lower dimension than
the semi-parametric model.
Example 4.2. Single Parameter Regression Analysis of Lung Cancer Data
We continue the analysis of the lung cancer data presented in Example 4.1.
Here we fit the Weibull, log-logistic and TDL single-parameter regression
4.5. PARAMETRIC MODELS 93
models to the data using the likelihood function given in (4.17). The esti-
mated parameters for each model are summarised in Table 4.3 along with the
maximised likelihood and AIC values. The results are similar across models.
The β values are all negative indicating that all treatments reduce the hazard
compared with palliative care. The models are in agreement as to the relative
merit of each treatment; surgery offers the largest hazard reduction followed
by the combined treatment (C+R), radiotherapy and finally chemotherapy.
Table 4.3. SPR Model Fits
Weibull Log-logistic TDL
Est. S.E. |Z| Est. S.E. |Z| Est. S.E. |Z|
Shape γ 0.93 (0.03) —— 1.32 (0.04) —— -0.03 (0.01) ——
Intercept β0 -1.48 (0.08) —— -1.25 (0.09) —— -1.27 (0.08) ——
Palliative — 0.00 —— —— 0.00 —— —— 0.00 —— ——
Surgery β1 -2.22 (0.23) 9.89 -3.33 (0.27) 12.17 -2.39 (0.23) 10.22
Chemo β2 -0.40 (0.17) 2.30 -0.65 (0.29) 2.27 -0.46 (0.20) 2.32
Radio β3 -0.57 (0.09) 6.50 -1.14 (0.14) 8.15 -0.66 (0.10) 6.48
C+R β4 -0.87 (0.20) 4.30 -1.81 (0.29) 6.26 -0.99 (0.22) 4.44
ℓ(θ̂) -1960.75 -1943.66 -1960.16
AIC 3933.51 3899.32 3932.32
∆AIC 34.19 0.00 33.00
The estimated hazard, hazard ratio and survivor functions for each model
are shown in Figure 4.2. Confidence intervals for the hazard ratios are given
in Fig. 4.3 and have been calculated using m.l.e. simulation (Section 2.3.2).
We see that the Weibull and TDL analyses are roughly in agreement, that
is to say, in this instance, the TDL model produces similar results to the
PH analysis even though it is a non-PH model. On the other hand, the log-
logistic model does produce non-proportional hazards which imply that the
effectiveness of each treatment diminishes with time.
The log-logistic model provides the best fit to the data based on a much
lower AIC value and the fact that the estimated survivor curves fit the
Kaplan-Meier curves more closely. However, clearly none of the models pro-
vide an adequate fit to the C+R group. This is a result of the fact that they
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lack the flexibility to model crossing hazards, due to the constant shape pa-
rameter. We can overcome this in the more general setting of multi-parameter




































































Figure 4.2. Estimated hazard function, hazard ratio and survivor func-
tion for the Weibull, log-logistic and TDL SPR models. The Kaplan-
Meier curves (step function) appear in bottom panels for comparison.
















































































Figure 4.3. Hazard ratios with confidence intervals for the Weibull,





The classical approach to (parametric) regression analysis is to have a clear
parameter of interest which is allowed to depend on covariates, for example,
in generalized linear models (McCullagh & Nelder, 1989) where traditionally
the location parameter is regressed on a set covariates. Other parameters
remain constant and are typically only present to allow the model to adapt
to data. We will refer to these models as single parameter regression (SPR)
models as the regression structure appears in one distributional parameter
(such as the models considered in Section 4.5). When more than one pa-
rameter is available, the question is why should one take precedence over
the others in terms of covariate analysis? A more flexible approach is to
regress multiple parameters simultaneously on covariates. In the context of
normal linear regression, Park (1966) and Harvey (1976) modelled the dis-
persion parameter as a function of covariates to address heteroscedasticity,
while Smyth (1989) modelled dispersion in the more general case of general-
ized linear models. More recently, structured dispersion has been studied by
Lee & Nelder (2001, 2006). Other modern frameworks with more than one
regression component are generalized additive models for location, scale and
shape (Rigby & Stasinopoulos, 2005) and joint mean-covariance modelling in
longitudinal data analysis (Pan & MacKenzie, 2003, 2006, 2007). Hereafter,
we refer to this flexible approach as multi-parameter regression, MPR.
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In our parametric survival setup we have a scale parameter, λ, which
controls the overall magnitude of the hazard, and a shape parameter γ, which
controls the time evolution of the hazard (Section 1.4). As we saw in Section
4.5, the scale parameter is the parameter of interest in standard SPR survival
models. We now extend the SPR model, defined by (4.18), to a multi-
parameter regression model by setting
g(λ) = xTβ, h(γ) = zTα, (5.1)
where x = (1, x1, . . . , xp)
T and z = (1, z1, . . . , zq)
T are covariate vectors which
may or may not contain covariates in common, β = (β0, β1, . . . , βp)
T and α =
(α0, α1, . . . , αq)
T are the corresponding regression coefficients and g(·) and
h(·) are appropriate link functions (often the log link in cases we consider).
Thus, the addition of h(γ) = zTα extends the typical SPR models to allow
shape to depend on covariates; the resulting MPR models will be able to
handle a wider variety of survival data more readily, e.g., crossing, converging
or diverging hazards. Moreover, the shape parameter has an important role
to play in describing the underlying process (Aalen & Gjessing, 2001) and,
therefore, gaining an understanding of how this depends on covariates is
of key interest. This is not something available to us within the context
of the Cox model, which is mainly focussed on the estimation of relative
risk (see Section 4.4), though it is worth noting that the Cox model can be
extended in a variety of different ways (Therneau & Grambsch, 2000) to gain
further flexibility. While these extensions may require specialised theory, the





δi log λ(ti | xi, zi) + log S(ti | xi, zi), (5.2)
which only differs from the SPR case, given in (4.17), notationally by the
presence of zi. The associated likelihood theory remains unchanged where
we are now estimating p + q + 2 regression coefficients; there are no extra
(constant) distributional parameters in this case as these are all structured
to depend on covariates.
Multi-parameter regression is not wholly novel in a survival setting; early
references include Taulbee (1979) and Gaynor (1987). More recently, the
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approach has been applied to the inverse Gaussian model (Lee & Whitmore,
2006, 2010; Aalen et al., 2008). The reason for this specific interest in the
inverse Gaussian model as a candidate for multi-parameter regression is its
derivation as the distribution of time until a Wiener process reaches an ab-
sorbing barrier/threshold. Thus, its parameters can be interpreted as drift
and distance from the threshold where, for example, the underlying Wiener
process may represent physical deterioration leading to failure upon reaching
some critical level (the threshold)1. Viewing survival in terms of this par-
ticular underlying mechanism is interesting, but of course multi-parameter
regression is a broader concept which is not limited to any particular family
of models. Furthermore, as mentioned in Section 1.4, we are not considering
models, such as the inverse Gaussian model, where the survivor function does
not have a closed form; the log-logistic model, which we do consider, has a
very similar shape to the inverse Gaussian model.
It is clear from the above that multi-parameter regression in survival has
not previously received much attention as a general procedure and is not
in mainstream use. This may be, in part, due to the fact that even stan-
dard parametric methods (e.g., SPR models) receive less attention in survival
analysis compared with non- and semi-parametric counterparts (as we have
noted in Section 1.4). We therefore explore and discuss the consequences
of the MPR approach and show its flexibility both analytically and via real
data analyses.
5.2 Multi-Parameter Regression Models
Parallelling Section 4.5, we will interpret the MPR models below in terms
of the (time-dependent) hazard ratio which we denote by ψ(t). Let c be a
binary covariate whose effect we wish to determine (via ψ(t)). As we now
have scale and shape regressions, we will assume that c is common to both
and, furthermore, that it is the first covariate in the vectors x and z, i.e.,
1It is noteworthy that ascribing a mechanistic interpretation to model parameters is
speculative since the data may not have been generated by this mechanism. A similar
problem was noted by MacKenzie (1986) in a different context.
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x1 = z1 = c. Thus we have
xTβ = β0 + cβ1 + . . .+ xpβp z
Tα = α0 + cα1 + . . .+ zqαq
= cβ1 + β0 + . . .+ xpβp = cα1 + α0 + . . .+ zqαq
= cβ1 + x̃
Tβ, = cα1 + z̃
Tα, (5.3)
where x̃ = (1, 0, x2, . . . , xp)
T and z̃ = (1, 0, z2, . . . , zq)
T .
The hazard ratio, at time t, for the covariate c = x1 = z1 is therefore
given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
, (5.4)




ψ(t), ψ(∞) = lim
t→∞
ψ(t).
In the proceeding sections we merely show results; derivations of these results
(e.g., differentiation and limit calculation) can be found in Appendix B.3.
Moreover, we will see that ψ(t) is conditional on x̃ or z̃ (i.e., we could write
ψ(t | x̃, z̃)) for some models; this is discussed in Section 5.3.
5.2.1 Weibull
For the Weibull MPR model, log(λ) = xTβ and log(γ) = zTα where (β, α)T ∈
R
p+q+2. Thus, the hazard and survivor functions are given by
λ(t | x, z) = exp(xTβ) exp(zTα)texp(z
Tα)−1, (5.5)
and
S(t | x, z) = exp[− exp(xTβ)texp(z
Tα)]. (5.6)
The hazard ratio, at time t, for c = x1 = z1 is given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
= exp(β1) exp(α1)t
exp(z̃Tα)[exp(α1)−1], (5.7)
which generalises the Weibull SPR hazard ratio, (4.21), to time-dependence.
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and, therefore, it is the sign of α1 which solely determines the path of the





Increasing if α1 > 0,
Constant if α1 = 0,
Decreasing if α1 < 0.
In particular, as ψ(t) is constant (= exp(β1)) if α1 = 0, the Weibull MPR
model directly extends the proportional hazards model, thus providing a
test of proportionality adjusted for other scale and shape covariates. Fur-
thermore, it is clear that the Weibull MPR model, being more general, can






0 if α1 > 0,
exp(β1) if α1 = 0,





∞ if α1 > 0,
exp(β1) if α1 = 0,
0 if α1 < 0,
we know ψ(t∗) = 1 for some t∗ if α1 6= 0. This represents the time point where
the hazards cross, i.e., the Weibull MPR model implies that the hazards must
cross when α1 is non-zero. Indeed we may be interested in the value of t
∗
which we easily find, for α1 6= 0, as






While the Weibull MPR model implies a theoretical crossing of hazards,
the value of t∗ may be such that we can ignore this crossing for practical
purposes. For example, if t∗ ≈ 0 then we may consider ψ(t) for values of
t > t∗ + ǫ (and ǫ small) which represents diverging hazards. In this case
ψ(t) is either increasing from ψ(t∗ + ǫ) > 1 or decreasing from ψ(t∗ + ǫ) < 1
(as in Fig. 5.1 when (β1, α1) = (−0.5,−0.3)). Conversely, if t∗ ≫ tmax and
ψ(tmax) ≈ 1, where tmax is the largest time in the dataset, then we may
treat the hazards as converging (as in Fig. 5.1 when (β1, α1) = (−1, 0.25)).
Another point worth noting is that, when α1 6= 0, ψ(0) is either infinity
or zero. A hazard ratio of infinity/zero means that having c = 1 infinitely
increases/decreases the hazard relative to c = 0. This is again a theoretical
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(β1, α1) = (−0.5, −0.3)
(β1, α1) = (−1, 0.25)
(β1, α1) = (−2.5, 0.8)
(β1, α1) = (0.4, 0)
Figure 5.1. Weibull MPR hazard ratio shapes (solid). In all cases
z̃Tα = 0. Reference line (dot) represents equality of hazards.
implication of the model which may not always be useful in practice. Thus,
we may prefer to view ψ(t) for values of t > ǫ (for some small ǫ) such that
ψ(ǫ) is a more reasonable (finite, non-zero) value, i.e., ψ(ǫ) is sufficiently
smaller than infinity or sufficiently larger than zero. These comments apply
equally to the other MPR models considered in Sections 5.2.2 - 5.2.6.
5.2.2 Gompertz
For the Gompertz MPR model, log(λ) = xTβ and γ = zTα where (β, α)T ∈
R
p+q+2. Thus, the hazard and survivor functions are given by
λ(t | x, z) = exp(xTβ) exp(zTα t), (5.8)
and








The hazard ratio, at time t, for c = x1 = z1 is given by
ψ(t) = exp(β1) exp(α1t), (5.10)
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which, like the Weibull MPR model, generalises its SPR counterpart, (4.24),
to time-dependence, i.e., non-proportional hazards. The Gompertz MPR
hazard ratio has a very simple and appealing form; the effect of c is fully





which is the same differential representation as that for the Gompertz hazard
function in Section 1.4.3. Clearly, the nature of the time-dependence is con-
trolled by the sign of α1 and, as in the Weibull MPR case, ψ(t) can increase
(α1 > 0), decrease (α1 < 0) or remain constant (α1 = 0). Thus, like the
Weibull MPR model, the Gompertz MPR model provides us with a test of
proportionality of hazards (by testing H0 : α1 = 0).
Note that




∞ if α1 > 0,
exp(β1) if α1 = 0,
0 if α1 < 0,
and, therefore, unlike the Weibull case, ψ(t) here is not guaranteed to be
equal to one for some t = t∗ when α1 6= 0. However, it is clear that if β1 < 0
and α1 > 0 then ψ(t) will increase from exp(β1) < 1 to ∞, i.e., ψ(t∗) = 1 for
some t∗. Similarly, the hazards cross if β1 > 0 and α1 < 0. Thus, ψ(t
∗) = 1
if sgn(β1) 6= sgn(α1) 6= 0, and, furthermore,




It is clear from the above that the Gompertz MPR model has some ap-
pealing properties. The shape of ψ(t) is similar to the Weibull MPR model
(see Fig. 5.2) although it does not depend on z̃ and increases/decreases at
a faster rate. Nonetheless, analyses using both models may produce sim-
ilar results. Moreover, both models offer a straightforward extension into
non-proportional hazards modelling.
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(β1, α1) = (−0.25, −0.3)
(β1, α1) = (−1, 0.08)
(β1, α1) = (−2, 0.4)
(β1, α1) = (0.4, 0)
Figure 5.2. Gompertz MPR hazard ratio shapes (solid). Reference line
(dot) represents equality of hazards.
5.2.3 Log-Logistic
The log-logistic MPR model requires a log-link for the parameters, i.e.,
log(λ) = xTβ and log(γ) = zTα where (β, α)T ∈ Rp+q+2. Thus, the haz-
ard and survivor functions are given by






S(t | x, z) = [1 + exp(xTβ)texp(z
Tα)]−1. (5.12)
The hazard ratio, at time t, for c = x1 = z1 is given by




1 + exp(β1 + x̃Tβ)texp(α1+z̃
Tα)
, (5.13)
which is time-dependent. Of course, as noted in Section 4.5.3, the SPR
hazard ratio was already time-dependent. However, the functional form of
(5.13) above is more general than (4.27) and will therefore support a wider
variety of shapes.
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0 if α1 > 0,
exp(β1) if α1 = 0,
∞ if α1 < 0,
ψ(∞) = exp(α1) ∀α1.
Thus, ψ(t) increases when α1 > 0 (from 0 to exp(α1)), decreases when α1 < 0
(from∞ to exp(α1)) and, when α1 = 0, ψ(t) can increase, decrease or remain
equal to one depending on the value of β1. Furthermore, it is clear that the
hazards cross if α1 6= 0. However, unlike the Weibull and Gompertz models,
t∗, the crossing point, cannot be expressed analytically but, nonetheless, it
can easily be calculated numerically/graphically in practice.









+ λ(t | c = 0)[1− ψ(t)]
}
ψ(t),
and while this derivative is more complicated than the Weibull or Gompertz
cases, we can still use it to tell us about the nature of ψ(t) over time (see





Increasing if α1 > 0,
Increasing (monotonic) if α1 = 0 and β1 < 0,
Decreasing (monotonic) if α1 = 0 and β1 > 0,
Decreasing if α1 < 0.
Figure 5.3 shows some possible shapes that ψ(t) can take.
Clearly the log-logistic MPR model extends its SPR counterpart. The
SPR model forces ψ(t) to converge to one whereas the MPR model allows ψ(t)
to converge to exp(α1) and can handle crossing hazards and non-monotonic
hazard ratios. Furthermore, whereas the Weibull and Gompertz MPR models
assume ψ(t) continues to increase/decrease over time (when α1 6= 0), the fact
that ψ(t) levels off over time for the log-logistic MPR model may be more
realistic in some situations.
Although we are interpreting the models in terms of the hazard ratio, it
is worth noting that the log-logistic model is often interpreted in terms of
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(β1, α1) = (1, −0.8)
(β1, α1) = (−0.6, 0)
(β1, α1) = (−2.5, 0.6)
(β1, α1) = (0.6, 0.4)
Figure 5.3. Log-logistic MPR hazard ratio shapes (solid). In all cases
x̃Tβ = z̃Tα = 0. Reference line (dot) represents equality of hazards.
the odds of survival (Bennett, 1983). One easily finds that, at time t, the
odds ratio for the c = x1 = z1 is given by
S(t | c = 1)
1− S(t | c = 1)
1− S(t | c = 0)
S(t | c = 0)
= exp(−β1)t
exp(z̃Tα)[1−exp(α1)],
and thus we see that the SPR log-logistic model (α1 = 0, z̃
Tα = α0) is a
proportional odds model (see Section 4.3) whereas the MPR model gener-
alises this to allow the odds ratio to depend on time. When viewed in this
way, the α1 coefficient can be used to test proportionality of odds; this is not
something we will pursue.
5.2.4 Burr
The Burr distribution (Section 1.4.5) has three distributional parameters and
thus the Burr MPR model has three regression components: log(λ) = xTβ,
log(γ) = zTα and log(ρ) = wT τ where, in the third component, w =
(1, w1, . . . , wr)
T and τ = (τ0, τ1, . . . , τr)
T respectively. Thus (β, α, τ)T ∈
R
p+q+r+3. As the Burr MPR model contains the log-logistic MPR model
5.2. MULTI-PARAMETER REGRESSION MODELS 107
as a special case (wT τ = 0) and the Weibull MPR model as a limiting case
(wT τ → −∞), it will be capable of modelling a range of phenomena.
The hazard and survivor functions are given by
λ(t | x, z, w) =
exp(xTβ) exp(zTα)texp(z
Tα)−1
1 + exp(xTβ) exp(wT τ)texp(zTα)
, (5.14)
and
S(t | x, z, w) = [1 + exp(xTβ) exp(wT τ)texp(z
Tα)]−1/ exp(w
T τ). (5.15)
The hazard ratio, at time t, for c = x1 = z1 = w1 is given by
ψ(t) = exp(β1+α1)t
exp(z̃Tα)[exp(α1)−1]
1 + exp(x̃Tβ + w̃T τ)texp(z̃
Tα)












+ exp(w̃T τ)λ(t | c = 0)[1− exp(τ1)ψ(t)]
}
ψ(t).
Clearly these are similar to those of the log-logistic MPR model. Further-





0 if α1 > 0,
exp(β1) if α1 = 0,
∞ if α1 < 0,
ψ(∞) = exp(α1 − τ1) ∀α1.
Remembering that for the log-logistic MPR model ψ(∞) = exp(α1), we can
see the extended flexibility of the Burr model where ψ(∞) = exp(α1 − τ1),
i.e., while α1 describes both the time-evolution and the end point of ψ(t) in
the log-logistic model, the Burr model is not restricted by this constraint. In
any case, as with the other models considered so far, α1 is the key parameter







Increasing if α1 > 0,
Increasing (monotonic) if α1 = 0 and β1 + τ1 < 0,
Constant if α1 = 0 and β1 + τ1 = 0,
Decreasing (monotonic) if α1 = 0 and β1 + τ1 > 0,
Decreasing if α1 < 0.
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Thus, ψ(t) increases if α1 > 0 and decreases if α1 < 0 (both possibly non-
monotonically). The case where α1 = 0 is interesting as ψ(t) can increase
or decrease (monotonically) from exp(β1) to exp(−τ1); the start and end
points are finite and non-zero which may be desirable in practice. Of course,
the model also handles (approximately) infinite/zero limits depending on the
values of β1 and τ1. Note that when α1 = 0 and β1 + τ1 = 0, ψ(t) = exp(β1)
which is of particular interest given the status of PH regression in survival
analysis. Thus, the Burr MPR model provides a test of proportionality
which supports a larger variety in alternative hypotheses than the Weibull
or Gompertz MPR models. Figure 5.4 shows some possible shapes that ψ(t)
can take.














(β1, α1, τ1) = (−0.7, 0, −1)
(β1, α1, τ1) = (−3, 0.5, −3)
(β1, α1, τ1) = (0.4, 0, −0.4)
(β1, α1, τ1) = (0.8, 0.7, 1)
(β1, α1, τ1) = (−0.8, 0, 2)
Figure 5.4. Burr MPR hazard ratio shapes (solid). In all cases x̃Tβ =
z̃Tα = w̃T τ = 0. Reference line (dot) represents equality of hazards.
The Burr MPR model is clearly more flexible than its SPR counterpart
(Section 4.5.4), the latter having ψ(t) constrained to increase/decrease mono-
tonically from exp(β1) to one (as α1 = τ1 = 0). Furthermore, the Burr
SPR model supports PH effects but is limited in the sense that it assumes
such effects are consistent across all covariates, i.e., either all covariates have
time-constant effects or not. The MPR model supports PH effects on a per
5.2. MULTI-PARAMETER REGRESSION MODELS 109
covariate basis.
It is clear from the above that the Burr MPR model is capable of mod-
elling a variety of situations. It is a flexible model which relaxes the limita-
tions of other models considered up to now, unifying and extending the (also
quite flexible) Weibull MPR and log-logistic MPR models. Furthermore, it
contains standard simpler SPR models (Weibull, log-logistic and Burr) as
special cases. It can therefore provide a better fit to data than these mod-
els and will reduce to them in cases where its full flexibility is not required.
Hence, this model provides robust parametric regression2.
5.2.5 Time-Dependent Logistic
For the time-dependent logistic MPR model, λ = xTβ and γ = zTα where
(β, α)T ∈ Rp+q+2. Thus, the hazard and survivor functions are given by
λ(t | x, z) =
exp(zTα t+ xTβ)
1 + exp(zTα t + xTβ)
, (5.17)
and
S(t | x, z) =
[




The hazard ratio, at time t, for c = x1 = z1 is given by
ψ(t) = exp(α1t + β1)
1 + exp(z̃Tα t+ x̃Tβ)
1 + exp[(α1 + z̃Tα)t+ β1 + x̃Tβ]
, (5.19)
which generalises the functional form of the hazard ratio for the time-dependent






Tαλ(t | c = 0)− (α1 + z̃
Tα)λ(t | c = 1)
]
ψ(t),
and thus we see that both α1 and z̃
Tα are important in characterising the





2In our practical work so far, the flexibility of the Burr MPR model has not led to sig-
nificant gains over the log-logistic MPR model. Moreover, we have found that convergence
issues are common when attempting to fit the Burr MPR model.
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1 if α1 ≥ 0 and z̃
Tα > 0,




if α1 > 0 and z̃
Tα = 0,




if α1 = 0 and z̃
Tα = 0,




if α1 < 0 and z̃
Tα = −α1,
0 if α1 < 0 and z̃
Tα < −α1,
(5.21)
where cases with z̃Tα exactly equal to zero or to −α1 (not likely in practice)
are highlighted in grey. We can see that, unlike the models considered up to
now, the α1 coefficient alone is not enough to tell us about the time evolution
of ψ(t). Some possible shapes are given in Fig. 5.5. The time-dependent














(β1, α1, z~Tα) = (0.2, 0.8, 0.4)
(β1, α1, z~Tα) = (−1, 0.2, −0.3)
(β1, α1, z~Tα) = (1, 0, −0.1)
(β1, α1, z~Tα) = (0.2, −0.6, 0.5)
Figure 5.5. Time-dependent logistic MPR hazard ratio shapes (solid).
In all cases x̃Tβ = 0. Reference line (dot) represents equality of hazards.
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logistic SPR model (Section 4.31), with α1 = 0 and z̃
Tα = α0, is limited to
ψ(t) increasing/decreasing either to one (α0 > 0) or to exp(β1) (α0 < 0). A
third possibility is that ψ(t) remains constant at ψ(0) (α0 = 0); we discuss
this in the proceeding paragraph.
As we’ve mentioned, z̃Tα = 0 is unlikely in practice. However, one way
in which this can arise is the case where αj = 0 for j = 0, 1, . . . , q. This leads
to ψ(∞) = ψ(0) and, moreover, ψ′(t) = 0, i.e., the hazard ratios are time-
independent for all covariates. This special case is a type of proportional
hazards model, although not in the classical sense (defined in (4.3)) as the
hazard ratios depend on x̃.
5.2.6 Piecewise Exponential
The piecewise exponential model is, of course, different to the other para-
metric models above in that its dimension depends on how many intervals we
split the time axis into (see Sections 1.4.7 and 4.5.6). There are m intervals
in total, Ij = [t(j−1), t(j)) for j = 1, . . . , m, and hence m distributional pa-
rameters: λ1,. . . ,λm. Thus the multi-parameter regression model is defined
by modelling each of these parameters via
log λj = x
Tβj , (5.22)
where x = (1, x1, . . . , xp)
T , βj = (β0j , β1j , . . . , βpj)
T and j = 1, . . . , m (com-
pare this with (4.37)). The hazard function is given by
λ(t | x) = a(t)T (λ1, . . . , λm)
T , (5.23)
where λj = exp(x
Tβj) and a(t) is an m-dimensional vector indicating which
interval t lies in, e.g., if m = 4 and t ∈ I3 then a(t) = (0, 0, 1, 0)T . The
survivor function is given by
S(t) = exp
[




where d(t) represents the time spent in each interval for a particular value of
t, e.g., if m = 4 and t ∈ I3 then d(t) = (t(1) − t(0), t(2) − t(1), t− t(2), 0)
T .
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At time t ∈ Ij , the hazard ratio for x1 is given by





where β1j is the coefficient of x1 in the jth time interval. Thus, the hazards
are proportional within an interval of time; the hazard ratio is a step function
when viewed over time. Furthermore, we may write
ψ(t) = exp[β1(t)], (5.26)
where β1(t) is a step function such that β1(t ∈ Ij) = β1j . The form of the haz-
ard ratio in this model is appealing and easily interpreted by exponentiating
the m regression coefficients corresponding to the covariate in question.
Clearly the piecewise exponential MPR model can approximate any co-
variate effect but the dimension can become high as the number of parameters
is m× (p+1). The PH piecewise exponential model (Section 4.5.6) is a spe-
cial case of this model which arises by setting all regression coefficients (apart
from the intercept) to constants, i.e., βk(t) = βk for k = 1, . . . , p. We may, of
course, specify a model in which some covariate effects are time-dependent
and some are time-constant.
Example 5.1. Multi-Parameter Regression Analysis of Lung Cancer Data
In Example 4.2 we analysed the (unadjusted) effect of treatment in the
lung cancer data using three SPR models (Weibull, log-logistic and time-
dependent logistic). We continue now with this analysis within the more gen-
eral framework of multi-parameter regression. Hence, we fitted the Weibull,
log-logistic and time-dependent logistic MPR models to the data for direct
comparison with our previous SPR analysis. The estimated scale and shape
regression coefficients for the three models are given in Table 5.1.
In this MPR setting, quantifying covariate effects directly through the
individual regression coefficients is more difficult than it is for SPR models.
As the effect of a covariate now depends both on its scale effect (β coefficient)
and its shape effect (α coefficient), it seems reasonable to view the overall
effect in terms of a quantity which takes both of these into account. Thus,
we use the hazard ratio to measure the overall effect.
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Table 5.1. MPR Model Fits
Weibull Log-logistic TDL
Scale β̂ S.E. |Z| β̂ S.E. |Z| β̂ S.E. |Z|
Intercept -1.28 (0.08) —— -1.14 (0.10) —— -0.94 (0.10) ——
Palliative 0.00 —— —— 0.00 —— —— 0.00 —— ——
Surgery -3.91 (0.83) 4.69 -4.26 (0.87) 4.87 -3.44 (0.46) 7.44
Chemo -0.50 (0.32) 1.56 -0.56 (0.36) 1.57 -0.81 (0.32) 2.58
Radio -1.26 (0.19) 6.72 -1.63 (0.22) 7.56 -1.30 (0.16) 7.92
C+R -4.06 (0.88) 4.60 -5.65 (1.13) 4.98 -2.76 (0.49) 5.60
Shape α̂ S.E. |Z| α̂ S.E. |Z| α̂ S.E. |Z|
Intercept -0.19 (0.04) —— 0.18 (0.04) —— -0.11 (0.02) ——
Palliative 0.00 —— —— 0.00 —— —— 0.00 —— ——
Surgery 0.59 (0.20) 2.90 0.31 (0.20) 1.53 0.18 (0.05) 3.63
Chemo 0.07 (0.14) 0.51 -0.02 (0.14) 0.15 0.09 (0.05) 1.78
Radio 0.34 (0.07) 4.66 0.25 (0.07) 3.39 0.14 (0.03) 5.25
C+R 0.97 (0.16) 5.90 0.93 (0.17) 5.50 0.30 (0.06) 5.00
ℓ(θ̂) -1938.12 -1927.74 -1934.48
AIC 3896.24 3875.47 3888.95
∆AIC 20.77 0.00 13.48
Before examining hazard ratios, we inspect the estimates and standard er-
rors in Table 5.1 from which we can draw some preliminary conclusions. The
β coefficients are negative which means that all treatments tend to reduce
the hazard relative to palliative care. However, the α coefficients are positive
(except chemotherapy in the log-logistic model) and, therefore, the hazards
are increasing relative to palliative care. In other words, the effectiveness of
each treatment reduces over time. The Z-scores show that chemotherapy is
not significant in either the scale or the shape (for the Weibull and log-logistic
models), i.e., the overall effect of chemotherapy is not significant.
Recall that the AIC values for the three models in SPR form (Table 4.3)
were 3933.51, 3899.32 and 3932.32 respectively. Thus, we can see that the fit
has improved in all cases by generalising to MPR form (with AIC reductions
of 37.27, 23.85 and 43.37 respectively). The improvement in fit is also evident
































































Figure 5.6. Estimated hazard function, hazard ratio and survivor func-
tion for the Weibull, log-logistic and TDL MPR models. The Kaplan-
Meier curves (step function) appear in bottom panels for comparison.
from Fig. 5.6 (bottom panel) where all estimated survivor curves match the
corresponding Kaplan-Meier curves more closely than in the SPR case (see
Fig. 4.2), particularly for the C+R group. The log-logistic MPR model fits
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the data most closely (notable in the palliative care and radiotherapy groups)
as is reflected in its AIC value.
The top two panels of Fig. 5.6 show the covariate effects in terms of the








































































Figure 5.7. Hazard ratios with confidence intervals for the Weibull,
log-logistic and TDL MPR models.
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inspecting the β and α coefficients in Table 5.1, i.e., the effect of treatment
(relative to palliative care) is to reduce the hazard but this is not maintained
over the full range of time. Figure 5.6 shows each hazard ratio separately
with the corresponding confidence interval (calculated using m.l.e. simulation
- see Section 2.3.2). The three models are roughly in agreement.
Surgery significantly reduces the hazard but its effect may wear off to-
wards the end of the time period (according to the log-logistic and time-
dependent logistic models). Nonetheless, it is clear that this treatment is
superior to the other three. Chemotherapy may reduce the hazard some-
what but this is not statistically significant (apart from a brief period early
in time). Both radiotherapy and the combined treatment (chemo + radio)
reduce the hazard significantly but their effects wear off after about 5 - 7
months. Of these two treatments, the combined treatment offers a greater
reduction in the hazard up to this point. However, it appears to be more
hazardous later in time.
It is clear from the above that the MPR approach provides a more flex-
ible framework than conventional SPR methods. With this we can discover
more complicated relationships between covariates and survival which sim-
pler methods may fail to capture.
Example 5.2. MPR Burr Analysis of Lung Cancer Data
In Section 5.2.4 we showed that the Burr MPR model can support a variety
of hazard effects and generalises other models we have considered. Thus, we
applied this model to the lung cancer data (again considering the unadjusted
effect of treatment only). The resulting estimates are given in the first column
of Table 5.2.
In this full Burr MPR model, with three regression components, none of
the τ coefficients are statistically significant. Thus, a reduced Burr MPR
model with τ = τ0 is shown in the second column of Table 5.2. In this model
τ0 is still not statistically different from zero and, as discussed in Section
5.2.4, Burr(β, α, τ = 0) = log-logistic(β, α). Indeed the estimated β and
α coefficients for this reduced Burr MPR model are numerically very close
to those from the log-logistic MPR analysis (Table 5.1), as are the hazard
ratios (not shown for the Burr model). Therefore, the extra complexity of
the Burr model is not needed in this case so it reduces to a log-logistic model.
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Table 5.2. Burr MPR Model Fit
Burr(β, α, τ) Burr(β, α, τ0) Burr(β, α0, τ0)
Scale β̂ S.E. |Z| β̂ S.E. |Z| β̂ S.E. |Z|
Intercept -1.16 (0.10) —— -1.18 (0.10) —— -1.27 (0.10) ——
Palliative 0.00 —— —— 0.00 —— —— 0.00 —— ——
Surgery -4.54 (1.23) 3.68 -4.16 (0.87) 4.81 -3.25 (0.34) 9.64
Chemo -0.62 (0.33) 1.91 -0.54 (0.35) 1.56 -0.64 (0.28) 2.29
Radio -1.47 (0.22) 6.67 -1.54 (0.22) 7.00 -1.10 (0.17) 6.49
C+R -5.57 (1.69) 3.29 -5.28 (1.12) 4.74 -1.73 (0.33) 5.23
Shape 1 α̂ S.E. |Z| α̂ S.E. |Z| α̂ S.E. |Z|
Intercept 0.15 (0.08) —— 0.10 (0.07) —— 0.25 (0.06) 3.93
Palliative 0.00 —— —— 0.00 —— —— —— —— ——
Surgery 0.46 (0.38) 1.22 0.36 (0.21) 1.76 —— —— ——
Chemo -0.27 (0.16) 1.68 -0.01 (0.14) 0.07 —— —— ——
Radio 0.10 (0.14) 0.73 0.26 (0.07) 3.57 —— —— ——
C+R 0.95 (0.32) 2.97 0.94 (0.17) 5.57 —— —— ——
Shape 2 τ̂ S.E. |Z| τ̂ S.E. |Z| τ̂ S.E. |Z|
Intercept -0.11 (0.27) —— -0.29 (0.25) 1.16 -0.09 (0.21) 0.42
Palliative —— —— —— —— —— —— —— —— ——
Surgery 1.03 (1.71) 0.60 —— —— —— —— —— ——
Chemo -10.52 (12.24) 0.86 —— —— —— —— —— ——
Radio -0.96 (1.01) 0.95 —— —— —— —— —— ——
C+R 0.06 (1.11) 0.05 —— —— —— —— —— ——
ℓ(θ̂) -1925.77 -1926.93 -1943.57
AIC 3881.54 3875.85 3901.13
∆AIC 5.68 0.00 25.28
Note also that the only statistically significant α coefficient in the full Burr
MPR model is that of the C+R group. Thus, we may have tried removing
treatment from both shape components (α and τ) leading to the Burr SPR
model (shown in the third column) which has increased AIC; hence, we would
not choose this model. This is a very simple example of variable selection
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within an MPR model. Of course variable selection in standard SPR models
is more straightforward as there is only one regression component in which
covariates can appear. We consider MPR variable selection more generally
in Section 5.4.
Another noteworthy feature of MPR models, evident in Table 5.2, is that
estimated regression coefficients (and standard errors) of a covariate in one
component can vary somewhat upon removal of the covariate from another
regression component. A good example of this behaviour is noticeable in the
β coefficients of both surgery and the combined treatment across the three
models. This is due to correlation across the distributional parameters (see
Section 3.6.3) - a matter which is discussed further, along with its potential
consequences for hypothesis testing, in Section 5.4. Moreover, the correlation
structure of estimates is investigated by simulation in Section 5.5.1.
Example 5.3. MPR Piecewise Exponential Analysis of Lung Cancer Data
Continuing with the single factor (treatment covariate) analysis of lung can-
cer data, we now look at the piecewise exponential MPR model. The number
of time intervals was varied from one (giving an SPR exponential model) to











Figure 5.8. AIC difference versus number of intervals.
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fifteen. Figure 5.8 shows the AIC differences for the fifteen models consid-
ered. Based on this, we will consider the model with four time intervals (a
two-interval model is also plausible). Note that the intervals were constructed
so that the number of events in each one is approximately equal. In partic-
ular, the four-interval model has I1 = [0.0, 1.3), I2 = [1.3, 3.2), I3 = [3.2, 6.8)
and I4 = [6.8, 21.0), respectively, with approximately 168 events contained
in each.
Table 5.3. Piecewise Exponential MPR Model Fit
β̂(t) S.E. |Z| β̂(t) S.E. |Z|
t ∈ [0.0, 1.3) t ∈ [1.3, 3.2)
Intercept -1.24 (0.09) —— -1.45 (0.10) ——
Palliative 0.00 —— —— 0.00 —— ——
Surgery -∞ —— —— -2.45 (0.59) 4.19
Chemo -0.21 (0.30) 0.69 -0.78 (0.42) 1.86
Radio -1.51 (0.24) 6.32 -0.63 (0.17) 3.71
C+R -∞ —— —— -2.71 (1.00) 2.70
t ∈ [3.2, 6.8) t ∈ [6.8, 21)
Intercept -1.84 (0.11) —— -2.11 (0.13) ——
Palliative 0.00 —— —— 0.00 —— ——
Surgery -2.15 (0.46) 4.67 -1.55 (0.31) 5.03
Chemo -0.34 (0.35) 0.97 -0.13 (0.34) 0.38
Radio -0.37 (0.17) 2.19 0.07 (0.18) 0.40
C+R -0.62 (0.35) 1.76 0.20 (0.28) 0.72
ℓ(θ̂) -1924.87
AIC 3889.74
The estimated regression coefficients for the model are shown in Table 5.3.
The results are consistent with the other models fitted: all treatments reduce
the hazard, surgery is significant over the full time range, chemotherapy is
not significant and both radiotherapy and the combined treatment become
non-significant later in time. Note that there were no events in the surgery
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or combined treatment groups in the first time interval. This led to infinite
(negative) coefficients as discussed in Appendix B.2.6.
The hazard ratio plots are given in Fig. 5.9. The resemblance with those
previously seen in Fig. 5.7 is clear, increasing credence in our earlier findings
since the piecewise exponential model does not impose any structure on the
data. Essentially, this model lets the data speak for themselves (within the
framework of a parametric model) but it does have disadvantages: firstly, it is
non-continuous in time and, secondly, its parameters can become inestimable
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Figure 5.9. Hazard ratios with confidence intervals for the piecewise
exponential MPR model.
5.3 The Hazard Ratio: Covariate Dependence
In Sections 5.2.1 - 5.2.6 we saw that MPR hazard ratios typically depend on
terms such as x̃Tβ (defined in (5.3)). In other words, MPR hazard ratios are
conditional on a specific covariate profile (except in the case of the Gompertz
or piecewise exponential models). Up to now (Examples 5.1 - 5.3) we have
considered single-factor analyses where, of course, the only other terms in
the regression components are the intercepts, i.e., x̃Tβ = β0. Thus, the issue
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of covariate-dependent hazard ratios did not arise. These simple examples
serve as a good starting point in exhibiting the increased utility of multi-
parameter regression over single-parameter regression analyses. Multi-factor
analyses, however, are typically of greater scientific interest; covariate effects
are adjusted in the presence of the other covariates in the model3. In this
multi-factor case, covariate-dependent hazard ratios do arise (i.e., x̃Tβ 6= β0).
In the notation of Section 5.2, we first assume an MPR model with scale
and shape regression components g(λ) = xTβ = cβ1+x̃
Tβ and h(γ) = zTα =
cα1 + z̃
Tα, respectively, where c is a binary covariate. The hazard ratio, at
time t, for the covariate c is therefore
ψ(t | x̃, z̃) =
λ(t | c = 1, x̃, z̃)
λ(t | c = 0, x̃, z̃)
, (5.27)
which differs from (5.4) notationally in the sense that we now explicitly show
the dependence on other covariates via x̃ and z̃ respectively, i.e., the effect
of c is conditional on the other covariates in the model via (x̃, z̃).
Thus, one can evaluate (5.27) for different values of (x̃, z̃), e.g., setting
(x̃, z̃) to values corresponding to high/low risk groups may be of interest.
Clearly, examining the hazard ratio for different covariate values may be quite
informative. However, Karrison (1987) noted that this approach gives rise
to a multiple comparisons problem (in the context of a different covariate-
dependent quantity). Essentially, there may be a very large, potentially
infinite, number of possible (x̃, z̃) values which is not helpful in making clear
statements about the individual effect of c, the covariate of interest4.
In light of the above, an overall adjusted measure of the effect of c is






ψ(t | x̃i, z̃i), (5.28)
3Of course, this does not imply that single-factor MPR analyses are not of interest in
their own right. In Example 5.1 we found that the MPR approach can enable us to match
the Kaplan-Meier curves very closely (much more so than SPR) which is noteworthy as
the KM curves are closest to the data by definition (Section 1.3). Thus, the MPR models
are very close to the data in this case whilst providing more insight than KM curves.
4However, if the analysis is based on a small number of categorical covariates (say, two
or three), evaluating ψ(t | x̃, z̃) at all values of (x̃, z̃) seems appropriate and useful.
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i.e., evaluate the hazard ratio for c at every value of (x̃, z̃) observed in the
dataset and then compute the average. Quantities of this type have been
considered previously by many authors, e.g., Nelder & Lane (1982) in gener-
alized linear models, Shen & Fleming (1997) who estimated mean survival,
Karrison (1987), Zucker (1998) and Chen & Tsiatis (2001) in the study of
restricted mean life (a quantity we consider in Section 6.3.1) and Martinussen
& Pipper (2013) in relation to a concordance measure. Alternatively we may
wish to evaluate the average-covariates hazard ratio
ψ(t | ¯̃x, ¯̃z), (5.29)
where (¯̃x, ¯̃z) is an “average of the covariates” value. In this case it seems
reasonable to set each categorical covariate to its modal class and each con-
tinuous covariate to its arithmetic mean.
Of course ψ̄(t) 6= ψ(t | ¯̃x, ¯̃z) in general and, furthermore, these two measures
have different interpretations: ψ(t | ¯̃x, ¯̃z) is the effect of c for an average in-
dividual whereas ψ̄(t) is the average effect of c over all individuals in the
dataset. However, often the two measures are close numerically (although
ψ̄(t) has wider confidence intervals - see Figs. 5.11 - 5.19). A third possibility
is to approximate log λ(t | x, z) using a linear model, thus separating covariate
effects (at time t) in a more familiar manner, i.e., through regression coef-
ficients which, upon exponentiation, provide estimates of the hazard ratios.
In Chapter 6 we discuss a (least squares) solution to approximating implied
regression models; in particular Section 6.4 deals with the hazard ratio.
It is worth noting that the hazard ratio for the Gompertz MPR model,
given in (5.10), depends only on the scale and shape coefficients of the co-
variate of interest, c. Thus, the hazard ratio is fully summarised by these
two values and does not depend on other covariates. Similarly, the piecewise
exponential MPR hazard ratio, (5.26), is summarised by the m regression co-
efficients (one for each time interval) corresponding to the covariate c. This
is noteworthy as we do not need to calculate ψ̄(t), i.e., ψ̄(t) = ψ(t) for either
of these MPR models which simplifies data analysis.
Example 5.4. Full Covariate Analysis of Lung Cancer Data: Log-Logistic
MPR Model
We continue with the analysis of the lung cancer data. In our previous
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analyses, we investigated the unadjusted effect of treatment. We now carry
out a full covariate analysis of the data using the log-logistic MPR model5.
Unsurprisingly, the AIC value for this full model (= 3683.91) is much
lower than any of the single factor models considered in previous examples,
i.e., the variation in the data is better explained by considering the effects of
all covariates. However, it is clear from the Z-scores in Table 5.4 that a more
parsimonious model (and hence lower AIC) is achievable. Variable selection,
when applied to MPR models, is complicated by the fact that there exists
correlation across regression components. Figure 5.10 shows the correlation
matrix for the estimated regression coefficients of the fitted model6. The pat-
tern of correlation is clear: (β̂, α̂) pairs corresponding to the same covariate
are highly (negatively) correlated whereas other estimates are relatively un-
correlated. Thus, variable selection procedures should be adapted to account
for this correlation (see Section 5.4). At this point however, we consider the
full model (i.e., saturating the scale and shape) without attempting to reduce
its dimension.
Inspecting the individual regression coefficients in Table 5.4 may give us
some idea of the effect of particular covariates on the hazard (e.g., as was done
in Example 5.1), however it is more instructive to look at the hazard ratios
which quantify the total effect. Of course, in this full covariate analysis (i.e.,
multi-factor model) hazard ratios depend on the specific covariate profile
via the presence of x̃ and z̃. As discussed previously, we eliminate this
covariate-dependence by calculating overall hazard ratios, defined in (5.28).
Figures. 5.11 - 5.19 show the overall hazard ratios for the log-logistic MPR
analysis of the lung cancer data with confidence intervals calculated using the
method of m.l.e. simulation (Section 2.3.2). The average-covariates hazard
5We also considered Weibull and time-dependent logistic MPR models whose AIC
values are 3700.88 and 3718.42 respectively. Thus, the log-logistic model has a considerably
lower AIC value (= 3683.91). It is noteworthy that this was also the case in Examples
4.2 and 5.1. Moreover, the Burr MPR model has AIC = 3682.8 providing only a marginal
improvement over the log-logistic model.
6Recall that the variance-covariance matrix for the estimated parameters is obtained
by inverting the observed information matrix (Section 2.3). Thus, from the variance-
covariance matrix, we can work out the corresponding correlation matrix for the estimated
parameters.
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Table 5.4. Log-Logistic MPR Full Covariate Analysis
Scale Shape
β̂ S.E. |Z| α̂ S.E. |Z|
Intercept -3.70 (0.80) —— 0.10 (0.22) ——
Treatment Palliative 0.00 —— —— 0.00 —— ——
Surgery -1.67 (0.90) 1.86 -0.03 (0.20) 0.13
Chemo -0.33 (0.43) 0.77 -0.16 (0.15) 1.08
Radio -1.16 (0.25) 4.72 0.21 (0.07) 2.85
C+R -5.07 (1.22) 4.17 0.64 (0.19) 3.34
Age Group < 50 0.00 —— —— 0.00 —— ——
50 - 60 -1.07 (0.52) 2.04 0.40 (0.16) 2.51
60 - 70 -1.16 (0.46) 2.49 0.44 (0.15) 3.02
70 - 80 -0.91 (0.47) 1.92 0.32 (0.15) 2.16
80 + -0.79 (0.50) 1.58 0.35 (0.17) 2.10
WHO Status Normal 0.00 —— —— 0.00 —— ——
Light Work -0.04 (0.53) 0.07 -0.01 (0.12) 0.04
No Work 1.09 (0.51) 2.11 -0.08 (0.13) 0.66
> 50% Bed 1.76 (0.53) 3.34 -0.06 (0.14) 0.45
Bedbound 2.38 (0.64) 3.71 -0.02 (0.21) 0.11
Sex Female 0.00 —— —— 0.00 —— ——
Male 0.15 (0.18) 0.80 -0.04 (0.06) 0.78
Smoker No 0.00 —— —— 0.00 —— ——
Yes -0.01 (0.29) 0.05 0.15 (0.09) 1.62
Ex-smoker -0.02 (0.30) 0.07 0.13 (0.09) 1.35
Missing 0.21 (0.52) 0.40 -0.03 (0.20) 0.15
Cell Type Squamous 0.00 —— —— 0.00 —— ——
Small 1.06 (0.33) 3.20 0.07 (0.11) 0.64
Adeno. 0.04 (0.36) 0.12 0.09 (0.10) 0.93
Other 0.38 (0.25) 1.54 -0.04 (0.07) 0.56
Metastases No 0.00 —— —— 0.00 —— ——
Yes 1.58 (0.34) 4.57 -0.15 (0.08) 1.87
Missing 0.86 (0.37) 2.33 -0.12 (0.09) 1.31
Sodium ≥ 136 mmol/l 0.00 —— —— 0.00 —— ——
< 136 mmol/l 0.44 (0.18) 2.42 0.003 (0.05) 0.06
Missing -1.06 (0.55) 1.94 0.36 (0.15) 2.41
Albumen ≥ 35 g/l 0.00 —— —— 0.00 —— ——
< 35 g/l 0.73 (0.20) 3.68 -0.01 (0.06) 0.13
Missing 0.59 (0.35) 1.70 -0.03 (0.11) 0.27
ℓ(θ̂) = -1789.95 AIC = 3683.91




















































































































































































































































Figure 5.10. Correlation matrix for estimated regression coefficients
in the log-logistic MPR model.
ratios, (5.29), are also shown for comparison7.
Naturally, the effect of treatment is of special interest from a medical
point of view and, hence, we discuss Fig. 5.11 first in detail. Both the overall
and average-covariates hazard ratios are numerically very similar for all treat-
ments. Thus, in this particular case, it does not matter whether we wish to
look at the effects over all individuals or for a common individual. Compar-
ing these adjusted hazard ratios to the unadjusted ones in Fig. 4.3 (middle
column = log-logistic model), we can see that the trajectories are similar in
both cases. However, the effects of surgery, radiotherapy and the combined
7All covariates are categorical in the lung cancer dataset and, hence, each is set to its
modal class in the calculation of average-covariates hazard ratios. The modal classes are
as follows: treatment = “palliative”, age group = “60 - 70”, WHO status = “no work”,
sex = “male”, smoker = “yes”, cell type = “other”, metastases = “yes”, sodium = “≥
136 mmol/l” and albumen = “≥ 35 g/l”.
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Figure 5.11. Treatment (reference: palliative care) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
log-logistic MPR model.
treatment have all reduced slightly (closer to one). Conversely, the effect of
chemotherapy has increased slightly. Furthermore, the confidence intervals
for the adjusted hazard ratios are much wider than for the unadjusted case.
Clearly all treatments are beneficial (adjusted hazard ratios below one)
for some period of time. Surgery offers a large reduction in the hazard (rela-
tive to palliative care) and its effect is statistically significant until about 12
- 13 months; it has the longest lasting effect. Chemotherapy has a modest
beneficial effect for a brief period ending after about 4 - 5 months. Radio-
therapy has a larger effect than chemotherapy but wears off after about 3 -
4 months. The combined treatment is very effective early in time (possibly
superior to surgery in the first 2 - 3 months) but wears off after about 5
months.
We will now briefly summarise the effects of the other covariates (Figs. 5.12
- 5.19) via the overall adjusted hazard ratios. Note that the average-covariates
lead to somewhat similar interpretations but differ mainly in that they have
narrower confidence intervals. This is not surprising as these hazard ratios
apply to a specific “average” individual whereas the overall hazard ratios
take into account the variation across all individuals.
5.3. THE HAZARD RATIO: COVARIATE DEPENDENCE 127 Age group: Older age groups have a greater risk of death but this is
only statistically significant for groups 50 - 60 and 60 - 70 and only after
5 - 7 months. In other words, the risk is higher for older individuals
who have lung cancer for longer periods of time. WHO status : The worse one’s health status is, the greater the risk of
death (not statistically significantly for the light work group). As can
be seen from the y-axis, the hazard ratios are very large in magnitude. Sex : Males are not significantly different from females. Smoker : Smokers / ex-smokers have a higher risk of death. Note that
the confidence intervals include the value of one, but only just. Cell type: All cell types appear to be more hazardous than squamous
cell but this is only statistically significant for the small cell type (for
almost the entire time range). Metastases : Where metastases are present, the risk of death is much
higher. This is significant for about 7 - 8 months. As can be seen from
the y-axis, this hazard ratio is large in magnitude. Sodium: Lower sodium levels leads to a slightly higher risk of death in
the first 6 months. Albumen: Lower albumen levels increase the risk of death (statistically
significant for about 9 months).
Clearly, the hazard ratio plots contain useful information. However, we
may be interested in their numeric values at some key time points. To this
end, Table 5.5 contains the values of the overall adjusted hazard ratios at
1.75, 4.75 and 12 months respectively. These are the 25th, 50th and 75th
percentiles as estimated using the Kaplan-Meier curve for the whole sample.
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Figure 5.12. Age (reference: < 50) overall (solid) and average-
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Figure 5.13. WHO status (reference: normal) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
log-logistic MPR model.
















Figure 5.14. Sex (reference: female) overall (solid) and average-
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Figure 5.15. Smoker (reference: no) overall (solid) and average-
covariates (dash) hazard ratios with confidence intervals for the log-
logistic MPR model.

















0 5 10 15 20
Small
0 5 10 15 20
Adenocarcinoma





Figure 5.16. Cell type (reference: squamous) overall (solid) and
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Figure 5.17. Metastases (reference: no) overall (solid) and average-
covariates (dash) hazard ratios with confidence intervals for the log-
logistic MPR model.
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Figure 5.18. Sodium (reference: ≥ 136 mmol/l) overall (solid) and
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Figure 5.19. Albumen (reference: ≥ 35 g/l) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
log-logistic MPR model.
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Table 5.5. Log-Logistic MPR Overall Hazard Ratios with C.I.s
t = 1.75 t = 4.75 t = 12
Treatment Palliative 1.00 —— 1.00 —— 1.00 ——
Surgery 0.26 (0.10, 0.60)∗ 0.38 (0.26, 0.58)∗ 0.58 (0.40, 0.95)∗
Chemo 0.61 (0.38, 0.97)∗ 0.62 (0.40, 0.99)∗ 0.69 (0.45, 1.08)
Radio 0.61 (0.48, 0.77)∗ 0.95 (0.77, 1.19) 1.18 (0.96, 1.46)
C+R 0.04 (0.01, 0.21)∗ 0.31 (0.15, 0.76)∗ 1.20 (0.63, 2.37)
Age Group < 50 1.00 —— 1.00 —— 1.00 ——
50 - 60 0.90 (0.59, 1.49) 1.44 (0.92, 2.37) 1.74 (1.08, 2.98)∗
60 - 70 0.91 (0.65, 1.48) 1.54 (1.01, 2.48)∗ 1.87 (1.19, 3.13)∗
70 - 80 0.89 (0.62, 1.40) 1.28 (0.85, 2.01) 1.51 (0.97, 2.48)
80 + 1.00 (0.64, 1.67) 1.45 (0.86, 2.66) 1.66 (0.96, 2.95)
WHO Status Normal 1.00 —— 1.00 —— 1.00 ——
Light Work 0.96 (0.58, 1.67) 0.96 (0.69, 1.36) 0.97 (0.71, 1.38)
No Work 2.12 (1.25, 3.68)∗ 1.51 (1.04, 2.19)∗ 1.13 (0.81, 1.62)
> 50% Bed 3.61 (2.06, 6.41)∗ 2.16 (1.40, 3.46)∗ 1.34 (0.92, 2.03)
Bedbound 5.74 (2.49,13.91)∗ 2.94 (1.34, 6.63)∗ 1.56 (0.81, 2.88)
Sex Female 1.00 —— 1.00 —— 1.00 ——
Male 1.04 (0.86, 1.27) 0.97 (0.79, 1.19) 0.95 (0.79, 1.13)
Smoker No 1.00 —— 1.00 —— 1.00 ——
Yes 1.27 (0.93, 1.82) 1.42 (1.01, 2.03)∗ 1.38 (0.99, 2.00)
Ex-smoker 1.22 (0.90, 1.79) 1.35 (0.98, 1.91) 1.32 (0.95, 1.89)
Missing 1.11 (0.60, 2.19) 1.04 (0.53, 2.43) 1.00 (0.52, 2.16)
Cell Type Squamous 1.00 —— 1.00 —— 1.00 ——
Small 2.49 (1.65, 3.79)∗ 2.01 (1.33, 3.22)∗ 1.50 (1.06, 2.24)∗
Adeno. 1.23 (0.88, 1.75) 1.31 (0.93, 1.83) 1.26 (0.90, 1.71)
Other 1.26 (0.97, 1.65) 1.11 (0.87, 1.41) 1.02 (0.81, 1.29)
Metastases No 1.00 —— 1.00 —— 1.00 ——
Yes 2.75 (1.90, 4.04)∗ 1.67 (1.30, 2.12)∗ 1.12 (0.88, 1.41)
Missing 1.66 (1.13, 2.44)∗ 1.22 (0.91, 1.65) 0.99 (0.76, 1.28)
Sodium ≥ 136 mmol/l 1.00 —— 1.00 —— 1.00 ——
< 136 mmol/l 1.40 (1.13, 1.70)∗ 1.26 (1.04, 1.55)∗ 1.12 (0.95, 1.37)
Missing 0.86 (0.47, 1.54) 1.61 (0.90, 3.32) 1.74 (1.08, 2.80)∗
Albumen ≥ 35 g/l 1.00 —— 1.00 —— 1.00 ——
< 35 g/l 1.73 (1.37, 2.19)∗ 1.43 (1.14, 1.81)∗ 1.18 (0.97, 1.44)
Missing 1.51 (0.99, 2.16) 1.27 (0.85, 1.95) 1.09 (0.77, 1.60)
Note: Symbol “∗” indicates that the C.I. does not contain the value one.
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Example 5.5. Full Covariate Analysis of Lung Cancer Data: Gompertz
MPR
We have mentioned that the Gompertz MPR model has the advantage of
its hazard ratios being covariate-independent, obviating the need to average
over the covariate distribution. Hence, we now show the results of the full
covariate Gompertz analysis of the lung cancer data. This analysis mirrors
the log-logistic analysis of Example 5.4 and is mainly included for the purpose
of comparison with the earlier analysis.
Firstly, comparing Tables 5.6 and 5.4, we can see similarities in the signs,
relative magnitudes and Z-scores of the β and α coefficients. Thus, even
though the models are structurally different, it seems they are roughly in
agreement as to the size and significance of the various scale and shape
effects. Note however that the AIC value for the Gompertz model is quite a
bit higher than the log-logistic model (3709.74 versus 3683.91).
We can see from Fig. 5.20 that the estimated regression coefficients are
correlated in a manner which is virtually indistinguishable from the log-
logistic case (Fig. 5.10). Thus, the correlation pattern that we observed
earlier is not just a feature of the log-logistic model, but rather, it applies
more generally. Indeed we have found in practice that this pattern emerges
for all of the MPR models we consider. Furthermore, we also show by sim-
ulation (Section 5.5.1 and Appendix B.4) that the correlation pattern arises
across a variety of different scenarios and models.
The Gompertz hazard ratio plots are given in Figs. 5.21 - 5.29. However,
we will not go into detail interpreting these hazard ratios. Instead we briefly
compare them to those from the log-logistic analysis (Figs. 5.11 - 5.19). We
can see that the exact results from the two analyses are slightly different. For
example, the Gompertz hazard ratios have wider confidence intervals later
in time. Nonetheless, when the hazard ratios are compared side by side,
it is apparent that the basic conclusions from both analyses are very simi-
lar. We reiterate the fact that the log-logistic model has a much lower AIC
value. Thus, while the Gompertz MPR hazard ratio has an appealingly sim-
ple functional form, this, of course, does not ensure that the model provides
a superior fit.
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Table 5.6. Gompertz MPR Full Covariate Analysis
Scale Shape
β̂ S.E. |Z| α̂ S.E. |Z|
Intercept -2.92 (0.53) —— -0.15 (0.09) ——
Treatment Palliative 0.00 —— —— 0.00 —— ——
Surgery -1.47 (0.48) 3.06 0.02 (0.06) 0.41
Chemo -0.54 (0.32) 1.70 0.03 (0.06) 0.48
Radio -0.65 (0.16) 4.11 0.07 (0.03) 2.52
C+R -2.24 (0.50) 4.47 0.23 (0.07) 3.25
Age Group < 50 0.00 —— —— 0.00 —— ——
50 - 60 -0.70 (0.40) 1.77 0.17 (0.06) 2.61
60 - 70 -0.59 (0.36) 1.62 0.14 (0.06) 2.35
70 - 80 -0.52 (0.37) 1.41 0.11 (0.06) 1.81
80 + -0.48 (0.39) 1.23 0.11 (0.07) 1.65
WHO Status Normal 0.00 —— —— 0.00 —— ——
Light Work -0.14 (0.32) 0.44 0.04 (0.04) 0.97
No Work 0.67 (0.31) 2.13 -0.02 (0.04) 0.55
> 50% Bed 1.11 (0.33) 3.42 -0.04 (0.05) 0.82
Bedbound 1.53 (0.43) 3.58 0.02 (0.13) 0.15
Sex Female 0.00 —— —— 0.00 —— ——
Male -0.02 (0.12) 0.18 0.001 (0.02) 0.07
Smoker No 0.00 —— —— 0.00 —— ——
Yes 0.13 (0.20) 0.63 0.06 (0.03) 1.72
Ex-smoker 0.03 (0.21) 0.15 0.06 (0.04) 1.64
Missing 0.20 (0.38) 0.53 0.01 (0.08) 0.17
Cell Type Squamous 0.00 —— —— 0.00 —— ——
Small 0.76 (0.23) 3.35 -0.02 (0.05) 0.48
Adeno. 0.21 (0.22) 0.96 0.02 (0.03) 0.72
Other 0.25 (0.16) 1.58 -0.01 (0.03) 0.26
Metastases No 0.00 —— —— 0.00 —— ——
Yes 1.00 (0.20) 4.88 -0.04 (0.03) 1.56
Missing 0.49 (0.22) 2.21 -0.02 (0.03) 0.54
Sodium ≥ 136 mmol/l 0.00 —— —— 0.00 —— ——
< 136 mmol/l 0.32 (0.12) 2.58 -0.01 (0.02) 0.30
Missing -0.32 (0.33) 0.96 0.07 (0.06) 1.13
Albumen ≥ 35 g/l 0.00 —— —— 0.00 —— ——
< 35 g/l 0.60 (0.14) 4.43 -0.04 (0.03) 1.73
Missing 0.40 (0.24) 1.67 0.003 (0.05) 0.06
ℓ(θ̂) = -1802.87 AIC = 3709.74




















































































































































































































































Figure 5.20. Correlation matrix for estimated regression coefficients
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Figure 5.21. Treatment (reference: palliative care) hazard ratios with
confidence intervals for the Gompertz MPR model.
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Figure 5.22. Age (reference: < 50) hazard ratios with confidence in-
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Figure 5.23. WHO status (reference: normal) hazard ratios with con-
fidence intervals for the Gompertz MPR model.
















Figure 5.24. Sex (reference: female) hazard ratio with confidence in-
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Figure 5.25. Smoker (reference: no) hazard ratios with confidence
intervals for the Gompertz MPR model.
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Figure 5.26. Cell type (reference: squamous) hazard ratios with confi-
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Figure 5.27. Metastases (reference: no) hazard ratios with confidence
intervals for the Gompertz MPR model.
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Figure 5.28. Sodium (reference: ≥ 136 mmol/l) hazard ratios with















0 5 10 15 20
< 35 g/l





Figure 5.29. Albumen (reference: ≥ 35 g/l) hazard ratios with confi-
dence intervals for the Gompertz MPR model.
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Example 5.6. Lung Cancer Cure Probabilities via the Gompertz MPR Model
A novel feature of the Gompertz model (mentioned in Section 1.4.3) is the
fact that, when its shape parameter is negative, it has a survivor curve which
does not fall to zero but rather to some positive limit8. This positive limit
is the cure probability. Thus, the Gompertz MPR model implies a regression
model for the cure probability,

















if zTα < 0.
(5.30)
From this we can compute the overall cure probability for a given group
which, analogous to the overall hazard ratio defined in (5.28), is given by





pcure(c = 1, x̃i, z̃i), (5.31)
where c is a binary variable indicating membership of the group of interest
and x̃ and z̃ are as defined in (5.3). In words, we fix c to the value of one
and average over the full distribution of covariates in the dataset.
Continuing with the Gompertz analysis in Example 5.5, we now investi-
gate the cure probabilities implied by this fitted model. These are shown in
Table 5.7 with confidence intervals calculated using m.l.e. simulation (Sec-
tion 2.3.2). As a reference, it is worth estimating the population cure prob-
ability by
∑n
i=1 pcure(xi, zi)/n which, for this dataset, is 0.016; clearly there
is very little chance of being cured of lung cancer. Furthermore, most of
the cure probabilities in Table 5.7 are not statistically different from this
reference probability. The only exceptions to this are the youngest indi-
viduals (i.e., < 50) with p̄cure = 0.144 (0.024, 0.279) and non-smokers with
p̄cure = 0.07 (0.024, 0.206). It is also noteworthy that in the surgery group
p̄cure = 0.1 (0.015, 0.315) which only just includes the reference probability.
One caveat to the above results is that calculation of cure probabilities
represents extrapolation (i.e., to time infinity) and, therefore, the degree of
8This is also the case for the time-dependent logistic model (Section 1.4.6).
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Table 5.7. Gompertz MPR Overall Cure Probabilities with C.I.s
p̄cure
Treatment Palliative 0.017 (0.010, 0.059)
Surgery 0.100 (0.015, 0.315)
Chemo 0.021 (0.002, 0.179)
Radio 0.006 (0.002, 0.033)
C+R 0.000 (0.000, 0.024)
Age Group < 50 0.144 (0.024, 0.279)
50 - 60 0.002 (0.000, 0.035)
60 - 70 0.004 (0.002, 0.039)
70 - 80 0.015 (0.007, 0.068)
80 + 0.014 (0.004, 0.092)
WHO Status Normal 0.034 (0.010, 0.153)
Light Work 0.012 (0.005, 0.058)
No Work 0.021 (0.011, 0.078)
> 50% Bed 0.016 (0.004, 0.076)
Bedbound 0.001 (0.000, 0.124)
Sex Female 0.016 (0.008, 0.060)
Male 0.016 (0.010, 0.052)
Smoker No 0.070 (0.024, 0.206)
Yes 0.008 (0.004, 0.044)
Ex-smoker 0.009 (0.005, 0.047)
Missing 0.033 (0.000, 0.280)
Cell Type Squamous 0.023 (0.011, 0.074)
Small 0.013 (0.002, 0.084)
Adeno. 0.006 (0.002, 0.043)
Other 0.018 (0.010, 0.061)
Metastases No 0.023 (0.011, 0.080)
Yes 0.016 (0.008, 0.054)
Missing 0.018 (0.009, 0.064)
Sodium ≥ 136 mmol/l 0.018 (0.012, 0.057)
< 136 mmol/l 0.013 (0.006, 0.054)
Missing 0.002 (0.000, 0.079)
Albumen ≥ 35 g/l 0.016 (0.009, 0.059)
< 35 g/l 0.023 (0.011, 0.074)
Missing 0.008 (0.001, 0.074)
142 CHAPTER 5. MULTI-PARAMETER REGRESSION
belief in such probabilities depends on one’s belief in the model. It is well
known that estimated tail probabilities (for survival data) have bad prop-
erties due to censoring and, of course, cure probabilities are extreme tail
probabilities. Indeed, we have found this to be the case in Sections 3.6.5
and 3.6.6 and generally caution is advised in their use (extrapolation was
also discussed in Section 3.6.2). Nonetheless, the results of this particular
analysis do not appear to be unreasonable.
5.4 Hypothesis Testing and Variable
Selection
It is natural to enquire if certain covariates affect the scale, λ, or the shape, γ,
of the distribution by performing hypothesis tests on regression coefficients
(or through the use of variable selection procedures). However, as we observe
correlation across the regression components (mentioned in Examples 5.2, 5.4
and 5.5), these components cannot be considered separately. Thus, we must
account for this correlation when carrying out any such testing.
Firstly we note that an orthogonal parametrisation is obviously attractive
as the regression components are independent (i.e, λ ⊥ γ ⇒ β ⊥ α) and,
therefore, can be considered separately. However, most parametrisations are,
of course, non-orthogonal. Furthermore, even if an orthogonal parametrisa-
tion does exist for a particular model, the parameters of a corresponding
non-orthogonal version may have a more appealing interpretation. For ex-
ample, the orthogonal Weibull model (Appendix C), when generalised to
multi-parameter regression form, does not provide us with a test of propor-
tional hazards (via the testing of α-coefficients) as in the standard Weibull
(see Appendix C.5) and so the standard form may be preferable. In rela-
tion to this matter, Cox (2006, sec. 6.4.4) said that “so far as parameters of
interest are concerned, subject-matter interpretability has primacy.” In ad-
dition to this, orthogonality is defined in terms of the expected information
matrix, I = E(Io), see Cox & Reid (1987), which is difficult to construct for
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survival data due to censoring9. Indeed Cox & Reid (1987) did not consider
censored data and derived the orthogonal Weibull model under the condition
of full information (see Appendix C.4). Thus “orthogonal” parametrisations,
defined in this way, do not retain orthogonality in the presence of censoring
which we confirm by simulation in Section 5.5.1.
Clearly, we are much more likely to encounter the use of non-orthogonal
models in practice (orthogonal models may be considered a special, often
unattainable, case). Therefore we will only consider hypothesis testing within
non-orthogonal models. First we will assume, as before, that the scale and
shape regression components are g(λ) = xTβ = cβ1+ x̃
Tβ and h(γ) = zTα =
cα1 + z̃
Tα, respectively, where c is a binary covariate.
Note that in single-parameter regression models (SPR), covariates only
appear in the scale regression. In this case, the importance of the covariate
c is determined by testing if its estimated effect, β̂1, differs statistically from
zero. This effect is adjusted for the other covariates which, being an SPR
model, appear in the same regression component as c. However, this situ-
ation is generalised in the multi -parameter regression (MPR) case. In the
two component (scale and shape) MPR model we are considering, there are
two hypotheses of interest, namely: (i) H0 : β1 = 0 and (ii) H0 : α1 = 0.
These hypotheses cannot be tested independently due to the correlation that
exists across the scale-shape space. The consequence of this correlation is as
follows: the effect of c in one regression is adjusted for the other covariates in
that regression and all covariates in the other regression. It is important to
note that c itself appears in the other regression and β̂1 and α̂1 will be highly
correlated10. Thus, the scale effect of c is significantly adjusted for its shape
effect (and vice versa). It is clear then that it is not appropriate to judge
the importance of c in one component without it being present in the other
component; we can imagine scenarios where a covariate only becomes signifi-
cant when present in both components. Of course, the individual hypothesis
tests are carried out in the usual way, i.e., Wald tests based on the fact that
9Recall from Section 2.3.1 that I is not usable; its functional form is unknown due to
the presence of censoring. Even in the uncensored case I, while known, can be intractable.
10We have found in practice that scale and shape coefficients of the same covariate
are highly correlated (see Examples 5.4 and 5.5). Furthermore, we investigate this by
simulation in Section 5.5.1 and Appendix B.4.
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(asymptotically) β̂1 ∼ N{β1, var(β̂1)} and α̂1 ∼ N{α1, var(α̂1)}, respectively,
where the variances are obtained from the diagonal of the covariance matrix,
Σ(θ̂) = I−1o (θ̂) (Section 2.3).
It is also of interest to determine the total (or joint) effect of c, i.e.,
by testing (iii) H0 : β1 = α1 = 0. Using the fact that (asymptotically)
(β̂1, α̂1)
T ∼ N [(β1, α1)T ,Σβ̂1,α̂1 ], where Σβ̂1,α̂1 is the relevant 2× 2 covariance
sub-matrix of Σ(θ̂), we have that
[(β̂1, α̂1)




T − (β1, α1)
T ] ∼ χ22. (5.32)
Thus a p-value can be obtained by setting (β1, α1)
T = (0, 0)T in (5.32)
and comparing this statistic to the χ22 distribution. Furthermore, the corre-
sponding (1 − α)100% confidence ellipse for (β1, α1)T is given by the set of
(β1, α1)
T points defining the contour line such that (5.32) is equal to χ22,1−α
(see Friendly et al. (2013) for detailed account of confidence ellipses).
We now define M(x, z) to be a model with scale and shape covariate
vectors x and z, respectively. Hence, let M0 = M(x̃, z̃) be a model where
c does not appear (i.e., c 6∈ x̃, z̃) and the three models which include c are:
Mβ1 = M(x̃ ∪ c, z̃), Mα1 = M(x̃, z̃ ∪ c) and Mβ1α1 = M(x̃ ∪ c, z̃ ∪ c), re-
spectively. Therefore, we can test hypotheses (i), (ii) and (iii) by comparing
Mβ1α1 with Mα1 , Mβ1α1 with Mβ1 and Mβ1α1 with M0, respectively. This can
be done by means of likelihood ratio tests (as the models are nested) or using
information criteria (see Section 2.2 and Burnham & Anderson (2002)); such
approaches are more in line with variable selection procedures (Miller, 2002).
Of course inferential problems associated with variable selection methods are
well documented (Miller, 1984; Hurvich & Tsai, 1990; Zhang, 1992) and auto-
matic selection procedures are much criticised. Nonetheless, such procedures
may be useful when the number of covariates is large, so that methods for
MPR models are required (just as they are for SPR models). To this end we
discuss MPR forward selection in the proceeding paragraph.
Algorithm 1 below shows the pseudocode for MPR forward selection (the
corresponding R code is given in Appendix B.5.3) which we also describe here
in words. The algorithm begins by fitting the null model M(x = ∅, z = ∅).
Thereafter, in each iteration of the main while loop, the algorithm seeks
a model which is better than the current model; “better” in this context
5.4. HYPOTHESIS TESTING AND VARIABLE SELECTION 145
Algorithm 1: Multi-Parameter Regression Forward Selection
x← z ← ∅;
Fit model Mnew ← M(x, z);
finish ← false;
while finish = false do
Mold ←Mnew ;
foreach c 6∈ x do
Fit model M∗ ← M(x ∪ c, z);




foreach c 6∈ z do
Fit model M∗ ← M(x, z ∪ c);




foreach c 6∈ x, z do
Fit model M∗ ← M(x ∪ c, z ∪ c);




if Mold 6=Mnew then





Result: Mnew (the “best” model)
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may be based on likelihood ratio tests, AIC, BIC, etc. Of course, at each
such iteration, there are candidate covariates to be considered for inclusion
in the scale {c | c 6∈ x}, the shape {c | c 6∈ z} and for simultaneous inclusion
{c | c 6∈ x, z}. Hence, this main loop is composed of three for loops where all
of these new models are fitted and compared to the current model. If, at the
end of the while loop, the algorithm finds a better model, then this becomes
the current model and another iteration of the loop commences. Otherwise,
the loop ends as the best model has been found. Extending the algorithm to
include backward steps as well as forward steps is straightforward (Appendix
B.5.3 shows the output of such a procedure applied to the lung cancer data),
and, furthermore, the starting model need not be the null model.
If one were not aware of the issues discussed in this section, then other
strategies for determining important covariates may seem reasonable. We
now discuss some possibilities that such a user may implement. These are
all special cases of Algorithm 1 and are, therefore, sub-optimal. Standard (“good”) advice suggests that one should start with a simpler
model and then increase complexity. To this end a user may choose
to start by considering the scale only (i.e., the standard SPR model).
Once the best SPR model has been found, the user then proceeds to
include covariates in the shape to try to improve the model further
(i.e., the model is now MPR). This is equivalent to running Algorithm
1 with the first for loop only, to find the best SPR model, followed
by running the algorithm again (starting at this SPR model) with the
second for loop only. Alternatively, one may realise that the whole regression space (scale
and shape) should be considered at once. However, analogous to stan-
dard selection procedures which include covariates one-at-a-time, this
user does not implement the simultaneous step (i.e., the third for loop
of Algorithm 1). While this procedure is more general than the first-
mentioned, it may still miss out on covariates which only show signifi-
cance when present in both components (as discussed previously). A third possibility is a user who only considers simultaneous steps, i.e.,
covariates are either in the model (in both components) or not in the
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model. While this approach does account for the fact that β̂ and α̂
coefficients of the same covariate are highly correlated, it may lead to
an over-parametrised model. Conversely, a covariate could be missed
using this method if its effect in one component is highly insignificant
and, hence, renders the joint component effect statistically insignificant.
Another option for selecting covariates is the popular lasso method (Tib-
shirani, 1996). While we have not explored the use of this method in MPR
models, it seems reasonable to assume that alteration of the penalty term
is required in order to consider (β, α) pairs simultaneously. It is likely that
this can be achieved within the framework of the group lasso (Yuan & Lin,
2006; Yuan et al., 2009; Zhao et al., 2009; Bach et al., 2012) which allows
certain covariate structures to be built into the lasso penalty. Whereas the
standard lasso defines all terms to be equal, the group lasso has been de-
veloped to handle the groupings that arise due to derived (binary) variables
representing a categorical covariate and the hierarchy of terms that exists in
models with interactions11. In a similar spirit Bien et al. (2013) have devel-
oped the hierarchical lasso which may also be useful for our intended purpose
in MPR modelling. Furthermore, the Bayesian lasso (Park & Casella, 2008;
Hans, 2009, 2010) may lend itself well to our MPR case where, for example,
we may wish to put greater prior probability on certain (β, α) pairs being
jointly non-zero. Further work in this area is required.
Example 5.7. Log-Logistic MPR Full Covariate Analysis Continued
In Example 5.4 we carried out a full covariate analysis of the lung cancer
data but noted that a more parsimonious model is achievable (see Table
5.4). Thus, we continue our analysis with a view to removing unnecessary
covariates from the model. Table 5.8 and Fig. 5.30 show the p-values and
95% confidence regions for the scale, shape and joint effects respectively12.
11When interaction terms are present, it is proper practice to include all lower order
terms, e.g., if A.B is in the model then A and B should also be present. This practice
is known as respecting marginality and has been discussed by Nelder (1977, 1998) and
McCullagh & Nelder (1989). If this is not done then one imposes restrictions on the
interpretation of the model which are usually undesirable.
12The p-values and confidence ellipses for the joint effects are calculated using (5.32).
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Table 5.8. Log-Logistic MPR: Significance of Scale and Shape Effects
Scale Shape Joint
|Z| p |Z| p χ2
2
p
Treatment Palliative —— —— —— —— —— ——
Surgery 1.86 0.063 0.13 0.893 27.24 0.000
Chemo 0.77 0.443 1.08 0.280 4.75 0.093
Radio 4.72 0.000 2.85 0.004 23.08 0.000
C+R 4.17 0.000 3.34 0.001 17.78 0.000
Age Group < 50 —— —— —— —— —— ——
50 - 60 2.04 0.041 2.51 0.012 6.48 0.039
60 - 70 2.49 0.013 3.02 0.002 9.53 0.009
70 - 80 1.92 0.055 2.16 0.031 5.08 0.079
80 + 1.58 0.115 2.10 0.036 4.53 0.104
WHO Status Normal —— —— —— —— —— ——
Light Work 0.07 0.942 0.04 0.965 0.05 0.974
No Work 2.11 0.035 0.66 0.509 8.57 0.014
> 50% Bed 3.34 0.001 0.45 0.653 23.23 0.000
Bedbound 3.71 0.000 0.11 0.910 16.70 0.000
Sex Female —— —— —— —— —— ——
Male 0.80 0.423 0.78 0.434 0.75 0.688
Smoker No —— —— —— —— —— ——
Yes 0.05 0.964 1.62 0.105 4.12 0.127
Ex-smoker 0.07 0.944 1.35 0.176 2.90 0.235
Missing 0.40 0.690 0.15 0.881 0.16 0.921
Cell Type Squamous —— —— —— —— —— ——
Small 3.20 0.001 0.64 0.523 19.96 0.000
Adeno. 0.12 0.901 0.93 0.351 2.81 0.246
Other 1.54 0.122 0.56 0.576 3.17 0.205
Metastases No —— —— —— —— —— ——
Yes 4.57 0.000 1.87 0.061 32.48 0.000
Missing 2.33 0.020 1.31 0.190 6.20 0.045
Sodium ≥ 136 mmol/l —— —— —— —— —— ——
< 136 mmol/l 2.42 0.015 0.06 0.951 10.62 0.005
Missing 1.94 0.052 2.41 0.016 5.84 0.054
Albumen ≥ 35 g/l —— —— —— —— —— ——
< 35 g/l 3.68 0.000 0.13 0.897 23.18 0.000
Missing 1.70 0.089 0.27 0.790 4.44 0.109
ℓ(θ̂) = -1789.95 AIC = 3683.91
Note: A value of p = 0.000 ⇒ p < 0.001.
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Figure 5.30. Joint 95% confidence ellipses (solid) and individual 95%
confidence intervals (dash) for the scale and shape coefficients.
150 CHAPTER 5. MULTI-PARAMETER REGRESSION
Looking at the joint effects, the main conclusions are as follows: Treatment : The overall effect of chemotherapy is not statistically sig-
nificant. Age Group: The two older age groups (80+ and 70 - 80) are not signif-
icantly different from the < 50 group. Furthermore, the 50 - 60 group
is only just significant. WHO Status : The light work group is not significantly different from
the normal group. Sex : Males are not significantly different from females. Smoker : Neither current nor ex-smokers are significantly different from
non-smokers. Cell Type: Adenocarinoma and other cells are not significantly different
from squamous cell. All other effects are highly statistically significant (apart from the
“missing” groups which we are not interested in anyway).
These conclusions echo our earlier findings which were based on the hazard
ratio plots (Figs. 5.11 - 5.19). Of course this is not surprising as the hazard
ratios take into account both the scale and shape effects of covariates.
In addition to the above, while WHO status, cell type and albumen level
have categories which are statistically significant, the shape effects are all
non-significant. Thus, the extra flexibility afforded by shape regression is
unnecessary in these cases13.
Clearly we can reduce the dimension of the model by dropping non-
significant terms. To this end we fitted the 27 reduced models which arise
from excluding each of the nine covariates from scale, the shape and simul-
taneously from the scale and shape. We then compared these models to the
13It is worth noting that testing for non-zero shape coefficients in the log-logistic MPR
model provides a test of proportional odds of survival (see Section 5.2.3).
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full model in order to determine the importance of each covariate in these re-
gression components (using likelihood ratio tests and AIC differences). The
results are shown in Table 5.9.
Table 5.9. Likelihood Ratio Tests and AIC differences
L.R. Test ∆AIC
Scale Shape Joint Scale Shape Joint
Treatment 0.000 0.000 0.000 39.11 13.74 64.67
Age Group 0.146 0.012 0.090 -1.19 4.86 -2.31
WHO Status 0.000 0.865 0.000 46.26 -6.72 67.01
Sex 0.421 0.434 0.686 -1.35 -1.39 -3.25
Smoker 0.974 0.342 0.549 -5.78 -2.66 -7.04
Cell Type 0.008 0.432 0.001 5.79 -3.25 10.22
Metastases 0.000 0.175 0.000 26.49 -0.51 36.32
Sodium 0.004 0.073 0.002 7.01 1.24 8.75
Albumen 0.001 0.963 0.000 9.94 -3.93 15.85
Note: A value of p = 0.000 ⇒ p < 0.001. Furthermore, ∆AIC = AICreduced − AICfull.
Therefore, ∆AIC > 0 represents superiority of the full model fit.
Before attempting to reduce the dimension of the model, we first note
that the joint ∆AIC values give us a sense of the relative importance of each
covariate. In particular, treatment and WHO status are the most important
in determining survival of the patient, followed by the presence of metastases.
Next, cell type, sodium and albumen are similar in importance. Finally, age
group, sex and smoking status are less important.
Taking into consideration all of the p-values and AIC differences in the
above table, we initially removed age group, sex and smoking status from
the model (i.e., from both regressions). Furthermore, WHO status, cell type,
metastases and albumen were dropped from the shape regression. This gave a
model with AIC = 3660.92. Removing covariates further did not improve on
this AIC value, however the re-inclusion of metastases in the shape regression
gave AIC = 3659.67. Although this last improvement is small, we accepted
it as our final model (see Table 5.10). In any case we have significantly
improved on the AIC value of the full model (3683.91− 3659.67 = 24.24).
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The overall and average-covariates hazard ratios under this reduced model
(shown in Figs. 5.31 - 5.36) are similar to those from the full model (see
Example 5.4) but the C.I.s are generally narrower. Of course this analysis
concludes that age group, sex and smoking status do not impact survival.
Table 5.10. Reduced Log-Logistic MPR Model Fit
Scale Shape Joint
β̂ S.E. |Z| p α̂ S.E. |Z| p χ2
2
p
Intercept -4.47 (0.44) —— —— 0.50 (0.08) —— —— —— ——
Treatment Palliative 0.00 —— —— —— 0.00 —— —— —— —— ——
Surgery -1.87 (0.83) 2.25 0.025 0.06 (0.19) 0.31 0.757 25.09 0.000
Chemo -0.55 (0.41) 1.33 0.183 -0.03 (0.13) 0.23 0.815 3.45 0.178
Radio -1.23 (0.23) 5.28 0.000 0.25 (0.07) 3.84 0.000 27.93 0.000
C+R -5.18 (1.18) 4.39 0.000 0.77 (0.17) 4.54 0.000 20.85 0.000
WHO Status Normal 0.00 —— —— —— —— —— —— —— —— ——
Light Work 0.03 (0.26) 0.13 0.897 —— —— —— —— —— ——
No Work 0.88 (0.27) 3.30 0.001 —— —— —— —— —— ——
> 50% Bed 1.63 (0.29) 5.59 0.000 —— —— —— —— —— ——
Bedbound 2.29 (0.47) 4.90 0.000 —— —— —— —— —— ——
Cell Type Squamous 0.00 —— —— —— —— —— —— —— —— ——
Small 1.09 (0.25) 4.26 0.000 —— —— —— —— —— ——
Adeno. 0.19 (0.21) 0.88 0.379 —— —— —— —— —— ——
Other 0.30 (0.16) 1.87 0.061 —— —— —— —— —— ——
Metastases No 0.00 —— —— —— 0.00 —— —— —— —— ——
Yes 1.69 (0.34) 4.89 0.000 -0.18 (0.08) 2.31 0.021 33.91 0.000
Missing 1.02 (0.37) 2.77 0.006 -0.16 (0.09) 1.80 0.071 8.15 0.017
Sodium ≥ 136 mmol/l 0.00 —— —— —— 0.00 —— —— —— —— ——
< 136 mmol/l 0.46 (0.17) 2.64 0.008 -0.01 (0.05) 0.18 0.860 10.83 0.004
Missing -0.98 (0.50) 1.95 0.051 0.34 (0.13) 2.62 0.009 6.88 0.032
Albumen ≥ 35 g/l 0.00 —— —— —— —— —— —— —— —— ——
< 35 g/l 0.68 (0.14) 4.67 0.000 —— —— —— —— —— ——
Missing 0.50 (0.25) 2.01 0.044 —— —— —— —— —— ——
ℓ(θ̂) = -1802.84 AIC = 3659.67
Note: Age group, sex and smoking status were not selected in this reduced model.
A value of p = 0.000 ⇒ p < 0.001.
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Figure 5.31. Treatment (reference: palliative care) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
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Figure 5.32. WHO status (reference: normal) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
reduced log-logistic MPR model.
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Figure 5.33. Cell type (reference: squamous) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
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Figure 5.34. Metastases (reference: no) overall (solid) and average-
covariates (dash) hazard ratios with confidence intervals for the reduced
log-logistic MPR model.
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Figure 5.35. Sodium (reference: ≥ 136 mmol/l) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
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Figure 5.36. Albumen (reference: ≥ 35 g/l) overall (solid) and
average-covariates (dash) hazard ratios with confidence intervals for the
reduced log-logistic MPR model.
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Example 5.8. MPR Variable Selection in Lung Cancer Data
We now show the results of applying automatic MPR variable selection to
the lung cancer data. The procedure used here is more general than Algo-
rithm 1, as it contains backward steps as well as forward steps. We applied
this procedure to a variety of MPR and SPR models (in the latter case the
procedure reduces to standard selection in one regression component) where
the objective was to minimise the AIC value; the resulting selections are
shown in Table 5.11. Note that in all cases considered here, starting from
the full model gave the same results as starting from the null model14.
Table 5.11. Variable Selection in the Lung Cancer Data
Weibull Log-Logistic TDL Gompertz
MPR SPR MPR SPR MPR SPR MPR SPR
Treatment β, α β β, α β β, α β β, α β
Age Group — — — — — — — —
WHO Status β β β β β, α β β, α β
Sex — — — — — — — —
Smoker α β — — α β α β
Cell Type β β β β β β β β
Metastases β, α β β, α β β, α β β β
Sodium β β β, α β β β β β
Albumen β, α β β β β, α β β, α β
ℓ(θ̂) -1809.8 -1839.5 -1802.8 -1822.8 -1813.4 -1845.1 -1811.3 -1840.9
AIC 3679.7 3723.1 3659.7 3683.7 3694.7 3734.2 3686.5 3725.8
∆AIC 20.0 63.4 0.00 24.0 35.0 74.5 26.8 66.1
dim(θ) 30 22 27 19 34 22 32 22
Note: β = “chosen in scale”, α = “chosen in shape” and — = “not chosen”.
14In the lung cancer data the sample size is large (855) with a relatively low level of
censoring (≈ 20%) and, furthermore, the number of covariates is not too large. Thus, the
information per covariate is quite high which may explain why the starting model did not
impact the results; in general, automatic procedures can be much more unstable than in
this particular case.
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The models are all in agreement that neither age group nor sex affect
survival. The log-logistic models (MPR and SPR), however, also remove
smoking status. The log-logistic MPR model has a much lower AIC value
than all of the other models (the next best is the Weibull MPR model with an
AIC value 20 units higher) which we have found in other examples previously.
Indeed, the log-logistic model in SPR form has the third lowest AIC of the
eight models considered, i.e., it is better even than the TDL and Gompertz
MPR models.
It is noteworthy that the covariates selected in the log-logistic MPR model
by this automatic procedure are the same as those selected in Example 5.7 by
non-automatic means. Thus, even though such procedures typically receive
criticism (as we have mentioned previously), this does not imply that they
are destined to lead to unreasonable results. For the sake of interest we show
the selection path that led to this final, automatically selected, model in
Appendix B.5.3.
Comparing each MPR model with its corresponding SPR model, we find
that extending to MPR form reduces the AIC significantly in all cases, i.e.,
the values of AICSPR−AICMPR are 43.4 (Weibull), 24.0 (log-logistic), 39.5
(TDL) and 39.3 (Gompertz) respectively. Of course, MPR models can only
improve the fit; if the extra flexibility of the MPR extension is not required,
then no shape covariates will be selected and the model reduces to SPR.
Finally, recall that the Weibull and Gompertz SPR models are PH models
and, therefore, selection of covariates in the shape represents a departure
from proportional hazards (see Sections 5.2.1 and 5.2.2)15. Thus, within the
Weibull MPR model, treatment, smoking status, metastases and albumen
are deemed non-PH whereas, the Gompertz MPR analysis finds treatment,
WHO status, smoking status and albumen to have non-PH effects. Of course,
in any case, we would need to investigate the hazard ratio plots to ascertain
the degree of non-proportionality (i.e., departure from a straight line) and
nature of the effect (increasing / decreasing), however we will not pursue this
here.
15Analogously, shape covariates in the log-logistic MPR model represents departure
from proportional odds of survival (see Section 5.2.3). Thus, in this example we find that
treatment, metastases and sodium have non-PO effects.
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5.5 Simulation Studies
In the following sections we investigate (by simulation) the correlation struc-
ture for the estimated regression coefficients (Section 5.5.1) and also the bias
in these estimates (Section 5.5.2). In particular, we compare the standard
Weibull MPR model with the orthogonal Weibull MPR model16. Moreover,
we evaluate the proposed MPR variable selection procedure of Section 5.4
in the standard Weibull MPR case (Section 5.5.3). Some additional simula-
tion studies involving the log-logistic and Gompertz MPR models appear in
Appendix B.4.
5.5.1 Correlation Matrix for Estimated Parameters
In Section 5.4 we discussed the implications of correlated estimates in hy-
pothesis testing and variable selection. While we have shown previously that
correlation exists across the scale-shape space in some practical examples
(see Figs. 5.10 and 5.20), we now investigate the structure of this correlation
more formally by simulation.
We simulated data from a standard Weibull MPR model (using the
method of Chapter 3) with regression components log λ = β0 + x1β1 + x2β2
and log γ = α0 + x1α1 + x2α2, respectively, where x1 and x2 are inde-
pendent binary covariates17. We selected 30 different parameter vectors,
θ = (β0, β1, β2, α0, α1, α2)
T , to simulate from - the values of which are given
in Appendix B.4 and were chosen based on fitting the Weibull MPR model
first to real data (i.e., data-directed simulation). In addition to this we also
varied the sample size (n = 100, 500 and 1000) and censored proportion (p =
20%, 50% and 80%). Thus, there are 30 × 3 × 3 = 270 scenarios in total;
each scenario was repeated 500 times. At the jth repetition of a particular
scenario the Weibull MPR model (i.e., the true model) was fitted to the sim-
ulated data producing an m.l.e. vector. Hence, after 500 replicates, we have
a 500 × 6 matrix of estimates, the columns of which can be plotted against
each other to investigate the correlation structure (for that scenario).
16Appendix C contains details on the orthogonal Weibull model and its MPR extension.
17The binary variables were both generated using rbinom(n, size=1, prob=0.5) in R.
This code creates a sample of n Bernoulli variables with Pr(X = 1) = Pr(X = 0) = 0.5.
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Figure 5.37 shows three scatter matrices of estimated regression coeffi-
cients. We only show results for scenarios with n = 1000 as the correlation
pattern is virtually identical at the other sample sizes18. Furthermore, we
omit all scatter plots involving the intercepts as we are primarily interested in
the way coefficients of covariates are correlated with each other. We can see
that the “same-covariate-pairs”, (β̂1, α̂1) and (β̂2, α̂2) (i.e., pairs correspond-
ing to the same covariate), are highly correlated whereas the other estimates
are relatively uncorrelated; this matches the structure previously found in
practice (see Figs. 5.10 and 5.20). Furthermore, the same pattern emerges
in log-logistic and Gompertz MPR simulation studies (Appendix B.4).
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n = 1000    p = 80%
Figure 5.37. Scatter matrices of estimated regression coefficients for
the Weibull MPR model. Each cell in the lower triangle contains all 30
scatter plots with least squares lines overlayed (red). The upper triangle
shows the corresponding average absolute correlation value.
We have found that this particular correlation pattern arises over a range
of different sample sizes, censoring levels, MPR models and parameter values.
Hence, we have “proved” by simulation that this is indeed a general feature of
MPR models which supports the earlier discussion, and proposed extensions,
of Section 5.4. Note that in the study presented here (and those in Appendix
18There are three censoring levels and 30 parameter vectors which, therefore, gives
30 + 30 + 30 = 90 scenarios with n = 1000. Hence, each of the three scatter matrices in
Fig. 5.37 is based on 30 scenarios (one for each parameter vector) and so each individual
cell contains 30 scatter plots.
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B.4) the covariates, x1 and x2, are independent. If they are correlated then,
of course, the other regression coefficients will also become correlated (in
addition to same-covariate-pairs). However, we have found that these corre-
lations are not at the same level as correlations between same-covariate-pairs.
In any case, the methods described in Section 5.4 could be generalised further
to handle such correlations if so desired.
In addition to the above simulation study, we also carried out a study in-
volving the orthogonal Weibull MPR model. The study proceeded in exactly
the same manner described for the standard Weibull MPR model and, hence,
the corresponding scatter matrix plots are given in Fig. 5.38. The orthogonal
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Figure 5.38. Scatter matrices of estimated regression coefficients for
the Orthogonal Weibull MPR model. Each cell in the lower triangle con-
tains all 30 scatter plots with least squares lines overlayed (red). The up-
per triangle shows the corresponding average absolute correlation value.
Weibull model is derived based on the assumption of full information (see
Appendix C.4) and, therefore, β and α are only truly orthogonal when there
is no censoring. It is no surprise then that same-covariate-pairs, (β̂1, α̂1)
and (β̂2, α̂2), are not so highly correlated when censoring is low but become
more correlated as the censored proportion increases. Hence the advantage
of orthogonality breaks down in the presence of censoring.
It is worth noting a connection between our work and Lee & Whitmore
(2006) who discussed the inverse-Gaussian MPR model (which they refer to
as a threshold regression model - see Section 5.1 for further details). These
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authors also found that estimated regression coefficients are correlated but
suggested that it was a consequence of censoring: “Where (the) models are
estimated only from censored survival data, parameter estimators may ex-
hibit significant multicollinearity”. Our simulation work allows us to expand
on this statement. While it is true for “orthogonal” models (i.e., those or-
thogonal in uncensored data), it is not true in general. We have shown that
the correlation pattern arises in a variety of models due to an inherent lack
of orthogonality across the scale-shape space irrespective of censoring. Lee
& Whitmore also state that this correlation “raises some new issues for esti-
mation and inference”. Firstly, we agree that the correlation raises issues for
inference and we have discussed solutions to this in Section 5.4. With respect
to estimation, however, we disagree. In our simulation work and practical
applications, such issues did not arise; the models fitted easily and quickly
using the Newton-Raphson method and estimates were stable upon altering
starting values. Furthermore, we show that the estimates are unbiased in the
following section (see Section 3.6.3 for a related, but simpler, study).
5.5.2 Bias of Estimated Parameters
We now investigate the bias in parameter estimates for the standard and or-
thogonal Weibull MPR models. In particular, we wish to ascertain the effect
of varying the sample size, n, and censored proportion, p. Each combina-
tion of n and p (3 × 3 = 9 in total) comprises 30 scenarios - one for each θ
vector. For a particular n-p combination, let θjk be the true jth parameter
(j = 1, . . . , 6) in the kth scenario (k = 1, . . . , 30) and, furthermore, θ̂jkl is
the corresponding estimated value from the lth repetition (l = 1, . . . , 500) of
this (kth) scenario. Thus, we define the average relative bias in the estimate




















l=1 θ̂jkl/500. The results for the standard and orthogonal
Weibull MPR models are given in Tables 5.12 and 5.13 respectively. We can
see that the estimates are generally unbiased; the only exception to this is
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α̂0 when n = 100 (relative bias = 0.16 - 0.3). Naturally the bias decreases
when information increases (i.e., n ↑ or p ↓). Note that similar results are
found in the log-logistic and Gompertz MPR models (Appendix B.4).
Table 5.12. Weibull MPR Model: Average Relative Bias
n p β̂0 β̂1 β̂2 α̂0 α̂1 α̂2
100
80% -0.086 0.031 -0.001 0.278 -0.020 0.011
50% -0.051 -0.013 0.017 0.177 -0.007 0.011
20% -0.046 0.088 0.021 0.170 -0.001 0.003
500
80% -0.014 0.000 0.006 0.051 0.000 0.005
50% -0.009 -0.010 0.015 0.032 0.003 -0.002
20% -0.009 0.021 -0.009 0.035 -0.007 0.006
1000
80% -0.008 0.024 0.006 0.032 -0.010 0.002
50% -0.006 0.007 0.012 0.021 -0.002 -0.009
20% -0.004 0.005 0.008 0.016 -0.001 -0.005
Table 5.13. Orthogonal Weibull MPR Model: Average Relative Bias
n p β̂0 β̂1 β̂2 α̂0 α̂1 α̂2
100
80% -0.008 -0.038 0.094 0.299 0.044 0.011
50% 0.006 -0.013 -0.009 0.203 -0.005 -0.019
20% 0.007 -0.007 0.006 0.166 -0.006 -0.005
500
80% 0.000 0.012 -0.013 0.049 -0.009 0.000
50% 0.001 -0.002 0.009 0.042 -0.004 -0.011
20% 0.001 0.007 0.002 0.028 0.001 -0.003
1000
80% -0.001 -0.009 -0.001 0.029 -0.004 0.009
50% 0.000 -0.005 -0.001 0.021 -0.004 -0.002
20% 0.001 0.002 0.004 0.019 -0.003 -0.004
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5.5.3 Variable Selection
In Section 5.4 we discussed MPR variable selection which involves carrying
out scale steps, shape steps and simultaneous steps. Here we investigate this
procedure by means of simulation. Specifically, we evaluate the performance
of an algorithm which starts from the null model, contains both forward and
backward steps and uses AIC as the basis of selection (see Appendix B.5.3
for an example of this algorithm applied to the lung cancer data).
We simulated data from the standard Weibull MPR model with
log λ = xT (−1.5,−1.0, 1.0, 0.5,−0.5, 0.0, 0.0,−0.8, 0.5, 0.0, 0.0)T
log γ = zT ( 0.5, 0.4,−0.4, 0.2,−0.2, 0.4,−0.2, 0.0, 0.0, 0.0, 0.0)T ,
where x = z = (1, x1, . . . , x10)
T and each covariate is a binary variable (gen-
erated independently using rbinom in R). Thus, the first four covariates, x1,
x2, x3 and x4, affect both the scale and the shape, x5 and x6 affect the shape
only, x7 and x8 affect the scale only and, finally, x9 and x10 have no affect on
either component. This setup gives a good variety of scale and shape effects
of different strengths where the specific values of the regression coefficients
were chosen to lead to realistic survival data. Furthermore, we varied the
sample size (n = 100, 500 and 1000) and censored proportion (p = 20%, 50%
and 80%) giving 9 scenarios in total, each of which was repeated 500 times.
At the jth repetition of a particular scenario we applied the variable
selection algorithm described above and, hence, we let x(j) and z(j) denote the
vectors of scale and shape covariates selected in this repetition. The relative
frequency of selection of the covariate xk, k = 1, . . . , 10, in a particular
scenario was then calculated as







for the scale and







for the shape. The numeric results for each scenario are given in Table 5.14
but are much more clearly visualised in Fig. 5.39.
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Table 5.14. Relative Frequency of Selections
n 100 500 1000
x Coefficient p 80% 50% 20% 80% 50% 20% 80% 50% 20%
1 β1 = -1.0 0.56 0.73 0.80 1.00 1.00 1.00 1.00 1.00 1.00
2 β2 = 1.0 0.64 0.77 0.85 1.00 1.00 1.00 1.00 1.00 1.00
3 β3 = 0.5 0.36 0.56 0.58 0.79 0.91 0.96 0.97 1.00 1.00
4 β4 = -0.5 0.38 0.51 0.58 0.81 0.89 0.95 0.96 1.00 1.00
5 β5 = 0.0 0.28 0.28 0.22 0.18 0.15 0.18 0.15 0.19 0.17
6 β6 = 0.0 0.22 0.23 0.24 0.16 0.20 0.14 0.17 0.17 0.20
7 β7 = -0.8 0.52 0.75 0.82 0.97 1.00 1.00 1.00 1.00 1.00
8 β8 = 0.5 0.36 0.47 0.61 0.76 0.95 0.97 0.95 1.00 1.00
9 β9 = 0.0 0.23 0.19 0.21 0.18 0.16 0.19 0.15 0.15 0.15
10 β10 = 0.0 0.25 0.23 0.23 0.17 0.18 0.17 0.13 0.17 0.21
1 α1 = 0.4 0.38 0.57 0.74 0.91 1.00 1.00 1.00 1.00 1.00
2 α2 = -0.4 0.40 0.58 0.72 0.94 1.00 1.00 1.00 1.00 1.00
3 α3 = 0.2 0.30 0.42 0.50 0.61 0.84 0.96 0.82 0.99 1.00
4 α4 = -0.2 0.31 0.46 0.50 0.62 0.82 0.94 0.84 0.99 1.00
5 α5 = 0.4 0.43 0.73 0.88 0.98 1.00 1.00 1.00 1.00 1.00
6 α6 = -0.2 0.30 0.42 0.55 0.62 0.89 0.97 0.85 0.99 1.00
7 α7 = 0.0 0.25 0.28 0.26 0.16 0.17 0.17 0.18 0.17 0.16
8 α8 = 0.0 0.23 0.25 0.25 0.25 0.18 0.17 0.16 0.18 0.16
9 α9 = 0.0 0.20 0.21 0.22 0.20 0.19 0.15 0.22 0.15 0.17
10 α10 = 0.0 0.26 0.20 0.19 0.19 0.16 0.19 0.18 0.16 0.17
We can see (from Fig. 5.39) that it is difficult to determine which covari-
ates affect survival when the information available is low, i.e., small sample
size (n = 100) with a high censored proportion (p = 80%). However, even
when the sample size is small, the covariates with stronger effects (i.e., those
with larger regression coefficients) are still selected 75% - 85% of the time if
censoring is not so high (p = 20%). When a moderate level of information is
available, (n, p) = (500, 50%), the covariates with stronger effects are selected
100% of the time while those with weaker effects are all selected over 80% of
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the time. Furthermore, as the sample size increases, the relative frequency

















































Figure 5.39. Relative frequency of selection of each covariate in
the scale (black) and shape (red). Solid circles denote covariates with
stronger effects (i.e., larger regression coefficients), open circles denote
those with weaker effects and asterisks denote those with no effect. The
order of terms in the legend matches the order of relative frequencies
from the first scenario, (n, p) = (100, 80%), e.g., x2 in the scale has the
highest frequency whereas x9 in the shape has the lowest.
We can also see that covariates with no effect are selected approximately
20% of the time in all scenarios. To combat this, the algorithm could be
altered so that a new model is only accepted if the AIC reduction is larger
than some threshold (Table 2.1 would suggest using 0 < ∆AIC ≤ 2). Of
course this will have some impact on the probability of selecting important
covariates too - we will not pursue the issue of selecting an optimum threshold
value however. Rather, in practical applications, one can track the AIC
reductions to ascertain the merit of each step of the algorithm. In other
words, automatic procedures are best used to guide us in finding important
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covariates; more detailed consideration is advisable in practice. Nonetheless,
this study shows the basic performance of the algorithm in its own right.
In addition to applying the selection procedure to the simulated data,
the full model was also fitted at each repetition. Figure 5.40 shows boxplots
of estimated regression coefficients from this full model over 500 replicates
(for the three scenarios with p = 50%). The level of uncertainty at different
sample sizes is clearly visualised in these boxplots and serves to explain the
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Figure 5.40. Boxplots of estimated regression coefficients for scenarios




Regression models are often constructed so that covariates act linearly on
a particular scale (see Sections 4.2 and 4.3 for standard survival regres-
sion models); the effects of these covariates, on some quantity of interest,
are then directly interpreted via their corresponding regression coefficients.
Of course, specifying a (linear) model for one quantity leads to implied
regression models for other quantities. However, in terms of these other
quantities, covariate effects are unlikely to be described by simple param-
eters as, typically, the implied regression models are such that covariates
appear in a functionally complicated manner. For example, consider the PH
model, λ(t | x) = exp(xTβ)λ0(t), which is linear on the log-hazard scale but
implies a model for median survival which is generally difficult to interpret,
i.e., t0.5(x) = S
−1
0 (0.5
exp(−xTβ)) using the fact that S(t | x) = S0(t)exp(x
T β).
In order to formalise the above, assume a model for survival with density
function f(t | x, θ) where x = (1, x1, . . . , xp)
T is a vector of covariates and θ =
(θ1, . . . , θk)
T is the vector of model parameters. Furthermore, let θ = (β, ζ)T
where (β0, β1, . . . , βp)
T is the vector of regression coefficients and ζ is a vector
of any remaining parameters such that dim(ζ) = k − p − 1. Moreover, let
φ be a (possibly time-dependent) quantity which, in our model, depends on
covariates via
φ(x) = g−1(xTβ | ζ),
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where g−1(·) is assumed to have a functional form such that
g[φ(x1 = 1)]− g[φ(x1 = 0)] = β1,
i.e., g(φ) is linear in the covariates so that β coefficients are directly inter-
pretable; we may say that g(φ) is the natural scale of the model. Now, let
ψ(x) be another quantity which can be derived from the model. However,
unlike φ(x), we assume that the functional form of ψ(x) prevents interpre-
tation of the corresponding covariate effects using simple parameters. Note
that we can write
ψ(x) = h[φ(x)],
for some function h(·), i.e., it is clear that by specifying a model for φ, one
also specifies an implied model for ψ.
The aim of this chapter is to evaluate covariate effects in implied regres-
sion models. One could argue that if interest lies in the quantity ψ then it
should be modelled directly, rather than modelling φ and attempting to in-
terpret the implied model for ψ. This view is reasonable of course - however
it may be desirable to interpret implied effects in certain situations such as:
1. Adjunct interpretation: Assume the quantity φ is fundamental in the
statistical formulation of the problem and is well understood by the
expert. Nonetheless, it may be useful to translate results to the ψ-scale
if this is more easily understood by a wider (non-specialist) audience.
2. Difficulty modelling ψ directly : We are interested in ψ but difficulties
in modelling it directly lead us to fit the φ-model; we then interpret
this fitted model in terms of ψ = h(φ) which is an implied regression.
3. Avoiding multiple models : Several quantities are of interest (φ, ψ1, ψ2,
ψ3, . . . ) but we do not wish to specify/fit a separate model for each one
(e.g., for computational reasons). Rather, we fit the φ-model and use
it as the basis for interpreting covariate effects on all of the quantities.
In Chapter 5 we developed multi-parameter regression (MPR) models
where issues of interpretation are inherent. Recall that the MPR framework
is defined by regressing distributional parameters on covariates, i.e., covari-
ate effects are linear on a scale functionally related (often via the log link) to
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the distributional parameters. We saw that while the individual regression
coefficients can give us some insight into covariate effects, these coefficients
are somewhat difficult to interpret - further hampered by correlation of es-
timates across the regression components (Sections 5.4 and 5.5). Hence, we
interpreted covariate effects through the implied regression model for the
hazard in the form of hazard ratios (given their widespread use in survival
analysis). The impetus for this chapter therefore arises from the need to in-
terpret complicated MPR effects, although the methodology can be applied
to any statistical model1.
In the following section we propose a method for interpreting covariate
effects on the scale of ψ. Of course ψ may be any quantity and, therefore, in
the interest of variety, we consider life time regression in Section 6.3 before
returning to the hazard in Section 6.4.
6.2 Approximating Implied Regression
Models
In Section 5.3 we described two approaches for evaluating the effect of a par-
ticular covariate, c, in an implied regression model (for the hazard), namely:
(i) calculating the effect of c conditional on a particular set of covariates
and (ii) averaging the effect of c over the empirical distribution of covari-
ates. While these approaches may be useful in their own right, the resulting
effects are not analogous to those of a directly specified (i.e., non-implied)
regression model. The effect determined by method (i) is clearly only valid
for a given covariate profile, whereas method (ii) produces a marginal effect.
In a directly specified regression model the estimated effects are conditional
on (i.e., adjusted for) other covariates in the model without being limited to
any given covariate profile.
In light of the above, it seems reasonable to seek estimated effects for an
1In this chapter we use f(t |x, θ) indiscriminately to represent regression models of any
type. Thus, in the MPR case x is the vector of all distinct covariates present in the model
without reference to the specific components in which they appear, i.e., this vector is x∪z
in the notation of Chapter 5.
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implied regression model, ψ(x), which are interpretable in a manner which
is analogous to that of a non-implied regression model, φ(x). In particular,
we will approximate ψ(x) using a linear model,
ψ(x) ≈ β∗0 + x1β
∗




where we use the superscript “∗” in order to distinguish these regression
coefficients from those which appear in the regression model for φ. Clearly,
if ψ(x) is well approximated by this linear model then the β∗ coefficients will
provide us with direct interpretation of covariate effects on the scale of ψ
(analogous to β coefficients in the context of φ).
6.2.1 Least Squares Solution
Let f(t | x, θ) be a survival model wherein ψ(x, θ) is an implied regression
that we aim to approximate with a linear model as in (6.1). Given the true
parameter vector θ, we can compute ψi = ψ(xi, θ): the true value of ψ at a
particular set of covariates, xi = (1, x1i, . . . , xpi)
T . We can repeat this for n
such covariate vectors and then form a system of equations
β∗0 + x11β
∗
























whose solution provides us with the β∗ coefficients required for (6.1). Note
that (6.2) can be written in the form
Xβ∗ = y, (6.3)
where X is the n× (p+1) matrix of covariate vectors, β∗ = (β∗0 , β
∗




and y = (ψ1, . . . , ψn)
T . Naturally, this system of equations has an approxi-
mate solution given by least squares,
β̂∗ = (XTX)−1XTy, (6.4)
6.2. APPROXIMATING IMPLIED REGRESSION MODELS 171
provided that XTX is invertible and n > p.
In a purely theoretical exercise, the parameter values in θ would be spec-
ified and also a grid of covariate values over which some feature of f(t | x, θ),
ψ(x), is to be investigated. However this is not our intended use of the
method presented above; rather, we consider its application in practice where
θ is not known. In this case we first fit the model f(t | x, θ) to data using max-
imum likelihood (Chapter 2) giving the m.l.e., θ̂. Thus, we have ψ̂i = ψ(xi, θ̂)
and ŷ = (ψ̂1, . . . , ψ̂n)
T (rather than ψi and y). Apart from this minor no-
tational modification however, everything remains the same as before. Of
course, in such practical applications, it seems most reasonable to use the
covariate profiles from the dataset (used to fit f(t | x, θ)) when forming the
system of n equations given in (6.2); n is therefore the number of individuals
in the dataset. Indeed, we have used this approach in our own practical work.
It is worth clarifying how the above procedure differs from fitting a multi-
ple linear regression model to data (where y is a random vector). Our use of
least squares here is for the purpose of model interpretation, it is not a data
fitting exercise. Note that, here, y is not a vector of random variables - it is
a vector of known quantities, ψ1, . . . , ψn, calculated from the model f(t | x, θ)
(this is true whether θ is known or estimated by maximum likelihood). Thus,
error arises solely due to the systematic departure of ψ(x, θ) from linearity,

















may be interpreted as the degree to which ψ can be approximated by a linear
function. If ψ is highly non-linear, then we could improve the approximation
using, for example, polynomials, splines or interaction terms; we will not
consider this in our work however.
6.2.2 Uncertainty
While it is true that ŷ is non-random given a fitted model f(t | x, θ̂) and set of
covariate profiles, x1, . . . , xn, as described above, it does, of course, vary from
sample to sample just as θ̂ does; indeed ŷ is a (vector-valued) function of θ̂.
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Hence, β̂∗, which is calculated using ŷ, clearly has sampling variation also
and this must be accounted for in our analyses, i.e., the associated standard
errors/confidence intervals must be reported.
Delta Method
Using the fact that ŷ = y(θ̂) is a vector-valued function of θ̂, the delta method













where Io(θ̂) is the observed information matrix for θ̂, which results from
fitting f(t | x, θ) to the data (Section 2.3), and (∂y/∂θ) represents the n× k




























Note that this (asymptotic) result arises from a version of the delta method
more general than that discussed in Section 2.3.2 (compare (6.5) with (2.25));
see Bishop et al. (2007, sec. 14.6.3) for further details.
The covariance matrix of ŷ is not really of interest in itself but is required
to estimate the covariance matrix of β̂∗ - just as ŷ is not of interest but is
used to estimate β̂∗. Using the fact that β̂∗ = (XTX)−1XT ŷ, and the identity
cov(Ay) = A cov(y)AT , the p× p covariance matrix for β̂∗ can be estimated
by
Σ(β̂∗) = (XTX)−1XT Σ(ŷ) X(XTX)−1, (6.6)
where Σ(ŷ) is given in (6.5). Confidence intervals for the β∗ coefficients can
be calculated in the usual way using the diagonal elements of Σ(β̂∗).
M.L.E. Simulation
Although the delta method is the classical approach for estimating the pre-
cision of functions of θ̂, it is not the approach we will be using. As has been
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the case throughout this thesis, we prefer to use our proposed method of
m.l.e. simulation due to its ease of implementation (see Section 2.3.2); we
now describe this method within the current setting. Recall that m.l.e. simu-
lation is based on simulating a sample of θ̂ vectors, {θ̂(1), . . . , θ̂(m)}, equivalent
to a sample arising from m independent datasets. Thus, for the bth of these
vectors, θ̂(b), we can compute ŷ(b) = (ψ(x1, θ̂
(b)), . . . , ψ(xn, θ̂
(b)))T . Repeating
this (for b = 1, . . . , m) produces a sample {ŷ(1), . . . , ŷ(m)} which can be stored
as an n×m matrix, Ŷ , i.e., the bth column of Ŷ is ŷ(b). Hence,







































is the (p + 1) × m matrix whose bth column is the vector β̂∗(b). Therefore,
row j + 1 of this matrix (j = 0, . . . , p) contains the sample {β̂∗(1)j , . . . , β̂
∗(m)
j }
which can be used to construct a 100(1− α)% confidence interval for β∗j (by
selecting the appropriate percentiles) or to calculate se(β̂∗j ).
6.3 Life Time
Although the (log-)hazard scale has become the natural scale for incorporat-
ing covariates in survival regression models - largely due to the influential
paper by Cox (1972) - it may be more intuitive to interpret covariate effects
on the scale of µ = E(T ), i.e., life expectancy. Thus, given some parametric
(MPR) model, f(t | x, θ), where µ(x) =
∫∞
0
t f(t | x, θ) dt is an implied re-
gression model, we can use the method of Section 6.2 to interpret covariate
effects on this scale by setting ψ̂(x) = µ̂(x). However, the tail of the dis-
tribution, and hence also the mean, can be quite unstable due to censoring.
Thus, we consider instead the implied effect of covariates on the restricted
mean, µt∗ = E[min(T, t
∗)], which is more stable (Section 6.3.1); the median
is also considered briefly in Section 6.3.2.
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Before proceeding, we note that relating covariates directly (i.e., in a
non-implied regression) to the survival time is also possible. The accelerated
failure time (AFT) class of models (mentioned in Section 4.3) is the most
prominent approach wherein E(log T ) = xTβ. Parametric AFT models are
quite standard and can be estimated using maximum likelihood (see Lawless
(2003, chap. 6) and Kalbfleisch & Prentice (1973, chap. 3)); indeed, it is easy
to show that the Weibull and log-logistic SPR models (Section 4.5) are AFT
models. Estimation of the semi-parametric AFT model (i.e., unspecified
distribution) has also been developed (Miller, 1976; Prentice, 1978; Buckley
& James, 1979; Ritov, 1990; Tsiatis, 1990; Ying, 1993) but computational
difficulties inhibit application2. Furthermore, these procedures require the
censoring distribution to be independent of covariates. Hence, the semi-
parametric AFT model is not widely used. Another interesting extension of
the parametric AFT model is the so-called transformation model - defined by
E[g(T )] = xTβ where g(·) is an unspecified, but strictly increasing, function
(Doksum, 1987; Cuzick, 1988; Cheng et al., 1995; Fine et al., 1998; Chen et al.,
2002). As with the semi-parametric AFT model, necessarily complicated
estimation procedures have hindered wider use of transformation models.
6.3.1 Restricted Mean Life
As mentioned above, the mean life time is generally ill-determined due to
censoring. Hence, we will use the restricted mean, µt∗ = E[min(T, t
∗)], which
was first suggested by Irwin (1949). Note that we can write
min(T, t∗) = 1(T ≤ t∗) T + 1(T > t∗) t∗
⇒ E[min(T, t∗)] =
∫ ∞
0
1(t ≤ t∗) tf(t) dt+
∫ ∞
0












2The situation was improved by Jin et al. (2003), using a linear programming approach,
and Tian et al. (2004), using importance sampling.





















Thus, µt∗ is straightforwardly calculated by integrating the survivor curve
over the range [0, t∗].
Clearly limt∗→∞min(T, t
∗) = T ⇒ µ∞ = µ, i.e., integrating to time
infinity gives the usual unrestricted mean. Thus, if [0, t∗] is the observed time
range in a study, it is clear that calculation of µ involves extrapolation beyond
the data and, hence, the value of µt∗ is more relevant given the observed time
range. The interpretation of the restricted mean is the “average life within
the first t∗ months/years”. Note that it is common in the literature to report
the t∗-month/year survival probability - the probability of surviving beyond
time t∗, i.e., S(t∗). However, the value of µt∗ is more intuitive being on
the time scale rather than the probability scale. Moreover, whereas S(t∗) is
simply a snapshot in time (i.e., the survivor curve evaluated at time t∗), the
value of µt∗ takes into account the whole distribution up to time t
∗. Thus,
the restricted mean has much to recommend it.
Once a model f(t | x) has been fitted to data, we can estimate the re-




S(t | x, θ̂) dt, (6.8)
which typically requires numerical integration3. Hence, using the method in
Section 6.2 (i.e., ψ̂(x) = µt∗(x, θ̂)) we can obtain an (approximate) regression





1x1 + . . .+ β̂
∗
pxp,
3In our work we have used the integrate function in R which implements routines
from the well-known “quadpack” numerical library (Piessens et al., 1983)).
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where the β̂∗ coefficients are straightforward to interpret, i.e., β̂∗j is the
amount by which covariate xj alters the average life time (in the first t
∗
months/years).
The restricted mean has been considered previously by authors within
a regression setting. Karrison (1987) and Zucker (1998) used the implied
regression model for the restricted mean (within the PH model) to quantify
the difference in two treatment groups; Chen & Tsiatis (2001) considered
the same problem but used a more general (non-PH) model. These authors
evaluated marginal effects by averaging over the empirical distribution of co-
variates, i.e., the same approach we used to calculate “overall hazard ratios”
in Section 5.3. Andersen et al. (2004) modelled the restricted mean directly
(i.e., E[min(T, t∗)] = xTβ) via the so called pseudo-observations approach
introduced by Andersen et al. (2003) (see Andersen & Perme (2010) and ref-
erences therein for a review of pseudo-observations and their use in survival
analysis). However, a disadvantage of the pseudo-observations estimation
procedure is that the censoring distribution is assumed to be independent of
covariates.
Example 6.1. Restricted Mean Regression in the Lung Cancer Data: Log-
Logistic MPR Model
We now estimate the linear model for the restricted mean based on the log-
logistic MPR model fit to the lung cancer data. In particular we use the full
model (i.e., all covariates) which was previously discussed in Example 5.4.
Furthermore, we estimate covariate effects on the 20-month restricted mean,
µ20, as this was the largest survival time, i.e., we set t
∗ = 20. Note that
Karrison (1987) discusses the issue of choosing an appropriate t∗ value (for
further related discussion see Royston & Parmar (2011)).
The resulting least squares estimates are shown in Table 6.1 along with
the corresponding standard errors and 95% confidence intervals - both cal-
culated using m.l.e. simulation (as described in Section 6.2.2). Furthermore,
Z-scores are also shown (to give an indication of significance) even though
the confidence intervals may be asymmetric. Before interpreting these re-
sults, we note that R2 = 0.98 and, therefore, the linear approximation to the
log-logistic MPR restricted mean is excellent.
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Table 6.1. Restricted Mean Regression: Log-Logistic MPR Model
β̂∗ S.E. |Z| C.I.
Intercept 14.17 (1.57) —— (10.83, 16.96)∗
Treatment Palliative 0.00 —— —— ——
Surgery 6.08 (0.91) 6.67 (3.98, 7.54) ∗
Chemo 2.02 (1.01) 2.00 (0.02, 3.98) ∗
Radio 1.26 (0.51) 2.48 (0.22, 2.18) ∗
C+R 4.37 (1.05) 4.15 (2.15, 6.30) ∗
Age Group < 50 0.00 —— —— ——
50 - 60 -0.95 (1.22) 0.78 (-3.37, 1.45)
60 - 70 -1.29 (1.13) 1.14 (-3.33, 0.99)
70 - 80 -0.77 (1.13) 0.68 (-2.89, 1.44)
80 + -1.27 (1.19) 1.07 (-3.66, 1.16)
WHO Status Normal 0.00 —— —— ——
Light Work -0.06 (0.85) 0.07 (-1.62, 1.57)
No Work -2.59 (0.88) 2.94 (-4.28, -0.86) ∗
> 50% Bed -4.24 (0.90) 4.68 (-5.95, -2.43) ∗
Bedbound -5.43 (1.07) 5.10 (-7.18, -3.08) ∗
Sex Female 0.00 —— —— ——
Male -0.01 (0.37) 0.04 (-0.70, 0.78)
Smoker No 0.00 —— —— ——
Yes -1.19 (0.64) 1.87 (-2.36, 0.03)
Ex-smoker -0.91 (0.65) 1.41 (-2.21, 0.34)
Missing -0.64 (1.31) 0.49 (-3.07, 2.08)
Cell Type Squamous 0.00 —— —— ——
Small -2.98 (0.66) 4.54 (-4.15, -1.65) ∗
Adeno. -0.94 (0.66) 1.43 (-2.28, 0.33)
Other -0.76 (0.53) 1.43 (-1.74, 0.26)
Metastases No 0.00 —— —— ——
Yes -2.99 (0.55) 5.42 (-4.00, -1.84) ∗
Missing -1.49 (0.62) 2.40 (-2.63, -0.24) ∗
Sodium ≥ 136 mmol/l 0.00 —— —— ——
< 136 mmol/l -1.19 (0.36) 3.34 (-1.91, -0.52) ∗
Missing -0.53 (0.91) 0.58 (-2.23, 1.28)
Albumen ≥ 35 g/l 0.00 —— —— ——
< 35 g/l -1.81 (0.43) 4.23 (-2.63, -0.92) ∗
Missing -1.37 (0.73) 1.88 (-2.69, 0.22)
Note: Symbol “∗” indicates that the C.I. does not contain the value zero.
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We now summarise the results which, of course, apply to the first 20
months of life: Treatment : Surgery increases life by just over 6 months compared to
palliative care. Similarly, the other treatments also increase life (al-
though not to the same extent): chemotherapy by 2 months, radiother-
apy by 1.3 months and the combined treatment (C+R) by 4.4 months. Age group: Older age groups have a slightly shorter life than the
youngest group but this is not statistically significant. WHO status : As one’s physical state deteriorates so too does one’s
lifespan - however those able to carry out light work are not significantly
different to the normal group. Sex : Males are not significantly different from females. Smoker : Both smokers and ex-smokers live approximately 1 month less
than non-smokers. While the effects are not significant, we note that
the confidence intervals only just include the value of zero. Cell type: The small cell type reduces life by 3 months compared with
squamous cell whereas other cell types are not significantly different
from this reference class. Metastases : The presence of metastases decreases lifespan by 3 months. Sodium: Lower sodium levels reduce life slightly (1.2 months). Albumen: Lower albumen levels reduce life by almost 2 months.
The above results are in line with those previously found in the examples
from Chapter 5. However, the analysis presented here is much more intuitive
as life time is immediately understood from a physical perspective whereas,
for example, a hazard ratio may not be. Indeed, while hazard ratio plots (see
Chapter 5) provide useful information, they can sometimes be difficult to
interpret. Furthermore, this example shows the utility of our proposed least
squares approach to interpreting models. Clearly the method can be applied
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to any quantity that we can estimate from our fitted model; we consider the
median briefly in Section 6.3.2 before considering the hazard in Section 6.4.
6.3.2 Median Life
The median, t0.5, is another simple measure of centrality for long-tailed dis-
tributions and is often used in survival analysis. Estimation is quite stable
provided that censoring is not too heavy (i.e., at least 50% of the distribu-
tion must be observed); inverting the Kaplan-Meier curve is the most popular
method for estimating t0.5 (see Example 1.1). In spite of the fact that the
median survival time is a commonly used quantity, relatively little work has
been done in the area of median regression (Ying et al. (1995) and Yang
(1999) have developed estimation procedures for semi-parametric median re-
gression).
In our current parametric setting, t0.5(x) = S
−1(0.5 | x, θ) is the implied
regression for the median, given the survival model f(t | θ), where S−1(u) is





1x1 + . . .+ β̂
∗
pxp.
Clearly, we can investigate covariate effects on other percentiles also but we
will only consider the median here.
Example 6.2. Median Regression in the Lung Cancer Data: Log-Logistic
MPR Model
Replicating Example 5.4, we now estimate the median regression model based
on the log-logistic MPR model fit to the lung cancer data. The results are
given in Table 6.2 below and are analogous to the restricted mean case; we will
not labour the specific details which are qualitatively similar to those from
the previous example. Furthermore, we note that R2 = 0.8 and, therefore,
the linear approximation to the median is very good (although not as good
as the restricted mean case which was almost perfect).
4Recall that the functional form of S−1(u) for each distribution we consider is given
in Section 1.4 and this function has previously been used for the purposes of simulation
(Chapter 3).
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Table 6.2. Median Regression: Log-Logistic MPR Model
β̂∗ S.E. |Z| C.I.
Intercept 25.98 (17.57) —— (12.23, 65.18) ∗
Treatment Palliative 0.00 —— —— ——
Surgery 21.93 (8.83) 2.48 (10.67, 42.96) ∗
Chemo 1.80 (2.00) 0.90 (-1.17, 5.97)
Radio 1.32 (0.72) 1.83 (-0.26, 2.63)
C+R 3.66 (2.29) 1.60 (-0.92, 6.85)
Age Group < 50 0.00 —— —— ——
50 - 60 -8.06 (12.39) 0.65 (-36.57, 1.91)
60 - 70 -9.37 (12.60) 0.74 (-38.98, 0.47)
70 - 80 -7.89 (12.57) 0.63 (-36.89, 2.05)
80 + -8.96 (12.89) 0.70 (-37.56, 0.88)
WHO Status Normal 0.00 —— —— ——
Light Work -1.18 (4.58) 0.26 (-10.96, 6.32)
No Work -4.21 (3.95) 1.06 (-13.27, 1.66)
> 50% Bed -5.26 (3.99) 1.32 (-14.12, 0.83)
Bedbound -6.28 (4.35) 1.44 (-16.38, 0.02)
Sex Female 0.00 —— —— ——
Male -0.09 (0.94) 0.09 (-2.32, 1.49)
Smoker No 0.00 —— —— ——
Yes -3.90 (3.79) 1.03 (-14.09, -0.40)∗
Ex-smoker -3.59 (3.68) 0.98 (-12.78, 0.11)
Missing -3.70 (3.90) 0.95 (-12.58, 1.65)
Cell Type Squamous 0.00 —— —— ——
Small -2.09 (2.01) 1.04 (-4.83, 2.47)
Adeno. -2.40 (2.17) 1.11 (-6.77, 1.15)
Other -0.51 (1.68) 0.31 (-3.17, 3.20)
Metastases No 0.00 —— —— ——
Yes -5.65 (1.87) 3.02 (-10.20, -3.22)∗
Missing -3.75 (1.50) 2.50 ( -7.47, -1.45)∗
Sodium ≥ 136 mmol/l 0.00 —— —— ——
< 136 mmol/l -1.50 (0.72) 2.09 (-2.97, -0.38) ∗
Missing -0.50 (1.16) 0.43 (-2.64, 1.86)
Albumen ≥ 35 g/l 0.00 —— —— ——
< 35 g/l -2.12 (0.61) 3.46 (-3.42, -0.99) ∗
Missing -1.83 (0.99) 1.86 (-3.67, 0.36)
Note: Symbol “∗” indicates that the C.I. does not contain the value zero.
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6.4 Hazard Ratio
We now return to the hazard function which, as previously discussed, is
generally considered to be the key quantity in survival analysis (see Sections
1.2.2 and 2.1.2 for details). While it may be of interest to interpret covariate
effects directly on the hazard scale (i.e., additive hazards), recall that in
Chapter 5 hazard ratios were used (and are ubiquitous in the literature).
For this reason we aim to approximate the log-hazard function (at time t),
i.e.,
log λ(t | x) = β̂∗0(t) + β̂
∗
1(t) x1 + . . .+ β̂
∗
p(t) xp,
using the least squares method described in Section 6.2. Thus,
log λ(t | x1 = 1, x̃)− log λ(t | x1 = 0, x̃) = β̂
∗
1(t),
where x̃ is the vector of all covariates other than x1, and, hence,
λ(t | x1 = 1, x̃)
λ(t | x1 = 0, x̃)
= exp[β̂∗1(t)]. (6.9)
In words, exponentiating β̂∗1(t) gives the hazard ratio (at time t) for the
covariate x1 assuming all other covariates are equal. Clearly this has a more
standard interpretation than the overall and average-covariate hazard ratios
introduced in Section 5.3 (compare (6.9) with (5.28) and (5.29) respectively).
Note that the regression coefficients are time-dependent (unlike those in
Section 6.3) and, therefore, we wish to evaluate these coefficients over a range
of times. In practice we choose a discrete grid of time points, t1, . . . , ts, at
which there are s implied regression models, log λ(t1 | x), . . . , log λ(ts | x), to
be approximated. Thus, we can apply least squares separately to each of
these implied regression quantities which, collectively, provides us with the
values of the regression coefficients over the desired time range. Of course,
using matrices, this can be achieved in one step (rather than considering each
time point separately). We will not discuss the details here as the approach is
essentially identical to that of m.l.e. simulation as discussed in Section 6.2.2
- albeit with the columns of Ŷ corresponding to s time points rather than m
simulated m.l.e. vectors.
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Example 6.3. Log-Hazard Regression in the Lung Cancer Data: Log-Logistic
MPR Model
We continue with the full covariate log-logistic MPR analysis of the lung
cancer data from Example 5.4. Using the method described above, the log-
hazard function was approximated at 100 points between t1 = 0 and t100 =
20. At each time point the linear approximation was very good with R2
values ranging from 0.92 to 1.00 (and average value of 0.95).
The hazard ratios were calculated by exponentiating the regression coef-
ficients (with 95% confidence intervals constructed using m.l.e. simulation);
plots of these hazard ratios are shown in Figs. 6.1 - 6.9 below. Recall that in
Example 5.4 we also investigated hazard ratios for this particular log-logistic
analysis (see Figs. 5.11 - 5.19). Indeed the hazard ratio plots given below are
very similar to those from Example 5.4 and, therefore, we will not reinterpret
the results here5. Finally, replicating Table 5.5 from Example 5.4, the least
squares hazard ratios evaluated at t = 1.75, t = 4.75 and t = 12, respectively,
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Figure 6.1. Treatment (reference: palliative care) hazard ratios with
confidence intervals for the log-logistic MPR model.
5The fact that the overall, average covariates and least squares hazard ratios are in
agreement gives assurance that these approaches produce reasonable estimates. However,
the least squares estimate has the most standard interpretation.
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Figure 6.2. Age (reference: < 50) hazard ratios with confidence inter-
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Figure 6.3. WHO status (reference: normal) hazard ratios with confi-
dence intervals for the log-logistic MPR model.
















Figure 6.4. Sex (reference: female) hazard ratio with confidence inter-
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Figure 6.5. Smoker (reference: no) hazard ratios with confidence in-
tervals for the log-logistic MPR model.
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Figure 6.6. Cell type (reference: squamous) hazard ratios with confi-
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Figure 6.7. Metastases (reference: no) hazard ratios with confidence
intervals for the log-logistic MPR model.
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Figure 6.8. Sodium (reference: ≥ 136 mmol/l) hazard ratios with
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Figure 6.9. Albumen (reference: ≥ 35 g/l) hazard ratios with confi-
dence intervals for the log-logistic MPR model.
6.4. HAZARD RATIO 187
Table 6.3. Log-Logistic MPR Hazard Ratios with C.I.s
t = 1.75 t = 4.75 t = 12
Treatment Palliative 1.00 —— 1.00 —— 1.00 ——
Surgery 0.18 (0.07, 0.54)∗ 0.21 (0.12, 0.39)∗ 0.31 (0.19, 0.60)∗
Chemo 0.66 (0.40, 1.04)∗ 0.67 (0.42, 1.05) 0.74 (0.49, 1.13)
Radio 0.58 (0.45, 0.75)∗ 0.92 (0.73, 1.18) 1.18 (0.94, 1.45)
C+R 0.05 (0.01, 0.19)∗ 0.38 (0.20, 0.76)∗ 1.59 (0.99, 2.85)
Age Group < 50 1.00 —— 1.00 —— 1.00 ——
50 - 60 0.82 (0.48, 1.57) 1.46 (0.84, 2.65) 1.85 (1.08, 3.30)∗
60 - 70 0.86 (0.52, 1.51) 1.61 (0.92, 2.70) 2.04 (1.16, 3.44)∗
70 - 80 0.83 (0.48, 1.45) 1.34 (0.78, 2.30) 1.65 (0.97, 2.81)
80 + 0.93 (0.54, 1.70) 1.48 (0.83, 2.67) 1.79 (1.00, 3.11)∗
WHO Status Normal 1.00 —— 1.00 —— 1.00 ——
Light Work 0.98 (0.54, 1.85) 1.01 (0.67, 1.53) 1.02 (0.65, 1.55)
No Work 2.21 (1.23, 4.07)∗ 1.56 (1.02, 2.42)∗ 1.14 (0.74, 1.74)
> 50% Bed 3.32 (1.80, 6.18)∗ 1.88 (1.20, 2.92)∗ 1.23 (0.82, 1.94)
Bedbound 4.14 (1.85, 8.45)∗ 2.11 (1.16, 3.80)∗ 1.33 (0.78, 2.38)
Sex Female 1.00 —— 1.00 —— 1.00 ——
Male 1.05 (0.86, 1.25) 0.99 (0.82, 1.18) 0.96 (0.81, 1.15)
Smoker No 1.00 —— 1.00 —— 1.00 ——
Yes 1.26 (0.93, 1.74) 1.39 (1.02, 1.85)∗ 1.35 (1.02, 1.79)∗
Ex-smoker 1.23 (0.91, 1.71) 1.34 (0.97, 1.84) 1.30 (0.96, 1.74)
Missing 1.14 (0.60, 2.14) 1.10 (0.58, 2.13) 1.07 (0.59, 1.91)
Cell Type Squamous 1.00 —— 1.00 —— 1.00 ——
Small 2.27 (1.55, 3.24)∗ 1.67 (1.20, 2.32)∗ 1.28 (0.95, 1.71)
Adeno. 1.25 (0.86, 1.80) 1.31 (0.96, 1.82) 1.25 (0.91, 1.72)
Other 1.29 (0.98, 1.67) 1.13 (0.88, 1.43) 1.02 (0.80, 1.29)
Metastases No 1.00 —— 1.00 —— 1.00 ——
Yes 2.94 (1.97, 4.28)∗ 1.79 (1.37, 2.30)∗ 1.17 (0.91, 1.47)
Missing 1.86 (1.26, 2.72)∗ 1.42 (1.05, 1.85)∗ 1.09 (0.82, 1.41)
Sodium ≥ 136 mmol/l 1.00 —— 1.00 —— 1.00 ——
< 136 mmol/l 1.37 (1.16, 1.66)∗ 1.22 (1.03, 1.46)∗ 1.09 (0.93, 1.28)
Missing 0.82 (0.50, 1.44) 1.43 (0.91, 2.26) 1.61 (1.07, 2.37)∗
Albumen ≥ 35 g/l 1.00 —— 1.00 —— 1.00 ——
< 35 g/l 1.65 (1.33, 2.02)∗ 1.33 (1.08, 1.61)∗ 1.12 (0.93, 1.33)
Missing 1.51 (1.03, 2.10)∗ 1.24 (0.87, 1.70) 1.07 (0.76, 1.43)





In Chapters 4 and 5 we discussed regression models as a method for describing
heterogeneity in the data through the inclusion of covariates. However, indi-
viduals will typically differ in ways that cannot be described entirely using
the covariates which have been measured. Indeed it is unrealistic to presume
that all sources of variation can be captured within a statistical model - no
matter how detailed the model may be. There will always be unobservable
features which affect the outcome. Hence, we may ask how much variation
remains unexplained by our model and, furthermore, to what extent is this
important? In the field of survival analysis frailty modelling - a topic which
has received much attention in the literature - is the name given to the study
of such variation.
Let U be a random variable representing all unmeasured, or indeed unob-
servable, features which affect survival; in the literature U is called the frailty
term. Furthermore, λ(t | u) is the hazard function for a given individual (or
sub-population) with U = u and is referred to as the conditional hazard1.
However, as U is unknown and varies over the population, what we observe
is the marginal distribution of T with hazard function denoted by λm(t) -
often referred to as the population hazard - which can be quite different from
1Note that the covariate-dependence has been suppressed for notational convenience
but, of course, we can write λ(t |x, u); see Section 7.4.1.
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λ(t | u). Vaupel & Yashin (1985), who investigated hazard rates in a variety
of theoretical scenarios, concluded that:
The observed dynamics at the population level will deviate from
the underlying dynamics at the individual level . . . (and) may be
surprisingly different (from each other). Researchers interested
in uncovering these individual patterns . . . might benefit from an
understanding of (unobservable) heterogeneity.
Aalen et al. (2008, sec. 6.5) contains similar developments and conclusions.
Aalen & Gjessing (2001) discuss hazard shapes from the perspective of an
underlying stochastic process and contrast this with frailty theory.
Note that in the above (and throughout the rest of this chapter) we as-
sume U is time-constant. However, in some situations there is a need to
extend to time-dependent frailty. This is commonly achieved by modelling
the hazard using a stochastic process. For example, authors have considered
diffusion (Woodbury & Manton, 1977; Myers, 1981; Yashin & Manton, 1997)
and Lévy processes (Kebir, 1991; Gjessing et al., 2003); see also Singpurwalla
(1995) and Aalen et al. (2008, chap. 11). Another approach is to generalise
the piecewise exponential model (of Section 1.4.7) by including a different
frailty term in each time-interval (Paik et al., 1994). Moreover, Perperoglou
et al. (2006) introduced a model which approximates time-dependent frailty
models (given their complexity). Although this is an interesting area for re-
search, time-dependent frailty is beyond the scope of this thesis; we stick to
the standard assumption that U does not depend on time.
7.2 Marginal Functions
If we let S(t | u) be the conditional survivor function, the marginal (or pop-
ulation) survivor function is given by
Sm(t) = Pr(T > t) =
∫
Pr(T > t, U = u) du
=
∫
Pr(T > t |U = u) Pr(U = u) du
=
∫
S(t | u)g(u) du, (7.1)
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where g(u) is the density function for U , and hence we can write
Sm(t) = EU [S(t | u)], (7.2)
i.e., the marginal survivor function is an average of conditional survivor func-
tions over the distribution of U . Similarly, it is easy to show that the marginal
density function is given by
fm(t) =
∫
f(t | u)g(u) du = EU [f(t | u)], (7.3)
where f(t | u) = λ(t | u)S(t | u) is the conditional density. Note that a model
of the form (7.3) is often referred to as a continuous mixture model where
g(u) is the mixing distribution (see Hougaard (2000, sec. 2.2.7) for details on
mixture models). Indeed Lancaster (1990, chap. 4) deals with frailty models
under the heading “mixture models”.
In light of the above, it is tempting to suggest that the marginal hazard
function is simply EU [λ(t | u)] - however this is incorrect. Using the relation-













Pr(T > t, U = u)
Pr(T > t)




λ(t | u) Pr(U = u | T > t) du
= EU [λ(t | u) | T > t]. (7.4)
In words, at time t, the marginal hazard is an average of conditional haz-
ards over the distribution of U given survival to that time point. Note that
an alternative derivation of (7.4) using probability statements is given in
Appendix D.2.
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7.3 Estimation
We now discuss how to estimate model parameters from a given set of data
whilst accounting for frailty. As in Chapter 2, we consider the case of right-
censored data where, for the ith individual (i = 1, . . . , n), ti is the observed
survival time and δi is the censoring indicator which equals zero if ti is a
censoring time and one otherwise. In addition to the observed pair (ti, δi),
we now also have the unobserved frailty, ui. If the frailties were observed
quantities, inference would be based on the full likelihood (also called the








λ(ti | ui, θ)
δiS(ti |, ui, θ) · g(ui | φ), (7.5)
where θ is the vector of parameters in the conditional survival model and φ




δi log λ(ti | ui, θ) + logS(ti |, ui, θ) + log g(ui | φ), (7.6)
which would be maximised in the usual way.
As frailty is unobservable, we cannot use the full likelihood above. In-










λ(ti | ui, θ)
δiS(ti |, ui, θ) g(ui | φ) dui
]
. (7.7)




λm(ti | θ, φ)
δiSm(ti | θ, φ), (7.8)
2We have omitted covariate dependence for notational convenience.
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which is unsurprising given that the observed data are marginal (as discussed




δi log λm(ti | θ, φ) + log Sm(ti | θ, φ). (7.9)
Although we use the marginal likelihood approach, it is not the only possibil-
ity. We now discuss some other approaches briefly (see Duchateau & Janssen
(2008) for further details).
Viewing ui as missing data in the full log-likelihood, (7.6), leads natu-
rally to the EM algorithm (Dempster et al., 1977) where, at the E step, all
ui terms (and functions of ui) are replaced by their conditional expectation,
given the data (ti, δi) and current estimates of (θ, φ). This is followed by the
M step which consists of maximising this likelihood w.r.t. (θ, φ) to produce
new estimates (the algorithm iterates between these two steps until conver-
gence). Klein (1992), Nielsen et al. (1992) and Andersen et al. (1993, chap. 9)
discuss this approach to fitting frailty models. In cases where the E step is
intractable, the so-called Monte-Carlo EM (MCEM) algorithm can be used:
here the E step is approximated by averaging over simulated samples of ui
(Wei & Tanner, 1990; Vaida & Xu, 2000; Ripatti et al., 2002).
McGilchrist & Aisbett (1991) and McGilchrist (1993) essentially treat
u = (u1, . . . , un)
T as vector of additional parameters and maximise (7.6)
w.r.t. (θ, u) for a given φ value. The estimated u vector is then used to up-
date the φ estimate - like EM, the procedure iterates between these two steps.
Three versions of this procedure were implemented, namely: the method of
best linear unbiased predictor (BLUP), maximum likelihood (ML) and re-
stricted maximum likelihood (REML). Following Breslow & Clayton (1993),
Ripatti & Palmgren (2000) applied a Laplace approximation to the integral
in (7.7) which led to a procedure equivalent to the ML method of McGilchrist
(1993). Note that these procedures may be viewed from a penalised likelihood
perspective (Therneau et al., 2003). Hierarchical likelihood (Lee & Nelder,
1996, 2001), or h-likelihood, was developed for estimating generalized linear
mixed models using a Laplace integral approximation. Ha et al. (2001, 2002)
and Ha & Lee (2003, 2005) used this approach for fitting frailty models and
noted equivalence with McGilchrist’s REML method.
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7.4 Multiplicative Frailty
Thus far we have not specified how the frailty component may enter the
model. However, we now consider the multiplicative frailty model defined by
λ(t | u) = u λ(t), (7.10)
which is the standard frailty model in the literature (cf. Lancaster (1990), An-
dersen et al. (1993), Hougaard (2000), Duchateau & Janssen (2008), Aalen
et al. (2008) and references therein). Here λ(t) is an underlying function
common to all individuals, which we will refer to as the basic hazard, and u
is a quantity that varies over the population with density function g(u) (as
described previously); it is clear (7.10) requires that u ∈ (0,∞). Further-
more, as g(u) and λ(t) both contain scale parameters, it is standard practice
to assume that E(U) = 1 in order to eliminate this redundancy (Hougaard,
2000, sec. 7.2). With this assumption we have that
λ[t |E(U)] = E(U) λ(t) = λ(t), (7.11)
i.e., the basic hazard, λ(t), corresponds to that of an average or reference
individual (the latter phrase appears in Duchateau & Janssen (2008, sec 1.5)).
From (7.4) we have that
λm(t) = λ(t)E(U | T > t), (7.12)
i.e., the basic and marginal hazards differ by the factor E(U | T > t) which is
easily shown to be decreasing as a function of time, i.e., dE(U | T > t)/dt < 0
(see Appendix D.2). That E(U | T > t) is decreasing intuitively reflects
the fact that larger u values imply larger hazards and, hence, the group
of survivors is increasingly composed of individuals with smaller u values
(i.e., those less likely to experience an event). Moreover, since E(U | T > t)
decreases from E(U | T > 0) = E(U) = 1, we have that E(U | T > t) < 1 for
t > 0 and, therefore, we can deduce that
λm(t) < λ(t),
for t > 0. Thus, we will underestimate the basic hazard rate if we do not
account for the effect of frailty.
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The multiplicative frailty model is generally attributed to Vaupel et al.
(1979) who introduced the term “frailty” in reference to u - a phrase which
has stuck in the literature - however, in the same year, Lancaster (1979) also
proposed the model (seemingly independently of Vaupel et al.) and referred
to u as an error term. In both cases u was assumed to follow a gamma distri-
bution - still the most common choice of frailty distribution (see Section 7.5).
The ubiquity of the multiplicative frailty model is such that we may refer to
it simply as the frailty model. One reason for its ubiquity is the obvious con-
nection with the PH model (see Example 7.1 and Lancaster (1990, sec. 4.2)).
Another advantage of the multiplicative specification (from a mathematical
point of view) is that various quantities of interest can be expressed in terms
of the Laplace transform of g(u); we discuss this in Section 7.4.2.
7.4.1 Interpreting Covariate Effects in the
Multiplicative Frailty Model
In the preceding sections we have suppressed covariate dependence in our
notation for convenience. However, it is generally intended that covariates
are present in the model. Indeed, a primary role of such analyses is to
adjust covariate effects in the presence of frailty3. Thus, making covariate
dependence explicit in our notation, we write
λ(t | x, u) = u λ(t | x),
which is conditional on observed heterogeneity via covariates, x = (1, x1, . . . ,
xp)
T , and unobserved heterogeneity via the multiplicative frailty term, u.
We have previously shown how covariates can enter λ(t | x) in Chapters 4
and 5, i.e., λ(t | x) may be a single parameter regression (SPR) model or a
multi-parameter regression (MPR) model.
As before, we can interpret covariate effects in terms of hazard ratios.
The hazard ratio, at time t, for an individual with x1 = 1 to an individual
with x1 = 0, given that all other things are equal (i.e., frailty and other
3Of course the frailty parameters, φ, are also of interest; they describe the degree of
unexplained heterogeneity remaining after accounting for observable heterogeneity.
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covariates), is given by
ψ(t | x̃, u) =
λ(t | x1 = 1, x̃, u)
λ(t | x1 = 0, x̃, u)
=
u λ(t | x1 = 1, x̃)
u λ(t | x1 = 0, x̃)
=
λ(t | x1 = 1, x̃)
λ(t | x1 = 0, x̃)
= ψ(t | x̃),
where x̃ represents all covariates in x other than x1. Thus, the individual
hazard ratio does not depend on u; it depends only on the functional form of
λ(t | x) and can be interpreted in the usual way. For example, if we assume
that λ(t | x) is a Weibull MPR model, then the hazard ratio is as described
in Section 5.2.1.
Although the functional form of the hazard ratio is the same in both the
frailty and non-frailty cases (as shown above), it is important to note the
difference between the two. Consider the following hazard models:
Frailty: u λ(t | x, θ), u ∼ g(u | φ),
Non-Frailty: λ(t | x, θ).
It is true that the hazard ratios in both models have the same functional form,
denoted by ψ(t | x̃, θ). However, given a set of data, the estimated hazard
parameters from the frailty analysis are adjusted for the frailty parameters ;
we may write θ̂(φ̂) to make this explicit. Hence, even though the functional
form of ψ(t | x̃, θ) is the same in both analyses, its numeric value is not
(owing to the fact that θ̂ will differ numerically in the two analyses - see
Example 7.1). The advantage of incorporating a frailty component in the
analysis is two-fold: first, the estimated effects of measured covariates may
be more robust as other sources of hazard variation have been accounted for
and, second, the frailty parameters, φ, can inform us about this unexplained
variation.
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Note that the above applies to the ratio of conditional (or individual)
hazards; however, the ratio of marginal (or population) hazards is given by
λm(t | x1 = 1, x̃)
λm(t | x1 = 0, x̃)
=
λ(t | x1 = 1, x̃)
λ(t | x1 = 0, x̃)
E(U | T > t, x1 = 1, x̃)
E(U | T > t, x1 = 0, x̃)
= ψ(t | x̃) ζ(t, x),
where ζ(t, x) = E(U | T > t, x1 = 1, x̃)/E(U | T > t, x1 = 0, x̃) and ψ(t | x̃)
is the individual hazard ratio as before. Thus, failure to account for frailty
can lead to incorrect conclusions being drawn about the basic hazard ratio.
For example, assume that hazards are proportional at an individual level so
that ψ(t | x̃) = exp(β1). However, as a consequence of frailty, the observed
(marginal data) hazard ratio is exp(β1) ζ(t, x). This may lead us to reject
(wrongly) the assumption of proportional hazards and to then consider more
complicated models which can handle time-dependent hazard ratios (e.g., a
Weibull MPR model). Furthermore, we could falsely conclude, for example,
that a treatment effect diminishes over time. This phenomenon is well known;
for further details see Aalen et al. (2008, sec. 6.5).
It is clear that accounting for frailty is important in making more robust
inferences about covariate effects. In practice the utility of incorporating
frailty in our analysis depends on: (i) the extent to which unobservable
heterogeneity can be captured by the multiplicative u term - largely a math-
ematical convenience - and (ii) the flexibility of the assumed frailty distri-
bution, g(u). Of course, assumptions must be made in any statistical model
with the aim of approximating reality and making reasonable conclusions (as
discussed in Section 2.2).
7.4.2 Laplace Transform
It is easy to show that, in the case of multiplicative frailty, Λ(t | u) = uΛ(t).
Hence, the conditional survivor function is
S(t | u) = exp [−Λ(t | u)]
= exp [−uΛ(t)] ,
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exp(−u s)g(u) du, (7.13)
(see Abramowitz & Stegun (1964, chap. 29)), it is then clear that
Sm(t) = L[Λ(t)], (7.14)
i.e., the marginal survivor function is the Laplace transform of g(u) evaluated
at s = Λ(t) (the basic integrated hazard function). Of course, we can also









Comparing this with (7.12) we see that E(U | T > t) = −L′[Λ(t)]/L[Λ(t)].
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where L(1)[Λ(t)] = L′[Λ(t)] and L(0)[Λ(t)] = L[Λ(t)]. An alternative deriva-
tion for the above log-likelihood is given in Appendix D.3.1.
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This connection with the Laplace transform appears to have first been
made by Lancaster & Nickell (1980) which, as it turns out, is more than
just a mathematical observation. For example, Elbers & Ridder (1982) ex-
ploit properties of the Laplace transform in proving that both the condi-
tional survival distribution and the frailty distribution can be identified from
marginal data if covariates are included (and E(U) <∞). Heckman & Singer
(1984) build on this work and also prove identifiability without the require-
ment of covariates; these authors instead assume that the conditional survival
model is specified up to a finite set of parameters (see also Lancaster (1990,
chap. 7)). Hougaard (1984, 1986, 2000) also made use of the Laplace trans-
form in his study of frailty models and, among other things, emphasised the
importance of assuming a frailty distribution with tractable Laplace trans-
form for the purpose of straightforward analysis (see Duchateau & Janssen
(2008) also); of course, this is clear from (7.14) - (7.16) above. Note that one
could start by specifying a functional form for L(s) and, if required, derive
the corresponding density, g(u), by means of Fourier inversion (Feller, 1971).
7.5 The Gamma Frailty Model
The results of Section 7.4 apply to any frailty distribution. We now consider
the so-called gamma frailty model where the multiplicative frailty, u, follows





Here Γ(·) is the gamma function (Abramowitz & Stegun, 1964, chap. 6)
and φ > 0. This distribution fulfills the requirement that E(U) = 1 and,
furthermore, it is easy to show that
φ = var(U). (7.18)
Thus, the φ parameter has an intuitive interpretation - it tells us the degree
of unobserved heterogeneity in the hazard. In particular, it is clear that as
φ → 0, all frailties are concentrated at E(U) = 1 and, hence, λm(t) = λ(t),
i.e., there is no unobserved variation in the hazard.
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The gamma distribution has Laplace transform given by
L(s) = (1 + φ s)−1/φ, (7.19)
(see Appendix D.3.2). This simple analytic form makes the gamma frailty
model easy to apply in practice; indeed Lancaster (1979) and Vaupel et al.
(1979) originally made the assumption of gamma distributed frailty and it
continues to be the most popular frailty model in the literature. Furthermore,




(1 + φ s)−1/φ−1 · φ = −(1 + φ s)−(1/φ+1). (7.20)
Hence, the marginal survivor and hazard function are given by










respectively; clearly limφ→0 Sm(t) = exp[−Λ(t)] = S(t) and limφ→0 λm(t) =
λ(t) as expected. Note that, from (7.19) and (7.20), we can write
L(δ)(s) = (−1)δ(1 + φ s)−(1/φ+δ),











δi log λ(ti) + log
{






δi log λ(ti)− (1/φ+ δi) log [1 + φΛ(ti)] . (7.23)
Of course we could also arrive at (7.23) using the fact that, from (7.9),
ℓm(θ, φ) =
∑
δi log λm(ti) + log Sm(ti) and the above expressions for λm(t)
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Recall from Chapter 2 that the log-likelihood for a standard non-frailty
model is given by ℓ(θ) =
∑n
i=1 δi log λ(ti) − Λ(ti) with corresponding score
equations given by ∂ℓ/∂θj =
∑n
i=1 δi ∂ log λ(ti)/∂θj − ∂Λ(ti)/∂θj . Thus,
for any standard survival model, we will have expressions for λ(t), Λ(t),
∂ log λ(t)/∂θj and ∂Λ(t)/∂θj , respectively. Hence, we can easily generalise
the estimation procedure to incorporate gamma frailty by plugging these
expressions into the above marginal likelihood, (7.23), and score equations,
(7.24) and (7.25) (See Example 7.3).
Example 7.1. Weibull-Gamma SPR Analysis of Lung Cancer Data
We now assume a Weibull SPR model for the hazard regression component,
i.e.,
λ(t | x) = exp(xTβ)γtγ−1, (7.26)
which, as shown in Section 4.5.1, is a proportional hazards model so that
the hazard ratio for covariate x1, for example, is simply exp(β1). Thus, the
conditional hazard is given by
λ(t | x, u) = u exp(xTβ)γtγ−1
= exp(xTβ + log u)γtγ−1
= exp(xTβ + ǫ)γtγ−1 (7.27)
where the last line shows that frailty can be interpreted as an error term
in the linear predictor for this model and indeed any proportional hazards
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model (see Lancaster (1990, sec. 4.2)). Therefore, multiplicative frailty is
quite natural in this setting4.
From (7.22), the marginal hazard is given by
λm(t | x) =
exp(xTβ)γtγ−1
1 + φ exp(xTβ)tγ
, (7.28)
which is that of a Burr model (see Section 4.5.4). Hence, the Weibull-gamma
model can be estimated using the Burr log-likelihood (Appendix B.2.4)5.
We fitted the above model to the lung cancer data and the corresponding
non-frailty Weibull SPR model (i.e., φ = 0) for comparison; the results are
given in Table 7.1. Firstly we note that the AIC is much lower in the frailty
analysis (∆AIC = 3732.54 − 3697.02 = 35.52) and, therefore, it appears
that there is unexplained variation in the hazard with φ̂ = 0.73. However,
we also note that, although the Weibull-gamma analysis adjusts for this
variation, both analyses are qualitatively similar (in terms of β̂ values and
their corresponding significance). The main differences are as follows:
1. Standard Errors : All standard errors are larger in the Weibull-gamma
analysis owing to the fact that other sources of variation have been
accounted for.
2. Smoker : In the Weibull analysis the effect of being a smoker (relative
to a non-smoker) is significant and, furthermore, the effect of being an
ex-smoker is near significant. However, in the Weibull-gamma analysis
both are non-significant.
3. Cell Type: All cell types are significant relative to the reference group
(squamous) in the Weibull analysis whereas, in the Weibull-gamma
analysis only the small cell type is significant.
We will not provide a detailed discussion of the covariate effects (i.e., hazard
ratios) as the results are clear from Table 7.1 and, moreover, a similar, but
more general, analysis is the subject of Example 7.4.
4Recall that the developments of the preceding sections do not require λ(t |x) to have
a PH specification but, as shown, this does allow a more specialised interpretation of u.
5Clearly the Burr model can be interpreted as the marginal model arising from the
Weibull-gamma frailty specification. However, it can also be viewed as a flexible survival
model without appealing to its frailty interpretation (as in Chapters 4 and 5 for example).
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Table 7.1. Weibull and Weibull-Gamma SPR Full Covariate Analyses
Weibull Weibull-Gamma
Est. S.E. |Z| H.R. Est. S.E. |Z| H.R.
Frailty: φ —— —— —— —— 0.73 (0.16) —— ——
Shape: γ 1.06 (0.03) —— —— 1.44 (0.09) —— ——
Scale: β
Intercept -3.70 (0.35) —— —— -4.19 (0.48) —— ——
Treatment Palliative 0.00 —— —— 1.00 0.00 —— —— 1.00
Surgery -1.23 (0.25) 4.94 0.29 -1.64 (0.31) 5.30 0.19
Chemo -0.49 (0.21) 2.35 0.61 -0.66 (0.31) 2.16 0.52
Radio -0.31 (0.10) 3.00 0.73 -0.53 (0.15) 3.51 0.59
C+R -0.92 (0.24) 3.84 0.40 -1.53 (0.36) 4.32 0.22
Age Group < 50 0.00 —— —— 1.00 0.00 —— —— 1.00
50 - 60 0.13 (0.26) 0.49 1.14 0.04 (0.35) 0.12 1.04
60 - 70 0.07 (0.24) 0.28 1.07 0.05 (0.33) 0.14 1.05
70 - 80 0.06 (0.25) 0.24 1.06 0.00 (0.33) 0.00 1.00
80 + 0.04 (0.27) 0.16 1.04 0.10 (0.37) 0.26 1.10
WHO Status Normal 0.00 —— —— 1.00 0.00 —— —— 1.00
Light Work 0.08 (0.19) 0.45 1.09 0.05 (0.24) 0.21 1.05
No Work 0.54 (0.19) 2.85 1.71 0.78 (0.25) 3.10 2.17
> 50% Bed 1.03 (0.20) 5.13 2.79 1.51 (0.28) 5.31 4.51
Bedbound 1.71 (0.29) 5.97 5.53 2.28 (0.44) 5.15 9.76
Sex Female 0.00 —— —— 1.00 0.00 —— —— 1.00
Male -0.04 (0.09) 0.44 0.96 0.01 (0.12) 0.09 1.01
Smoker No 0.00 —— —— 1.00 0.00 —— —— 1.00
Yes 0.40 (0.14) 2.79 1.49 0.30 (0.21) 1.46 1.35
Ex-smoker 0.27 (0.14) 1.84 1.31 0.19 (0.21) 0.89 1.21
Missing 0.30 (0.27) 1.10 1.35 0.22 (0.41) 0.54 1.25
Cell Type Squamous 0.00 —— —— 1.00 0.00 —— —— 1.00
Small 0.71 (0.16) 4.54 2.03 1.04 (0.24) 4.37 2.82
Adeno. 0.32 (0.14) 2.24 1.37 0.26 (0.20) 1.31 1.30
Other 0.21 (0.10) 2.02 1.23 0.27 (0.15) 1.82 1.31
Metastases No 0.00 —— —— 1.00 0.00 —— —— 1.00
Yes 0.78 (0.12) 6.49 2.18 0.97 (0.17) 5.69 2.63
Missing 0.36 (0.13) 2.68 1.43 0.40 (0.19) 2.12 1.49
Sodium ≥ 136 mmol/l 0.00 —— —— 1.00 0.00 —— —— 1.00
< 136 mmol/l 0.33 (0.09) 3.89 1.39 0.45 (0.13) 3.59 1.57
Missing -0.08 (0.22) 0.38 0.92 -0.13 (0.30) 0.42 0.88
Albumen ≥ 35 g/l 0.00 —— —— 1.00 0.00 —— —— 1.00
< 35 g/l 0.43 (0.09) 4.73 1.54 0.68 (0.14) 4.99 1.97
Missing 0.48 (0.17) 2.89 1.61 0.51 (0.23) 2.20 1.66
ℓ(θ̂) -1839.27 -1820.51
AIC 3732.54 3697.02
Note: H.R. = hazard ratio = exp(β).
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Example 7.2. A Comparison of Weibull Models for the Lung Cancer Data
Let the basic hazard be a Weibull MPR model (Section 5.2.1), i.e.,
λ(t | x, z) = exp(xTβ) exp(zTα)texp(z
Tα)−1, (7.29)
where x = (1, x1, . . . , xp)
T and z = (1, z1, . . . , zq)
T are the scale and shape co-
variate vectors with corresponding regression coefficients β = (β0, β1, . . . , βp)
T
and α = (α0, α1, . . . , αq)
T respectively. Hence, with multiplicative gamma
frailty, the marginal hazard function is
λm(t | x, z) =
exp(xTβ) exp(zTα)texp(z
Tα)−1
1 + φ exp(xTβ)texp(zTα)
, (7.30)
which is the Burr MPR hazard (Section 5.2.4) - albeit without φ depending
on covariates6.
In Example 7.1 we focussed on the Weibull SPR model (full covariate
analysis with and without gamma frailty). Here we compare a variety of
models contained in the family defined by (7.30) above (which clearly includes
the two models of Example 7.1). In particular we consider models with the
following regression structures:
1. Null Model: No covariates, i.e., xTβ = β0, z
Tα = α0.
2. Single Factor SPR: Scale depends on one factor7.
3. Single Factor MPR: Scale and shape depend on one factor.
4. Multi-Factor SPR: Scale depends on all factors.
5. Multi-Factor MPR: Scale and shape depend on all factors.
For each of the above regression structures we consider three frailty specifi-
cations:
(a) No Frailty: In this case φ = 0 so that (7.30) reduces to (7.29). Therefore,
we simply have a standard Weibull (non-frailty) model (Section 5.2.1).
6Recall that the φ parameter was denoted by ρ in Section 5.2.4. In the current context
of frailty, we consider regressing φ on covariates in Section 7.7.
7We consider the treatment model. Thus xTβ = β0+x1β1+x2β2+x3β3+x4β4, where
x1, x2, x3 and x4 are the four binary variables representing treatment.
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(b) Fixed Frailty: It is of interest to fix the frailty variance at φ = 1 as (7.30)
becomes that of a log-logistic model (Section 5.2.3).
(c) Frailty: The Weibull-gamma frailty model with φ estimated from the
data, i.e., the Burr model (Section 5.2.4).
Hence, there are 15 models (1a, 1b, 1c, 2a, . . . , 5c); these can be estimated
using the Weibull, log-logistic and Burr likelihoods given in Appendix B.2.
The models are summarised (in order of complexity) in Table 7.2 below8.
Table 7.2. Summary of Fitted Weibull Models
Model Scale Shape Frailty S.E. dim(θ) ℓ(θ̂) AIC ∆AIC
1a: Null —— —— φ = 0.00 —— 2 -2061.4 4126.8 445.8
1b: Null-G∗ —— —— φ = 1.00 —— 2 -2055.3 4114.5 433.5
1c: Null-G —— —— φ̂ = 0.70 (0.21) 3 -2054.4 4114.7 433.6
2a: SF-SPR Treat. —— φ = 0.00 —— 6 -1960.8 3933.5 252.4
2b: SF-SPR-G∗ Treat. —— φ = 1.00 —— 6 -1943.7 3899.3 218.2
2c: SF-SPR-G Treat. —— φ̂ = 0.91 (0.20) 7 -1943.6 3901.1 220.0
3a: SF-MPR Treat. Treat. φ = 0.00 —— 10 -1938.1 3896.2 215.2
3b: SF-MPR-G∗ Treat. Treat. φ = 1.00 —— 10 -1927.7 3875.5 194.4
3c: SF-MPR-G Treat. Treat. φ̂ = 0.74 (0.19) 11 -1926.9 3875.9 194.8
4a: MF-SPR All —— φ = 0.00 —— 27 -1839.3 3732.5 51.5
4b: MF-SPR-G∗ All —— φ = 1.00 —— 27 -1821.7 3697.5 16.4
4c: MF-SPR-G All —— φ̂ = 0.73 (0.16) 28 -1820.5 3697.0 15.9
5a: MF-MPR All All φ = 0.00 —— 52 -1798.4 3700.9 19.8
5b: MF-MPR-G∗ All All φ = 1.00 —— 52 -1790.0 3683.9 2.8
5c: MF-MPR-G All All φ̂ = 0.60 (0.16) 53 -1787.5 3681.1 0.0
Note: Model naming scheme: Null ⇒ no covariates, SF ⇒ single factor (i.e., treatment) and MF ⇒
multi-factor (i.e., all covariates); SPR ⇒ scale only and MPR ⇒ scale and shape; G ⇒ gamma frailty
model with φ estimated from the data and G∗ ⇒ gamma frailty model with φ = 1.
8Many of these have appeared in previous examples: Ex. 2.1 (1a, 1b), Ex. 4.2 (2a, 2b),
Ex. 5.1 (3a, 3b), Ex. 5.2 (2c, 3c), Ex. 5.4 (5b, alluded to 5a), Ex. 7.1 (4a, 4c).
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We can see that the best fitting model (according to AIC) is the most
complex model, i.e., the MF-MPR-G model. This is interesting because, in
light of the discussion at the end of Section 7.4.1 (second last paragraph), we
may question whether the MPR and frailty extensions (of the SPR model) are
required simultaneously - both offer explanations for time-dependent hazard
ratios9. However, if we drop the frailty component, and consider the MF-
MPR model, the AIC increases by 19.8 units. Similarly, if we maintain
frailty but reduce to SPR (i.e., the MF-SPR-G model) then AIC increases
by 15.9 units. Thus, we conclude that the effect of including frailty does not
abolish the usefulness of the MPR extension and vice versa.
As φ (= var(U)) describes the degree of unexplained variation, it is not
surprising to see that, of the five frailty models (i.e., those of type (c)), φ̂
is lowest for the most complex model (MF-MPR-G). However, the Null-G
model - which should have the largest amount of unexplained variation - has
the next lowest φ̂ value. Ignoring this null model however, the order of φ̂
values is as we would expect: the more complex the model and, hence, the
more variation it explains, the lower its φ̂ value. Still, we notice that the φ̂
values for the SF-MPR-G and MF-SPR-G models are approximately equal;
we would not expect this given the large difference in AIC values (≈ 179
in favour of the MF-SPR-G model). However, these somewhat anomalous
results are less surprising when viewed in conjunction with the corresponding
standard errors, i.e., the numerical differences in φ̂ values are small when
compared to the precision of these estimates.
Table 7.3 contains some comparisons of different model types. Firstly we
can see that extending the model to include frailty reduces the AIC signif-
icantly in all cases (24 units on average). However, in this dataset, there is
little difference between estimating the frailty variance (i.e., the Burr model)
and fixing it at φ = 1 (i.e., the log-logistic model). Comparing the single
factor models to the multi-factor models, we can see that the ∆AIC val-
ues are approximately equal to 200. Therefore, even though accounting for
9The MPR Weibull model assumes that hazard ratios are time-dependent at an indi-
vidual level, and, hence, at a population level (Section 5.2.1). The SPR Weibull-gamma
model assumes that hazard ratios are constant at an individual level (Section 4.5.1) but
time-dependent at a population level due to frailty (Section 7.4.1).
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Table 7.3. A Comparison of Weibull Models
Model 1 Model 2 AIC1 AIC2 ∆AIC
Non-Frailty vs Frailty
Null Null-G 4126.8 4114.7 12.1
SF-SPR SF-SPR-G 3933.5 3901.1 32.4
SF-MPR SF-MPR-G 3896.2 3875.9 20.4
MF-SPR MF-SPR-G 3732.5 3697.0 35.5
MF-MPR MF-MPR-G 3700.9 3681.1 19.8
∆̄AIC = 24.0
φ = 1 vs φ̂
Null-G∗ Null-G 4114.5 4114.7 -0.2
SF-SPR-G∗ SF-SPR-G 3899.3 3901.1 -1.8
SF-MPR-G∗ SF-MPR-G 3875.5 3875.9 -0.4
MF-SPR-G∗ MF-SPR-G 3697.5 3697.0 0.4
MF-MPR-G∗ MF-MPR-G 3683.9 3681.1 2.8
∆̄AIC = 0.2
Single Factor vs Multi-Factor
SF-SPR MF-SPR 3933.5 3732.5 201.0
SF-SPR-G∗ MF-SPR-G∗ 3899.3 3697.5 201.8
SF-SPR-G MF-SPR-G 3901.1 3697.0 204.1
SF-MPR MF-MPR 3896.2 3700.9 195.4
SF-MPR-G∗ MF-MPR-G∗ 3875.5 3683.9 191.6
SF-MPR-G MF-MPR-G 3875.9 3681.1 194.8
∆̄AIC = 198.1
SPR vs MPR
SF-SPR SF-MPR 3933.5 3896.2 37.3
SF-SPR-G∗ SF-MPR-G∗ 3899.3 3875.5 23.8
SF-SPR-G SF-MPR-G 3901.1 3875.9 25.3
MF-SPR MF-MPR 3732.5 3700.9 31.7
MF-SPR-G∗ MF-MPR-G∗ 3697.5 3683.9 13.6
MF-SPR-G MF-MPR-G 3697.0 3681.1 15.9
∆̄AIC = 24.6
Note: Model naming scheme is the same as in Table 7.2.
Also, here ∆AIC = AIC1 − AIC2.
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frailty (unobserved heterogeneity) reduces the AIC, it is not at the same
level as accounting for additional important covariates (observed heterogene-
ity). For a specific example, take the SF-SPR model and add frailty (i.e.,
SF-SPR-G) - the AIC reduces by 32.4 units. If, instead, we add all ad-
ditional covariates (i.e., MF-SPR) then the AIC reduces by 201 units. Of
course, the fit can still be improved by adding frailty to this multi-factor
model (i.e., AICMF-SPR − AICMF-SPR-G = 35.5); thus, we may conclude that
unexplained variation still remains. Furthermore, although unrelated to the
topic of frailty, we also compared the SPR models (scale regression) to the
MPR models (scale and shape regression); As in Chapter 5 we find that
extending to MPR reduces the AIC significantly in all cases (∆̄AIC = 24.6).
Example 7.3. Log-Logistic Gamma Frailty Model
In Examples 7.1 and 7.2 we did not show the log-likelihood / score equations
required to fit the Weibull-gamma model as it is a Burr model which has
been dealt with previously. In this example we consider the case where the
basic hazard is that of a log-logistic model. Note that, although that the
log-logistic model has a frailty interpretation already (as seen in Example
7.2), there is no reason why we cannot use it as the basic hazard model.







Λ(t) = log(1 + λtγ),





1 + φ log(1 + λtγ)
, (7.31)
which is not a model we have considered previously. In order to fit this model
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we need to maximise the marginal log-likelihood which, from (7.23), is
ℓm(λ, γ, φ) =
n∑
i=1




δi [log λ+ log γ + (γ − 1) log ti − log(1 + λt
γ
i )]
− (1/φ+ δi) log [1 + φ log(1 + λt
γ
i )] . (7.32)
Recall from (7.24) that the score functions (for λ and γ) are simple ex-
tensions of those required for the corresponding non-frailty model. From





























































































(1/φ2) log [1 + φ log(1 + λtγi )]
− (1/φ+ δi)
log(1 + λtγi )
1 + φ log(1 + λtγi )
. (7.35)
Of course we could arrive at (7.33) - (7.35) by simply by differentiating
(7.32) directly, but the purpose of this example is to show that, once we have
done the work for a particular non-frailty model, the extension to frailty is
straightforward.
If we wish to extend the basic hazard model to MPR (which of course
includes SPR) we simply write λi = exp(x
T
i β) and γi = exp(z
T
i α) (in place of
λ and γ) in the above log-likelihood, (7.32), and in the score equation for φ,
(7.35). For the β score equations note that, from the chain rule, ∂ℓm/∂βj =
∑
(∂ℓm/∂λi · ∂λi/∂βj) =
∑
(∂ℓm/∂λi · xjiλi) for j = 0, . . . , p, i.e., replace λ
and γ in (7.33) with λi and γi and multiply the summand by xjiλi. Similarly,
∂ℓm/∂αk =
∑
(∂ℓm/∂γi · ∂γi/∂αk) =
∑
(∂ℓm/∂γi · zkiγi) for k = 0, . . . , q.
We fitted the above model to the lung cancer data (not shown) with dif-
ferent regression structures - null model and SPR / MPR models with various
covariates - but found in all cases that φ̂ ≈ 0, i.e., the extra flexibility of this
parameter is not required. One might assume this to be an identifiability
issue but we can safely reject such concerns based on simulation work and
fitting the model to other datasets (also not shown).
7.6 Multi-Parameter Regression with
Error Terms
In Example 7.1 we saw that multiplicative frailty can be interpreted as an
error term in the linear predictor for the Weibull SPR model (and all PH
models). With this interpretation, the frailty component accounts for missing
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covariates and/or measurement errors in the included covariates (Lancaster,
1990, sec. 4.2)10. Therefore, analogous to this Weibull SPR model, we may
wish to extend the MPR models of Chapter 5 to include an error term in each
regression component. Although full development of such models is beyond
the scope of this thesis, we consider the Weibull MPR case here (upon which
future work will be based).
In the spirit of multiplicative frailty (Section 7.4), we extend the Weibull
hazard by multiplying each of its parameters (scale and shape) by a frailty
term, i.e.,
λ(t | u, v) = uλ vγ tvγ−1, (7.36)
such that E(U) = E(V ) = 1. Letting scale and shape depend on covariates
(as in Chapter 5), the hazard then becomes
λ(t | x, z, u, v) = u exp(xTβ)v exp(zTα)tv exp(z
Tα)−1
= exp(xTβ + ǫ) exp(zTα+ ω)texp(z
Tα+ω)−1, (7.37)
where ǫ = log u and ω = log v respectively11. Clearly this is a Weibull model
with
log λ = xTβ + ǫ, log γ = zTα+ ω, (7.38)
which extends the definition of multi-parameter regression, (5.1), to include
error terms - albeit in the Weibull case only. Although we could specify dis-
tributions for ǫ and ω, we will work in terms of u and v in order to preserve
the analogy with preceding sections. Furthermore, given the popularity of















10Of course, more generally, multiplicative frailty is viewed as representing all variation
(in the hazard) which remains unexplained by the regression component, λ(t |x).
11Note how the hazard in (7.27) has been generalised.
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respectively, such that φu = var(U) and φv = var(V ).
It is worth pointing out that the above model is defined by the following
statements:
T ∼Weibull[λ =u · exp(xTβ), γ = v · exp(zTα)]
U ∼ Gamma(φu) (7.39)
V ∼ Gamma(φv).
Of course, this represents but one set of possible assumptions12. Nonetheless,
these assumptions follow naturally from the work of the preceding sections
and, moreover, appear to be reasonable given the status of both the Weibull
model and gamma frailty in survival literature. Indeed, the family contains,
and extends, some commonly used models (i.e., null Weibull, PH Weibull,
PH Weibull-gamma frailty) as well as models introduced in this thesis (i.e.,
MPR Weibull, MPR Weibull-gamma frailty).
We can estimate this model using the marginal likelihood approach. From









λ(ti | ui, vi)
δiS(ti |, ui, vi) g(ui) dui g(vi) dvi
]
, (7.40)
as we have two frailty components to be integrated out. From (7.36) we see
that u appears multiplicatively in the hazard (for this Weibull case) which
allows us to write
λ(t | u, v) = u λ(t | u = 1, v),
and, hence,
S(t | u, v) = exp[−uΛ(t | u = 1, v)].
12We can choose different survival and frailty distributions and, furthermore, there is
no reason why g(u) and g(v) must have the same functional form. Alternatively we could
work with ǫ = log u and ω = log v where the (mean-zero) normal distribution may be
useful. Moreover, we may assume a bivariate distribution for (u, v) or (ǫ, ω).
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Thus, the double integral in (7.40) can be written as
∫ ∞
0








where the inner integral, Iui , is exactly of the form considered in Appendix
D.3.1 (i.e., multiplicative frailty). Therefore, we have that
Iui = (−1)
δiL(δi)u [Λ(ti | ui = 1, vi)]
= [1 + φu Λ(ti | ui = 1, vi)]
−(1/φu+δi),
where Lu(s) is the Laplace transform of g(u) and the second line comes
from the fact that L(δ)u (s) = (−1)δ(1 + φu s)−(1/φu+δ) in the gamma case
(see Section 7.5). Putting all of the above together, and using the fact that















where λi = exp(x
T
i β) and γi = exp(z
T
i α) respectively.
As the marginal likelihood is a product of n integrals which are unfortu-
nately non-analytic, numerical integration is required to fit the model (un-
like the multiplicative gamma frailty model of Section 7.5). Furthermore,
the burden is quite high as these n numeric integrals are required each time
Lm(θ, φu, φv) is to be evaluated in the optimisation algorithm
13. Nonethe-
less, we have fitted the model to the lung cancer data but, in the cases we
have tried, we have found that φ̂v ≈ 0, i.e., the model reduces to the MPR
Weibull-gamma frailty model considered in Example 7.2. Note that in some
preliminary simulation work (not shown) we have found that non-zero esti-
mates of φv are produced when the true value is indeed non-zero. Thus, we
13Alternatives to marginal likelihood, which avoid integration, exist (e.g., h-likelihood)
and these are likely to be useful for fitting MPR models with error components. Some
possibilities are discussed in the last paragraph of Section 7.3.
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conclude that the extra flexibility of this additional parameter is simply not
required in the lung cancer dataset; multiplicative frailty adequately captures
the unobserved heterogeneity.
7.7 Structured Dispersion
We now return to the gamma frailty model of Section 7.5 which is defined
by
λ(t | u, x, θ) = u λ(t | x, θ) where u ∼ Gamma(φ),
and, in the spirit of multi-parameter regression (Chapter 5), suggest a re-
gression structure for the dispersion parameter, φ, in addition to the hazard
regression model, λ(t | x, θ)14. Therefore, we have
λ(t | u, x, θ) = u λ(t | x, θ) where u ∼ Gamma[ exp(wT τ) ], (7.42)
i.e., w = (1, w1, . . . , wr)
T and τ = (τ0, τ1, . . . , τr)
T are the vectors of dis-
persion covariates and regression coefficients. Thus, rather than having a
single parameter, φ, governing the overall hazard dispersion (as in the stan-
dard gamma frailty model), we now have a vector, τ , which describes how
this dispersion varies with known covariates. Hence, we refer to (7.42) as a
structured dispersion model which, of course, fits under the broad heading of
multi-parameter regression15.
The gamma structured dispersion model extends the usual gamma frailty
model via φ = exp(wT τ) and, therefore, the results of Section 7.5 are gener-
alised by making this substitution. For example, the marginal log-likelihood








δi log λ(ti)− [exp(−w
T
i τ) + δi] log
[
1 + exp(wTi τ) Λ(ti)
]
.
14We previously alluded to φ-regression in Example 7.2 when noting that the Weibull
MPR gamma frailty model is a Burr MPR model.
15References to structured dispersion models in other contexts are given in Section 5.1.
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As before, the effect of a covariate on the level of the hazard can be
described by the individual hazard ratio (Section 7.4.1). Analogously, we
may use the variance ratio (V.R.) to describe the effect of a covariate on the
hazard variation, e.g., the ratio of variances for an individual with w1 = 1 to
an individual with w1 = 0 is given by
φ(w1 = 1, w̃)






where w̃T τ = wT τ − w1τ1 represents all other terms in the linear predictor.
Example 7.4. Weibull-Gamma Structured Dispersion Analysis of Lung Can-
cer Data
Here we extend the Weibull-gamma model of Example 7.1 to structured dis-
persion, i.e., we assume the following survival model:
λ(t | u, x) = u exp(xTβ)γtγ−1 where u ∼ Gamma[ exp(wT τ) ]. (7.43)
A useful feature of this model is that both the hazard and variance ratios are
given by exponentiation of β and τ coefficients respectively; thus, the model
is easily interpreted. Furthermore, the marginal model is a Burr MPR model
(with γ constant) and, hence, the log-likelihood given in Appendix B.2.4 is
used for estimation.
The model was fitted to the lung cancer data and the results are given in
Table 7.4. We now summarise the main findings: Treatment : Surgery reduces the hazard to 27% of the palliative level,
whereas the combined treatment (C+R) reduces the hazard to 16% of
the palliative level. Furthermore, while V.R.≈ 5 for surgery (almost
significant), the combined treatment has virtually no variance relative
to palliative care (significant). Interestingly, this is the only analysis in
this thesis where surgery is not deemed to be the most effective treat-
ment. As for the other treatments (chemotherapy and radiotherapy),
the risk is approximately 50% that of palliative care in both cases (the
dispersion effects are non-significant). Age group: The effect of age is not significant apart from the fact that
the 50 - 60 group has almost no variation (relative to the < 50 group).
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Table 7.4. Weibull-Gamma Structured Dispersion Full Covariate Analysis
Hazard: γ, β Dispersion: τ
Est. S.E. |Z| H.R. Est. S.E. |Z| V.R.
Shape: γ 1.48 (0.00) —— —— —— —— —— ——
Intercept -3.88 (0.49) —— —— 0.43 (1.21) —— ——
Treatment Palliative 0.00 —— —— 1.00 0.00 —— —— 1.00
Surgery -1.30 (0.47) 2.74 0.27 1.62 (0.85) 1.92 5.07
Chemo -0.64 (0.30) 2.15 0.52 0.38 (0.55) 0.68 1.46
Radio -0.72 (0.16) 4.36 0.49 -0.44 (0.33) 1.35 0.64
C+R -1.81 (0.28) 6.55 0.16 -10.17 (4.38) 2.32 0.00
Age Group < 50 0.00 —— —— 1.00 0.00 —— —— 1.00
50 - 60 -0.39 (0.34) 1.15 0.68 -12.42 (4.37) 2.84 0.00
60 - 70 -0.09 (0.33) 0.28 0.91 -0.38 (0.98) 0.39 0.68
70 - 80 -0.06 (0.34) 0.19 0.94 -0.15 (0.99) 0.15 0.86
80 + 0.25 (0.40) 0.63 1.28 0.12 (1.00) 0.12 1.13
WHO Status Normal 0.00 —— —— 1.00 0.00 —— —— 1.00
Light Work 0.31 (0.21) 1.50 1.37 0.67 (0.38) 1.76 1.95
No Work 0.98 (0.23) 4.28 2.67 0.72 (0.49) 1.49 2.06
> 50% Bed 1.77 (0.27) 6.66 5.84 0.62 (0.52) 1.21 1.87
Bedbound 2.11 (0.41) 5.08 8.22 -0.25 (0.88) 0.28 0.78
Sex Female 0.00 —— —— 1.00 0.00 —— —— 1.00
Male 0.10 (0.13) 0.74 1.10 0.29 (0.24) 1.23 1.34
Smoker No 0.00 —— —— 1.00 0.00 —— —— 1.00
Yes -0.03 (0.25) 0.11 0.97 -0.95 (0.34) 2.84 0.38
Ex-smoker 0.03 (0.25) 0.11 1.03 -0.48 (0.32) 1.49 0.62
Missing 0.22 (0.57) 0.38 1.24 -0.38 (0.64) 0.59 0.68
Cell Type Squamous 0.00 —— —— 1.00 0.00 —— —— 1.00
Small 0.99 (0.23) 4.27 2.68 -0.20 (0.44) 0.46 0.82
Adeno. 0.03 (0.21) 0.16 1.03 -1.22 (0.61) 2.01 0.29
Other 0.37 (0.18) 2.04 1.45 0.12 (0.29) 0.43 1.13
Metastases No 0.00 —— —— 1.00 0.00 —— —— 1.00
Yes 0.69 (0.16) 4.40 2.00 -0.58 (0.23) 2.53 0.56
Missing 0.27 (0.21) 1.29 1.31 -0.34 (0.29) 1.18 0.71
Sodium ≥ 136 mmol/l 0.00 —— —— 1.00 0.00 —— —— 1.00
< 136 mmol/l 0.32 (0.12) 2.66 1.38 -0.13 (0.20) 0.63 0.88
Missing -0.34 (0.30) 1.12 0.71 -0.51 (0.70) 0.73 0.60
Albumen ≥ 35 g/l 0.00 —— —— 1.00 0.00 —— —— 1.00
< 35 g/l 0.80 (0.14) 5.76 2.23 0.14 (0.23) 0.64 1.16
Missing 0.19 (0.24) 0.78 1.21 -0.82 (0.52) 1.57 0.44
ℓ(θ̂) = -1795.11 AIC = 3696.23
Note: H.R. = hazard ratio = exp(β) and V.R. = variance ratio = exp(τ).
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the normal group. Otherwise, the hazard increases as physical state
deteriorates - dramatically so - with H.R. values of 2.67, 5.84 and 8.22
respectively. The dispersion effects are not significant. Sex : Males are not significantly different from females in either the
level of the hazard or its dispersion. Smoker : The level of hazard is unaffected by smoking status. However,
the hazard variation for smokers is 38% that of non-smokers. Cell type: The small cell type increases the risk of death by a factor of
2.68 compared with the squamous cell type, the adenocarcinoma cell
type is not statistically significant and the “other” cell type is just sig-
nificant with H.R.= 1.45. In terms of dispersion, only adenocarcinoma
is significant (and only just) with approximately 30% the variability of
the squamous cell group. Metastases : Individuals with metastases have 4.4 times the risk (and
56% the variability) of those without metastases. Sodium: Lower sodium levels increase the hazard by almost 40% but
do not alter dispersion. Albumen: Lower albumen levels more than double the risk of death.
Comparing the above analysis to the earlier Weibull-gamma analysis of
Example 7.1, it is clear that they are generally quite similar in terms the
estimates/significance of covariate effects on the hazard level. However, the
advantage of the current analysis is that we can also determine how covariates
affect the variation of the hazard, rather than assuming that it is constant.
Furthermore, structuring the dispersion leads to a reduction in AIC, albeit
small in this particular case (∆AIC = 3697.02 − 3696.23 = 0.79). However,
it is clear from Table 7.4 that covariates can be dropped from the dispersion
to reduce the AIC further. Indeed, in the worst case, no dispersion effects
are significant and the model reduces to the standard gamma frailty model.
Of course the flexibility of multi-parameter regression has been discussed
previously in Chapter 5.
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7.7.1 Structured Dispersion with Error
Combining the ideas of structured dispersion and regression error terms (Sec-
tion 7.6), we now briefly consider the following model which extends (7.43):
λ(t | u, x) = u exp(xTβ)γtγ−1
u ∼ Gamma[ v exp(wT τ) ] (7.44)
v ∼ Gamma(φv).
This model has an error term, u, for the hazard regression, whose variance
is described by covariates, w = (1, w1, . . . , wr)
T , and, in turn, an error term,
v, for this dispersion regression16.
The above model can be fitted using a marginal likelihood approach
(similar to that of Section 7.6). Letting λi = exp(x
T
i β) and φu,i = exp(w
T
i τ),
respectively, the marginal likelihood is given by













































where the last line comes from the Laplace transform of g(ui | vi) which is
the same as the usual gamma case with φu replaced by vi φu,i.
Much like the model of Section 7.6, we have found that φ̂v ≈ 0 when we
fit model (7.44) to the lung cancer data (various combinations of covariates
tried)17. This is not to say that an error term in the dispersion is not useful
in other datasets; also note that Lee & Nelder (2006) have considered error
terms in dispersion in the context of generalized linear models.
16We could specify a regression model for φv also and, then, we then might consider
including an error term in this regression. Of course we could continue infinitely in this
fashion but it seems logical to assume that higher order terms are of less practical use; even
the model considered here, (7.44), is surplus to requirement in the lung cancer dataset.
17Recall, however, that φv played a different role in Section 7.6.
Chapter 8
Discussion
In this thesis we have developed multi-parameter regression (MPR) models in
the setting of survival analysis; in particular, we have mainly focused on two-
component (scale and shape) regression models. Of course, it is clear that
the MPR method is widely applicable and not limited to survival analysis or
indeed any single area of statistics; it can be used to increase the flexibility
of most standard parametric regression models. In spite of this fact, it is
quite surprising to find that the MPR approach has not received a great
deal of attention in the literature (see Section 5.1). This is particularly true
in survival literature, although not so surprising in this case, where much
emphasis is placed on non- and semi-parametric methods rather than the
development of fully parametric methods.
Our development of these MPR survival models was motivated by asking
the following simple question: why should the shape of the distribution be
covariate independent? In other words, why assume, a priori, that individ-
uals differ only with respect to the scale? This seems to be an unreasonable
limitation as the nature of the time evolution of the hazard function must
then be the same for all individuals. However, we can easily think of cases
where this is unlikely to hold. For example, an aggressive treatment may
cause the hazard to increase initially followed by a decrease, whereas another
treatment may simply decrease the hazard (but perhaps it never decreases
to level attained by the aggressive treatment). Such phenomena cannot be
handled within the framework of standard single parameter regression (SPR)
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models. Indeed, the inherent limitations of SPR models are clear (compare
the results of Sections 4.5 and 5.2) and, therefore, it is useful to relax the
assumptions of these models.
In a field of statistics where practitioners are accustomed to “letting the
data speak for themselves”, it seems particularly important to develop more
flexible parametric models (as an alternative to non-parametric approaches).
Of course, all parametric models impose some structure on the data but,
nonetheless, the simple MPR extension generates survival models which sup-
port a wider variety of phenomena (than SPR counterparts) such as diver-
gent, convergent or crossing hazards (Section 5.2). Perhaps, in many cases,
the data will have little more to say than what is supported by a flexible MPR
model, i.e., the fit may be very close to that of a competing non-parametric
estimator. Recall that in Example 5.1 the log-logistic MPR treatment model
was virtually indistinguishable from the corresponding treatment Kaplan-
Meier curves. This is quite noteworthy as the MPR model can provide more
insight than Kaplan-Meier curves (through the hazard function for example).
Although we have mainly focused on regression models with two com-
ponents (scale and shape), further flexibility can be achieved using more
general parametric models. To this end, we have also considered the Burr
MPR model which has three regression components and unifies the Weibull
and log-logistic MPR models. However, the extra flexibility of this model
is not required in the lung cancer dataset that we have analysed; the log-
logistic model provides the best fit to these data. It is worth noting that the
generalised gamma (three parameters) and the generalised F (four parame-
ters) distributions (Kalbfleisch & Prentice, 2002, chap. 2) may also be useful
candidates for multi-parameter regression but have not been considered in
this thesis (future work).
Irrespective of the specific model, we have shown, through a variety of
examples in Chapter 5 (and also Chapter 7), that the MPR extension can
lead to significant improvements in fit over the corresponding SPR model.
The price paid for this improvement is that MPR models are more difficult
to interpret - we might expect this given the aim of capturing more complex
structures. Of course, this is not an issue if we simply wish to make predic-
tions based on the fitted model (e.g., predicted survival probabilities) but,
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typically, we will want to interpret the individual covariate effects in addition
to making predictions. However, while the scale and shape regression coeffi-
cients (β and α respectively) can give us some insight into covariate effects,
we have found that these coefficients are somewhat difficult to interpret di-
rectly - further complicated by the fact that scale and shape estimates are
correlated (see next paragraph). Thus, we have used the hazard ratio - ubiq-
uitous in survival analysis - to measure the effect of covariates as it takes into
account both the β and α values. However, apart from the Gompertz and
piecewise exponential cases, the hazard ratio typically depends on the other
covariates in the model, i.e., these do not cancel out neatly, and, therefore, in
Section 5.3 we suggest using the overall hazard ratio and average-covariates
hazard ratio respectively: the former is an average hazard ratio over all indi-
viduals in the dataset, whereas the latter is the hazard ratio for an average
individual. Clearly these have different interpretations but, in our practical
work, we have found that the estimates are often numerically close (although
the overall hazard ratio has a larger standard error). An alternative estimate
comes from using a least squares approximation to the log-hazard function
(more on this technique later).
We have found that the following correlation structure exists among esti-
mated regression coefficients in MPR models: given some covariate c, which
is common to both the scale and shape regression components (i.e., c ∈ x, z),
its estimated effects, β̂c and α̂c say, will be highly correlated with each other.
We first discovered this in our practical work (correlation matrices given in
Examples 5.4 and 5.5) which motivated the simulation studies of Section 5.5
and Appendix B.4. These studies show that the correlation structure exists
over a range of sample sizes, censoring levels, models and parameter values;
it is a general feature of MPR models which arises due to a lack of orthogo-
nality across the scale-shape space. Of course, we could abolish this by using
a model where the scale and shape parameters are orthogonal but recall that
the definition of orthogonality does not extend to censored data (Cox & Reid,
1987) and, indeed, we have found that such “full-information-orthogonality”,
if it exists, breaks down in the presence of censoring (Section 5.5). Further-
more, although it is not something that we have pursued, extending Cox &
Reid’s orthogonality equations (Appendix C.4) to generate orthogonal models
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for censored data seems an undesirable task for two reasons, namely: (i) we
would have to specify the censoring distribution (or process) and, therefore,
orthogonality would only hold in this specific case, and (ii) these partial dif-
ferential (orthogonality) equations are generally not straightforward to solve
even in the usual full information case. Therefore, regarding orthogonality
as a special case, we may say that the regression components in MPR models
are typically non-orthogonal which leads to correlated estimates.
Naturally, it is of interest to discover if the scale or shape effects of covari-
ates are statistically significant; this can be achieved via hypothesis testing or
through variable selection. However, we must account for the correlation (de-
scribed above) between estimated regression coefficients when carrying out
such procedures (see Section 5.4). For example, given the covariate c ∈ x, it
seems unreasonable to investigate its scale effect if c is absent from the shape
regression, i.e., c 6∈ z. Indeed, it may be the case that c only becomes sig-
nificant when present in both the scale and shape components, i.e., c ∈ x, z.
Thus, we suggest that c should be present in both regression components
so that its scale effect, β̂c, is then adjusted for its shape effect, α̂c, and vice
versa (due to the fact that these estimates are correlated). Furthermore, we
suggest testing the three hypotheses: (i) H0 : βc = 0, (ii) H0 : αc = 0 and
(iii) H0 : βc = αc = 0. Note that we have implemented a variable selection
procedure which includes scale, shape and simultaneous selection steps (see
Section 5.4 and Appendix B.5.3). Although this procedure has performed
reasonably well in simulation (Section 5.5.3), it is of interest to explore the
use of the lasso method (Tibshirani, 1996) within this MPR context (future
work - for details see the last paragraph of Section 5.4).
When regression coefficients are highly correlated, stability of the estima-
tion procedure may be of concern. For example, Lee & Whitmore (2006), in
the case of the inverse Gaussian MPR model, observed that estimated regres-
sion coefficients are correlated and suggested that it “raises some new issues
for estimation and inference”. We agree that this correlation raises new is-
sues for inference, and have discussed our solution to this in the preceding
paragraph, however, we have not come across any issues as far as estimation
is concerned. We have found in all of our practical work to date that esti-
mation of MPR models is both stable and fast using the Newton-Raphson
223
method with different starting values (see Appendix B.5 for our implementa-
tion which uses the nlm function). Furthermore, in simulation (Section 5.5.2
and Appendix B.4) we have found that the estimates are generally unbiased
(except when the sample size is small with a high level of censoring).
While the primary focus of this thesis is MPR modelling, our work in
this area has led us to develop other techniques that have been used to
complement the main line of research, namely: M.l.e. simulation (Section 2.3.2). Simulating survival data (Chapter 3). Least squares approximation to implied regression models (Chapter 6). Frailty modelling (Chapter 7).
We now discuss each of these topics briefly.
In Section 2.3.2, we introduced the method of m.l.e. simulation which is
used to calculate the standard error and confidence intervals for functions of
model parameters. The method is akin to bootstrapping in the sense that it
produces a sample of m.l.e. vectors. However, it is much less computation-
ally expensive as it does not require fitting of the model to replicate datasets;
rather, m.l.e. vectors are simulated directly from the multivariate normal dis-
tribution N(θ̂, Σ̂). We have shown in practice (Example 2.2), and through a
simulation study (Section 3.6.4), that m.l.e. simulation performs comparably
to standard methods, i.e., the delta method and bootstrapping. However,
m.l.e. simulation is both easy to implement and computationally inexpensive.
Hence, we favour this method and have used it throughout our work (see
Chapters 4 - 6), e.g., in producing confidence intervals for hazard ratios.
We note that m.l.e. simulation is particularly useful when developing novel
methods (such as MPR) where the primary focus is unlikely to be the te-
dious calculation/programming of analytic derivatives required for the delta
method - a task in which room for error can be high. However, in developing
a software package for mainstream use, it might be preferable to implement
the delta method as it is analytic and, therefore, instantaneous.
Clearly simulation studies have played an important role in this thesis,
e.g., in exploring the properties of MPR models and the performance of
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m.l.e. simulation (as discussed previously). The method of simulation we
have used was originally proposed by MacKenzie (1994) and allows the cen-
sored proportion to be controlled (see Chapter 3). We have extended this
method to handle cure rate models (Section 3.5) which was motivated by an
interest in such models for practical application. However, our simulation
work in this area (Sections 3.6.5 and 3.6.6) has deterred us from pursuing
cure rate modelling in any great detail due to inherent difficulties in estimat-
ing the cured proportion reliably (although Example 5.6 does contain a cure
rate analysis). In particular, we have found that estimates of the cured pro-
portion are subject to appreciable bias and imprecision when the censored
proportion (of non-cured individuals) is high and, furthermore, it may be
difficult to distinguish between decreasing hazards and the presence of cured
individuals (particularly when censoring is high). Thus, it seems that one
should exercise great caution in reporting such estimates in practice. Indeed,
this is the general consensus in the literature and has been confirmed more
formally by our simulation work.
In Chapter 6 we proposed the use of least squares to approximate a
covariate-dependent model quantity, ψ(x) say, in which covariate effects can-
not be interpreted straightforwardly, i.e., we assume that the implied re-
gression model, ψ(x), has a complicated functional form. Thus, applying
the linear approximation allows direct interpretation of covariate effects via
ψ(x) ≈ xTβ∗. This easily applied method can be used, for example, to
aid interpretation of complicated models by translating results onto some
conceptually intuitive quantity. Indeed, the difficulties of interpreting MPR
models (as discussed previously) motivated our development of this method.
In particular, we used this approximation to interpret the log-logistic MPR
model in terms of the restricted mean, µt∗ = E[min(T, t
∗)], which we found
to be very intuitive (Section 6.3.1). Furthermore, in Section 6.4, we approxi-
mated the log-hazard function, i.e., log λ(t | x) ≈ xTβ∗(t), so that the hazard
ratio for a particular covariate is given by exponentiating the relevant β∗
coefficient. In practice, we found that this least squares estimate of the haz-
ard ratio was numerically close to the overall and average-covariates hazard
ratios (discussed previously) providing us with some assurance that all three
are quite reasonable estimates.
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Frailty modelling is the study of unobserved heterogeneity in survival
data. Our work in this area is largely based on the multiplicative gamma
frailty model (Section 7.5) - the most commonly used frailty model. Among
other things, Example 7.2 shows that both the MPR and (gamma) frailty
extensions of the Weibull SPR model are simultaneously supported by the
lung cancer data, i.e., the best fitting model is the Weibull MPR gamma
frailty model. This is noteworthy as it is well known that frailty causes
time-dependent effects (hazard ratios) at a population level even though the
effects may be proportional at an individual level (Section 7.4.1). Therefore,
one may question the need for the MPR extension of the Weibull SPR model
(which generates a time-dependent effects model) if we have accounted for
frailty. Thus, finding that the usefulness of MPR is not abolished by the
presence of a frailty component - albeit in a single example - adds credence
to MPR in this setting.
Apart from considering MPR in the context of the standard multiplica-
tive gamma frailty model we have also considered extensions which merge
these two concepts. In Section 7.6, motivated by the Weibull-gamma model,
we propose a general class of MPR models with error terms which extends
the standard MPR class of Chapter 5 via g(λ) = xTβ+ǫ and h(γ) = zTα+ω
(compare with (5.1)). Currently we have only considered the Weibull MPR
error model and, therefore, further work is needed in this area. In partic-
ular, the first challenge is computational as the marginal likelihood is non-
analytic; h-likelihood (Lee & Nelder, 1996, 2001) may provide a solution. An
alternative extension of the gamma frailty model is the structured dispersion
(gamma frailty) model (Section 7.7). This involves modelling the frailty vari-
ance parameter as a function of covariates simultaneously with any hazard
regression components. Of course, this is simply an application of the MPR
method but, in the context of frailty, it would be of interest to practitioners
to understand how the hazard variation depends on covariates.
It is clear from the above that there was a need to explore the conse-
quences of MPR survival modelling and, to this end, we feel that this thesis
represents a useful contribution to the area. While many interesting research
possibilities still remain, inevitably it is impossible to address them all within
the confines of a doctoral thesis. However, we have dealt the main issues of
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inference and interpretation which, we feel, are fundamental in the use of
such MPR models (not only in survival analysis). Furthermore, we have
shown that MPR models can greatly improve on SPR counterparts in terms
of their flexibility and, hence, their ability to adapt to a wider variety of
data. Indeed, practitioners might find themselves relying far less heavily on
non-parametric approaches if their parametric toolkit contained more useful
tools. To conclude, we have certainly found that MPR models are useful for
analysing survival data and suggest that the adoption of flexible parametric
approaches can improve current practice.
Appendix A
Lung Cancer Data
All of the models developed in this thesis have been applied, throughout, to
a particular lung cancer dataset (see examples); we describe this dataset here
in this appendix. Firstly, the dataset contains information on all individuals,
resident in Northern Ireland, who were diagnosed with lung cancer during
the one-year period October 1st 1991 – September 30th 1992. These data,
originally collected/analysed by Wilkinson (1995), and later re-analysed by
MacKenzie (1996), were accumulated from a number of different sources,
namely: general practitioners, hospital physicians/surgeons, radiotherapists,
pathology laborites, the general register office and the Northern Ireland Can-
cer Registry. Only cases of primary lung cancer were included; cases where
lung cancer was a secondary cancer were excluded.
In total there were 855 individuals recruited during the aforementioned
period and these individuals were followed-up until the study end date, May
30th 1993. The survival time was taken to be the number of months from the
date of diagnosis until the earlier of death or the study end date. Individuals
who were still alive at the end of the study, who had died from other causes
or who had dropped out of the study were taken to be censored; there were
182 cases where this occurred, i.e., approximately 20% of individuals had
survival times which were censored.
In addition to the survival times and corresponding censoring indicators,
a number of categorical covariates were also recorded. Table A.1 contains
a summary of these covariates and, although this table is generally quite
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Table A.1. Lung Cancer Covariates
Variable Category Individuals Proportion




Chemo. + Radio. 34 0.04
Age Group < 50 32 0.04
50 - 60 89 0.10
60 - 70 311 0.36
70 - 80 299 0.35
80 + 124 0.15
WHO Status Normal 78 0.09
Light Work Only 278 0.33
No Work 286 0.33
> 50% in Bed 191 0.22
Bedbound 22 0.03
Sex Female 291 0.34
Male 564 0.66








Metastases No 188 0.22
Yes 428 0.50
Missing 239 0.28
Sodium Level ≥ 136 mmol/l 505 0.59
< 136 mmol/l 310 0.36
Missing 40 0.05
Albumen Level ≥ 35 g/l 458 0.54
< 35 g/l 315 0.37
Missing 82 0.10
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self explanatory, we make note the following points: Palliative Care is a non-curative treatment providing pain relief only. WHO Status stands for “World Health Organization Status” and is a
commonly used scale indicating an individual’s physical state. Cell type describes the form of the lung cancer. Metastases means that cancer has spread from the lung to another
organ. Sodium Level is the concentration of sodium in the blood (measured in
millimoles per litre). Albumen Level is the concentration of albumen - a protein made by the
liver - in the blood (measured in grams per litre). There is missingness in the following covariates: smoker, metastases,
sodium level and albumen level. In the original coding of the data, each
of these covariates was given an additional category - called “Missing”
- in which individuals without a record were placed. Analysis then
proceeded in a routine manner, treating this category just as any other.
In our analyses we have followed the same approach, that is, we have
not attempted to impute these values as such procedures are beyond





Multi-parameter regression (MPR) models are developed in Chapter 5; this
appendix provides supplementary material. In the models we consider there
are typically two components, scale and shape1, which are modelled via
g(λ) = xTβ, h(γ) = zTα, (B.1)
where x = (1, x1, . . . , xp)
T and z = (1, z1, . . . , zq)
T are covariate vectors, β =
(β0, β1, . . . , βp)
T and α = (α0, α1, . . . , αq)
T are the corresponding regression
coefficients and g(·) and h(·) are appropriate link functions (often the log
link in cases we consider). Thus, the vector of parameters to be estimated
from the data is θ = (β, α) ∈ Rp+q+2
B.2 Likelihood and Score Functions
In this section we give the form of the likelihood function and score equations
which are used in estimating the MPR models considered in Chapter 5. First
we introduce some notation. The scale and shape for the ith individual,
i = 1, . . . , n, will be denoted by λi and γi, respectively, where the dependence
1The Burr MPR model has a third regression component given by log(ρ) = wT τ where
w = (1, w1, . . . , wr)
T and τ = (τ0, τ1, . . . , τr)
T .
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on covariates is implicitly assumed, i.e.,
λi = g
−1(xTi β), γi = h
−1(zTi α),
and xi = (1, x1i, . . . , xpi)
T and zi = (1, z1i, . . . , zqi)
T are the covariate vectors
for the ith individual. As is standard in regression literature we let X and
Z represent the covariate matrices, of dimension n× (p+ 1) and n× (q + 1)
respectively, whose ith rows are the vectors xi and zi.
It is notationally convenient to write the likelihood function in terms of
λ = (λ1, . . . , λn)
T and γ = (γ1, . . . , γn)
T . Of course these are not parameter
vectors (otherwise there would be 2n parameters!), but rather (vector-valued)
functions of β and α where we assume p + q + 2 ≪ 2n. Thus, given that

































































We will also require the use of Hadamard multiplication which we denote
by the “⊙” operator. Hadamard multiplication is element-wise multiplica-
tion of matrices or vectors, e.g., (a1, a2, a3) ⊙ (b1, b2, b3) = (a1b1, a2b2, a3b3).
Finally, we let ar×c represent a matrix of dimension r× c whose elements are
all equal to the constant a. In particular 0r×1 is a column of r zeros and 1r×1
is a column of r ones.
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B.2.1 Weibull
In the Weibull MPR model (Section 5.2.1) the hazard and survivor functions
for the ith individual (i = 1, . . . , n) are given by
λ(t | xi, zi) = λiγit
γi−1 S(t | xi, zi) = exp(−λit
γi),
where λi = exp(x
T
i β) and γi = exp(z
T





δi [log λi + log γi + (γi − 1) log ti]− λit
γi
i , (B.2)






































[δi (1 + γi log ti)− λiγit
γi
i log ti] zki, (B.4)
for j = 0, . . . , p and k = 0, . . . , q, which must be set equal to zero and solved
(numerically) in order to find the maximum likelihood estimates. These






and are also used to fit the Weibull SPR model (Section 4.5.1), by setting
Z = 1n×1, and the basic Weibull model (Section 1.4.2), by setting X = Z =
1n×1.
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B.2.2 Gompertz
In the Gompertz MPR model (Section 5.2.2) the hazard and survivor func-
tions for the ith individual (i = 1, . . . , n) are given by








where λi = exp(x
T
i β) and γi = z
T





δi (log λi + γiti)−
λi
γi
[exp(γi ti)− 1], (B.5)












































[(γiti − 1) exp(γi ti) + 1]
}
zki, (B.7)
for j = 0, . . . , p and k = 0, . . . , q, which must be set equal to zero and solved
(numerically) in order to find the maximum likelihood estimates. These






and are also used to fit the Gompertz SPR model (Section 4.5.2), by setting
Z = 1n×1, and the basic Gompertz model (Section 1.4.3), by setting X =
Z = 1n×1.
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B.2.3 Log-Logistic
In the log-logistic MPR model (Section 5.2.3) the hazard and survivor func-
tions for the ith individual (i = 1, . . . , n) are given by








where λi = exp(x
T
i β) and γi = exp(z
T





δi [log λi + log γi + (γi − 1) log ti]− (δi + 1) log(1 + λit
γi
i ), (B.8)




























































for j = 0, . . . , p and k = 0, . . . , q, which must be set equal to zero and solved
(numerically) in order to find the maximum likelihood estimates. These






and are also used to fit the log-logistic SPR model (Section 4.5.3), by setting
Z = 1n×1, and the basic log-logistic model (Section 1.4.4), by setting X =
Z = 1n×1.
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B.2.4 Burr
In the Burr MPR model (Section 5.2.4) the hazard and survivor functions
for the ith individual (i = 1, . . . , n) are given by




S(t | xi, zi, wi) =(1 + λiρit
γi)−1/ρi ,
where λi = exp(x
T
i β), γi = exp(z
T
i α) and ρi = exp(w
T
i τ). Thus, the log-
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for j = 0, . . . , p, k = 0, . . . , q and l = 0, . . . , r, which must be set equal to zero
and solved (numerically) in order to find the maximum likelihood estimates.










and are also used to fit the Burr SPR model (Section 4.5.4), by setting
Z = W = 1n×1, and the basic Burr model (Section 1.4.5), by setting X =
Z = W = 1n×1.
B.2.5 Time-Dependent Logistic
In the time-dependent logistic MPR model (Section 5.2.5) the hazard and
survivor functions for the ith individual (i = 1, . . . , n) are given by
λ(t | xi, zi) =
exp(γit + λi)
1 + exp(γit+ λi)
S(t | xi, zi) =
[




where λi = x
T
i β and γi = z
T














log[1 + exp(λi)], (B.15)
























ti exp(γiti + λi)
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ti exp(γiti + λi)










for j = 0, . . . , p and k = 0, . . . , q, which must be set equal to zero and solved
(numerically) in order to find the maximum likelihood estimates. These






and are also used to fit the time-dependent logistic SPR model (Section
4.5.5), by setting Z = 1n×1, and the basic time-dependent logistic model
(Section 1.4.6), by setting X = Z = 1n×1.
B.2.6 Piecewise Exponential
In the piecewise exponential MPR model (Section 5.2.6) the hazard function
for the ith individual (i = 1, . . . , n) is given by
λ(t | xi) = a(t)
T (λ1i, . . . , λmi)
T ,
where λji = exp(x
T
i βj) (for j = 1, . . . , m), a(t) is an m-dimensional vec-
tor indicating which interval t lies in (e.g., if m = 4 and t ∈ I3 then
a(t) = (0, 0, 1, 0)T ), x = (1, x1i, . . . , xpi)
T is the vector of covariates for the
ith individual and βj = (β0j , β1j, . . . , βpj)
T is the corresponding vector of re-
gression coefficients in the jth time interval. The survivor function is given
by
S(t | xi) = exp
[
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where d(t) represents the time spent in each interval for a particular value of
t, e.g., if m = 4 and t ∈ I3 then d(t) = (t(1) − t(0), t(2) − t(1), t− t(2), 0)
T .





T (λ1i, . . . , λmi)
T ]− d(ti)





δi log(a1iλ1i + . . .+ amiλmi)− (d1iλ1i + . . .+ dmiλmi),
where θ = (βT1 , . . . , β
T
m)
T ∈ Rm (p+1), aji is the jth element of a(ti) =
(a1(ti), . . . , am(ti))





1 if ti ∈ Ij,
0 otherwise,
the term log(a1iλ1i + . . .+ amiλmi) = log(λji) for ti ∈ Ij . Thus
log(a1iλ1i + . . .+ amiλmi) = a1i log λ1i + . . .+ ami log λmi.



























(δiaji − djiλji)xki, (B.19)
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for k = 0, . . . , p and j = 1, . . . , m, which must be set equal to zero and solved
(numerically) in order to find the maximum likelihood estimates. These













where ∇λj = (∂/∂λj1, . . . , ∂/∂λjn)
T . These score equations are also used
to fit the PH piecewise exponential model (Section 4.5.6), by imposing the
constraint βk1 = · · · = βkm (for k = 0, . . . , p), and the basic piecewise expo-
nential model (Section 1.4.7), by setting βk1 = · · · = βkm = 0.
Equation (B.19) deserves some further discussion. If xk is categorical (or
binary), only individuals with xki = 1 contribute to the sum, i.e., those who
are members of that group. Thus, the score equation for βkj becomes
∑
i | xki=1







Furthermore, we can write
λji = exp(β0j + x1iβ1j + . . .+ xk−1 iβk−1 j + xkiβkj + xk+1 iβk+1 j + . . .+ xmiβkj)
















































The numerator of the above fraction equals the number of individuals in the
group xki = 1 who experience an event (δi = 1) in the jth time interval
(aji = 1). Thus, if no individual is a members of this particular combination,
then β̂kj = log(0) = −∞. Karrison (1987) discussed this in a simpler version
of the model considered here. Furthermore, if all individuals in the group
xki = 1 experience an event before the jth time interval then all dji = 0 (as
nobody has passed through this time interval) and so β̂kj = log(0/0) which
is not defined. In fact, in this latter case, it is clear that any value of β̂kj
will satisfy (B.19). It is clear that as the number of time intervals, m, is
increased, so too is the frequency of such cases. Thus, it is undesirable for
m to be too large or we will have many inestimable parameters.
B.3 Properties of the Hazard Ratio
In Section 5.2 we explored the form of the hazard ratio, ψ(t), for each of
the MPR models, by examining its time-derivative and limits (at t = 0 and
t = ∞). In this section we produce the analytic work underpinning those
results.
First we reintroduce the notation used in Section 5.2. Let c be a binary
covariate whose effect we wish to determine. We will assume that c is common
to both the scale and shape regressions and, furthermore, that it is the first
covariate in the vectors x and z, i.e., x1 = z1 = c. Thus we have
xTβ = β0 + cβ1 + . . .+ xpβp z
Tα = α0 + cα1 + . . .+ zqαq
= cβ1 + β0 + . . .+ xpβp = cα1 + α0 + . . .+ zqαq
= cβ1 + x̃
Tβ, = cα1 + z̃
Tα,
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where x̃ = (1, 0, x2, . . . , xp)
T and z̃ = (1, 0, z2, . . . , zq)
T . The hazard ratio, at
time t, for the covariate c = x1 = z1 is then given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
,
which we will derive for each model. In addition to this we will derive ψ′(t) =
dψ(t)/dt, ψ(0) = limt→0 ψ(t) and ψ(∞) = limt→∞ ψ(t).
B.3.1 Weibull
The hazard function for the Weibull MPR model (Section 5.2.1) is given by
λ(t | x, z) = exp(xTβ + zTα)texp(z
Tα)−1
= exp(cβ1 + x̃
Tβ + cα1 + z̃
Tα)texp(cα1+z̃
Tα)−1.
Thus, the hazard ratio for c, at time t, is given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
=
exp(β1 + x̃




= exp(β1 + α1)t
exp(α1+z̃Tα)−exp(z̃Tα)
= exp(β1 + α1)t
exp(z̃Tα)[exp(α1)−1], (B.20)
and differentiating with respect to t gives
dψ(t)
dt











0 if α1 > 0,
exp(β1) if α1 = 0,





∞ if α1 > 0,
exp(β1) if α1 = 0,
0 if α1 < 0.
(B.22)
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B.3.2 Gompertz
The hazard function for the Gompertz MPR model (Section 5.2.2) is given
by
λ(t | x, z) = exp(xTβ + zTα t)
= exp[cβ1 + x̃
Tβ + (cα1 + z̃
Tα)t].
Thus, the hazard ratio for c, at time t, is given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
=
exp[β1 + x̃
Tβ + (α1 + z̃
Tα)t]
exp(x̃Tβ + z̃Tα t)
= exp(β1 + α1t), (B.23)
and differentiating with respect to t gives
dψ(t)
dt
= α1 exp(β1 + α1t)
= α1ψ(t). (B.24)
Clearly sgn[ψ′(t)] = sgn(α1). Furthermore, it is easy to see that




∞ if α1 > 0,
exp(β1) if α1 = 0,
0 if α1 < 0.
(B.25)
B.3.3 Log-Logistic
The hazard function for the log-logistic MPR model (Section 5.2.3) is given
by






Tβ + cα1 + z̃
Tα)texp(cα1+z̃
Tα)−1
1 + exp(cβ1 + x̃Tβ)texp(cα1+z̃
Tα)
.
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Thus, the hazard ratio for c, at time t, is given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
=
exp(β1 + x̃






1 + exp(β1 + x̃Tβ)texp(α1+z̃
Tα)








logψ(t) = β1 + α1 + exp(z̃
Tα)[exp(α1)− 1] log t + log[1 + exp(x̃
Tβ)texp(z̃
Tα)]
− log[1 + exp(β1 + x̃
Tβ)texp(α1+z̃
Tα)].














Tβ + α1 + z̃
Tα)texp(α1+z̃
Tα)−1


















+ λ(t | c = 0)[1− ψ(t)]
}
ψ(t)
= [a(t) + b(t)]ψ(t), (B.27)
where a(t) = exp(z̃Tα)[exp(α1)−1]/t and b(t) = λ(t | c = 0)[1−ψ(t)]. Clearly
sgn[a(t)] = sgn(α1) whereas sgn[b(t)] = sgn[1−ψ(t)]. Thus, in the case where
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α1 = 0, sgn[ψ
′(t)] = sgn[b(t)] = sgn[1− ψ(t)] and
1− ψ(t |α1 = 0) = 1−
exp(β1) + exp(β1 + x̃
Tβ)texp(z̃
Tα)
1 + exp(β1 + x̃Tβ)texp(z̃
Tα)
=
1 + exp(β1 + x̃
Tβ)texp(z̃
Tα) − exp(β1)− exp(β1 + x̃
Tβ)texp(z̃
Tα)




1 + exp(β1 + x̃Tβ)texp(z̃
Tα)
.
Thus, sgn[ψ′(t |α1 = 0)] = −sgn(β1) ⇒ ψ(t |α1 = 0) increases/decreases
monotonically (note that when α1 = β1 = 0, ψ(t) = 1). In the more general
case, where α1 6= 0, sgn[ψ′(t)] cannot be determined as straightforwardly
but we can still get some insight. Let’s consider the case where α1 > 0.
Inspection of the limits (calculated below) shows that ψ(t) increases from zero
to exp(α1) > 1. As ψ(t) crosses unity at some time, say, t
∗, b(t) changes sign
at this point: sgn[b(t)] = 1 for t < t∗, sgn[b(t)] = 0 for t = t∗ and sgn[b(t)] =
−1 for t > t∗. Due to the fact that sgn[a(t)] = 1 ∀ t ⇒ sgn[ψ′(t)] = 1
for t ≤ t∗. For t > t∗ ψ′(t) will change sign if |b(t)| > |a(t)| for some
t > t∗. Therefore, ψ(t) may increase monotonically or non-monotonically
when α1 > 0. Furthermore, using arguments similar to the above, we find
that ψ(t) may decrease monotonically or non-monotonically when α1 < 0.























0 if α1 > 0,
exp(β1) if α1 = 0,
∞ if α1 < 0,
(B.28)


























= exp(α1) ∀α1. (B.29)
B.3.4 Burr
The hazard function for the Burr MPR model (Section 5.2.4) is given by
λ(t | x, z, w) =
exp(xTβ + zTα)texp(z
Tα)−1
1 + exp(xTβ + wT τ)texp(zTα)
=
exp(cβ1 + x̃
Tβ + cα1 + z̃
Tα)texp(cα1+z̃
Tα)−1
1 + exp(cβ1 + x̃Tβ + cτ1 + w̃T τ)texp(cα1+z̃
Tα)
.
Thus, the hazard ratio for c, at time t, is given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
=
exp(β1 + x̃




1 + exp(x̃Tβ + w̃T τ)texp(z̃
Tα)
1 + exp(β1 + x̃Tβ + τ1 + w̃T τ)texp(α1+z̃
Tα)
= exp(β1 + α1)t
exp(z̃Tα)[exp(α1)−1]
1 + exp(x̃Tβ + w̃T τ)texp(z̃
Tα)





logψ(t) = β1 + α1 + exp(z̃
Tα)[exp(α1)− 1] log t+ log[1 + exp(x̃
Tβ + w̃T τ)texp(z̃
Tα)]
− log[1 + exp(β1 + x̃
Tβ + τ1 + w̃
T τ)texp(α1+z̃
Tα)].
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exp(x̃Tβ + z̃Tα + w̃T τ)texp(z̃
Tα)−1
1 + exp(x̃Tβ + w̃T τ)texp(z̃Tα)
−
exp(β1 + x̃
Tβ + α1 + z̃
Tα + τ1 + w̃
T τ)texp(α1+z̃
Tα)−1





+ exp(w̃T τ)λ(t | c = 0)− exp(τ1 + w̃













+ exp(w̃T τ)λ(t | c = 0)[1− exp(τ1)ψ(t)]
}
ψ(t)
= [a(t) + b(t)]ψ(t), (B.31)
where a(t) = exp(z̃Tα)[exp(α1) − 1]/t and b(t) = exp(w̃T τ)λ(t | c = 0)[1 −
exp(τ1)ψ(t)]. In the case where α1 = 0, sgn[ψ
′(t)] = sgn[b(t)] = sgn[1 −
exp(τ1)ψ(t)] and
1− exp(τ1)ψ(t |α1 = 0) = 1−
exp(β1 + τ1) + exp(β1 + x̃
Tβ + τ1 + w̃
T τ)texp(z̃
Tα)
1 + exp(β1 + x̃Tβ + τ1 + w̃T τ)texp(z̃
Tα)
=
1− exp(β1 + τ1)
1 + exp(β1 + x̃Tβ + τ1 + w̃T τ)texp(z̃
Tα)
.
Thus, sgn[ψ′(t |α1 = 0)] = −sgn(β1+τ1)⇒ ψ(t |α1 = 0) can increase/decrease
monotonically or remain constant. As was the case with the log-logistic
model, when α1 6= 0 in the Burr model, ψ(t) can increase or decrease either
monotonically or non-monotonically; this depends on the signs of a(t) and
b(t) and which is larger in magnitude over time.
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1 + exp(x̃Tβ + w̃T τ)texp(z̃
Tα)
















0 if α1 > 0,
exp(β1) if α1 = 0,







1 + exp(x̃Tβ + w̃T τ)texp(z̃
Tα)






exp(x̃Tβ + w̃T τ)texp(z̃
Tα)










= exp(α1 − τ1) ∀α1. (B.33)
B.3.5 Time-Dependent Logistic
The hazard function for the time-dependent logistic MPR model (Section
5.2.5) is given by
λ(t | x, z) =
exp(zTα t + xTβ)
1 + exp(zTα t+ xTβ)
=
exp[(cα1 + z̃
Tα)t+ cβ1 + x̃
Tβ]
1 + exp[(cα1 + z̃Tα)t+ cβ1 + x̃Tβ]
.
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Thus, the hazard ratio for c, at time t, is given by
ψ(t) =
λ(t | c = 1)
λ(t | c = 0)
=
exp[(α1 + z̃
Tα)t+ β1 + x̃
Tβ]
exp(z̃Tα t+ x̃Tβ)
1 + exp[(α1 + z̃
Tα)t+ β1 + x̃
Tβ]
1 + exp(z̃Tα t+ x̃Tβ)
= exp(α1t+ β1)
1 + exp(z̃Tα t+ x̃Tβ)
1 + exp[(α1 + z̃Tα)t+ β1 + x̃Tβ]
, (B.34)
and therefore
logψ(t) = α1t+ β1 + log[1 + exp(z̃
Tα t + x̃Tβ)]
− log{1 + exp[(α1 + z̃
Tα)t+ β1 + x̃
Tβ]}.





= α1 + z̃
Tα
exp(z̃Tα t+ x̃Tβ)
1 + exp(z̃Tα t + x̃Tβ)
− (α1 + z̃
Tα)
exp[(α1 + z̃
Tα)t+ β1 + x̃
Tβ]
1 + exp[(α1 + z̃Tα)t+ β1 + x̃Tβ]
= α1 + z̃
Tαλ(t | c = 0)− (α1 + z̃







Tαλ(t | c = 0)− (α1 + z̃
Tα)λ(t | c = 1)
]
ψ(t). (B.35)
We can see that sign and magnitude of both α1 and z̃
Tα play a central role
in characterising the time evolution of ψ(t).
We now investigate the limits of ψ(t). Firstly
ψ(0) = exp(0 + β1)
1 + exp(0 + x̃Tβ)
1 + exp[0 + β1 + x̃Tβ]
= exp(β1)
1 + exp(x̃Tβ)
1 + exp(β1 + x̃Tβ)
. (B.36)
Calculating ψ(∞) is a little bit more involved. It is helpful to express ψ(t)
in the following way:
ψ(t) = exp(β1)
exp(α1t) + exp[(α1 + z̃
Tα)t+ x̃Tβ]
1 + exp[(α1 + z̃Tα)t+ β1 + x̃Tβ]
, (B.37)
250 APPENDIX B. MULTI-PARAMETER REGRESSION
where it is clear that ψ(∞) depends on the sign and magnitude of both α1
and z̃Tα. There are a variety of possibilities to be considered:
sgn(α1) sgn(z̃
Tα) sgn(α1 + z̃
Tα)
1 1 1 1
2 1 0 1
3 1 -1 |α1| > |z̃Tα| 1
4 1 -1 |α1| = |z̃
Tα| 0
5 1 -1 |α1| < |z̃Tα| -1
6 0 1 1
7 0 0 0
8 0 -1 -1
9 -1 1 |α1| < |z̃Tα| 1
10 -1 1 |α1| = |z̃Tα| 0
11 -1 1 |α1| > |z̃
Tα| -1
12 -1 0 -1
13 -1 -1 -1
We now calculate ψ(∞), using ψ(t) in the form given in (B.37), for each of
the above possibilities.





exp(α1t) + exp[(α1 + z̃
Tα)t+ x̃Tβ]




exp(α1t) + exp[(α1 + z̃
Tα)t+ x̃Tβ]










1 if z̃Tα > 0,
1+exp(x̃T β)
exp(x̃T β)
if z̃Tα = 0,
∞ if − α1 < z̃Tα < 0.
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1 + exp(β1 + x̃Tβ)
=∞.





exp(α1t) + exp[(α1 + z̃
Tα)t+ x̃Tβ]











1 + exp(z̃Tα t+ x̃Tβ)









if z̃Tα = 0,
exp(β1) if z̃
Tα < 0.
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exp(α1t) + exp[(α1 + z̃
Tα)t+ x̃Tβ]






exp[(α1 + z̃Tα)t+ β1 + x̃Tβ]
= 1.











1 + exp(β1 + x̃Tβ)
.





exp(α1t) + exp[(α1 + z̃
Tα)t+ x̃Tβ]
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1 if α1 ≥ 0 and z̃Tα > 0,




if α1 > 0 and z̃
Tα = 0,





if α1 = 0 and z̃
Tα = 0,




if α1 < 0 and z̃
Tα = −α1,
0 if α1 < 0 and z̃
Tα < −α1.
(B.38)
B.4 MPR Simulation Studies
In Section 5.5, we presented simulation studies involving the standard and
orthogonal Weibull MPR models; data were simulated using 30 different
parameter vectors for each model. The values of the parameters in these
vectors are shown in Tables B.1 and B.2. These values were selected based
on fitting the models to a variety of real datasets first in order to create
realistic simulated data, i.e., data-directed simulation. Similarly, Tables B.3
and B.4 show the parameter vectors for log-logistic and Gompertz MPR
simulations; the results of these supplementary studies (alluded to in Section
5.5) are also given in this appendix.
Recall that in Sections 5.5.1 and 5.5.2 we studied the correlation structure
for estimated parameters and the bias in these estimates (for the standard
and orthogonal Weibull MPR models). Here the scatter matrix plots arising
from the log-logistic and Gompertz simulation studies are given in Figs. B.1
and B.2. Moreover, Tables B.5 and B.6 show the bias in estimation for these
two models. The results of these supplementary simulation studies mirror
those from Sections 5.5.1 and 5.5.2 apart from the fact that the Gompertz
MPR model has some very large estimation bias when the sample size is
small with a high censored proportion.
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Table B.1. Weibull MPR Simulation Settings
No. β0 β1 β2 α0 α1 α2 No. β0 β1 β2 α0 α1 α2
1 -3.4 0.0 3.0 0.1 0.0 -0.3 16 -12.3 0.5 7.7 0.9 0.0 -0.9
2 -2.2 0.4 0.0 -0.5 -0.2 0.1 17 -1.7 -0.8 0.4 -0.2 0.5 -0.2
3 -4.3 1.0 2.1 0.2 -0.5 -0.4 18 -2.9 -0.4 0.2 -0.2 -0.2 -0.1
4 -4.4 0.9 1.7 -0.1 0.1 -0.2 19 -2.7 0.3 0.2 -0.4 0.0 -0.1
5 -5.5 0.3 1.7 0.4 -0.2 -0.6 20 -3.1 0.4 0.3 -0.1 -0.3 -0.3
6 -3.5 -0.1 0.7 0.1 -0.1 -0.1 21 -2.7 0.1 0.2 -0.5 0.0 0.2
7 -3.0 -0.2 -2.3 -0.2 0.1 0.5 22 -3.9 -0.6 3.3 1.3 0.3 -1.5
8 -5.3 0.8 0.9 -0.2 -0.2 0.2 23 -3.9 3.2 0.1 1.2 -1.4 0.1
9 -5.0 0.9 0.6 0.0 -0.2 0.0 24 -3.5 3.2 -1.1 1.4 -1.5 0.1
10 -4.0 -0.3 -0.6 -0.1 0.1 0.1 25 -0.9 0.1 -0.2 -0.2 0.2 -0.1
11 -5.5 -0.2 0.9 -0.1 0.1 0.1 26 -0.9 1.5 -0.9 1.1 -1.2 -0.2
12 -4.1 -0.4 -1.8 0.0 0.0 0.1 27 -1.0 0.6 -1.1 0.9 -1.3 0.0
13 -4.2 -0.3 -0.2 -0.1 0.0 0.1 28 -2.6 -0.2 -0.9 -0.3 -0.1 0.4
14 -6.7 0.1 1.2 0.2 0.0 0.0 29 -2.7 0.1 0.0 -0.2 -0.3 0.1
15 -7.5 0.5 4.6 0.5 -0.2 -0.5 30 -1.4 -0.5 -0.7 -0.8 0.3 0.2
Table B.2. Orthogonal Weibull MPR Simulation Settings
No. β0 β1 β2 α0 α1 α2 No. β0 β1 β2 α0 α1 α2
1 -3.4 0.0 2.5 0.2 -0.1 -0.3 16 -5.3 0.3 0.4 0.9 -0.2 -0.8
2 -4.1 0.0 0.4 -0.5 -0.2 0.1 17 -2.4 0.3 0.1 -0.1 0.5 -0.2
3 -5.3 0.6 2.2 -0.6 0.6 0.0 18 -4.1 -1.3 0.0 -0.2 -0.2 0.0
4 -5.9 1.6 1.7 -0.3 0.5 -0.1 19 -4.6 0.4 -0.1 -0.4 0.0 -0.1
5 -3.8 -0.7 -1.0 0.4 -0.3 -0.4 20 -3.9 -0.7 -0.8 -0.2 -0.2 -0.2
6 -3.7 -0.4 0.1 0.1 -0.1 -0.2 21 -5.0 -0.1 1.2 -0.5 -0.1 0.2
7 -4.0 0.3 0.1 -0.1 0.0 0.5 22 -1.1 -0.3 -0.1 1.3 0.3 -1.5
8 -6.5 0.0 1.9 0.0 -0.2 0.1 23 -0.5 -0.7 -0.5 2.7 -2.8 -0.1
9 -5.2 0.1 0.5 0.1 -0.2 0.0 24 -1.4 0.6 -0.9 0.6 -0.7 0.1
10 -4.8 0.3 -0.3 0.0 0.0 0.0 25 -1.6 0.4 -0.2 -0.2 0.1 0.0
11 -6.6 0.3 1.4 -0.1 0.1 0.1 26 -0.8 1.0 -0.9 0.5 -0.6 -0.1
12 -4.5 -0.2 -1.0 0.0 0.0 0.1 27 -1.6 0.7 -1.1 0.1 -0.3 0.0
13 -5.0 -0.2 0.3 -0.1 0.1 0.1 28 -4.0 -0.7 0.6 -0.3 -0.1 0.4
14 -5.7 -0.1 0.8 0.2 0.0 0.0 29 -3.7 -0.9 0.4 -0.2 -0.3 0.1
15 -5.0 -0.3 1.8 0.2 0.2 -0.6 30 -4.3 0.5 -0.3 -0.8 0.3 0.2
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Table B.3. Log-Logistic MPR Simulation Settings
No. β0 β1 β2 α0 α1 α2 No. β0 β1 β2 α0 α1 α2
1 -3.7 0.2 3.8 0.3 0.0 0.0 16 -13.0 0.9 7.8 0.9 0.0 -0.8
2 -2.8 0.8 -0.3 0.1 -0.2 0.2 17 -1.7 -1.3 0.6 0.1 0.5 -0.2
3 -4.6 0.9 2.2 0.5 -0.5 -0.2 18 -3.2 -0.1 0.1 0.1 -0.3 0.0
4 -4.2 0.5 1.4 -0.1 0.2 0.1 19 -2.9 0.2 0.2 -0.2 0.1 -0.1
5 -6.0 2.4 -1.2 0.6 -0.6 0.1 20 -3.7 0.6 0.6 0.3 -0.4 -0.4
6 -4.4 0.1 1.0 0.4 -0.1 -0.2 21 -2.8 0.2 0.0 -0.3 0.0 0.3
7 -3.7 -0.4 -2.4 0.2 0.2 0.4 22 -3.9 -0.8 3.7 1.5 0.2 -1.5
8 -5.6 1.0 0.3 -0.1 -0.1 0.4 23 -3.9 3.5 0.1 1.3 -1.4 0.2
9 -5.5 1.0 0.3 0.2 -0.1 0.1 24 -3.4 3.7 -1.4 1.6 -1.5 0.1
10 -4.7 -0.4 -0.4 0.2 0.2 0.0 25 -0.6 0.2 -0.2 -0.1 0.2 -0.1
11 -5.7 -0.5 0.7 0.0 0.2 0.2 26 -0.6 1.9 -1.1 1.2 -1.1 -0.2
12 -4.9 -0.3 -1.3 0.3 0.0 -0.1 27 -0.7 0.7 -1.3 1.1 -1.3 0.0
13 -4.7 -0.3 -0.5 0.1 0.0 0.2 28 -2.7 -0.2 -1.0 -0.1 -0.1 0.4
14 -7.1 0.3 0.8 0.3 -0.1 0.1 29 -2.9 0.4 -0.2 0.1 -0.4 0.2
15 -7.8 0.0 4.5 0.6 -0.1 -0.2 30 -1.3 -0.6 -0.8 -0.6 0.3 0.2
Table B.4. Gompertz MPR Simulation Settings
No. β0 β1 β2 α0 α1 α2 No. β0 β1 β2 α0 α1 α2
1 -3.1 0.0 2.8 0.0 0.0 -0.1 16 -0.3 -0.4 0.5 -0.5 -0.2 -1.9
2 -2.0 0.0 0.7 -0.1 0.1 -0.1 17 -2.4 -0.4 2.0 1.6 -0.6 -2.0
3 -2.5 0.1 -0.6 0.0 0.0 0.0 18 -0.3 -0.9 0.1 -0.7 0.6 -0.7
4 -2.4 0.0 0.0 -0.1 0.0 0.0 19 -4.3 4.5 -1.3 1.8 -2.8 0.8
5 -4.8 1.8 -0.1 0.0 0.0 0.1 20 -0.4 0.7 -0.2 -1.9 -1.0 1.3
6 -4.0 1.0 -1.2 0.0 -0.1 0.1 21 -0.6 0.6 0.3 -0.4 -0.3 -2.0
7 -3.5 -0.8 1.5 0.1 0.0 -0.1 22 -0.4 0.7 -0.3 -1.3 -0.7 1.0
8 -4.4 0.5 -0.7 0.0 0.0 0.0 23 0.1 0.0 -1.4 -2.2 1.2 0.8
9 -5.2 -0.9 1.5 0.0 0.0 0.0 24 -0.5 0.0 0.4 -0.4 -0.1 -2.0
10 -7.0 -0.4 2.9 0.0 0.0 0.0 25 -3.0 0.3 2.3 2.5 -0.7 -2.7
11 -6.1 1.2 1.7 0.0 0.0 0.0 26 0.2 0.3 -1.2 -1.6 -0.8 1.5
12 -2.1 1.3 0.7 0.0 -0.1 0.2 27 -0.1 0.5 -1.3 -0.5 -2.0 0.7
13 -1.5 -0.8 0.5 -0.1 0.0 0.0 28 0.3 -0.1 -1.1 -1.9 0.7 1.0
14 -1.4 -0.8 1.0 -0.3 0.2 -0.3 29 -3.0 -0.5 -0.6 0.0 0.0 0.0
15 -0.1 -0.4 -0.2 -1.3 -0.5 0.9 30 -2.4 -0.8 -0.7 -0.1 0.0 0.0
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n = 1000    p = 20%




n = 1000    p = 50%




n = 1000    p = 80%
Figure B.1. Scatter matrices of estimated regression coefficients for the
Log-logistic MPR model. Each cell in the lower triangle contains all 30
scatter plots with least squares lines overlayed (red). The upper triangle
shows the corresponding average absolute correlation value.




n = 1000    p = 20%




n = 1000    p = 50%




n = 1000    p = 80%
Figure B.2. Scatter matrices of estimated regression coefficients for the
Gompertz MPR model. Each cell in the lower triangle contains all 30
scatter plots with least squares lines overlayed (red). The upper triangle
shows the corresponding average absolute correlation value.
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Table B.5. Log-Logistic MPR Model: Average Relative Bias
n p β̂0 β̂1 β̂2 α̂0 α̂1 α̂2
100
80% -0.094 0.064 -0.010 0.308 0.014 0.025
50% -0.056 0.022 0.008 0.170 0.011 0.023
20% -0.044 0.025 -0.015 0.151 -0.003 -0.003
500
80% -0.014 0.009 -0.009 0.050 0.000 -0.002
50% -0.009 0.007 -0.017 0.034 0.004 0.000
20% -0.008 0.007 0.013 0.028 -0.003 -0.007
1000
80% -0.007 0.014 -0.001 0.027 0.006 0.002
50% -0.005 -0.007 -0.003 0.019 0.002 0.001
20% -0.004 -0.008 -0.006 0.011 0.004 0.002
Table B.6. Gompertz MPR Model: Average Relative Bias
n p β̂0 β̂1 β̂2 α̂0 α̂1 α̂2
100
80% -1.388 -0.114 -0.147 -2.181 -3.939 0.159
50% -0.116 0.029 0.020 -0.080 -0.055 0.010
20% -0.013 0.005 -0.009 -0.036 -0.036 0.032
500
80% -0.028 0.000 -0.010 -0.200 -0.101 0.062
50% -0.009 0.001 -0.002 -0.020 -0.001 0.005
20% 0.003 0.002 0.004 -0.007 0.002 0.010
1000
80% -0.016 -0.002 -0.005 -0.082 -0.062 0.000
50% -0.001 0.004 -0.009 -0.013 0.010 0.008
20% -0.004 0.007 0.003 -0.003 0.000 0.004
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B.5 The mpr Class
In Appendix B.2 we derived the likelihood function and score equations for
each of the MPR models developed in Chapter 5 (which of course includes
the SPR models of Chapter 4). We have created the mpr class in R which
contains all of these models (except the piecewise exponential model - see
Appendix B.5.4). In this section we discuss samples of our code. Although
not yet ready for public use, this code forms the basis of an R package (in
development) - the mpr package.
B.5.1 mprfit
In order to fit an MPR model, one uses the mprfit function:
# ---------------------------------------------------------------------------------------- #
mprfit <- function(forms,data,family="Weibull",init=NA,hessian=F,iterlim=1000,varnames=T,...){





Here forms is a list (of formula objects), whose length is equal to the num-
ber of regression components in the specified model family (e.g., Weibull),
and data is a data.frame containing the survival data. Presently, we require
that the first two columns of data are the survival times and censoring indi-
cators, respectively; the remaining columns contain any covariates. In other
words, we have not used the Surv construct from the survival package to
store the survival time and censoring indicator. Thus, the three models in
Example 5.1 were fitted as follows:
# ---------------------------------------------------------------------------------------- #





Note that the shape formula comes first, forma, followed by the scale, formb.
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We can see from the above that mprfit is a wrapper function whose
purpose is to select mprfit2 for two-component models and mprfit3 for the
Burr model (i.e., the only three-component model we have considered). The
mprfit2 function is given below (mprfit3 is not shown but is very similar).
The output of this function is an mpr object which, among other things,











surdat <- cbind(surtim, cen, alpha.xis, beta.xis)
if(any(is.na(init))){










aic <- 2*npar - 2*loglik














names(gradient) <- c(aname, bname)
if(! is.null(hessian)){
rownames(hessian) <- colnames(hessian) <- c(aname,bname)
}
}




formab <- formula(paste("~",paste(abterms, collapse="+"), sep=""))
}
ab.mf <- model.frame(formab,data=data)
xlevels <- .getXlevels(terms(formab), ab.mf)
xvars <- sapply(attr(terms(formab), "variables"), deparse, width.cutoff = 500)[-1L]
out <- list(fit=data.frame(loglik,aic,bic,npar,stopcode,iter,family=family,stringsAsFactors=F),
mles.a=mles.a, mles.b=mles.b, gradient=gradient, hessian=hessian,





Note that mprfit2 uses the nlm function - a standard R implementation
of the Newton-Raphson algorithm - to maximise the log-likelihood function
(or rather minimise its negation). The appropriate log-likelihood function is
chosen by passing family into the wrapper function mprloglike:
# ---------------------------------------------------------------------------------------- #
mprloglike <- function(param,surdat,k,family="Weibull",...){






Here param is the vector of shape and scale parameters (in the two-component
case), i.e., θ = (α, β)T , and surdat is a data.frame whose first two columns
are the survival times and censoring indicators, whose next k columns are
the shape covariates and whose remaining columns are the scale covariates
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(recall that the shape and scale may have covariates in common so that there
may be duplicate columns in surdat).
The log-likelihood functions (and corresponding score functions) which
mprloglike selects from are given below, i.e., the R implementation of the
work in Appendix B.2. In particular, the Weibull case, loglikeweibmpr,
is shown in its entirety whereas the other cases are only partially shown as















dldalp <- t( deltai*(1+gam*log(ti)) - lam*gam*(ti^gam)*log(ti) )%*%xi1
dldbet <- t( deltai-lam*(ti^gam) )%*%xi2
loglike <- -sum(deltai*log(gam*lam*(ti^(gam-1)))-lam*(ti^gam))









dldalp <- t( deltai*ti + (lam/(gam^2))*(exp(gam*ti)-1) - (lam/gam)*exp(gam*ti)*ti)%*%xi1
dldbet <- t( deltai - (lam/gam)*(exp(gam*ti)-1) )%*%xi2
loglike <- -sum(deltai*(log(lam*exp(gam*ti))) -(lam/gam)*(exp(gam*ti)-1) )










dldalp <- t( deltai*(1+gam*log(ti)) -
(deltai+1)*(lam*gam*(ti^gam)*log(ti))/(1+lam*(ti^gam)) )%*%xi1
dldbet <- t( deltai - (deltai+1)*(lam*(ti^gam))/(1+lam*(ti^gam)) )%*%xi2
loglike <- -sum( deltai*log((lam*gam*(ti^(gam-1)))/(1+lam*(ti^gam))) - log(1+lam*(ti^gam)) )











dldalp <- t( deltai*ti - (deltai+(1/gam))*(ti*zi/(1+zi)) +
(1/(gam^2))*log((1+zi)/(1+wi)) )%*%xi1
dldbet <- t( deltai - (deltai+(1/gam))*(zi/(1+zi)) + (1/gam)*(wi/(1+wi)) )%*%xi2
loglike <- -sum(deltai*log(zi/(1+zi))-(1/gam)*log((1+zi)/(1+wi)))




We also show the Burr case below in its entirety which, of course, is used






















dldtau <- t( (1/rho)*log(1+lam*rho*(ti^gam)) -
(deltai+1/rho)*(lam*rho*(ti^gam))/(1+lam*rho*(ti^gam)) )%*%xi1
dldalp <- t( deltai*(1+gam*log(ti)) -
(deltai+1/rho)*(lam*gam*rho*(ti^gam)*log(ti))/(1+lam*rho*(ti^gam)) )%*%xi2
dldbet <- t( deltai - (deltai+1/rho)*(lam*rho*(ti^gam))/(1+lam*rho*(ti^gam)) )%*%xi3
loglike <- -sum( deltai*log((lam*gam*(ti^(gam-1)))/(1+lam*rho*(ti^gam))) -
(1/rho)*log(1+lam*rho*(ti^gam)) )





Once we have fitted a particular MPR model using mprfit, we have an mpr
object (as shown above). Naturally we would like to make predictions based
on our fitted model. This can be done using predict.mpr which works just
as other predict functions in R (e.g., predict.lm), i.e., we call it simply
using “predict” - R knows that predict.mpr must be used when predict
is applied to an mpr object.
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The above function calls either predmpr2 (shown below) or, in the case of a






if(m!=0 | is.list(MLES) ){
if(!is.list(MLES)){












mvars <- match(xvars, newnam)
vna <- is.na(mvars)
if(any(vna)){
errmess <- paste("The following variables not found:",
paste(xvars[vna], collapse=", ") )
stop(errmess)
}
nums <- match(setdiff(xvars,xfac), newnam)
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alevels <- xlevels[match(attr(terms(forma), "term.labels"), xfac)]
blevels <- xlevels[match(attr(terms(formb), "term.labels"), xfac)]
if(!is.null(alevels)){ alevels <- alevels[!is.na(names(alevels))] }
if(!is.null(blevels)){ blevels <- blevels[!is.na(names(blevels))] }
alpha.xis <- model.matrix(terms(forma), data=newdata, xlev=alevels)
beta.xis <- model.matrix(terms(formb), data=newdata, xlev=blevels)
alpha <- as.vector(alpha.xis%*%mles.a)
beta <- as.vector(beta.xis%*%mles.b)
parmat <- cbind(alpha, beta)









Thus, predmpr2 uses the mpr object and a data.frame called newdata con-
taining rows of individual covariate profiles at which predictions are to be
made; of course, these individuals may be real or hypothetical.
The type of prediction must also be specified - there are four options,
namely: survivor, hazard, time (percentile) and resmean (restricted mean
- see Section 6.3.1). As can be seen from the last few lines of the above code,
the type option is used to select between the functions mprsurv, mprhaz,





parmat <- matrix(parmat, nrow=1)
}








parmat <- matrix(parmat, nrow=1)
}







parmat <- matrix(parmat, nrow=1)
}







parmat <- matrix(parmat, nrow=1)
}
len <- dim(parmat)[1]








Clearly the first three of these functions (mprsurv, mprhaz and mprsim) are
wrapper functions, which select the appropriate survivor, hazard or inverse
survivor function for the given family, whereas, mprresmean integrates over
the mprsurv function (recall from Section 6.3.1 that the restricted mean is
calculated by integrating over the survivor function).
The code for the survivor, hazard and inverse survivor functions for each
of the models considered in this thesis is shown below (based on Section 1.4).






























































tdlsim <- function(u, parmat){
gam <- parmat[,1]
lam <- parmat[,2]
























Finally, we return to the predmpr2 function and point out that it makes
use of a function called msim2. This is our implementation of m.l.e. simulation
(Section 2.3.2) which uses the mvrnorm function from the MASS package - see





alen <- length(mles.a); blen <- length(mles.b)
hess <- object$hessian
varcov <- solve(hess)
MLES <- matrix(mvrnorm(m, c(mles.a,mles.b), varcov), nrow=m)
MLES.a <- matrix(t(MLES[,1:alen]), nrow=alen)





In Section 5.4 we discussed MPR stepwise variable selection. Here we present
the R code underpinning our selection procedure (mprstep). This is followed
by Example B.1 which shows an application of mprstep to the lung cancer
data.
At its most basic level, mprstep consists of repeated applications of the
addvar and dropvar functions which, given a formula object, are used to
add or remove variables.
# ---------------------------------------------------------------------------------------- #
addvar <- function(newvar,oldform){
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dropvar <- function(oldvar,oldform){




More specifically, the add.terms function (below) repeatedly calls addvar.
Given a particular set of candidate covariates (newterms), this function
fits all new models, i.e., the old model with the addition of one candi-
date covariate. Of course, as discussed in Section 5.4, we must specify
whether the covariates are to be added to the shape (whichpar="a"), the









forms <- list(addvar(newterms[i], forma),formb)
}else{
if(whichpar == "b"){
forms <- list(forma,addvar(newterms[i], formb))
}else{
if(whichpar == "both"){














Analogous to the add.terms function, we also have the drop.terms function
(below) which calls dropvar:









forms <- list(dropvar(oldterms[i], forma),formb)
}else{
if(whichpar == "b"){
forms <- list(forma,dropvar(oldterms[i], formb))
}else{
if(whichpar == "both"){














Thus, the stepmpr function (below) uses add.terms and drop.terms to fit
all possible new models in a given iteration of the while loop and, then,
the best model (based on AIC or BIC) is chosen at this iteration. The
while loop continues in this fashion until no improvement can be made and








names(forms) <- c("a", "b")
res <- mprfit(forms,data,family,init,hessian=F,iterlim=1000)
modcur <- res$fit
















k <- k + 1










aterms <- list(add.scope(forma, formup), drop.scope(forma, formlo))
if(length(aterms[[1]]) > 0 && (direction=="forward" || direction=="both")){
resterms <- add.terms(aterms[[1]],forms,data=data,family=family,whichpar="a")
results1 <- resterms[[1]]
midresult <- rbind(midresult, results1)
mleslist <- lrbind(mleslist,resterms[[2]])
}
if(length(aterms[[2]]) > 0 && (direction=="backward" || direction=="both")){
resterms <- drop.terms(aterms[[2]],forms,data=data,family=family,mles=mles,whichpar="a")
results1 <- resterms[[1]]
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### scale
if(select[2] == TRUE){
bterms <- list(add.scope(formb, formup), drop.scope(formb, formlo))
if(length(bterms[[1]]) > 0 && (direction=="forward" || direction=="both")){
resterms <- add.terms(bterms[[1]],forms,data=data,family=family,mles=mles,whichpar="b")
results1 <- resterms[[1]]
midresult <- rbind(midresult, results1)
mleslist <- lrbind(mleslist,resterms[[2]])
}
if(length(bterms[[2]]) > 0 && (direction=="backward" || direction=="both")){
resterms <- drop.terms(bterms[[2]],forms,data=data,family=family,mles=mles,whichpar="b")
results1 <- resterms[[1]]







if(length(abterms[[1]]) > 0 && (direction=="forward" || direction=="both")){
resterms <- add.terms(abterms[[1]],forms,data=data,family=family,mles=mles,whichpar="both")
results1 <- resterms[[1]]
midresult <- rbind(midresult, results1)
mleslist <- lrbind(mleslist,resterms[[2]])
}
if(length(abterms[[2]]) > 0 && (direction=="backward" || direction=="both")){
resterms <- drop.terms(abterms[[2]],forms,data=data,family=family,mles=mles,whichpar="both")
results1 <- resterms[[1]]







ordering <- order(midresult[,6], decreasing=F)
}else{










forms[[1]] <- forma <- as.formula(paste("~",midresult[1,11]))














out <- list(endresult, mlescur)
}
# ---------------------------------------------------------------------------------------- #
Note that the stepmpr function uses lrbind - a function for combining
two lists.
# ---------------------------------------------------------------------------------------- #









Example B.1. Log-Logistic MPR: Variable Selection Output
In Example 5.8 we gave the results of applying MPR variable selection (i.e.,
mprstep) to the lung cancer data. The procedure was carried out within a
variety of different models and the log-logistic MPR model had the lowest
AIC of all final models. Here we show the corresponding path of selection
(starting from the null model) that led to the final log-logistic model. This
serves to elucidate both the discussion of MPR variable selection given in
Section 5.4 and the mprstep code given in this appendix.
The output below comes from the mprstep function but has been edited
slightly for presentation. Note first that which specifies the component of
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the model in which selection has taken place: a = shape, b = scale and both
= simultaneous step. The next column, pm, contains a plus or a minus in-
dicating whether the algorithm is adding or removing a covariate; var gives
the name of covariate in question. Finally, loglike, aic and npar give the
log-likelihood value, the AIC value and the number of parameters in the
model respectively. At each iteration of the algorithm, all candidate models
are ranked by their AIC value (in ascending order). The outcome of each
iteration is given at the bottom of this table of candidate models, i.e., the
model chosen at each step.
-------------------------------------------------
which pm var loglike aic npar
b + who -1923.637 3859.274 6
both + who -1921.571 3863.143 10
both + treat -1927.737 3875.474 10
b + treat -1943.658 3899.317 6
both + met -1985.630 3983.261 6
b + met -1988.262 3984.524 4
b + alb -1998.763 4005.525 4
both + alb -1997.663 4007.327 6
a + treat -1997.921 4007.842 6
a + who -2007.928 4027.855 6
a + met -2020.869 4049.738 4
b + cell -2026.063 4062.126 5
both + cell -2024.593 4065.186 8
both + sod -2027.288 4066.576 6
b + sod -2031.064 4070.128 4
a + alb -2032.572 4073.143 4
a + sod -2042.054 4092.107 4
both + agegrp -2037.227 4094.455 10
b + agegrp -2044.017 4100.035 6
a + cell -2045.442 4100.884 5
a + agegrp -2050.115 4112.231 6
both +/- [none] -2055.274 4114.549 2
b + sex -2055.253 4116.506 3
a + sex -2055.264 4116.529 3
b + smoking -2053.434 4116.868 5
a + smoking -2053.764 4117.528 5
both + sex -2055.253 4118.506 4




iter 1 : b + who
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-------------------------------------------------
which pm var loglike aic npar
both + treat -1865.559 3759.117 14
b + treat -1879.945 3779.891 10
b + met -1887.398 3790.796 8
both + met -1885.486 3790.972 10
b + alb -1900.172 3816.344 8
a + treat -1898.684 3817.368 10
both + alb -1899.317 3818.635 10
a + met -1905.212 3826.425 8
both + sod -1907.762 3835.525 10
b + cell -1909.641 3837.282 9
b + sod -1911.239 3838.477 8
both + cell -1908.339 3840.679 12
a + alb -1915.492 3846.984 8
a + sod -1916.780 3849.559 8
a + cell -1917.797 3853.595 9
a + agegrp -1918.841 3857.682 10
both + agegrp -1915.578 3859.156 14
both +/- [none] -1923.637 3859.274 6
a + smoking -1921.231 3860.462 9
b + sex -1923.320 3860.640 7
a + sex -1923.622 3861.245 7
both + sex -1923.188 3862.377 8
b + smoking -1922.243 3862.486 9
a + who -1921.571 3863.143 10
both + smoking -1921.032 3866.065 12
b + agegrp -1923.437 3866.875 10
b - who -2055.274 4114.549 2
-------------------------------------------------
a: treat
b: who + treat
iter 2 : both + treat
-------------------------------------------------
which pm var loglike aic npar
both + met -1836.164 3708.328 18
b + met -1840.422 3712.844 16
b + alb -1851.238 3734.476 16
both + alb -1849.986 3735.971 18
both + sod -1850.315 3736.631 18
b + cell -1851.664 3737.328 17
both + cell -1849.756 3739.512 20
b + sod -1854.185 3740.370 16
a + met -1858.798 3749.595 16
a + cell -1858.943 3751.885 17
a + sod -1861.190 3754.381 16
a + alb -1861.914 3755.828 16
a + agegrp -1860.330 3756.660 18
both + agegrp -1857.221 3758.442 22
both +/- [none] -1865.559 3759.117 14
b + sex -1865.292 3760.584 15
B.5. THE MPR CLASS 277
a + sex -1865.491 3760.982 15
a + smoking -1863.681 3761.362 17
both + sex -1865.278 3762.556 16
b + smoking -1864.557 3763.115 17
a + who -1863.867 3763.735 18
b + agegrp -1864.427 3764.855 18
both + smoking -1863.513 3767.026 20
a - treat -1879.945 3779.891 10
b - treat -1898.684 3817.368 10
both - treat -1923.637 3859.274 6
b - who -1927.737 3875.474 10
-------------------------------------------------
a: treat + met
b: who + treat + met
iter 3 : both + met
-------------------------------------------------
which pm var loglike aic npar
b + alb -1822.355 3684.711 20
both + alb -1821.196 3686.392 22
both + sod -1822.175 3688.349 22
b + sod -1826.148 3692.295 20
b + cell -1826.946 3695.892 21
both + cell -1824.991 3697.982 24
a + alb -1832.208 3704.417 20
a + cell -1831.219 3704.438 21
a + sod -1832.223 3704.446 20
a + agegrp -1831.626 3707.252 22
both +/- [none] -1836.164 3708.328 18
b + sex -1835.808 3709.617 19
both + agegrp -1828.855 3709.710 26
a + sex -1836.102 3710.203 19
a + smoking -1834.431 3710.861 21
both + sex -1835.768 3711.535 20
b + smoking -1835.382 3712.764 21
a - met -1840.422 3712.844 16
a + who -1834.520 3713.040 22
b + agegrp -1835.898 3715.796 22
both + smoking -1834.404 3716.807 24
a - treat -1850.630 3729.259 14
b - met -1858.798 3749.595 16
both - met -1865.559 3759.117 14
b - treat -1868.549 3765.098 14
both - treat -1885.486 3790.972 10
b - who -1891.373 3810.746 14
-------------------------------------------------
a: treat + met
b: who + treat + met + alb
iter 4 : b + alb
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-------------------------------------------------
which pm var loglike aic npar
b + cell -1811.970 3669.940 23
both + cell -1809.960 3671.920 26
both + sod -1812.174 3672.349 24
b + sod -1815.662 3675.324 22
a + cell -1816.033 3678.066 23
a + sod -1819.592 3683.184 22
a + agegrp -1817.916 3683.832 24
both +/- [none] -1822.355 3684.711 20
both + agegrp -1814.938 3685.877 28
a + smoking -1820.047 3686.094 23
a + alb -1821.196 3686.392 22
b + sex -1822.234 3686.469 21
a + sex -1822.336 3686.672 21
both + sex -1821.977 3687.954 22
b + smoking -1820.979 3687.958 23
a - met -1826.019 3688.039 18
a + who -1820.822 3689.643 24
both + smoking -1819.928 3691.855 26
b + agegrp -1822.021 3692.043 24
a - treat -1836.281 3704.562 16
b - alb -1836.164 3708.328 18
b - met -1843.888 3723.775 18
b - treat -1850.260 3732.519 16
both - met -1851.238 3734.476 16
both - treat -1863.914 3751.829 12
b - who -1868.918 3769.835 16
-------------------------------------------------
a: treat + met
b: who + treat + met + alb + cell
iter 5 : b + cell
-------------------------------------------------
which pm var loglike aic npar
both + sod -1802.835 3659.670 27
b + sod -1805.969 3661.939 25
a + sod -1809.358 3668.716 25
a + agegrp -1807.705 3669.409 27
both + agegrp -1803.729 3669.458 31
both +/- [none] -1811.970 3669.940 23
b + sex -1811.750 3671.500 24
a - met -1814.801 3671.602 21
a + smoking -1809.894 3671.788 26
a + cell -1809.960 3671.920 26
a + sex -1811.968 3671.935 24
a + alb -1811.214 3672.428 25
both + sex -1811.507 3673.013 25
b + smoking -1811.069 3674.138 26
a + who -1810.371 3674.741 27
b + agegrp -1811.663 3677.326 27
both + smoking -1809.858 3677.717 29
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b - cell -1822.355 3684.711 20
a - treat -1826.321 3690.643 19
b - alb -1826.946 3695.892 21
b - met -1829.228 3700.457 21
both - met -1835.380 3708.761 19
b - treat -1840.483 3718.967 19
both - treat -1853.017 3736.034 15
b - who -1855.578 3749.156 19
-------------------------------------------------
a: treat + met + sod
b: who + treat + met + alb + cell + sod
iter 6 : both + sod
-------------------------------------------------
which pm var loglike aic npar
both +/- [none] -1802.835 3659.670 27
a + agegrp -1799.131 3660.262 31
both + agegrp -1795.182 3660.365 35
a - met -1805.458 3660.916 25
a + smoking -1800.677 3661.354 30
b + sex -1802.699 3661.397 28
a + cell -1800.723 3661.447 30
a + sex -1802.822 3661.645 28
a - sod -1805.969 3661.939 25
both + sex -1802.453 3662.905 29
a + alb -1802.515 3663.030 29
b + smoking -1802.068 3664.136 30
a + who -1801.294 3664.587 31
both + smoking -1800.432 3666.864 33
b + agegrp -1802.554 3667.108 31
b - sod -1809.358 3668.716 25
both - sod -1811.970 3669.940 23
b - cell -1812.174 3672.349 24
b - alb -1814.057 3678.114 25
a - treat -1816.847 3679.694 23
b - met -1819.577 3689.154 25
both - met -1826.188 3698.377 23
b - treat -1831.670 3709.340 23
both - treat -1844.504 3727.008 19
b - who -1844.072 3734.145 23
-------------------------------------------------
a: treat + met + sod
b: who + treat + met + alb + cell + sod
iter 7 : both +/- [none]
-------------------------------------------------
Inspection of the above output provides us with the extra insight of the
order in which covariates were selected - this indicates their relative impor-
tance. Indeed we see agreement with the order of importance as determined
previously in Example 5.7 (which was based on Table 5.9).
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B.5.4 Piecewise Exponential
In this appendix we provide our implementation of the piecewise exponential
MPR model (Section 5.2.6) which, as mentioned previously, has not been
incorporated into the mprfit function.
Recall from Section 5.2.6 that the piecewise exponential model is defined
using the vectors a(t) and d(t), respectively, which indicate the time-interval
that t lies in and the time spent in each of these intervals. Furthermore,
the likelihood function (given in Appendix B.2.6) requires a(ti) and d(ti) for
each individual, i = 1, . . . , n. It is useful to store all of these vectors using




A <- matrix(NA, length(ti), nint)
for(i in 1:nint){










D[D == 0] <- NA
D <- D*ti
D <- t(t(D) - tcut[-(nint+1)])
fin <- rep(F, lenA)
for(i in 1:nint){
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The A and D matrices are used in the log-likelihood function below (compare
























dldalp <- c(dldnon, dldph)
loglike <- -sum(((deltai*A*xibetas) - (D*lam))%*%rep(1,nint))




In Example 5.3 we considered a single factor (treatment) piecewise expo-
nential MPR model with four time intervals (approximately equal number of





tcut <- eti[seq(1, ne, by = ceiling(ne/nint))]
tcut[1] <- 0
tcut <- c(tcut, max(LungC$surtim)+1)
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A <- Afn(LungC$surtim, tcut)
D <- Dfn(LungC$surtim, tcut, A)
formnon <- formula(~treat) # Note: formnon and formph cannot
formph <- formula(~1) # have covariates in common.
beta.non <- model.matrix(formnon, data=LungC)
beta.ph <- model.matrix(formph, data=LungC)[,-1]
beta.xis <- cbind(beta.non, beta.ph)








In Chapter 3 we considered simulation by the method of inversion (of the
survivor function). Recall that MacKenzie’s (1994) “J-function” is used to
select an appropriate φ value, C ∼ Exp(φ), ensuring that the censored pro-
portion is equal to a pre-specified value, pfix. In Section 3.5 we generalised
this function to handle cure rate data where pfix is the censoring level for
non-cured individuals (as cured individuals are censored by definition). Our







pphi <- integrate(func1,lower=0,upper=tstr, stop.on.error=F)$value




The J∗-function must be minimised with respect to phi for a given survival
distribution (i.e., family) and values of pcen = pfix and parvec = θ =
(log γ, log λ)T respectively. As phi is a scalar, the optimize function can be
used:
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# ---------------------------------------------------------------------------------------- #
phirange <- c(0, 50)
phi <- optimize(Jfunc,phirange,pcen,parvec,family,maximum=F)$minimum
# ---------------------------------------------------------------------------------------- #
Note that if θ depends on covariates, we have a matrix of θ vectors - one for
each individual. In this case Jfunc must be minimised n times to produce a
vector of φ values.
Once the appropriate phi value/vector has been calculated, as shown






pcennotcure <- mean((1-pcure)*pcen) # Pr(ST > CT and ST < Inf)
ncennotcure <- round(n*pcennotcure)
ptot <- pcennotcure + pcure
cure <- cen <- rep(0,n)
if(pcen != 0){
# while loop ensures that number of individuals censored AND not cured
# is equal to "ncennotcure"







ti <- ifelse(st<ct, st, ct)
cen <- ifelse(st<ct, 1, 0)
}
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tbig <- mprsim( mprsurv(parmat,Inf,family)+1e-15, parmat, family)
ticure <- runif(sum(cure), 0, tbig)
ct[cure] <- ticure
ti <- ifelse(st<ct, st, ct)









In Section 5.4 we discussed the implications of orthogonality and noted that
there exists an orthogonal parametrisation of the Weibull distribution. In
this appendix we will derive the orthogonal Weibull distribution and show
its extension to multi-parameter regression form which we then compare to
the standard Weibull MPR model (Section 5.2.1).
Firstly, note the definition of orthogonality which is as follows. Upon
partitioning the full parameter vector, θ, into two sub-vectors, θ1 and θ2, of
length p1 and p2 respectively, where p1+ p2 = p = dim(θ), then we have that








for r = 1, . . . , p1 and s = p1 + 1, . . . , p. Orthogonality guarantees that the
maximum likelihood estimates, θ̂1 and θ̂2, are asymptotically independent
(see Cox & Reid (1987)).
C.2 Gamma and Related Functions
In the Appendix C.3 we will calculate the expected information matrix (un-
censored case) for the standard Weibull distribution; in doing so, integrals
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related to the gamma function arise. Thus, we briefly review some proper-
ties of this function which will be necessary to make progress (for further
information see Abramowitz & Stegun (1964, chap. 6)).




tx−1 exp(−t) dt, (C.2)
where Γ(x) = (x−1)! when x is a natural number. Furthermore, the digamma













The properties of the above three functions are well-known, thus enabling
us to evaluate integrals which are functionally related to them. We will









tx−1 exp(−t)(log t)2 dt,
respectively, which, using (C.3) and the product rule of differentiation, can
be written as
Γ′(x) = Ψ(x)Γ(x) Γ′′(x) = Ψ′(x)Γ(x) + Ψ(x)Γ′(x)
= Ψ′(x)Γ(x) + [Ψ(x)]2Γ(x)
= {Ψ′(x) + [Ψ(x)]2}Γ(x).
Standard theory of the digamma and trigamma functions give the special
values Ψ(2) = 1− γE , where γE ≈ 0.57721 is known as Euler’s constant, and
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Ψ′(2) = π2/6− 1. We require these values as we will need to evaluate Γ′(2)
and Γ′′(2) in the next section. Thus, using the above, we arrive at
Γ′(2) = Ψ(2)Γ(2) Γ′′(2) = {Ψ′(2) + [Ψ(2)]2}Γ(2)








= 1− γE =
π2
6






− 2γE + γ
2
E.
C.3 Standard Weibull Expected Information
In Appendix C.4, we will derive the orthogonal parametrisation of the Weibull
distribution. This derivation requires the computation of the expected infor-
mation matrix, I(θ), which we will carry out in this section. We will consider
only the case of full information (i.e., the uncensored case) mirroring the work
of Cox & Reid (1987); recall from Section 2.3.1 that the functional form of
I(θ) is unknown in general (due to censoring).
For the standard Weibull distribution (Section 1.4.2), the hazard and
survivor functions are given by
λ(t) = λγtγ−1 S(t) = exp(−λtγ).




log λ+ log γ + (γ − 1) log ti − λt
γ
i ,
















+ log ti − λt
γ
i log ti.
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and these are the elements of the Hessian matrix, H(θ), i.e., h11 = ∂
2ℓ/∂λ2,
h22 = ∂
2ℓ/∂γ2, and h12 = h21 = ∂
2ℓ/∂λ∂γ respectively.
The observed information matrix is given by Io(θ) = −H(θ) and, hence,
the expected information matrix is











where expectation is with respect to the Weibull distribution. Therefore we
must evaluate E[tγ log t] and E[tγ(log t)2] respectively. Firstly,
E[tγ log t] =
∫ ∞
0




t2γ−1 exp(−λtγ) log t dt,
which, after making the substitution u = λtγ , becomes

































[Γ′(2)− log λ], (C.5)

























[Γ′′(2)− 2Γ′(2) logλ + (log λ)2], (C.6)
where, from Appendix C.2, we know the values of Γ′(2) and Γ′′(2) respec-











[Γ′(2)− log λ] 1
γ2
[1 + Γ′′(2)− 2Γ′(2) log λ+ (log λ)2]

 .
C.4 Derivation of the Orthogonal Weibull
While it is not possible to construct orthogonal parameters in general, Cox
& Reid (1987) provide a set of differential equations whose solution yields
a model where one parameter is orthogonal to the remaining parameters.
Thus, the method can be used to transform the parameters of the Weibull
model from (λ, γ) to (λ∗ = g(λ, γ), γ), for some function g(·), such that


















= log λ− Γ′(2), (C.7)
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which can be solved by making the substitution















⇒ u = c(λ∗) γ,
where c(λ∗) is an arbitrary function of λ∗. As u = log λ−Γ′(2) we have that
log λ− Γ′(2) = c(λ∗) γ
log λ = c(λ∗) γ + Γ′(2)
λ = exp[Γ′(2)] exp[c(λ∗) γ]
λ = exp[Γ′(2)]{exp[c(λ∗)]}γ
λ = exp[Γ′(2)](λ∗)γ , (C.8)
where the last line follows by taking c(λ∗) = log(λ∗) for mathematical con-
venience (but the solution is non-unique as it holds for any c(λ∗)).





∗−1 S(t) = exp{− exp[Γ′(2)](λ∗t)γ
∗
},
where we have now superscripted both parameters to distinguish the model
from the standardWeibull; clearly both are equivalent as λ = exp[Γ′(2)](λ∗)γ
∗





′(2) + γ∗ log λ∗ + log γ∗ + (γ∗ − 1) log ti]− exp[Γ
′(2)](λ∗ti)
γ∗ ,
where θ = (λ∗, γ∗) ∈ R2+. It is easy to show that the mixed term in the
expected information matrix, iλ∗γ∗ , is now equal to zero and, hence, λ
∗ ⊥ γ∗.
However, we will not reproduce the calculation of iλ∗γ∗ here, as it amounts
to evaluating integrals essentially identical to those of Appendix C.3.
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C.5 Orthogonal Weibull MPR Model
We now extend the orthogonal Weibull to multi-parameter regression form
by setting λ∗ = exp(xTβ∗) and γ∗ = exp(zTα∗), respectively, where x =
(1, x1, . . . , xp)
T , z = (1, z1, . . . zq)
T , β∗ = (β∗0 , β
∗
1 , . . . , β
∗
p)
T and α∗ = (α∗0, α
∗
1,
. . . , α∗q)
T are the scale and shape covariate vectors and corresponding re-
gression coefficients. Note that the scale and shape regression components
are orthogonal in this MPR model (i.e., λ∗ ⊥ γ∗ ⇒ β∗ ⊥ α∗) which may
be advantageous from an inferential point of view as the components can be
considered separately (see Section 5.4 for further details); this only holds true
when there is no censoring however.
As in Section 5.2 and Appendix B.3, we let c be a binary covariate com-
mon to both the scale and shape regressions. Furthermore we assume that
x1 = z1 = c and write x
Tβ∗ = cβ∗1 + x̃
Tβ∗ and zTα∗ = cα∗1+ z̃
Tα∗. Thus, the
hazard function is
λ(t | x, z) = exp[Γ′(2)][exp(xTβ∗)]exp(z
Tα∗) exp(zTα∗)texp(z
Tα∗)−1









and, the hazard ratio for c, at time t, is
ψ(t) =
λ(t | c = 1)






























Recall that in the standard Weibull MPR model, the hazard ratio is ψ(t) =
exp(β1) exp(α1)t
exp(z̃Tα)[exp(α1)−1] where α1 = 0 implies that the effect of c is
PH, i.e., the standard Weibull MPR model provides a test of proportionality.
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It is clear from (C.9) that, in the orthogonal Weibull MPR model, the effect
of c does not become proportional when α∗1 = 0.
Clearly the parameters in the standard and orthogonal MPR models have
different interpretations. However, what may not be obvious at first sight
is the fact that we now have entirely different models. Even though the
two parametrisations are equivalent when there are no covariates (Appendix
C.4), the generalisation to multi-parameter regression leads to models which
are no longer equivalent. It is easy to see this when we look at both models
in terms of the original λ parameter. In the standard Weibull MPR model
we have
log(λ) = xTβ,




log(λ) = Γ′(2) + xTβ∗ exp(zTα∗).
which is a non-linear regression model for the original scale parameter, λ. In
order for these two MPR models to be equivalent we require that the system
of equations given by
xTβ = Γ′(2) + xTβ∗ exp(zTα∗), (C.10)
can be solved for all βr, r = 0, . . . , p, at all possible values of x and z, i.e., each
β coefficient must be expressible in terms of β∗ and α∗ coefficients. This will
not be true in general. However, two special cases where this occurs are: (i)
when the shape is a constant and (ii) the single-factor model, i.e., a model
containing a single binary covariate (or a categorical covariate coded as a
binary design matrix) which is common to both the scale and shape.
In the case where the shape is constant (i.e., no covariates) (C.10) becomes












and, trivially, we find that β0 = Γ
′(2) + β∗0 exp(α
∗





r = 1, . . . , p (obviously γ = γ∗ ⇒ α0 = α∗0 also). We now consider the single-
factor model where both the scale and shape depend a categorical covariate.
Assuming three levels A, B and C, this covariate can be coded as two binary
variables x1 and x2 such that A ⇔ x1 = x2 = 0, B ⇔ x1 = 1, x2 = 0 and
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C ⇔ x1 = 0, x2 = 1. As the covariate appears in both regressions we have
that x = z = (1, x1, x2)
T . Therefore (C.10) becomes
β0 + x1β1 + x2β2 = Γ











and this must be solvable for the three possible combinations of x1 and x2.
One easily finds that
x1 = 0, x2 = 0 : β0 = Γ
′(2) + β∗0 exp(α
∗
0)


























Furthermore, as γ = γ∗, we have that α0 = α
∗
0, α1 = α
∗
1 and α2 = α
∗
2 respec-
tively. We reiterate the fact that (C.10) is not solvable in general. Thus, it is
clear that the orthogonal Weibull MPR model is not just a reparametrisation
of the standard Weibull MPR model - they are different models. Of course
they are closely related being derived from two equivalent parametrisations
of the Weibull distribution.
Example C.1. A Comparison of the Standard and Orthogonal Weibull MPR
Models
We now show by example (using the lung cancer data) that the two Weibull
MPR models are equivalent in the single-factor case but non-equivalent more
generally. To this end we consider a single-factor model (treatment) and a
two-factor model (treatment + sodium). The results are shown in Table C.1.
Firstly, we compare the two single-factor models and note that the log-
likelihood values are the equal. Furthermore, the shape regression coefficients
are also equal. From above, we know that the β coefficients are be expressible
in terms of the β∗ and α∗ coefficients, i.e., β0 = Γ















0) for r 6= 0. We now check these
relationships hold for the values in Table C.1. Noting that Γ′(2) ≈ 0.42,
we find 0.42 − 2.07 exp(−0.19) ≈ −1.28 = β̂0. Furthermore, looking at
the coefficient of surgery, we find that (−2.07 − 1.70) exp(−0.19 + 0.59) +
2.07 exp(−0.19) ≈ −3.91 = β̂1. Similarly, we can show this for the other
coefficients. Thus, the two models are clearly equivalent in this special case.
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More generally, the models are not equivalent as can be seen by the inclu-
sion of one additional covariate (sodium level). The log-likelihood values are
not equal so the models are clearly non-equivalent. Furthermore, the shape
coefficients are not equal and obviously we cannot express the β coefficients
in terms of the β∗ and α∗ coefficients.
Table C.1. Standard and Orthogonal Weibull MPR Fits
Standard Orthogonal
Scale β̂ β̂ β̂∗ β̂∗
Intercept -1.28 -1.52 -2.07 -2.22
Treatment Palliative 0.00 0.00 0.00 0.00
Surgery -3.91 -3.54 -1.70 -1.71
Chemo -0.50 -0.62 -0.42 -0.46
Radio -1.26 -1.30 -0.50 -0.50
C+R -4.06 -4.18 -0.59 -0.70
Sodium ≥ 136 mmol/l —— 0.00 —— 0.00
< 136 mmol/l —— 0.62 —— 0.43
Missing —— -0.55 —— 0.19
Shape α̂ α̂ α̂∗ α̂∗
Intercept -0.19 -0.16 -0.19 -0.18
Treatment Palliative 0.00 0.00 0.00 0.00
Surgery 0.59 0.49 0.59 0.53
Chemo 0.07 0.09 0.07 0.06
Radio 0.34 0.34 0.34 0.33
C+R 0.97 0.98 0.97 0.81
Sodium ≥ 136 mmol/l —— 0.00 —— 0.00
< 136 mmol/l —— -0.06 —— -0.02
Missing —— 0.32 —— 0.32




In Chapter 7 we studied the topic of frailty modelling. This appendix pro-
vides all necessary supplementary material which was previously excluded in
the interest of conciseness.
D.2 Marginal Hazard Function
In Section 7.2 we established that the marginal hazard function is given by
λm(t) = EU [λ(t | u) | T > t],
using the relationship λm(t) = fm(t)/Sm(t) and previously derived expres-
sions for fm(t) and Sm(t). Here we offer an alternative derivation using
probability statements which do not rely on having fm(t) and Sm(t).
First note that the conditional hazard function is









Pr(t ≤ T < t+∆t, T ≥ t, U = u)
Pr(T ≥ t, U = u)
.
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Now, multiplying both sides by Pr(T ≥ t, U = u)/Pr(T ≥ t) gives
λ(t | u)






Pr(t ≤ T < t+∆t, U = u | T ≥ t).





















λ(t | u) Pr(U = u | T ≥ t) du,
= EU [λ(t | u) | T ≥ t],
as required. Furthermore, for the multiplicative frailty model (Section 7.4),
where λ(t | u) = u λ(t), the marginal hazard is given by
λm(t) = λ(t)E(U | T ≥ t).
It is of interest to explore the behaviour of E(U | T ≥ t) in this particular
case of multiplicative frailty. Hence, we first write
E(U | T ≥ t) =
∫ ∞
0















where S(t | u) and Sm(t) are the conditional and marginal survivor functions
for T , respectively, and g(u) is the density function for U ∈ (0,∞) (see
Section 7.2).
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Now, using the fact that S ′(t) = −f(t) = −λ(t)S(t), we find
d
dt

























= −λ(t)E(U2 | T ≥ t) + λm(t)E(U | T ≥ t)
= −λ(t)E(U2 | T ≥ t) + λ(t)E(U | T ≥ t)2
= −λ(t)
[
E(U2 | T ≥ t)− E(U | T ≥ t)2
]
= −λ(t) var(U | T ≥ t),
and, since λ(t) and var(U | T ≥ t) are both non-negative,
d
dt
E(U | T ≥ t) < 0,
i.e., E(U | T ≥ t) is a decreasing function of time. Moreover, since E(U) = 1
(see Section 7.4), we have that E(U | T ≥ 0) = E(U) = 1 and, therefore,
E(U | T ≥ t) < 1 for t > 0. Thus,
λm(t) = λ(t)E(U | T ≥ t)
< λ(t),
for t > 0. In words, the marginal (or population) hazard function is less than
the basic hazard.
D.3 Laplace Transform
In Section 7.4.2 we showed that the marginal survivor and hazard functions
(arising from multiplicative frailty) can be written in terms of the Laplace
transform, L(s), of the frailty distribution, g(u). We now show how L(s) is



























i.e., the Laplace transform of g(u) is simply its moment generating function
multiplied by (−1)k. Thus, in terms of L(k)(s), the kth moment of g(u) is
given by
E(Uk) = (−1)kL(k)(0). (D.2)
In particular, we require that
E(U) = −L′(0) = 1,
for the multiplicative frailty model (see Section 7.4).
D.3.1 Marginal Likelihood
In Section 7.4.2 we showed that the marginal log-likelihood for the multi-









We now derive this result by different means. First recall from Section 7.3





λ(ti | ui, θ)
δiS(ti | ui, θ) g(ui | φ) dui
]
,
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uδii exp[−uiΛ(ti | θ)] g(ui | φ) dui
]
.
Furthermore, from (D.1) above, we can see that
∫
uδii exp[−uiΛ(ti | θ)] g(ui | φ) dui = (−1)
δiL(δi)[Λ(ti | θ)].






where it is understood that the φ parameters appear on the right-hand side









In Section 7.5 we discussed the gamma frailty model. This is a multiplicative


















u1/φ−1 exp[−u(1/φ+ s)] du,
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= φ−1/φ (1/φ+ s)−1/φ
= (1 + φ s)−1/φ.
Furthermore,
L′(s) = (−1/φ)(1 + φ s)−1/φ−1 · φ
= −(1 + φ s)−(1/φ+1),
and
L′′(s) = (1/φ+ 1)(1 + φ s)−(1/φ+1)−1 · φ
= (1 + φ)(1 + φ s)−(1/φ+2),
which can be used to calculate the first two moments of g(u) since E(Uk) =
(−1)kL(k)(0) (as shown above). The expected value is
E(U) = −
[




Similarly, we have that
E(U2) = (1 + φ)(1 + φ · 0)−(1/φ+2)
= 1 + φ,
and, therefore,
var(U) = E(U2)− E(U)2
= φ.
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